data_2lak_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lak _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.374 0.607 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CD2' ' H ' ' A' ' 16' ' ' HIS . 5.4 p80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.511 ' CE2' ' OG1' ' A' ' 29' ' ' THR . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.511 ' OG1' ' CE2' ' A' ' 25' ' ' PHE . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.518 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 14.6 p-90 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 71' ' ' PRO . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 121.224 0.535 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 99' ' ' ILE . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 77.9 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.361 0.6 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.523 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.523 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 34' ' ' ILE . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.176 0.512 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.504 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 . . . . . 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HE ' HG22 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.8 tp . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.537 ' NH1' ' OG1' ' A' ' 110' ' ' THR . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.46 ' CE1' ' HE1' ' A' ' 127' ' ' TRP . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.46 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.618 0.723 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH2' ' CD1' ' A' ' 127' ' ' TRP . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 34' ' ' ILE . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.521 0.677 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.207 0.527 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.413 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.403 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HE ' ' CE1' ' A' ' 73' ' ' HIS . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 96' ' ' ILE . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.47 ' HD1' ' N ' ' A' ' 112' ' ' SER . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.47 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 124' ' ' GLU . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 29' ' ' THR . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 34' ' ' ILE . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 42.9 p-90 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.402 HE21 ' CE1' ' A' ' 123' ' ' HIS . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.402 ' CE1' HE21 ' A' ' 119' ' ' GLN . 32.2 m170 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' ILE . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' CD2' ' O ' ' A' ' 37' ' ' TRP . 40.0 p-90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' PRO . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.104 0.478 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.524 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 105' ' ' THR . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.234 0.54 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 96' ' ' ILE . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 19' ' ' ALA . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.524 ' NH2' ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.322 0.582 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.551 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 67.6 p-90 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 99' ' ' ILE . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.418 ' HG ' ' N ' ' A' ' 113' ' ' GLY . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 112' ' ' SER . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.537 ' HG ' ' N ' ' A' ' 117' ' ' ALA . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.537 ' N ' ' HG ' ' A' ' 116' ' ' SER . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.551 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . . . . . . 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.617 0.723 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 45.4 p-90 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.288 0.565 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.41 ' C ' ' CD2' ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.626 ' HD1' ' N ' ' A' ' 112' ' ' SER . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.626 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 119' ' ' GLN . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.447 ' CD ' ' HG ' ' A' ' 116' ' ' SER . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.384 0.612 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.601 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 76.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.601 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.46 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 105' ' ' THR . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 37' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 71' ' ' PRO . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.597 0.713 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 19' ' ' ALA . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.491 ' HD1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.491 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' GLY . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.548 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 96' ' ' ILE . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.462 0.649 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 96' ' ' ILE . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 120' ' ' CYS . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 116' ' ' SER . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.43 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 . . . . . 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.333 0.587 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.0 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 114' ' ' LEU . 3.2 p90 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.504 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.673 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.673 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 135' ' ' THR . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 131' ' ' LEU . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 8.9 p-90 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.466 ' HD1' ' N ' ' A' ' 112' ' ' SER . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.466 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.417 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.417 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.601 ' CD2' ' H ' ' A' ' 16' ' ' HIS . 4.6 p80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.405 0.621 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.55 ' HG ' ' N ' ' A' ' 117' ' ' ALA . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.55 ' N ' ' HG ' ' A' ' 116' ' ' SER . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.653 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.653 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -162.24 67.38 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.945 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -68.27 -104.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.357 -0.839 . . . . 0.0 110.545 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.55 149.15 36.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 110.683 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 mtt 43.43 76.92 0.48 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.613 -0.679 . . . . 0.0 110.168 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 7' ' ' GLU . 35.7 Cg_exo -59.69 144.57 99.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.665 2.243 . . . . 0.0 112.409 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.4 mm-40 44.46 -169.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.414 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 9' ' ' PHE . 87.2 p -121.87 -71.22 0.74 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.78 -0.575 . . . . 0.0 109.487 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 8' ' ' SER . 58.6 m-85 49.89 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.627 . . . . 0.0 109.38 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CD2' ' H ' ' A' ' 16' ' ' HIS . 5.4 p80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.511 ' CE2' ' OG1' ' A' ' 29' ' ' THR . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.511 ' OG1' ' CE2' ' A' ' 25' ' ' PHE . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.518 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 14.6 p-90 -132.89 86.51 2.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.56 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 1.8 tpt 82.54 158.43 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.544 0.687 . . . . 0.0 110.309 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.98 113.69 1.97 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.5 m -95.86 -18.56 20.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -1.081 . . . . 0.0 108.588 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -157.33 119.02 3.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.17 146.18 40.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 109.45 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -150.7 126.41 10.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 108.598 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.77 156.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.019 -1.051 . . . . 0.0 109.728 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 41.43 56.19 8.88 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.716 -0.615 . . . . 0.0 110.466 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.56 -89.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.436 2.09 . . . . 0.0 112.218 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -79.88 157.85 73.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.613 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.08 137.73 28.77 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.017 1.811 . . . . 0.0 112.487 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 127.81 -19.82 5.8 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.24 122.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.94 112.76 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.24 . . . . 0.0 108.601 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.28 123.45 36.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 109.933 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.7 tp -164.83 129.31 2.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 108.888 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.99 137.2 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.234 -0.916 . . . . 0.0 109.128 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -86.67 86.4 7.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.89 -46.78 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.317 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -141.63 154.59 45.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.287 -0.883 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 42.99 -129.32 5.4 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.49 50.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -126.84 136.93 53.02 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.84 0.829 . . . . 0.0 110.202 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 63' ' ' ARG . 53.7 p90 -173.84 5.21 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.62 -81.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.908 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 61' ' ' PHE . 62.4 ttm-85 -141.57 141.78 33.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.227 -0.921 . . . . 0.0 109.654 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.7 164.79 54.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 m -159.76 89.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 108.85 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -73.39 136.89 44.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -103.74 -52.48 2.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -153.09 138.38 17.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 71' ' ' PRO . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -165.49 165.64 18.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 p -132.82 150.08 52.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 80' ' ' GLY . 16.5 p90 -169.83 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' ' CE2' ' A' ' 79' ' ' PHE . . . 84.11 160.95 31.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -89.96 -0.96 57.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.0 108.796 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.12 31.06 10.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.782 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.54 -8.65 76.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 85' ' ' GLU . 93.3 p -162.63 160.68 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.254 . . . . 0.0 109.738 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 84' ' ' SER . 96.4 mt-10 40.42 -105.58 0.06 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.623 0.725 . . . . 0.0 110.236 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.06 -33.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t 58.45 80.81 0.27 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' O ' ' OG ' ' A' ' 91' ' ' SER . 37.8 Cg_endo -78.22 168.25 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.476 2.117 . . . . 0.0 111.942 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.67 136.99 59.13 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.202 1.935 . . . . 0.0 113.33 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.25 -27.84 10.89 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 88' ' ' PRO . 80.8 p -68.62 -22.0 64.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.264 . . . . 0.0 109.527 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.5 p -156.99 162.51 39.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 108.523 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.1 tp -133.93 129.57 36.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.311 -0.868 . . . . 0.0 109.607 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 99' ' ' ILE . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 77.9 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.56 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.48 126.08 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -70.57 -178.65 1.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -1.051 . . . . 0.0 111.021 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.7 OUTLIER 57.78 74.95 0.58 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 109.477 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.53 145.16 98.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.766 2.311 . . . . 0.0 112.365 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 145' ' ' PRO . . . -65.71 -44.01 93.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 144' ' ' GLY . 37.8 Cg_exo -60.65 148.81 90.27 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.776 2.317 . . . . 0.0 112.802 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 145' ' ' PRO . 76.6 m-20 -136.55 61.29 36.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 -38.07 38.25 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.003 1.802 . . . . 0.0 111.06 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -149.83 -53.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -80.13 140.61 36.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.299 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.06 65.12 0.05 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.11 135.38 55.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -1.036 . . . . 0.0 110.398 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 153' ' ' LEU . 12.2 tpp85 -161.27 71.53 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 108.8 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 152' ' ' ARG . 91.5 mt 39.93 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.433 0.635 . . . . 0.0 110.343 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 154' ' ' GLU . 2.0 pm0 -112.88 147.53 36.83 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.468 0.652 . . . . 0.0 109.367 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -63.24 175.36 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 110.496 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.73 165.45 30.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.316 -0.865 . . . . 0.0 109.391 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -73.23 133.91 44.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -78.02 150.42 33.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.301 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 141.75 56.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.464 -0.773 . . . . 0.0 110.133 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.022 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -65.36 140.41 58.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.432 -0.792 . . . . 0.0 110.232 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.4 143.0 40.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.71 . . . . 0.0 110.106 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.04 122.16 2.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.1 mtm 42.34 71.6 1.34 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.429 -0.794 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 7' ' ' GLU . 32.6 Cg_exo -58.99 143.76 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 0.0 112.71 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' PRO . 81.9 tt0 57.72 151.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.709 0.766 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 p -73.11 164.91 25.99 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -73.05 143.63 47.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 110.02 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.523 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.72 HH22 ' HE ' ' A' ' 141' ' ' ARG . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.525 ' O ' ' CB ' ' A' ' 38' ' ' MET . 30.8 p-90 -104.04 23.83 12.34 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER 90.69 147.33 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.495 0.664 . . . . 0.0 110.681 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.67 -163.57 27.42 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' GLU . 43.6 p -107.43 53.29 0.69 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.357 -1.084 . . . . 0.0 109.349 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' THR . 97.8 mt-10 58.58 140.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.446 0.641 . . . . 0.0 110.71 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.35 11.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.493 -0.755 . . . . 0.0 109.668 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.42 163.77 15.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.474 -0.766 . . . . 0.0 109.85 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.89 144.38 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.628 -0.67 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -166.37 155.29 10.05 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.167 -0.958 . . . . 0.0 108.883 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -43.4 -37.76 7.8 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.051 1.834 . . . . 0.0 112.186 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.27 112.12 61.34 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 109.115 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.55 136.72 33.33 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.799 1.666 . . . . 0.0 112.814 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.7 -40.95 1.06 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 52' ' ' TYR . . . 75.51 19.34 79.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.0 mt 55.18 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.91 . . . . 0.0 110.133 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' A' ' 50' ' ' GLY . 96.1 m-85 -75.74 157.17 33.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.971 . . . . 0.0 110.395 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 tp -75.75 125.61 29.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 109.742 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' ASN . 31.2 m -141.04 161.12 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.327 -0.858 . . . . 0.0 109.913 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' VAL . 39.6 p30 22.1 -142.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.678 0.751 . . . . 0.0 112.687 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.39 135.52 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.888 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 m -119.74 129.45 54.51 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.17 -125.53 5.41 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . -93.55 -166.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.0 110.643 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 55.31 3.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 59' ' ' ALA . 89.9 t80 -84.93 -68.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.338 -0.851 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.0 176.4 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.191 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -135.91 152.1 50.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.89 -47.46 0.64 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.0 p -107.81 0.04 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.934 . . . . 0.0 108.997 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -73.37 146.37 45.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -104.87 -30.74 9.65 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -161.4 131.63 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -157.79 162.23 38.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -137.69 142.61 41.08 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -151.03 127.27 10.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.888 -1.132 . . . . 0.0 109.283 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.51 -175.31 43.2 Favored Glycine 0 N--CA 1.498 2.802 0 O-C-N 121.149 -0.969 . . . . 0.0 110.805 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.423 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 65.7 p-90 -72.18 139.13 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.518 -0.989 . . . . 0.0 110.407 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 82.8 m-20 -145.62 72.86 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.47 -13.57 57.66 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' VAL . 13.9 m -84.76 158.37 20.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.1 -1.235 . . . . 0.0 110.266 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 86' ' ' VAL . 58.4 mp0 -58.93 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.9 m 31.21 89.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.09 0.472 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.4 m 29.21 75.32 0.37 Allowed Pre-proline 0 N--CA 1.5 2.068 0 CA-C-O 121.154 0.502 . . . . 0.0 111.593 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 12.1 Cg_exo -55.14 -44.13 52.39 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.034 1.822 . . . . 0.0 112.421 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 93.7 Cg_endo -84.66 -8.21 9.43 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.912 1.741 . . . . 0.0 111.116 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 97.9 -28.99 11.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 92' ' ' SER . 97.9 p 33.04 -90.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.034 -0.686 . . . . 0.0 110.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 90' ' ' GLY . 21.2 m 46.29 -113.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 109.62 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp -119.86 121.33 38.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' CE1' ' O ' ' A' ' 89' ' ' PRO . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.523 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . -153.54 -134.79 2.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.72 ' HE ' HH22 ' A' ' 36' ' ' ARG . 80.2 mtp85 -42.71 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 110.714 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.84 81.46 58.27 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.703 . . . . 0.0 109.741 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.86 144.16 89.03 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.588 2.192 . . . . 0.0 112.365 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.61 177.31 0.23 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 158.11 57.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.824 2.349 . . . . 0.0 112.18 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.12 76.39 69.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 149' ' ' TYR . 49.2 Cg_exo -55.3 -36.68 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.636 2.224 . . . . 0.0 111.403 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 53.76 7.16 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 147' ' ' PRO . 90.6 t80 -63.01 -42.9 99.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 87.29 69.65 1.3 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.04 137.73 47.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 109.7 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -138.95 134.23 32.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 3.8 mm? -87.79 -99.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.01 124.71 50.0 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.605 0.717 . . . . 0.0 109.624 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -92.79 -19.95 21.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -133.46 126.64 31.61 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.57 0.7 . . . . 0.0 109.744 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -155.67 -7.15 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.4 t-80 -74.86 138.51 42.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 110.486 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 158' ' ' HIS . 86.5 t60 46.74 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.16 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 160' ' ' HIS . 52.8 p-80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.109 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.19 140.89 58.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.454 -0.779 . . . . 0.0 109.958 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' ALA . 65.5 tttm -155.2 109.42 2.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' LYS . . . 60.5 130.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 5' ' ' MET . 0.4 OUTLIER -156.51 55.02 0.97 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 5' ' ' MET . 67.8 Cg_endo -71.49 152.46 60.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.841 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.91 58.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' PHE . 8.4 m -72.16 132.57 44.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.76 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' SER . 95.7 m-85 36.39 76.87 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 34' ' ' ILE . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.407 ' O ' ' SD ' ' A' ' 38' ' ' MET . 15.3 p-90 -106.78 18.06 22.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 37' ' ' TRP . 96.8 mmm -141.51 -162.96 1.47 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.1 -1.0 . . . . 0.0 110.566 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.63 175.98 15.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.7 p -87.93 0.94 55.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.918 . . . . 0.0 108.991 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.54 131.01 27.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 109.103 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 55' ' ' ASN . . . -158.35 152.93 24.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.9 pm0 -132.06 148.21 52.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.46 132.81 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.742 . . . . 0.0 109.204 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -171.88 85.7 0.46 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.44 -34.7 62.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.058 1.839 . . . . 0.0 111.142 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -81.89 152.03 68.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.501 -0.749 . . . . 0.0 109.914 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.65 145.58 70.3 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.989 2.46 . . . . 0.0 112.918 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.25 0.94 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.9 92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.65 146.37 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 109.994 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -81.96 -11.37 58.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.569 -0.707 . . . . 0.0 109.147 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.29 148.37 39.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.034 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 56' ' ' VAL . 27.3 m -135.2 161.91 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.537 -0.727 . . . . 0.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ALA . 25.9 t-20 55.73 -77.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.256 0.551 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.9 t 58.85 129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.862 0.839 . . . . 0.0 110.757 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.4 p -101.93 -6.16 23.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.17 -13.32 64.18 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 61' ' ' PHE . . . 43.68 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.503 -0.998 . . . . 0.0 110.877 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' ALA . 95.6 mtt180 40.95 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.864 -0.522 . . . . 0.0 110.17 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 59' ' ' ALA . 50.5 t80 60.97 -70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.821 -0.549 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -100.21 147.06 26.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -143.41 149.07 37.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.466 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.69 89.83 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.0 m -91.38 -140.37 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.339 -1.095 . . . . 0.0 109.683 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 65' ' ' SER . 97.1 m-85 57.32 152.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.731 0.776 . . . . 0.0 110.535 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -86.11 -58.62 2.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.68 131.55 19.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.669 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -165.51 156.62 14.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 p -82.36 151.79 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.959 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 71.6 t80 -177.48 -58.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . 67.22 -142.61 41.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -106.65 121.83 45.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.361 -1.082 . . . . 0.0 109.143 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 67.4 t0 -66.4 141.91 57.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.668 0.747 . . . . 0.0 110.674 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 91.75 8.01 64.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -119.19 120.11 36.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.663 -0.904 . . . . 0.0 109.411 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 87' ' ' VAL . 79.6 mm-40 -101.54 -16.97 16.61 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.06 21.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' A' ' 85' ' ' GLU . 17.0 t -140.2 67.31 32.61 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -59.38 -178.11 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.344 2.029 . . . . 0.0 111.657 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 145.03 98.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.51 2.14 . . . . 0.0 112.745 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.94 -28.23 5.61 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -63.69 -40.86 97.85 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.475 -1.014 . . . . 0.0 109.702 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -138.24 154.03 49.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp -149.1 128.71 13.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.432 -0.793 . . . . 0.0 109.026 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -175.48 -166.63 33.38 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 142' ' ' ASP . 87.7 mtm180 -144.22 161.58 38.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -1.008 . . . . 0.0 109.917 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 141' ' ' ARG . 3.7 p-10 41.76 69.08 2.24 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.782 -0.574 . . . . 0.0 110.286 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.57 -37.84 90.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.61 2.207 . . . . 0.0 111.237 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.84 -160.43 29.34 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.19 -163.91 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.848 2.365 . . . . 0.0 112.555 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -125.04 82.26 61.81 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.701 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 149' ' ' TYR . 17.2 Cg_exo -63.59 156.08 59.14 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.99 2.46 . . . . 0.0 112.063 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.5 t80 66.91 -61.56 0.33 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 147' ' ' PRO . 89.8 t80 -61.27 -44.58 97.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.12 174.53 3.39 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.036 -1.04 . . . . 0.0 110.787 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 153' ' ' LEU . 35.1 ptt180 -69.57 -10.39 57.95 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.516 -0.991 . . . . 0.0 109.114 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 59.38 -74.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.632 . . . . 0.0 109.69 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 151' ' ' ARG . 5.1 tp -140.07 -130.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.882 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 153' ' ' LEU . 98.1 mt-10 56.5 34.18 23.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -67.59 138.37 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 110.065 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -99.42 99.29 10.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.679 ' CG ' ' H ' ' A' ' 158' ' ' HIS . 73.8 t60 49.55 179.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.79 0.805 . . . . 0.0 111.157 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.679 ' H ' ' CG ' ' A' ' 157' ' ' HIS . 80.8 m80 -74.96 135.2 41.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.453 -0.779 . . . . 0.0 110.102 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.91 128.1 34.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.386 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.065 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.459 0.647 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.4 -2.45 57.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.59 103.14 13.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.515 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.06 149.0 23.93 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.0 mtt -81.51 158.2 69.04 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.234 -0.917 . . . . 0.0 109.528 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 8' ' ' SER . 63.6 Cg_exo -47.16 -40.3 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.988 1.792 . . . . 0.0 112.144 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 6' ' ' PRO . 97.3 mt-10 38.26 -90.2 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.524 0.678 . . . . 0.0 110.561 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 6' ' ' PRO . 2.6 p 63.02 127.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.558 0.694 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -99.63 153.47 19.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.569 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 40' ' ' THR . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.504 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -110.28 40.95 1.84 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 tpt -150.46 -55.82 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.65 78.41 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 72.0 m -117.58 107.92 14.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.516 -0.991 . . . . 0.0 109.017 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 57.8 mp0 -42.44 155.67 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.336 0.589 . . . . 0.0 110.255 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.32 152.87 32.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 109.918 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 96.8 mt-10 -82.93 163.54 21.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.96 140.36 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -100.86 148.53 35.17 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.4 -35.41 16.03 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.972 1.781 . . . . 0.0 112.276 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.9 mm-40 176.51 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.728 . . . . 0.0 109.082 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 92.6 Cg_endo -78.08 147.77 23.99 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.154 1.903 . . . . 0.0 112.712 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.06 95.04 0.5 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.51 157.27 3.02 Favored Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.51 -0.994 . . . . 0.0 110.618 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -50.26 -101.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.985 -0.715 . . . . 0.0 110.505 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 52' ' ' TYR . 55.6 t80 59.97 7.24 1.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 51' ' ' LEU . 86.0 mt -111.36 149.2 31.5 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.98 157.41 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.627 -0.671 . . . . 0.0 109.655 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' THR . 72.4 m-20 -81.18 -170.43 2.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 110.052 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' ASN . 16.0 m 32.64 35.77 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.88 0.848 . . . . 0.0 110.404 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ASN . 86.1 m -106.29 -11.81 15.9 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.38 21.73 64.05 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.1 153.53 35.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.186 -1.185 . . . . 0.0 109.584 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 61' ' ' PHE . 10.8 ptp85 -141.9 153.43 44.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.326 -0.859 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 62' ' ' ALA . 84.7 m-85 38.78 -102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.669 -0.644 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 49.92 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.629 -0.669 . . . . 0.0 109.429 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.8 148.02 50.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.382 -0.823 . . . . 0.0 109.106 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.38 -85.85 1.65 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -138.31 120.54 15.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.454 -1.027 . . . . 0.0 109.316 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -70.16 135.14 48.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -74.11 -79.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.944 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -147.4 134.94 20.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG22 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HE ' HG22 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -125.06 129.01 49.4 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.5 117.87 33.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.404 -0.81 . . . . 0.0 109.537 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 85.9 t80 -161.38 132.29 5.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.088 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . -70.69 168.47 49.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.9 t90 -84.73 157.61 21.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -1.017 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.34 -83.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.421 -0.799 . . . . 0.0 109.48 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TRP . . . 176.27 -30.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 86' ' ' VAL . 11.0 p -86.02 -175.28 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.497 -1.002 . . . . 0.0 109.975 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -70.26 3.1 3.09 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 84' ' ' SER . 22.9 m -68.85 138.58 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.84 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 m -150.1 68.02 8.59 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.401 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 17.2 Cg_exo -54.64 -42.99 63.27 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.162 1.908 . . . . 0.0 112.26 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 45.0 Cg_endo -80.87 -4.44 12.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.465 1.443 . . . . 0.0 111.084 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.71 31.59 26.5 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 p -64.93 152.67 42.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.5 -1.0 . . . . 0.0 110.308 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 93' ' ' LEU . 1.8 t -176.4 -94.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' N ' ' OG ' ' A' ' 92' ' ' SER . 36.8 tp -111.57 120.51 42.33 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.537 ' NH1' ' OG1' ' A' ' 110' ' ' THR . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 92' ' ' SER . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 89' ' ' PRO . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.46 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.45 -115.97 0.62 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -172.34 54.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -1.068 . . . . 0.0 109.239 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.67 80.62 12.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.473 -0.767 . . . . 0.0 109.731 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.05 -37.3 78.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.378 2.052 . . . . 0.0 111.29 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 146' ' ' ASP . . . 53.99 -176.57 0.31 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.67 13.91 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.512 2.141 . . . . 0.0 111.322 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 144' ' ' GLY . 1.1 m-20 62.98 60.36 2.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.927 -0.483 . . . . 0.0 110.243 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.96 -17.14 41.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.298 1.999 . . . . 0.0 111.833 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.442 ' CD2' ' O ' ' A' ' 148' ' ' PHE . 82.5 t80 -84.27 59.34 5.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.32 -46.09 90.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.14 -46.12 0.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.72 134.09 38.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -1.225 . . . . 0.0 110.143 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -65.88 -42.62 90.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.533 -0.73 . . . . 0.0 109.977 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.52 129.1 56.47 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.405 -0.809 . . . . 0.0 109.909 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -110.38 159.57 17.34 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.734 -0.604 . . . . 0.0 109.497 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.8 114.16 22.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.739 . . . . 0.0 110.192 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.95 -11.67 32.72 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 73.9 t60 -65.7 -43.81 88.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.598 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 157' ' ' HIS . 19.6 m-70 -146.55 150.47 35.6 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.88 89.56 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.048 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' N ' ' SD ' ' A' ' 1' ' ' MET . 5.1 mpp? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 59.12 62.24 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.443 0.64 . . . . 0.0 109.882 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 58.41 161.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.818 0.818 . . . . 0.0 110.861 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.71 58.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.774 -0.579 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -146.36 76.13 12.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 109.238 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.74 138.3 84.75 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.727 2.285 . . . . 0.0 112.011 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -175.19 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p 43.44 -128.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.664 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.1 152.0 21.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 110.268 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH2' ' CD1' ' A' ' 127' ' ' TRP . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 34' ' ' ILE . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.455 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -111.54 -26.98 8.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.505 ' SD ' ' OH ' ' A' ' 130' ' ' TYR . 1.2 tmm? -79.9 -71.12 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.166 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' O ' ' OG1' ' A' ' 40' ' ' THR . . . 80.06 -165.47 49.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLU . 44.0 p 54.89 48.91 18.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.819 -0.812 . . . . 0.0 110.231 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 40' ' ' THR . 79.4 mm-40 56.65 144.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.779 0.799 . . . . 0.0 110.8 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.28 153.2 6.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -136.33 144.38 44.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.775 . . . . 0.0 109.067 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.1 p -83.41 28.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.057 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLU . 28.6 tp10 -125.43 76.73 68.97 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.85 80.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.506 2.138 . . . . 0.0 112.148 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 45' ' ' GLU . 44.4 tt0 -174.04 83.02 0.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 136.28 61.65 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.315 2.01 . . . . 0.0 112.495 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.02 16.95 79.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.46 -109.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.196 -1.179 . . . . 0.0 110.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 9.5 mp -84.02 -0.64 52.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.505 -0.997 . . . . 0.0 109.665 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 56.76 84.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.557 0.694 . . . . 0.0 109.968 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.3 pt? -165.39 140.33 5.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.335 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' VAL . 18.7 m -146.44 170.54 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.174 -0.954 . . . . 0.0 108.832 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 56' ' ' VAL . 17.7 t-20 54.34 -90.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 110.232 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.494 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 14.5 p -63.05 121.67 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 110.271 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.2 m -133.89 132.37 40.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -0.826 . . . . 0.0 109.493 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.12 117.67 6.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 41.65 -111.26 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.596 -0.944 . . . . 0.0 110.449 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.4 105.48 3.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.186 -0.946 . . . . 0.0 108.791 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -73.66 131.78 42.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 0.0 109.917 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.29 120.79 9.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 109.072 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -146.03 145.23 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.115 -0.991 . . . . 0.0 109.542 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.32 120.49 5.59 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -164.78 -159.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 109.746 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER 62.54 176.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.757 0.789 . . . . 0.0 110.84 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.53 -51.75 67.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.354 0.597 . . . . 0.0 109.815 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.49 147.39 26.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.301 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.69 156.85 37.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 8.3 t -143.75 124.39 14.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.315 -0.866 . . . . 0.0 108.976 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 78' ' ' SER . 85.1 m-85 -157.95 96.5 1.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.61 111.75 4.24 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -108.97 138.0 46.01 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -1.012 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 54.78 46.7 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.764 . . . . 0.0 109.37 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -39.27 148.82 0.11 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 86' ' ' VAL . 4.9 m 49.98 -164.48 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 59.05 -70.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.326 0.584 . . . . 0.0 109.854 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 84' ' ' SER . 4.0 p -153.28 110.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 109.093 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.18 70.88 12.02 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 11.8 Cg_exo -56.74 -44.66 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.618 2.212 . . . . 0.0 113.186 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' SER . 72.2 Cg_endo -81.29 161.19 20.1 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.205 1.937 . . . . 0.0 112.673 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -51.64 85.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' PRO . 33.2 t -88.64 56.93 3.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -1.127 . . . . 0.0 108.966 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 113' ' ' GLY . 16.3 t -165.46 -130.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -0.905 . . . . 0.0 109.579 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -102.08 114.3 28.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.505 ' OH ' ' SD ' ' A' ' 38' ' ' MET . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -171.19 96.89 0.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -74.06 156.33 37.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -1.112 . . . . 0.0 110.145 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 60.45 60.84 3.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.637 -0.664 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.1 -4.22 14.84 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.447 2.098 . . . . 0.0 111.083 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.21 58.64 0.7 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.82 155.41 65.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.758 2.306 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.54 77.11 3.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.225 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.89 143.24 96.23 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.689 2.259 . . . . 0.0 112.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.55 83.86 4.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.799 . . . . 0.0 109.329 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -70.3 129.5 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.04 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.17 109.64 3.73 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.22 131.77 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.362 -1.081 . . . . 0.0 109.887 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -127.69 7.85 6.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.6 tt -107.36 117.5 34.25 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.411 -0.806 . . . . 0.0 109.261 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -171.84 71.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -101.03 -2.84 30.6 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -57.65 112.1 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.733 . . . . 0.0 109.971 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -167.38 -9.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -62.71 -42.16 99.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.466 -0.772 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -64.38 -44.5 91.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.528 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.638 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.51 0.671 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.92 135.32 50.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.455 -0.778 . . . . 0.0 110.522 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -84.67 -78.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.565 0.697 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.45 48.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.887 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 tpt 44.76 58.87 14.23 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.623 -0.673 . . . . 0.0 110.126 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.53 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' A' ' 8' ' ' SER . 17.1 pt-20 -98.12 -3.42 37.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.462 -0.774 . . . . 0.0 109.315 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 7' ' ' GLU . 91.4 p 52.22 169.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.719 . . . . 0.0 110.965 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -75.17 145.21 42.29 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.413 ' CG2' ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 141' ' ' ARG . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -123.35 21.61 9.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttm -139.82 -135.08 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.174 -0.954 . . . . 0.0 110.426 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.8 175.58 1.96 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.96 -14.73 15.86 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -147.88 118.66 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 109.067 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.29 153.19 5.22 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.41 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.0 pm0 -141.02 163.73 32.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.47 -0.769 . . . . 0.0 109.545 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.36 131.74 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.622 0.725 . . . . 0.0 109.216 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -163.14 81.75 1.55 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.2 -43.75 55.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.515 2.143 . . . . 0.0 111.9 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -111.15 -42.82 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.887 -0.508 . . . . 0.0 109.764 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.603 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 36.2 Cg_exo -59.16 157.76 28.71 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.598 2.199 . . . . 0.0 113.001 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.02 -15.21 65.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 38.43 -142.36 0.36 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.66 -0.906 . . . . 0.0 111.243 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.2 mt -86.42 -162.9 0.81 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.995 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 70.2 t80 -75.92 -101.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.565 0.697 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 32.9 tp -149.27 114.78 5.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 109.684 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 2.6 m -147.44 132.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' VAL . 1.7 p30 163.83 128.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.521 0.677 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' THR . 78.3 t -65.99 -42.21 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.637 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 56' ' ' VAL . 72.1 p -39.21 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.609 -0.682 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -160.04 -143.85 3.79 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.064 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -87.34 -159.39 0.51 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.628 -0.925 . . . . 0.0 110.689 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 59' ' ' ALA . 60.5 ttt85 58.26 154.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.494 0.664 . . . . 0.0 109.906 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CG ' ' OE2' ' A' ' 45' ' ' GLU . 53.4 m-85 -61.47 -43.72 98.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.577 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.81 -112.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' GLY . 88.2 mtm180 -142.9 140.89 31.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ARG . . . 36.69 -108.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 78' ' ' SER . 34.6 t -155.87 154.69 31.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -1.082 . . . . 0.0 109.619 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -71.02 141.58 50.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.797 . . . . 0.0 110.471 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HE ' ' CB ' ' A' ' 78' ' ' SER . 96.0 mtt-85 -134.86 -59.46 0.8 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -155.29 139.03 16.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.403 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' HE ' ' CE1' ' A' ' 73' ' ' HIS . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 -146.56 150.52 35.67 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 65' ' ' SER . 5.4 p -81.12 -178.42 6.89 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.305 0.574 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -135.58 133.26 38.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.96 -132.57 11.18 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -171.03 148.61 2.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -1.094 . . . . 0.0 109.454 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 66.0 t0 -64.49 137.89 58.11 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 81.17 8.95 86.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p -78.02 164.41 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -1.067 . . . . 0.0 110.264 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 57.9 mp0 -120.78 -34.79 3.49 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.54 -39.32 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.3 t -148.92 78.79 8.76 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 109.255 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.7 158.12 4.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 123.132 2.555 . . . . 0.0 112.098 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.94 143.61 95.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.564 2.176 . . . . 0.0 112.711 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.04 -14.63 37.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t -68.88 -17.31 63.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.309 -1.113 . . . . 0.0 109.915 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 p -155.23 160.71 41.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.869 -1.144 . . . . 0.0 110.013 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.07 130.87 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.54 -0.725 . . . . 0.0 109.505 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 96' ' ' ILE . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.47 ' HD1' ' N ' ' A' ' 112' ' ' SER . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.47 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.645 ' CD2' ' N ' ' A' ' 124' ' ' GLU . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -135.85 -149.51 5.77 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.491 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 59.6 ttt85 -148.08 -32.06 0.27 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.544 -0.974 . . . . 0.0 109.681 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -153.56 70.09 6.64 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.048 -1.033 . . . . 0.0 110.572 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.13 155.89 60.52 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.299 1.999 . . . . 0.0 113.101 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.33 -166.33 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.25 -32.92 89.52 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.887 2.392 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 61.01 62.98 2.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.902 -0.499 . . . . 0.0 109.937 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.27 147.34 59.38 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.457 2.104 . . . . 0.0 112.359 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.45 20.79 0.29 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -70.92 138.7 50.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.546 -0.721 . . . . 0.0 110.228 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.92 -44.36 1.21 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -169.01 138.17 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -90.09 144.02 26.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.468 -0.77 . . . . 0.0 109.644 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.58 130.83 39.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.487 -0.758 . . . . 0.0 109.215 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.2 mp0 -121.95 109.12 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -92.61 128.9 38.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -130.49 133.47 46.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.637 ' H ' ' CD2' ' A' ' 157' ' ' HIS . 5.8 p80 -91.18 -13.94 31.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 109.022 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.439 ' NE2' ' CE1' ' A' ' 157' ' ' HIS . 95.1 m-70 -71.78 141.19 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -67.12 -39.45 86.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.566 -0.709 . . . . 0.0 109.773 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.834 -179.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 3' ' ' LYS . 28.4 tp10 -75.12 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.041 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' SD ' ' A' ' 5' ' ' MET . 68.1 mttm 56.2 50.25 13.83 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.634 0.73 . . . . 0.0 109.276 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' MET . . . -83.45 -2.82 56.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 109.201 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.564 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER 57.18 150.29 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 CA-C-O 121.177 0.513 . . . . 0.0 110.257 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 7' ' ' GLU . 57.0 Cg_endo -69.6 129.97 18.71 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.358 2.039 . . . . 0.0 112.99 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' PRO . 97.7 mt-10 56.56 142.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.121 0.962 . . . . 0.0 111.286 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' PHE . 93.3 p -79.75 167.05 21.13 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.642 0.734 . . . . 0.0 110.687 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.3 m-85 45.51 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 29' ' ' THR . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.412 ' HB3' ' H ' ' A' ' 44' ' ' VAL . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 34' ' ' ILE . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 42.9 p-90 -140.69 44.36 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.7 tpp -171.23 108.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.754 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.76 175.6 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 m -103.28 -15.87 15.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.891 . . . . 0.0 108.848 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -137.54 138.01 39.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.444 -0.785 . . . . 0.0 109.568 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.04 148.7 2.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.384 -0.823 . . . . 0.0 109.269 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -150.97 102.58 2.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.131 -0.981 . . . . 0.0 109.429 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' GLU . 90.8 t -76.02 -79.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' VAL . 24.0 mt-10 56.3 153.68 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.851 -0.531 . . . . 0.0 109.918 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' GLU . 53.9 Cg_exo -34.34 141.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.644 2.229 . . . . 0.0 112.594 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE2' ' CE1' ' A' ' 66' ' ' PHE . 6.1 mt-10 -38.14 -63.86 0.51 Allowed Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.904 -0.498 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 40.1 Cg_endo -64.51 -22.31 65.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.213 1.942 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.22 32.26 4.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.95 85.71 0.56 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.27 149.03 31.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.557 -0.966 . . . . 0.0 110.384 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 52.91 -162.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.744 -0.597 . . . . 0.0 110.583 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.6 tp -114.78 146.24 41.22 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.3 t -110.45 122.35 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.833 0.825 . . . . 0.0 109.729 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -105.09 102.35 11.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.7 t -99.31 48.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.42 -0.8 . . . . 0.0 108.936 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.7 p 44.9 14.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' VAL . . . -89.23 -7.62 69.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.84 -15.45 0.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.815 . . . . 0.0 109.621 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 58' ' ' GLY . 61.6 ttt85 -72.56 151.05 42.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.391 -0.818 . . . . 0.0 110.748 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -62.61 -45.35 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.852 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.76 168.18 28.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.942 -1.099 . . . . 0.0 110.211 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.89 153.7 51.09 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.906 0.86 . . . . 0.0 110.265 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.69 76.3 0.04 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -130.4 30.53 4.71 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.577 -0.955 . . . . 0.0 108.846 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' OE2' ' A' ' 47' ' ' GLU . 49.7 p90 -59.28 135.51 57.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 110.274 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -107.13 -30.89 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -158.5 141.12 14.42 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 78' ' ' SER . 27.7 t80 -141.76 160.06 40.96 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 70.7 m -110.52 127.61 55.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 47.0 m-85 -129.3 151.68 49.69 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.803 0.811 . . . . 0.0 110.27 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.23 52.37 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -114.23 130.8 56.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 48.15 28.83 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.35 -128.92 0.18 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 85' ' ' GLU . 5.0 m -61.6 -172.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.546 -0.973 . . . . 0.0 110.446 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 56.8 mp0 -39.92 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.498 0.666 . . . . 0.0 110.286 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' CG2' ' H ' ' A' ' 87' ' ' VAL . 3.0 m -74.22 -109.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 109.987 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.422 ' H ' ' CG2' ' A' ' 86' ' ' VAL . 3.2 t 61.51 67.84 1.28 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.673 -0.642 . . . . 0.0 109.681 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.84 164.64 28.74 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.466 2.111 . . . . 0.0 111.727 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.67 139.92 92.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.05 -139.46 38.32 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p 46.06 23.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 109.57 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -144.93 144.71 31.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.336 -0.852 . . . . 0.0 109.464 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.02 124.83 17.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.762 . . . . 0.0 109.357 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.402 HE21 ' CE1' ' A' ' 123' ' ' HIS . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.402 ' CE1' HE21 ' A' ' 119' ' ' GLN . 32.2 m170 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.25 5.13 90.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.05 162.44 14.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.479 -1.012 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.17 141.82 62.94 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.586 -0.697 . . . . 0.0 109.641 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.4 145.98 60.96 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.495 2.13 . . . . 0.0 112.709 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.21 177.11 53.77 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.88 151.24 68.34 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.008 2.472 . . . . 0.0 112.476 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.92 74.43 76.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.94 -10.98 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.654 2.236 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -74.56 122.22 22.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -159.55 106.75 1.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.55 -0.718 . . . . 0.0 109.505 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . 77.0 0.25 69.0 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' GLY . 66.5 ttp85 60.73 137.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.993 . . . . 0.0 110.09 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -77.97 144.86 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.48 -0.762 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.0 tp -86.05 129.34 34.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.683 -0.636 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -125.59 139.33 53.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.571 0.701 . . . . 0.0 110.212 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.9 m80 56.05 87.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.711 0.767 . . . . 0.0 110.094 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 51.1 p-80 -148.88 114.1 5.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.572 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -147.84 144.65 28.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -157.01 156.21 32.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.418 -0.802 . . . . 0.0 109.518 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.5 p-80 -150.61 -45.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.523 -0.736 . . . . 0.0 109.106 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 52.9 p-80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.149 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 4' ' ' ALA . 12.6 pt-20 -65.76 140.6 58.44 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.505 0.669 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt 53.74 6.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.671 -0.643 . . . . 0.0 109.585 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 2' ' ' GLU . . . -86.83 2.77 47.87 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.839 . . . . 0.0 108.908 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 5' ' ' MET . 0.2 OUTLIER -121.01 86.18 41.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.542 -0.724 . . . . 0.0 109.259 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.25 146.4 82.26 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.553 2.169 . . . . 0.0 111.73 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -55.22 135.13 49.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.678 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.6 p -160.39 165.56 30.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 57.57 23.38 9.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' GLU . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.544 HH21 ' CG ' ' A' ' 146' ' ' ASP . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' CD2' ' A' ' 37' ' ' TRP . 40.0 p-90 -111.14 57.63 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 13.2 ttt 79.87 163.46 0.18 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.777 0.799 . . . . 0.0 110.628 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 147.78 -20.3 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m 62.24 -69.88 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.692 -0.887 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 39' ' ' GLY . 96.0 mt-10 -141.27 149.05 40.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 109.632 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.778 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 80.7 tt0 -83.63 142.65 30.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.802 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 p -153.9 -9.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -99.76 148.48 34.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.282 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.92 159.32 53.71 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.538 2.159 . . . . 0.0 112.446 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 59.17 86.91 0.15 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.625 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.33 139.24 64.52 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.859 2.372 . . . . 0.0 112.645 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.72 -10.25 1.65 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.44 -73.33 0.98 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' LEU . 87.2 mt -77.48 -5.35 49.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.4 t80 54.11 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 110.028 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' LEU . 37.7 tp -93.66 127.61 39.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.66 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.01 138.05 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.486 0.66 . . . . 0.0 109.798 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 65.22 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.777 0.799 . . . . 0.0 110.711 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 p -63.54 -41.83 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.0 m -120.63 127.78 52.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.599 -0.688 . . . . 0.0 109.616 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.92 46.35 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . -111.02 126.72 55.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.61 -0.935 . . . . 0.0 109.78 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.6 mtt180 38.89 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.454 0.645 . . . . 0.0 110.261 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 55.77 13.58 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.616 -0.677 . . . . 0.0 109.331 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.32 3.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.667 -0.645 . . . . 0.0 109.743 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 65' ' ' SER . 76.9 ttt180 -138.79 -26.56 0.86 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -74.66 28.93 1.06 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 63' ' ' ARG . 45.7 m -131.8 149.49 52.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.386 -1.067 . . . . 0.0 109.714 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -163.45 98.97 0.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -107.12 -41.88 5.03 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -164.4 128.81 2.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.451 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.477 ' C ' ' O ' ' A' ' 71' ' ' PRO . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -124.4 128.86 49.69 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.505 ' OG ' ' CE2' ' A' ' 79' ' ' PHE . 12.6 p -84.85 176.7 8.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.518 -0.739 . . . . 0.0 109.951 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.505 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 17.6 m-85 64.1 162.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.493 0.663 . . . . 0.0 109.823 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.14 109.34 0.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 78.8 t90 -109.2 139.25 44.37 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.48 -1.012 . . . . 0.0 109.574 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 72.2 m-20 -152.26 -166.37 2.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.732 . . . . 0.0 109.909 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 85' ' ' GLU . . . -65.9 159.58 46.13 Favored Glycine 0 N--CA 1.495 2.598 0 CA-C-O 121.923 0.735 . . . . 0.0 111.635 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 p 64.9 -5.24 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.824 -0.809 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.539 ' H ' ' C ' ' A' ' 83' ' ' GLY . 96.7 mt-10 46.85 25.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.375 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.63 3.83 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.396 -0.815 . . . . 0.0 109.217 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.85 74.99 76.6 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' CD ' ' HG ' ' A' ' 91' ' ' SER . 24.0 Cg_exo -58.98 -173.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.492 2.128 . . . . 0.0 111.453 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 91' ' ' SER . 35.6 Cg_exo -61.67 140.37 86.02 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.465 2.11 . . . . 0.0 112.675 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.82 0.38 2.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.524 ' HG ' ' CD ' ' A' ' 88' ' ' PRO . 4.6 m -77.16 -8.3 57.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.507 -0.996 . . . . 0.0 109.371 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.0 p -149.98 160.25 43.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.114 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp -137.21 125.42 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -102.76 -73.87 1.0 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -166.66 -152.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.448 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -137.77 97.47 10.11 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.504 -0.747 . . . . 0.0 109.199 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 31.9 Cg_exo -51.02 108.47 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.307 2.005 . . . . 0.0 112.446 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 54.02 160.4 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 146' ' ' ASP . 97.9 Cg_endo -79.72 -93.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.312 2.008 . . . . 0.0 111.673 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.544 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.4 OUTLIER 60.35 68.05 1.48 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.68 -0.638 . . . . 0.0 109.915 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.25 144.88 29.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.523 2.149 . . . . 0.0 112.419 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' ' N ' ' A' ' 149' ' ' TYR . 76.2 t80 -81.48 -89.82 0.07 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.562 ' N ' ' CD2' ' A' ' 148' ' ' PHE . 95.2 m-85 39.22 66.51 0.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.845 0.831 . . . . 0.0 110.341 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.4 -176.5 51.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 60.15 33.97 21.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.564 -0.962 . . . . 0.0 108.716 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -137.77 128.4 26.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.74 -3.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -121.52 133.98 55.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.655 0.74 . . . . 0.0 109.863 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -85.94 -67.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.436 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 156' ' ' HIS . 24.6 p-80 -174.02 91.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.31 142.29 21.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 109.617 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.28 -56.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 44.03 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.519 -0.738 . . . . 0.0 109.973 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.695 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -90.18 -4.86 57.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -80.04 137.11 36.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.473 -0.767 . . . . 0.0 109.684 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.98 141.88 57.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.461 -0.774 . . . . 0.0 110.35 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.7 tpt -162.0 72.41 2.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.792 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.75 -93.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.742 2.295 . . . . 0.0 111.686 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -157.48 60.08 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -88.02 163.33 16.34 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.503 -0.748 . . . . 0.0 110.57 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 63.84 91.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.921 -0.487 . . . . 0.0 109.742 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.524 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 105' ' ' THR . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 -122.28 81.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.435 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 14.3 ttt 74.75 136.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.399 0.618 . . . . 0.0 110.123 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 40' ' ' THR . . . 141.64 -58.97 0.56 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' GLY . 4.4 p 41.09 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.792 -0.828 . . . . 0.0 110.016 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 55.03 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.686 -0.634 . . . . 0.0 109.717 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 147.45 28.86 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.831 . . . . 0.0 109.94 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -94.97 164.11 13.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.662 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 11.3 p -56.03 122.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -174.23 79.04 0.36 Allowed Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.43 159.4 51.62 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.915 1.743 . . . . 0.0 112.133 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 64.29 89.15 0.11 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.288 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.1 137.9 53.83 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.736 2.291 . . . . 0.0 112.931 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.9 -17.45 2.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.15 -160.48 31.1 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -59.23 137.82 57.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.977 . . . . 0.0 109.559 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.423 ' C ' ' O ' ' A' ' 51' ' ' LEU . 90.1 m-85 -39.03 135.84 0.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.31 0.576 . . . . 0.0 110.009 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 53' ' ' LEU . 10.0 mp -75.68 123.96 26.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.514 0.673 . . . . 0.0 110.255 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 m -155.07 150.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -93.54 14.28 19.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 109.342 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.48 -45.43 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.4 112.43 8.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.58 122.87 6.38 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 -70.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.473 -1.016 . . . . 0.0 109.056 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -159.73 -170.52 2.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 9.1 p90 -135.8 75.91 1.58 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.586 -0.696 . . . . 0.0 109.304 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.08 75.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 0.0 110.26 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -163.69 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.1 64.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.2 t -155.89 95.2 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -1.135 . . . . 0.0 109.428 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -86.62 140.98 29.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.395 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -76.81 -78.83 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.526 -0.734 . . . . 0.0 109.591 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -145.61 135.5 23.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -122.29 135.38 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -112.19 122.13 46.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 54.8 p90 -160.58 126.52 4.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 109.638 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.25 43.79 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.8 m95 65.61 156.77 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.617 -0.931 . . . . 0.0 110.868 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 t0 55.83 25.33 8.35 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.49 -174.83 49.66 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.4 p -79.44 174.74 11.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.905 . . . . 0.0 110.488 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -40.57 117.61 0.84 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 87' ' ' VAL . 43.7 t 46.83 82.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 86' ' ' VAL . 2.1 m -27.48 93.11 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 CA-C-O 120.795 0.331 . . . . 0.0 110.701 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 25.5 Cg_exo -53.39 -42.33 66.21 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.786 1.658 . . . . 0.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 98.1 Cg_endo -84.13 -9.84 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.671 1.581 . . . . 0.0 111.517 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 101.18 -30.0 11.31 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 33.03 95.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 122.222 -0.575 . . . . 0.0 110.756 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -155.85 -134.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 109.471 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -103.06 124.44 48.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.555 -0.716 . . . . 0.0 109.183 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 96' ' ' ILE . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 19' ' ' ALA . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.524 ' NH2' ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 162.26 133.37 1.46 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 90.6 mtm-85 -70.73 175.54 4.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.36 -1.083 . . . . 0.0 110.545 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 1.3 m-20 81.24 77.94 0.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 121.234 0.54 . . . . 0.0 110.196 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.93 145.86 89.32 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.809 2.34 . . . . 0.0 112.083 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.98 -64.34 1.67 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.66 141.21 75.75 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.778 1.652 . . . . 0.0 113.023 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.685 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.4 m-20 -104.18 -27.04 0.21 Allowed Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.206 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 59.6 Cg_endo -82.71 151.85 14.86 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.81 1.673 . . . . 0.0 112.491 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -99.46 134.82 41.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.452 -0.78 . . . . 0.0 109.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.6 t80 46.46 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.639 -0.663 . . . . 0.0 109.832 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.32 114.45 3.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.7 -14.0 35.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -1.096 . . . . 0.0 109.091 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -129.56 132.99 46.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.558 0.695 . . . . 0.0 110.007 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 153' ' ' LEU . 10.7 mp -64.08 -40.4 96.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.573 -0.704 . . . . 0.0 109.301 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.1 mp0 -99.61 167.06 10.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.532 -0.73 . . . . 0.0 109.854 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -155.7 -165.22 1.91 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 86.7 t60 41.23 44.78 2.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.708 -0.62 . . . . 0.0 109.833 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 46.33 84.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -148.73 137.44 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -170.96 48.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.179 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' GLU . 66.6 mtt . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 57.3 mp0 40.28 74.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.508 0.67 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -75.78 149.09 38.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' SD ' ' A' ' 5' ' ' MET . . . -164.43 -115.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.307 -0.871 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 5' ' ' MET . 2.1 mpt? -142.11 79.22 16.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.96 . . . . 0.0 109.158 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.9 146.75 92.41 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.676 2.251 . . . . 0.0 111.98 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.48 144.79 24.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.555 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.666 ' HG ' ' N ' ' A' ' 9' ' ' PHE . 98.9 p -65.1 -126.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.761 -0.587 . . . . 0.0 110.56 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.666 ' N ' ' HG ' ' A' ' 8' ' ' SER . 87.6 m-85 41.0 97.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.551 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CD2' ' N ' ' A' ' 38' ' ' MET . 67.6 p-90 -141.58 -50.21 0.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.492 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 4.3 ttt -64.17 -135.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.883 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 38' ' ' MET . . . -60.53 -168.35 0.41 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -141.22 28.28 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.944 . . . . 0.0 108.723 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -155.28 117.46 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 109.242 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.6 149.27 5.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.034 . . . . 0.0 109.184 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 58.8 mp0 -85.67 158.09 20.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.136 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.82 150.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 109.059 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -103.26 151.58 38.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.67 -42.22 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.893 1.729 . . . . 0.0 113.018 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 7.7 mm-40 -151.06 -63.89 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.809 -1.182 . . . . 0.0 110.863 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 21.0 Cg_endo -60.09 143.24 99.56 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.871 1.714 . . . . 0.0 112.872 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -85.99 38.32 3.06 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.47 34.02 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 49' ' ' GLY . 4.3 tp -120.61 -67.48 0.97 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -1.055 . . . . 0.0 109.123 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CZ ' ' O ' ' A' ' 49' ' ' GLY . 47.7 m-85 63.34 9.89 4.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.833 -0.542 . . . . 0.0 110.099 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.34 127.22 55.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' VAL . 4.9 t -135.76 133.53 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m120 68.41 -56.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 54' ' ' VAL . 23.1 m -66.68 141.13 18.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 110.1 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.7 p -126.14 159.59 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -157.19 11.48 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.34 39.99 3.77 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.47 -1.018 . . . . 0.0 109.285 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -148.0 141.29 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.014 -1.054 . . . . 0.0 109.966 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.48 -43.42 5.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.548 -0.72 . . . . 0.0 109.622 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.77 103.44 0.69 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.346 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -150.89 164.12 37.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 109.883 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.37 -128.0 27.13 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 p -149.21 147.69 28.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.265 . . . . 0.0 109.86 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -78.19 147.26 34.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.646 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.36 -77.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -143.2 132.54 23.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.907 . . . . 0.0 108.996 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.606 ' CD2' ' N ' ' A' ' 78' ' ' SER . 86.1 t80 -167.27 178.44 5.58 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.606 ' N ' ' CD2' ' A' ' 77' ' ' TYR . 99.9 p -88.99 99.81 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.672 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.44 -3.37 27.07 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.374 -0.829 . . . . 0.0 108.803 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.98 148.8 23.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -99.44 136.21 39.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.34 -1.094 . . . . 0.0 110.421 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 34.5 p-10 -94.41 -2.17 52.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.201 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.94 -89.27 0.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -66.23 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 123' ' ' HIS . 98.3 mt-10 -58.56 129.76 43.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.274 -0.891 . . . . 0.0 109.838 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.21 129.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.677 . . . . 0.0 109.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.8 t -154.88 88.13 3.27 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 34.2 Cg_exo -56.23 -173.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.347 2.032 . . . . 0.0 111.858 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 39.1 Cg_exo -58.1 -155.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.891 2.394 . . . . 0.0 112.794 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.65 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' PRO . 82.6 p -151.82 -55.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.454 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -80.86 162.99 23.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -154.89 127.26 7.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.595 -0.691 . . . . 0.0 109.249 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 99' ' ' ILE . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.418 ' HG ' ' N ' ' A' ' 113' ' ' GLY . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.418 ' N ' ' HG ' ' A' ' 112' ' ' SER . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.537 ' HG ' ' N ' ' A' ' 117' ' ' ALA . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.537 ' N ' ' HG ' ' A' ' 116' ' ' SER . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.443 ' CD2' ' OE1' ' A' ' 85' ' ' GLU . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.551 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . 107.26 -10.73 39.81 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -75.38 153.5 37.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.019 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -141.58 74.75 23.01 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.309 -0.869 . . . . 0.0 109.113 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.34 158.5 44.62 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.433 2.088 . . . . 0.0 112.442 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.92 71.23 0.48 Allowed Glycine 0 N--CA 1.505 3.234 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.52 152.42 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.47 2.113 . . . . 0.0 112.449 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.27 60.67 2.12 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.12 -62.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.391 2.061 . . . . 0.0 111.653 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -100.6 -3.24 30.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 108.931 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.82 129.61 38.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.656 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.28 -176.11 31.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 106.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -1.009 . . . . 0.0 109.36 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -79.92 148.07 31.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.539 -0.725 . . . . 0.0 109.753 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 155' ' ' HIS . 0.1 OUTLIER -90.81 146.68 23.75 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.819 . . . . 0.0 109.701 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 53.1 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.384 -0.823 . . . . 0.0 110.254 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 86.3 t60 50.82 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.5 t60 50.17 81.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 110.322 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' HIS . 11.5 p80 -67.7 -45.38 75.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 0.0 109.597 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 157' ' ' HIS . 53.1 t-80 -170.8 -73.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.44 ' NE2' ' CD2' ' A' ' 160' ' ' HIS . 74.1 t60 -124.13 124.09 41.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.556 -0.715 . . . . 0.0 109.812 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' CD2' ' NE2' ' A' ' 159' ' ' HIS . 60.0 m-70 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.041 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' H2 ' ' H ' ' A' ' 2' ' ' GLU . 98.3 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 17.5 pt-20 -68.1 -37.77 81.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.739 0.781 . . . . 0.0 109.565 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.84 130.11 34.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.134 -0.979 . . . . 0.0 110.04 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 95.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 158.37 40.26 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.71 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.55 143.39 28.24 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.522 2.148 . . . . 0.0 112.897 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.79 -21.29 17.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.187 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.403 ' HG ' ' N ' ' A' ' 9' ' ' PHE . 36.9 t -77.22 154.61 32.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.646 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.403 ' N ' ' HG ' ' A' ' 8' ' ' SER . 69.0 m-85 -75.37 142.97 43.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.91 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 38' ' ' MET . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 45.4 p-90 -118.6 62.85 0.77 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.482 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 3.8 ttt 81.35 150.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.082 0.944 . . . . 0.0 110.91 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 139.03 -25.21 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 41' ' ' GLU . 6.3 p 60.01 -70.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.847 -0.796 . . . . 0.0 109.676 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 39' ' ' GLY . 80.0 mm-40 -131.84 145.21 51.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.871 0.843 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 124.47 6.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -144.68 113.84 6.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.285 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -125.67 132.54 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -134.65 154.97 79.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -42.75 139.06 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.805 2.337 . . . . 0.0 113.093 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.03 156.49 0.15 Allowed Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.92 145.09 84.99 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.1 63.12 0.44 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.15 149.85 51.7 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.463 -1.022 . . . . 0.0 110.663 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.27 145.26 44.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.691 -0.888 . . . . 0.0 109.814 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 42.65 -161.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.843 0.83 . . . . 0.0 110.585 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 3.7 mm? -75.57 145.53 41.14 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.759 0.79 . . . . 0.0 110.12 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.89 138.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.825 0.821 . . . . 0.0 109.772 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -89.23 85.2 6.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.552 0.691 . . . . 0.0 109.471 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.81 -153.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.738 . . . . 0.0 110.39 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -116.06 130.63 56.9 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.821 0.82 . . . . 0.0 110.273 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.81 -8.4 79.86 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 -147.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.348 -1.09 . . . . 0.0 109.94 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' PHE . 30.3 ptt85 -155.45 115.89 3.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.229 -0.919 . . . . 0.0 110.017 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 62' ' ' ALA . 80.6 t80 53.14 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.842 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 61' ' ' PHE . . . 69.05 -17.5 0.2 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' PHE . 13.2 mmp_? -129.67 156.03 44.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 0.0 109.812 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.74 83.87 0.97 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' PHE . 81.1 p -102.82 -0.01 32.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.253 -1.146 . . . . 0.0 108.55 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' SER . 96.9 m-85 39.7 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.883 0.849 . . . . 0.0 110.627 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -67.39 -42.41 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.246 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -151.49 129.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.04 -1.038 . . . . 0.0 109.599 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -149.37 150.76 32.95 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 96.3 p -82.06 161.49 22.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.445 0.64 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -134.19 153.16 52.01 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.725 0.774 . . . . 0.0 109.61 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' O ' ' CZ ' ' A' ' 63' ' ' ARG . . . 88.07 -116.5 4.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' GLY . 11.4 m0 58.23 121.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.936 0.874 . . . . 0.0 110.418 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 55.99 28.73 13.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.576 0.703 . . . . 0.0 109.458 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.95 148.72 25.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -110.4 123.22 49.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -1.043 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 51.84 27.18 4.03 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.485 0.66 . . . . 0.0 109.584 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.14 115.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.115 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.408 ' CG1' ' HG ' ' A' ' 92' ' ' SER . 85.9 t 49.9 91.62 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.759 -0.588 . . . . 0.0 110.474 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -52.89 161.78 3.01 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.618 2.212 . . . . 0.0 111.492 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.89 135.78 58.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.83 2.353 . . . . 0.0 113.196 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.89 -176.96 52.2 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m 58.92 -159.41 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.92 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.408 ' HG ' ' CG1' ' A' ' 87' ' ' VAL . 4.7 p 42.93 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.453 0.644 . . . . 0.0 109.982 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp -122.68 127.32 49.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.41 ' C ' ' CD2' ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.626 ' HD1' ' N ' ' A' ' 112' ' ' SER . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.626 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 119' ' ' GLN . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.447 ' CD ' ' HG ' ' A' ' 116' ' ' SER . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.509 ' HE ' ' CG ' ' A' ' 145' ' ' PRO . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -158.94 -150.47 5.81 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -148.25 16.16 1.04 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.547 -0.973 . . . . 0.0 108.724 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -119.24 89.57 40.08 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.347 -0.845 . . . . 0.0 109.664 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.16 145.52 75.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.751 2.301 . . . . 0.0 111.954 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.88 -81.32 0.14 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.509 ' CG ' ' HE ' ' A' ' 133' ' ' ARG . 38.2 Cg_endo -63.66 147.9 92.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.503 2.135 . . . . 0.0 112.474 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 16.3 p-10 -158.1 62.89 2.53 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.92 -89.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.83 2.353 . . . . 0.0 112.034 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 149' ' ' TYR . 98.5 m-85 -138.62 4.22 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 148' ' ' PHE . 97.9 m-85 42.58 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.031 0.92 . . . . 0.0 110.496 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 85.29 164.37 38.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -82.68 -15.92 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.973 . . . . 0.0 109.24 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -92.25 132.3 36.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.734 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 154' ' ' GLU . 10.4 mp -64.39 -40.44 95.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.589 -0.694 . . . . 0.0 109.807 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 153' ' ' LEU . 71.9 mm-40 58.66 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.751 0.786 . . . . 0.0 110.53 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -135.63 159.24 42.23 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.743 0.782 . . . . 0.0 109.927 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.451 ' C ' ' H ' ' A' ' 158' ' ' HIS . 12.3 t-80 42.8 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.901 0.858 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 157' ' ' HIS . 18.7 t-80 -78.67 17.34 0.71 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 156' ' ' HIS . 80.7 m80 55.92 10.39 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.643 0.735 . . . . 0.0 109.648 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.536 ' CD2' ' H ' ' A' ' 160' ' ' HIS . 86.4 t60 52.44 -111.34 0.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.561 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.536 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 86.7 m-70 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.113 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.578 0.704 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 3' ' ' LYS . 97.9 mt-10 -73.65 159.58 32.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.808 0.813 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 2' ' ' GLU . 88.7 tttt 60.01 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.897 0.856 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 66.82 166.79 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.782 0.801 . . . . 0.0 110.565 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.9 tpt 64.8 51.77 1.02 Allowed Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 121.83 -0.544 . . . . 0.0 110.029 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 5' ' ' MET . 50.9 Cg_endo -67.39 142.54 60.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.1 -13.71 16.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.472 -0.767 . . . . 0.0 109.604 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.7 m -107.9 31.59 5.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 -66.41 145.0 56.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 109.844 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.601 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -146.48 9.64 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.3 ttm -160.55 100.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.51 157.75 32.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -109.57 -20.93 12.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.673 -0.898 . . . . 0.0 108.786 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -156.59 126.39 6.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.148 -0.97 . . . . 0.0 109.782 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.34 151.59 5.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -141.27 127.72 20.0 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.843 0.83 . . . . 0.0 109.373 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.33 -77.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLU . 88.7 mt-10 54.07 68.23 2.92 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.576 -0.703 . . . . 0.0 109.753 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.64 0.7 3.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.233 1.955 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.4 tt0 -178.87 -45.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 24.3 Cg_exo -63.82 132.83 36.4 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.488 2.125 . . . . 0.0 112.479 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . 36.0 92.74 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.67 84.64 1.52 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -95.64 -172.84 2.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.63 -0.923 . . . . 0.0 110.051 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -72.88 133.42 44.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.749 0.785 . . . . 0.0 110.022 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.14 155.26 16.81 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.601 0.715 . . . . 0.0 109.617 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.7 t -131.08 162.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.622 0.725 . . . . 0.0 109.6 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 55.91 -175.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.872 0.844 . . . . 0.0 110.707 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t 61.93 124.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.841 0.829 . . . . 0.0 110.381 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.1 t -101.77 176.58 5.17 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.823 0.82 . . . . 0.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.1 -16.25 61.47 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.18 129.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -1.14 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -118.72 -36.79 3.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.621 -0.674 . . . . 0.0 109.697 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.81 -45.94 91.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.99 . . . . 0.0 109.435 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.09 -172.86 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 109.693 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -104.97 0.44 27.77 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.68 -125.59 23.14 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 t -134.96 141.09 46.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.551 -0.97 . . . . 0.0 109.819 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -73.89 147.29 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.708 0.766 . . . . 0.0 110.401 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -73.11 -74.61 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.481 0.658 . . . . 0.0 109.658 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.2 136.03 37.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.467 -0.771 . . . . 0.0 109.168 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.636 ' CG ' ' N ' ' A' ' 78' ' ' SER . 60.7 t80 -169.38 176.96 4.89 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.636 ' N ' ' CG ' ' A' ' 77' ' ' TYR . 14.7 p -85.77 155.41 21.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.831 0.824 . . . . 0.0 110.551 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -156.61 101.72 2.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.18 -171.35 47.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -91.93 149.38 21.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.988 . . . . 0.0 110.292 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 48.6 p-10 -66.37 -25.85 66.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 110.065 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -60.32 -126.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 t -138.8 8.96 2.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.391 -1.064 . . . . 0.0 109.458 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.57 139.42 57.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -80.53 121.3 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.715 0.769 . . . . 0.0 110.222 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.1 t -155.22 85.77 3.44 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -54.05 156.11 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.987 2.458 . . . . 0.0 112.145 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.88 -22.78 42.05 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.324 2.016 . . . . 0.0 111.453 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.18 -23.49 29.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -69.29 -34.05 74.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.995 . . . . 0.0 109.711 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -140.28 148.65 41.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp -124.11 130.38 52.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 76.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.601 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.81 119.79 0.08 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.418 ' CG ' ' H ' ' A' ' 142' ' ' ASP . 24.8 ttm180 -171.32 -132.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -1.088 . . . . 0.0 109.847 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 141' ' ' ARG . 34.8 m-20 -148.34 80.0 8.69 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 144' ' ' GLY . 52.7 Cg_exo -50.93 -174.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.637 2.225 . . . . 0.0 112.639 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -48.01 179.28 0.01 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.2 -40.28 86.58 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.399 2.066 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.1 OUTLIER 173.38 -48.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.583 -0.698 . . . . 0.0 109.52 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 73.4 Cg_endo -83.82 178.16 5.65 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.659 2.239 . . . . 0.0 112.816 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.434 ' CZ ' ' OD2' ' A' ' 82' ' ' ASP . 77.6 m-85 -72.18 143.45 48.9 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.874 0.845 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 49.06 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.955 0.884 . . . . 0.0 110.301 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.56 -7.81 60.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -64.6 -42.95 95.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.14 -1.212 . . . . 0.0 109.418 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -168.03 140.71 3.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 153' ' ' LEU . 10.7 mp -78.28 144.69 35.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.2 127.79 56.28 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.675 0.75 . . . . 0.0 109.455 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 155' ' ' HIS . 57.5 t-80 -84.33 24.07 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.711 0.767 . . . . 0.0 109.209 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.08 -43.97 98.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.69 7.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.029 -1.044 . . . . 0.0 108.6 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -85.96 127.87 34.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.472 ' NE2' ' CD2' ' A' ' 160' ' ' HIS . 72.9 t60 -139.84 133.82 30.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 0.0 109.954 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.472 ' CD2' ' NE2' ' A' ' 159' ' ' HIS . 46.8 m-70 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 59.2 mp0 -68.36 135.8 52.38 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.841 0.829 . . . . 0.0 110.111 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 5' ' ' MET . 99.4 mttt -66.6 -81.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 42.34 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.986 0.898 . . . . 0.0 109.027 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' LYS . 21.3 ptt? -82.84 147.42 54.81 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.479 -0.763 . . . . 0.0 109.41 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.05 -69.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.464 2.109 . . . . 0.0 112.218 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.29 137.2 0.51 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.651 -0.656 . . . . 0.0 109.556 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.531 ' HG ' ' H ' ' A' ' 9' ' ' PHE . 2.5 t 75.51 -167.57 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.988 0.899 . . . . 0.0 111.474 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.531 ' H ' ' HG ' ' A' ' 8' ' ' SER . 72.6 m-85 -75.59 149.36 38.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -124.07 51.88 1.52 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.7 tpp -158.39 -74.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.59 -140.01 3.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.66 -1.257 . . . . 0.0 109.981 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -116.17 7.57 14.18 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.94 148.2 40.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.396 -0.815 . . . . 0.0 109.048 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.45 132.93 12.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 109.605 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -106.19 121.07 43.43 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.3 t -139.78 -1.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 5.7 mp0 -81.28 150.16 67.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' HG2' ' H ' ' A' ' 47' ' ' GLU . 56.7 Cg_endo -71.04 -85.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 111.555 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 6.1 mt-10 -156.19 -63.12 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 73.2 Cg_exo -31.45 96.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.786 2.324 . . . . 0.0 112.923 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.22 37.25 46.64 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.41 97.63 0.15 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.7 tp -157.13 -57.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -1.074 . . . . 0.0 109.073 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' A' ' 52' ' ' TYR . 90.1 t80 -78.99 4.1 15.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.2 mt -92.04 132.22 36.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.86 161.56 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.7 t-20 69.64 -53.05 0.61 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.913 -0.492 . . . . 0.0 109.701 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 55' ' ' ASN . 35.8 m 35.08 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.642 0.734 . . . . 0.0 111.166 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 58' ' ' GLY . 2.5 t -167.58 -128.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -74.26 165.76 54.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.17 17.61 3.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.844 . . . . 0.0 109.335 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -64.54 152.13 42.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 0.0 110.884 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.96 126.23 36.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 110.094 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.41 27.68 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -139.15 144.77 38.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.323 -0.861 . . . . 0.0 109.661 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -110.61 0.45 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -87.29 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.328 -1.101 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -64.54 134.89 55.33 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.818 0.818 . . . . 0.0 110.299 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -64.03 -64.6 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 109.383 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -159.14 137.38 10.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.074 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -140.22 164.25 30.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 11.9 p -153.5 159.6 42.3 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.639 0.733 . . . . 0.0 109.857 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 78' ' ' SER . 44.1 m-85 -158.18 -151.2 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.89 119.51 0.51 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.4 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 66.2 t-105 -67.99 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.53 -0.982 . . . . 0.0 109.94 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 80.1 m-20 -63.7 140.62 58.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.881 0.848 . . . . 0.0 110.187 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.7 91.44 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 86' ' ' VAL . 27.3 t -154.75 99.37 2.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -1.174 . . . . 0.0 109.21 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 84' ' ' SER . 80.2 mm-40 38.9 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.711 0.767 . . . . 0.0 110.502 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' SER . 3.9 p -158.52 115.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.481 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -153.93 74.16 6.33 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 24.4 Cg_exo -64.75 -173.67 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.944 2.43 . . . . 0.0 111.617 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 50.0 Cg_exo -55.05 -35.58 90.68 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.705 2.27 . . . . 0.0 111.265 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.22 -13.07 60.79 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 69.98 33.02 2.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.827 -0.808 . . . . 0.0 110.319 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 m -158.05 -172.36 3.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 0.0 110.128 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.98 131.55 46.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.469 -0.77 . . . . 0.0 109.207 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.46 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -172.62 100.1 0.15 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' PRO . 83.1 mmt-85 -35.95 -67.55 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.038 -0.684 . . . . 0.0 110.416 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 15.2 p-10 -25.99 89.34 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 CA-C-O 121.056 0.455 . . . . 0.0 110.574 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' ARG . 36.3 Cg_exo -57.06 158.87 16.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.642 2.228 . . . . 0.0 112.452 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.558 ' C ' ' H ' ' A' ' 146' ' ' ASP . . . -45.14 177.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.54 12.42 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.32 2.013 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 144' ' ' GLY . 23.0 t0 56.36 55.81 8.91 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.514 -0.742 . . . . 0.0 109.647 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 34.6 Cg_endo -64.58 149.76 89.34 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 0.0 113.19 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -71.95 137.24 47.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.973 0.892 . . . . 0.0 110.485 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -145.97 -6.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.93 -144.63 9.35 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 55.36 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.614 -0.933 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -77.61 145.42 36.79 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.85 0.833 . . . . 0.0 110.76 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 153' ' ' LEU . 10.3 mp -76.29 145.57 39.52 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.747 0.784 . . . . 0.0 110.168 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.94 167.08 17.29 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.683 0.754 . . . . 0.0 110.371 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -95.33 135.88 36.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.801 0.81 . . . . 0.0 110.292 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.502 ' O ' ' CE1' ' A' ' 159' ' ' HIS . 77.6 m80 -72.81 135.73 45.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -85.65 -14.09 46.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.217 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 159' ' ' HIS . 86.4 t60 -65.49 -41.44 93.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.248 -0.907 . . . . 0.0 109.376 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 156' ' ' HIS . 67.5 m80 46.37 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.766 0.793 . . . . 0.0 110.93 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.226 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.691 0.757 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -67.4 142.3 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.526 -0.734 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.08 -54.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.28 144.04 55.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.991 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.3 mtt 49.84 58.02 17.66 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.524 -0.735 . . . . 0.0 109.906 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.09 150.2 42.52 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.87 2.38 . . . . 0.0 113.033 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.29 73.98 0.82 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.341 -0.85 . . . . 0.0 108.876 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -157.06 -61.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.55 -5.64 38.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.436 -0.79 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 105' ' ' THR . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 38' ' ' MET . 43.2 p-90 -118.26 72.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 6.0 tpt 82.94 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.72 0.771 . . . . 0.0 110.208 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 40' ' ' THR . . . 156.76 -58.31 0.37 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 34.07 95.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.432 0.634 . . . . 0.0 110.67 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 60.0 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.53 140.93 51.81 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.618 0.723 . . . . 0.0 109.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.5 150.68 21.95 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.735 0.779 . . . . 0.0 110.25 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.63 142.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -119.53 88.08 37.96 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.54 -0.725 . . . . 0.0 109.146 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.19 -37.13 87.63 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.647 2.231 . . . . 0.0 111.967 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.635 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -173.61 -38.53 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 45.9 Cg_exo -59.05 142.84 99.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.325 2.017 . . . . 0.0 113.107 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.49 67.84 0.56 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . 89.5 130.57 4.04 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.486 -1.008 . . . . 0.0 110.711 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 53' ' ' LEU . 3.7 tt -156.64 114.51 3.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -1.064 . . . . 0.0 108.276 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -46.63 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.648 0.737 . . . . 0.0 109.943 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 51' ' ' LEU . 6.2 tt -147.97 112.08 5.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.352 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.77 150.21 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.31 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER 72.68 -162.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.799 0.809 . . . . 0.0 111.263 179.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.675 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 12.7 p -59.46 126.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.843 0.83 . . . . 0.0 110.644 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.9 p -88.64 169.89 11.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.624 0.726 . . . . 0.0 110.567 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.85 -35.66 92.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.44 -168.73 2.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.971 -1.311 . . . . 0.0 109.857 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 61' ' ' PHE . 95.4 mtt-85 -64.76 -48.39 74.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 60' ' ' ARG . 53.0 m-85 38.83 -166.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.818 0.818 . . . . 0.0 111.159 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.48 55.51 4.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -131.48 137.24 48.48 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.802 0.811 . . . . 0.0 109.927 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.24 -1.11 51.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 m -89.38 -148.25 0.18 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -1.111 . . . . 0.0 110.372 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 59.12 164.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.838 0.828 . . . . 0.0 110.802 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.96 -45.03 87.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.638 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.44 132.67 3.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 108.874 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.503 ' C ' ' O ' ' A' ' 71' ' ' PRO . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 78' ' ' SER . 68.7 t80 -167.33 162.03 14.57 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 31.4 t -107.86 123.59 48.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.503 -0.748 . . . . 0.0 109.343 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.34 -61.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.81 -136.85 46.46 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -119.4 105.2 11.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.892 . . . . 0.0 109.213 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.45 -11.22 60.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -3.93 63.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 85' ' ' GLU . 42.5 m -127.39 119.24 25.74 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.89 . . . . 0.0 109.717 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 84' ' ' SER . 97.9 mt-10 41.97 -167.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.899 0.856 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.45 129.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.452 0.644 . . . . 0.0 109.698 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.7 t -137.92 76.49 39.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' O ' ' OG ' ' A' ' 91' ' ' SER . 17.7 Cg_exo -65.92 -174.39 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 33.4 Cg_exo -61.11 143.31 98.83 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.323 2.015 . . . . 0.0 112.487 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.43 -39.16 3.04 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 88' ' ' PRO . 79.2 p -70.95 -15.43 62.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -1.057 . . . . 0.0 110.051 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.0 p -154.49 161.71 41.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.871 -1.143 . . . . 0.0 109.583 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.13 124.03 11.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.278 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 19' ' ' ALA . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.491 ' HD1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.491 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.59 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' OE1' ' OD2' ' A' ' 142' ' ' ASP . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 142.43 150.35 5.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -52.75 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.568 -0.96 . . . . 0.0 110.465 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.2 OUTLIER 176.25 -60.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 142' ' ' ASP . 22.0 Cg_endo -59.55 145.7 97.28 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.218 1.946 . . . . 0.0 112.921 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 160.81 58.26 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.35 -12.93 37.61 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.438 2.092 . . . . 0.0 111.411 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.611 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER 174.95 -45.15 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 32.8 Cg_exo -56.61 141.76 90.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.873 2.382 . . . . 0.0 113.258 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 149' ' ' TYR . 53.3 p90 -144.29 -12.88 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 148' ' ' PHE . 89.9 m-85 58.93 129.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -176.97 163.9 33.01 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -64.39 -34.37 78.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.941 . . . . 0.0 109.566 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 150' ' ' GLY . 89.9 mtm-85 58.34 173.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.733 0.778 . . . . 0.0 110.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.01 -42.61 94.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 47.56 -166.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.938 0.875 . . . . 0.0 110.8 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.402 ' O ' ' ND1' ' A' ' 157' ' ' HIS . 74.6 m80 51.14 -171.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.906 0.86 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.578 ' CG ' ' H ' ' A' ' 157' ' ' HIS . 51.2 t-80 57.09 -120.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.409 0.623 . . . . 0.0 110.336 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.578 ' H ' ' CG ' ' A' ' 156' ' ' HIS . 69.7 m80 46.99 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.887 0.851 . . . . 0.0 109.981 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -68.33 133.38 48.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.704 0.764 . . . . 0.0 110.536 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -76.48 134.51 39.49 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.755 0.788 . . . . 0.0 110.148 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.748 -1.12 . . . . 0.0 108.961 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.618 0.723 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.1 138.02 57.72 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.674 0.75 . . . . 0.0 109.864 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.77 132.05 36.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.572 0.701 . . . . 0.0 109.88 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.58 146.97 46.32 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.792 0.806 . . . . 0.0 110.307 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -82.79 153.07 67.24 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-O 121.158 0.504 . . . . 0.0 109.849 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.29 143.39 76.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.808 2.339 . . . . 0.0 111.617 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -101.53 -9.75 20.73 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 t -63.77 149.94 45.71 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.704 0.764 . . . . 0.0 109.994 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -91.14 -0.94 57.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.548 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -107.01 -19.44 13.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.4 tpt -95.17 -56.78 2.61 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.819 -1.176 . . . . 0.0 109.382 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 76.63 -163.03 52.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 m 62.09 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.549 0.69 . . . . 0.0 109.907 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' GLY . 81.3 tt0 -167.56 149.56 5.73 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.849 0.833 . . . . 0.0 109.882 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.49 119.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.989 0.899 . . . . 0.0 109.725 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -140.15 119.05 12.53 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.898 0.856 . . . . 0.0 109.377 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.61 -38.56 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 0.0 109.239 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 54.81 81.6 0.26 Allowed Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.466 -0.772 . . . . 0.0 109.533 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.84 -36.97 76.24 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.629 2.219 . . . . 0.0 111.727 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -43.82 155.73 0.32 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.955 -0.466 . . . . 0.0 110.542 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -50.86 136.82 43.59 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.027 1.818 . . . . 0.0 112.27 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLY . . . 77.19 -76.98 1.58 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 48.02 -177.65 0.01 OUTLIER Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.7 140.64 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.624 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -97.69 1.03 48.13 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.345 0.593 . . . . 0.0 109.438 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.1 mt -111.06 136.29 50.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.291 -0.881 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.52 135.89 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.116 0.96 . . . . 0.0 109.76 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 56' ' ' VAL . 62.4 t30 47.9 -130.05 1.66 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.129 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' H ' ' CG ' ' A' ' 55' ' ' ASN . 21.9 t 48.35 -108.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.483 0.659 . . . . 0.0 109.462 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.5 t -150.97 146.46 26.26 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.98 0.895 . . . . 0.0 109.305 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.5 93.17 1.69 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.12 18.66 0.08 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.137 -0.977 . . . . 0.0 110.231 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -84.42 -30.49 25.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.493 0.663 . . . . 0.0 109.795 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.14 152.17 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.413 HH22 ' H ' ' A' ' 82' ' ' ASP . 79.4 ttt180 -150.16 -83.62 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.559 0.695 . . . . 0.0 109.722 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.39 112.82 4.36 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -82.14 166.6 19.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.727 0.775 . . . . 0.0 110.131 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -97.16 120.42 37.49 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.718 0.77 . . . . 0.0 109.235 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -81.48 -74.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -141.55 138.75 32.91 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -166.14 152.64 9.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 153.78 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.631 0.729 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 86.9 t80 -170.11 163.0 9.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.912 0.863 . . . . 0.0 109.898 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 177.74 174.51 44.14 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -110.45 125.77 53.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.487 -1.008 . . . . 0.0 109.7 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.413 ' H ' HH22 ' A' ' 63' ' ' ARG . 64.0 t0 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.662 0.744 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' SER . . . -42.76 102.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 83' ' ' GLY . 4.3 m 56.71 149.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.867 0.842 . . . . 0.0 110.343 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' SER . 82.3 tt0 46.88 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.446 0.641 . . . . 0.0 109.944 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.49 133.97 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.625 0.726 . . . . 0.0 109.191 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.84 82.64 10.85 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.53 164.99 31.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.598 2.199 . . . . 0.0 111.471 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.67 137.53 26.49 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.632 2.222 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.92 -40.44 2.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.6 t -64.14 -43.3 95.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -1.017 . . . . 0.0 109.767 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.55 ' OG ' ' NE2' ' A' ' 111' ' ' HIS . 35.3 t -145.81 143.52 29.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.007 0.908 . . . . 0.0 110.144 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -129.31 134.39 47.9 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 96' ' ' ILE . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.55 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' NH2' ' C ' ' A' ' 144' ' ' GLY . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . 53.52 107.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -159.12 -110.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.806 0.812 . . . . 0.0 109.6 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 25.5 p-10 -147.32 77.83 10.5 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.417 -0.802 . . . . 0.0 109.311 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 146.86 64.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.967 2.445 . . . . 0.0 112.412 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' C ' ' NH2' ' A' ' 133' ' ' ARG . . . -88.93 -161.47 37.5 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.41 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.182 2.588 . . . . 0.0 112.979 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -122.4 85.11 47.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.179 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.97 148.95 73.67 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.397 2.731 . . . . 0.0 112.483 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.29 148.74 3.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.665 0.745 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -61.25 -42.71 99.09 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.61 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -85.78 103.58 2.77 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -95.12 -9.34 33.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.801 -0.823 . . . . 0.0 109.072 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 154' ' ' GLU . 95.3 mtt-85 -67.75 -38.9 84.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.14 9.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 152' ' ' ARG . 49.1 tp10 -152.83 88.84 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.909 0.862 . . . . 0.0 108.961 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -85.55 154.71 21.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.024 0.916 . . . . 0.0 110.386 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -69.09 95.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.681 0.753 . . . . 0.0 109.964 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.4 -43.72 85.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 45.8 p-80 -160.14 74.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.737 0.779 . . . . 0.0 109.266 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.52 -42.1 87.77 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.199 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -149.76 -21.89 0.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -77.61 145.02 37.02 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.697 0.761 . . . . 0.0 110.286 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.38 171.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.873 0.844 . . . . 0.0 110.574 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.552 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.4 mtm 175.43 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.638 -0.664 . . . . 0.0 109.415 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 5' ' ' MET . 27.0 Cg_exo -59.43 145.04 99.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.95 1.767 . . . . 0.0 111.749 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -125.44 -28.23 3.36 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -77.96 168.08 20.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 110.631 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.42 106.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -111.75 22.82 14.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttp -157.61 120.31 3.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.686 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.1 91.85 1.67 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.3 m -164.16 103.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -1.027 . . . . 0.0 109.438 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' OE1' ' ND2' ' A' ' 55' ' ' ASN . 59.4 mp0 -48.99 138.01 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.373 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.1 153.68 26.29 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.767 0.794 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -150.22 104.75 3.29 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.48 136.77 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.466 -0.771 . . . . 0.0 109.677 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -95.37 152.38 39.28 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' O ' ' CD ' ' A' ' 47' ' ' GLU . 84.1 Cg_exo -44.55 -54.92 3.63 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 1.8 mp0 -142.34 -64.45 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.561 -0.712 . . . . 0.0 109.271 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.457 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 18.4 Cg_endo -59.23 145.64 97.16 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.775 1.65 . . . . 0.0 112.436 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.0 -66.9 0.23 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.08 13.56 83.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.91 143.66 49.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.666 -0.902 . . . . 0.0 110.488 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -157.46 84.83 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.7 mt -118.12 136.84 53.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.583 0.706 . . . . 0.0 109.667 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 55' ' ' ASN . 30.0 m -127.58 134.62 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.48 0.657 . . . . 0.0 109.374 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' ND2' ' OE1' ' A' ' 41' ' ' GLU . 8.7 m120 35.31 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.407 0.622 . . . . 0.0 111.258 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.32 132.95 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 110.395 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -113.13 160.28 18.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.783 0.801 . . . . 0.0 109.721 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 146.69 38.88 0.05 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.586 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . 55.81 -156.55 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.597 -0.943 . . . . 0.0 110.643 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 64.94 -12.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.355 0.598 . . . . 0.0 109.592 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 59' ' ' ALA . 61.3 m-85 -78.09 143.58 37.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.145 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 45.46 -174.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.737 0.78 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -109.15 -1.89 18.43 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.84 -11.26 66.26 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.3 m -137.99 147.37 44.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -1.122 . . . . 0.0 110.12 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -76.55 143.22 40.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.736 0.779 . . . . 0.0 110.376 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -77.55 -75.89 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 109.554 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -147.44 129.46 15.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.301 -0.874 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 78' ' ' SER . 85.8 t80 -167.18 145.58 4.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 77' ' ' TYR . 95.8 p -76.3 150.8 36.89 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.65 0.738 . . . . 0.0 110.667 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 91.2 t80 -173.39 169.8 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.704 . . . . 0.0 109.766 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.585 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 152.43 -3.07 0.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -81.49 177.28 9.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.4 -1.059 . . . . 0.0 110.641 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 63.19 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.792 0.806 . . . . 0.0 111.002 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.74 -21.79 7.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -84.22 154.75 22.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.514 -0.991 . . . . 0.0 110.52 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -100.93 -19.75 15.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.539 -0.726 . . . . 0.0 110.015 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.7 p -154.46 124.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.988 -1.07 . . . . 0.0 109.709 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.1 t -150.87 88.53 4.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 19.0 Cg_exo -59.32 -173.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.531 2.154 . . . . 0.0 111.588 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 35.8 Cg_exo -61.81 145.72 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.632 2.221 . . . . 0.0 112.7 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 81.96 -22.52 5.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' GLY . 81.0 p 34.85 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.772 0.796 . . . . 0.0 111.463 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 113' ' ' GLY . 28.4 m -90.54 -177.6 5.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.743 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp -120.27 129.12 53.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 96' ' ' ILE . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.406 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 120' ' ' CYS . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 116' ' ' SER . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.43 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.43 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.82 -144.82 6.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -172.28 87.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -1.044 . . . . 0.0 109.549 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.31 56.9 0.23 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 109.866 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.46 154.14 50.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.763 2.309 . . . . 0.0 112.637 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.0 57.43 0.12 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.3 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.567 2.178 . . . . 0.0 111.662 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -156.24 57.41 1.46 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.22 147.17 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.544 2.163 . . . . 0.0 112.672 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.39 16.08 26.17 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 54.27 -98.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.604 -0.685 . . . . 0.0 110.585 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 54.77 80.37 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -70.45 138.18 50.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.987 . . . . 0.0 110.081 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -104.99 140.36 38.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.852 0.834 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.67 131.46 34.94 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.67 0.747 . . . . 0.0 110.002 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -143.69 119.11 10.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.458 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 57.1 p-80 -89.74 114.35 26.02 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.625 0.726 . . . . 0.0 109.739 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -94.31 118.57 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.57 -0.706 . . . . 0.0 109.365 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 80.5 m80 41.92 85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.313 0.578 . . . . 0.0 109.977 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -113.37 122.16 46.53 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.522 0.677 . . . . 0.0 109.347 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -108.01 132.46 53.51 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.539 0.685 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.99 -179.705 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' LYS . 15.8 ptp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 52.71 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.533 0.682 . . . . 0.0 110.177 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' O ' ' SD ' ' A' ' 5' ' ' MET . 17.3 mmmt 52.83 179.0 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 122.029 0.919 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.78 151.96 37.44 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.967 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -146.39 74.3 12.79 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 108.997 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 49.6 Cg_exo -55.38 -159.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.993 2.462 . . . . 0.0 112.475 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.94 160.93 37.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' PHE . 8.0 t -149.45 121.73 8.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 90.1 m-85 56.82 147.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -105.5 -21.11 13.28 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 tpp -84.55 -74.54 0.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 109.498 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.53 89.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.0 m -85.41 -75.53 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.41 -1.053 . . . . 0.0 109.412 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' CD ' ' ND2' ' A' ' 55' ' ' ASN . 84.6 tt0 -171.76 149.76 2.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.555 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.0 131.81 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.94 . . . . 0.0 109.055 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -86.55 151.09 23.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.927 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.25 143.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 5.1 mp0 -97.36 153.78 38.27 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 109.717 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -15.74 38.77 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.572 2.181 . . . . 0.0 111.38 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -178.34 -47.69 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.223 -0.923 . . . . 0.0 110.818 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 51.9 Cg_exo -52.25 139.45 53.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 112.757 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.57 77.56 0.04 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . -136.92 42.31 1.32 Allowed Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 53' ' ' LEU . 86.6 mt -87.7 -7.16 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.035 . . . . 0.0 109.031 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.86 38.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 51' ' ' LEU . 82.7 mt -105.11 130.64 53.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 110.031 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.7 156.24 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.646 -0.659 . . . . 0.0 109.399 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' ND2' ' CD ' ' A' ' 41' ' ' GLU . 98.4 m-20 -107.92 19.12 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 57' ' ' THR . 7.2 p -62.69 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.421 ' N ' ' CG1' ' A' ' 56' ' ' VAL . 3.2 m -131.84 -15.52 3.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.98 -165.39 54.79 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.875 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 56.23 -117.75 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.015 -0.697 . . . . 0.0 110.486 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 59' ' ' ALA . 99.6 mtt180 40.22 -98.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.432 0.634 . . . . 0.0 110.48 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 63' ' ' ARG . 37.6 t80 -62.14 -45.85 91.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.6 -0.687 . . . . 0.0 109.494 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 40.91 -91.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.317 0.58 . . . . 0.0 110.27 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 61' ' ' PHE . 77.7 ttt-85 -144.31 143.71 31.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.96 110.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 19.5 p -159.98 -141.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.452 -1.028 . . . . 0.0 109.917 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' N ' ' OG ' ' A' ' 65' ' ' SER . 35.1 t80 58.18 119.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.862 0.839 . . . . 0.0 110.552 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 78' ' ' SER . 20.0 ptp180 -138.21 -34.64 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.3 128.06 7.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.007 -1.058 . . . . 0.0 109.981 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.52 ' O ' ' CB ' ' A' ' 78' ' ' SER . 5.5 p90 -166.94 179.43 5.26 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 77' ' ' TYR . 3.5 p 86.37 159.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.73 0.776 . . . . 0.0 110.204 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -54.53 -167.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.8 0.809 . . . . 0.0 110.755 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.45 125.69 0.03 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.533 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 24.9 t90 -175.02 171.61 3.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.672 -0.899 . . . . 0.0 109.96 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 98.6 m-20 55.19 108.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.731 0.777 . . . . 0.0 110.373 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 108.39 2.54 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 m -160.59 -112.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -1.078 . . . . 0.0 109.561 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.3 -169.13 0.37 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.009 0.909 . . . . 0.0 110.928 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -86.72 168.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.678 0.752 . . . . 0.0 110.891 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 87' ' ' VAL . 34.5 m -108.97 98.44 30.09 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 35.7 Cg_exo -52.53 -44.57 46.27 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.887 1.725 . . . . 0.0 111.958 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.588 ' C ' ' H ' ' A' ' 91' ' ' SER . 71.5 Cg_endo -81.79 163.46 18.48 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.133 1.889 . . . . 0.0 113.098 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' SER . . . -59.21 2.97 0.21 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.588 ' H ' ' C ' ' A' ' 89' ' ' PRO . 10.4 m -39.61 126.9 1.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.638 -0.919 . . . . 0.0 110.215 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.1 m -134.48 150.55 50.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.729 -0.607 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.0 tp -113.72 125.13 53.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . 159.89 -122.38 1.12 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -156.34 109.26 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -1.1 . . . . 0.0 109.103 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 35.0 t0 -169.75 48.21 0.12 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 37.8 Cg_endo -65.62 128.19 19.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.314 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 39.61 -164.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 144' ' ' GLY . 50.8 Cg_exo -56.12 -135.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.903 2.402 . . . . 0.0 111.975 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -121.62 55.43 5.55 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 109.456 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.08 145.4 96.53 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.48 2.12 . . . . 0.0 111.644 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -90.27 77.95 6.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.681 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -156.98 113.11 2.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.16 -168.99 44.09 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -66.21 -92.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.492 -1.004 . . . . 0.0 110.119 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -88.19 9.48 22.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.532 -0.73 . . . . 0.0 109.318 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 153' ' ' LEU . 3.8 mm? -73.05 137.68 45.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.507 -0.745 . . . . 0.0 110.177 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.05 -123.39 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -138.64 29.23 2.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 108.72 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 156' ' ' HIS . 55.4 p-80 -69.8 70.25 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.678 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -67.11 -39.93 86.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.632 -0.668 . . . . 0.0 109.288 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -153.11 160.24 42.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 109.76 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -83.97 128.18 34.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.432 -0.793 . . . . 0.0 110.367 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.474 ' ND1' ' OXT' ' A' ' 160' ' ' HIS . 59.3 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.955 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.783 0.801 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.35 141.8 55.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.45 -9.47 52.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.349 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.18 54.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 ptt? -154.86 51.74 0.65 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 109.135 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 5' ' ' MET . 47.6 Cg_endo -67.32 150.15 81.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.815 2.343 . . . . 0.0 112.94 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.16 -40.68 86.68 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.783 0.801 . . . . 0.0 109.074 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' C ' ' CG ' ' A' ' 9' ' ' PHE . 18.5 m -154.96 57.32 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.226 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CG ' ' C ' ' A' ' 8' ' ' SER . 3.2 p90 36.75 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.504 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CH2' ' SD ' ' A' ' 38' ' ' MET . 27.4 p-90 -104.11 8.2 36.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.524 ' SD ' ' CH2' ' A' ' 37' ' ' TRP . 7.5 ptm -157.98 84.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.914 -1.116 . . . . 0.0 109.069 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.11 89.22 1.61 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' GLU . 7.4 m -156.45 51.86 0.52 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 108.35 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' THR . 82.7 tt0 53.84 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.624 0.726 . . . . 0.0 110.194 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.062 -1.024 . . . . 0.0 110.334 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -150.71 112.7 4.55 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.65 -86.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 108.968 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' GLU . 70.6 mt-10 -157.3 76.08 4.08 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.7 18.44 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.248 1.965 . . . . 0.0 110.591 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' GLU . 1.3 pp20? -174.93 150.54 1.31 Allowed Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.81 135.6 28.39 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.357 2.038 . . . . 0.0 113.153 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.59 17.46 79.89 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.59 145.91 47.78 Favored Glycine 0 N--CA 1.494 2.525 0 O-C-N 121.347 -1.09 . . . . 0.0 110.536 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.76 147.69 26.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.355 -1.085 . . . . 0.0 110.039 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -82.16 128.26 33.97 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.823 0.82 . . . . 0.0 110.5 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 tp -157.79 120.7 3.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.48 -0.762 . . . . 0.0 108.994 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 55' ' ' ASN . 25.6 m -133.09 129.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.374 -0.829 . . . . 0.0 109.822 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' VAL . 28.9 t-20 36.77 -103.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 110.776 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 5.3 p -42.71 144.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.898 0.856 . . . . 0.0 110.492 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.6 t -143.49 158.1 43.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.95 136.47 3.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.44 -143.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.893 . . . . 0.0 110.332 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 20.9 tpt85 -128.23 131.21 48.81 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.739 0.78 . . . . 0.0 109.768 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 62' ' ' ALA . 69.5 m-85 -81.18 -6.29 58.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.721 0.772 . . . . 0.0 109.413 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 63' ' ' ARG . . . -59.91 -148.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 62' ' ' ALA . 95.3 mtt-85 55.81 158.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.01 0.909 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.12 -176.95 36.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.7 p -156.85 164.01 38.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -1.025 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -65.57 151.42 46.5 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.57 -0.706 . . . . 0.0 110.106 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -102.36 -27.75 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -158.18 137.16 11.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.639 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 1.7 t80 -118.61 129.41 55.3 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.5 t -101.19 132.68 46.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.639 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 50.0 m-85 -131.23 152.36 50.57 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.916 0.865 . . . . 0.0 109.749 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 75.69 -117.98 5.33 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 98.2 m95 46.94 17.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -1.033 . . . . 0.0 109.305 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' GLY . 63.3 t0 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.91 . . . . 0.0 109.296 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.82 -30.73 8.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 m -105.19 -52.76 2.78 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -1.028 . . . . 0.0 109.73 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.63 125.56 28.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -48.71 176.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.771 0.796 . . . . 0.0 110.608 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.55 79.11 72.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 109.598 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 40.5 Cg_exo -55.54 -174.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.395 2.063 . . . . 0.0 111.014 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 91' ' ' SER . 34.8 Cg_exo -60.13 143.19 99.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.637 2.225 . . . . 0.0 113.072 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.11 -23.67 1.77 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 89' ' ' PRO . 19.3 m -85.61 100.43 11.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -1.174 . . . . 0.0 110.216 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.532 ' OG ' ' NE2' ' A' ' 111' ' ' HIS . 8.0 p -175.25 -140.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 92' ' ' SER . 53.1 tp -109.92 120.9 43.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.716 . . . . 0.0 109.558 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.532 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.673 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.673 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 135' ' ' THR . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 131' ' ' LEU . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . 96.94 147.9 23.34 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.747 ' HE ' ' H ' ' A' ' 142' ' ' ASP . 8.2 tpm_? 59.61 139.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.809 -0.819 . . . . 0.0 110.422 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.747 ' H ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER 160.68 -39.02 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 36.0 Cg_exo -57.78 142.9 96.3 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.14 1.893 . . . . 0.0 112.451 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 154.36 -69.77 0.29 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.51 152.06 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.375 2.05 . . . . 0.0 112.699 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 20.0 p-10 -159.33 54.43 0.66 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.725 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 41.5 Cg_endo -67.05 150.61 82.57 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.963 2.442 . . . . 0.0 112.318 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -74.98 135.49 41.33 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.001 0.905 . . . . 0.0 110.199 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -62.98 -45.4 92.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.726 0.774 . . . . 0.0 109.831 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . -62.17 148.71 48.28 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 150' ' ' GLY . 88.2 mtm180 51.4 171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.649 -0.912 . . . . 0.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -138.64 144.22 39.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 109.633 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.25 78.12 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.6 mp0 -119.31 122.81 42.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.87 133.7 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.48 -0.763 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 157' ' ' HIS . 8.1 t60 -66.54 -42.83 86.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.642 0.734 . . . . 0.0 109.675 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 93.8 m-70 -148.7 -59.39 0.23 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.189 -0.945 . . . . 0.0 109.205 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.66 130.38 55.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.828 0.823 . . . . 0.0 110.297 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.37 -42.87 87.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.9 0.857 . . . . 0.0 109.621 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.5 t60 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.683 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.614 0.721 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.56 139.31 57.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.77 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -92.81 -9.03 41.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 109.25 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 43.5 65.27 1.02 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.915 0.864 . . . . 0.0 109.353 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.1 ttt -89.69 131.48 39.65 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 148.5 64.23 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.066 1.844 . . . . 0.0 112.518 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 9' ' ' PHE . 6.4 pt-20 -162.95 123.91 2.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.918 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m 58.38 -0.68 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.513 -0.742 . . . . 0.0 110.103 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 7' ' ' GLU . 65.5 m-85 -99.76 7.66 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 108.648 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CG ' ' N ' ' A' ' 38' ' ' MET . 8.9 p-90 -110.31 -65.39 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.576 ' SD ' ' CE1' ' A' ' 130' ' ' TYR . 23.1 ttt -142.1 154.55 45.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.827 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . 139.18 127.19 2.43 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.0 p -98.04 -17.58 19.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -1.21 . . . . 0.0 108.922 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 97.0 mt-10 -145.76 146.03 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.988 -1.07 . . . . 0.0 110.013 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.18 113.89 1.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 0.0 109.21 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -85.97 160.66 19.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.759 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -123.89 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.724 0.774 . . . . 0.0 109.53 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -176.71 148.75 0.83 Allowed Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' GLY . 37.4 Cg_endo -65.39 152.17 82.81 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -40.5 -62.24 1.0 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.638 -0.664 . . . . 0.0 110.049 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 29.1 Cg_endo -62.33 -18.92 65.31 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.135 1.89 . . . . 0.0 110.883 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 46' ' ' PRO . . . -42.16 -78.03 0.07 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.7 -26.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt 47.05 85.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.965 . . . . 0.0 109.563 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.75 -119.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.673 -0.642 . . . . 0.0 110.327 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.98 132.29 54.08 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.53 0.681 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.34 145.56 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.567 -0.708 . . . . 0.0 109.996 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.75 129.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.048 0.928 . . . . 0.0 111.287 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.407 ' C ' ' N ' ' A' ' 58' ' ' GLY . 18.8 m -65.62 -39.03 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 110.427 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.9 p 49.92 16.02 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.027 -1.046 . . . . 0.0 109.909 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 56' ' ' VAL . . . 152.19 -64.2 0.37 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.81 141.76 5.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -1.131 . . . . 0.0 109.818 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' NH2' ' OE2' ' A' ' 41' ' ' GLU . 42.4 ttm180 -71.17 135.62 47.68 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.585 0.707 . . . . 0.0 110.415 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -99.92 -102.93 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.451 -0.78 . . . . 0.0 109.891 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -169.68 -18.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 109.318 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -140.78 151.11 44.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.981 -1.074 . . . . 0.0 109.985 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.66 124.96 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 18.2 m -140.46 26.58 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . 53.7 m-85 56.79 151.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.355 1.074 . . . . 0.0 111.439 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -80.76 -74.84 0.3 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.914 0.864 . . . . 0.0 108.92 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -146.17 142.49 28.49 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 78' ' ' SER . 91.1 t80 -125.46 127.09 45.96 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 17.0 p -76.89 162.51 27.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 110.017 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -147.6 136.9 22.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 80.36 -101.82 2.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 26.2 t90 50.75 -88.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.551 -0.97 . . . . 0.0 110.364 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' GLY . 48.6 p-10 -69.33 140.2 54.3 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -0.912 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 84' ' ' SER . . . 60.3 -127.19 43.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 83' ' ' GLY . 10.1 p 63.16 178.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.933 0.873 . . . . 0.0 110.334 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.73 -54.37 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.679 0.752 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.3 m -90.79 3.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 109.56 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -130.15 78.28 74.92 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.169 -0.957 . . . . 0.0 109.802 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 27.1 Cg_exo -59.69 -173.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.689 2.26 . . . . 0.0 111.603 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 91' ' ' SER . 40.3 Cg_exo -58.65 140.31 94.36 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.916 2.411 . . . . 0.0 113.664 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 41.62 17.3 0.02 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 89' ' ' PRO . 93.7 p -74.49 -15.44 60.88 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.094 -1.239 . . . . 0.0 108.654 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 p -148.06 155.7 41.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 110.11 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp -161.04 129.14 4.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.466 ' HD1' ' N ' ' A' ' 112' ' ' SER . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.466 ' N ' ' HD1' ' A' ' 111' ' ' HIS . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.417 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.417 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.576 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CZ ' ' O ' ' A' ' 143' ' ' PRO . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . 152.68 -109.69 0.42 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -144.07 107.35 4.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -1.1 . . . . 0.0 109.395 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -165.81 68.91 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.56 -0.713 . . . . 0.0 109.079 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 31.2 Cg_exo -56.91 -30.28 85.27 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.646 2.23 . . . . 0.0 110.405 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.74 172.04 24.66 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.95 144.88 78.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.892 2.395 . . . . 0.0 112.351 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 4.1 p30 -158.37 54.97 0.79 Allowed Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.508 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 25.3 Cg_endo -61.69 106.57 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.533 2.155 . . . . 0.0 111.409 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 150' ' ' GLY . 76.0 m-85 -84.0 144.57 29.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.05 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -54.23 88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.822 0.82 . . . . 0.0 109.803 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 148' ' ' PHE . . . -67.6 110.59 3.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.405 HH21 ' CD1' ' A' ' 153' ' ' LEU . 16.7 ptm180 -84.49 132.54 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.459 -1.024 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.87 -35.32 74.57 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.851 0.834 . . . . 0.0 109.711 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.489 ' CG ' ' H ' ' A' ' 154' ' ' GLU . 5.8 tp 47.25 -131.08 1.41 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.713 0.768 . . . . 0.0 110.376 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.489 ' H ' ' CG ' ' A' ' 153' ' ' LEU . 97.5 mt-10 41.5 -168.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.015 0.912 . . . . 0.0 110.877 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.49 151.24 32.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.6 t60 41.54 47.87 3.36 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.899 0.857 . . . . 0.0 109.758 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.44 -44.1 97.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.54 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 86.2 t60 -164.12 77.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.459 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 77.9 m80 54.99 84.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.889 0.852 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 158' ' ' HIS . 97.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.036 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 56.62 27.04 11.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.14 131.06 45.29 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.742 0.782 . . . . 0.0 110.213 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.41 22.17 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.755 0.788 . . . . 0.0 109.82 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.1 tpt -172.1 73.0 0.47 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.12 141.14 96.26 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.761 2.308 . . . . 0.0 112.349 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -88.43 156.21 19.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.725 0.774 . . . . 0.0 110.055 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.532 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 8.5 p -74.26 130.82 40.46 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.342 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.532 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 5.2 p90 28.55 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.601 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 4.6 p80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 -109.84 -18.41 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.8 ttp -129.24 74.76 1.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.66 68.4 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -92.57 -88.43 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -1.007 . . . . 0.0 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -169.73 138.62 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.762 0.791 . . . . 0.0 110.633 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.06 153.79 2.62 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.486 0.66 . . . . 0.0 109.849 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 46.4 tp10 -92.57 98.83 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.543 0.687 . . . . 0.0 110.075 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 43' ' ' GLU . 2.3 m -161.87 24.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.722 -0.611 . . . . 0.0 109.695 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -142.35 69.9 21.83 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.0 109.664 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 -37.35 79.42 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.701 2.267 . . . . 0.0 111.441 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -46.27 150.39 1.13 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.91 -0.493 . . . . 0.0 109.841 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.4 -18.27 38.77 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.858 2.372 . . . . 0.0 111.893 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.82 95.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.567 ' C ' ' H ' ' A' ' 52' ' ' TYR . . . -97.69 -101.17 2.11 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TYR . 5.5 tp 51.44 7.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.765 . . . . 0.0 109.748 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 6.3 p90 -59.7 -144.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.738 0.78 . . . . 0.0 109.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 3.6 mm? -68.77 136.64 53.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.393 -0.817 . . . . 0.0 109.784 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 163.04 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.764 0.792 . . . . 0.0 109.716 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -69.6 78.93 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.781 0.8 . . . . 0.0 110.192 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 57' ' ' THR . 13.4 p -65.13 -32.02 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.658 -0.651 . . . . 0.0 109.397 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER 74.45 69.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.858 0.837 . . . . 0.0 109.717 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.48 158.44 19.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 44.8 -158.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.85 0.833 . . . . 0.0 110.858 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 62' ' ' ALA . 85.5 mtp180 -72.8 -167.98 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.56 0.695 . . . . 0.0 109.901 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 49.75 16.87 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . -102.71 95.68 6.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 109.284 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -110.01 -29.56 8.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.18 147.01 42.04 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 66' ' ' PHE . 45.6 t -157.61 176.12 13.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.655 -0.909 . . . . 0.0 109.839 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.618 ' H ' ' HG ' ' A' ' 65' ' ' SER . 92.2 m-85 -151.06 59.36 0.91 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.01 -46.17 88.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.786 -1.196 . . . . 0.0 109.434 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -164.98 140.7 5.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.788 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -122.37 153.82 38.5 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' OG ' ' A' ' 65' ' ' SER . 25.3 p -93.08 6.47 47.85 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 62.0 t80 56.74 -105.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.596 0.712 . . . . 0.0 110.262 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . -88.53 -74.98 1.29 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 74.1 t90 60.52 0.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.979 -0.718 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 47.9 p-10 -66.88 -33.99 76.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.476 -0.765 . . . . 0.0 109.771 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 80.06 21.05 66.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -59.32 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -1.152 . . . . 0.0 109.928 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.08 -81.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -140.66 76.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.332 -0.855 . . . . 0.0 109.155 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 5.4 t -144.4 54.95 2.98 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.495 -0.753 . . . . 0.0 109.471 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 87' ' ' VAL . 18.8 Cg_endo -58.19 166.01 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.724 2.282 . . . . 0.0 111.646 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.35 131.24 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.212 1.941 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.94 -24.86 26.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 t -74.55 151.85 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -1.024 . . . . 0.0 110.493 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 113' ' ' GLY . 22.2 p 46.65 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.739 0.781 . . . . 0.0 110.674 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp -123.4 128.91 50.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.55 ' HG ' ' N ' ' A' ' 117' ' ' ALA . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.55 ' N ' ' HG ' ' A' ' 116' ' ' SER . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.653 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.653 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -146.02 -150.56 5.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 59.2 ttt85 -173.08 154.99 2.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.828 . . . . 0.0 109.852 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 3.9 t70 77.59 58.82 0.21 Allowed Pre-proline 0 N--CA 1.494 1.77 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.231 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 144' ' ' GLY . 43.8 Cg_endo -68.69 152.91 74.14 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.141 1.894 . . . . 0.0 112.351 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -46.86 176.82 0.01 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.22 141.6 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.295 1.997 . . . . 0.0 112.246 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.721 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 23.1 t70 -129.22 23.72 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.997 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 51.9 Cg_exo -47.65 77.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 111.971 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 149' ' ' TYR . 86.6 t80 48.98 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.971 0.891 . . . . 0.0 111.001 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 47.1 m-85 -64.94 -73.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.518 -0.739 . . . . 0.0 110.016 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 151' ' ' ARG . . . 163.33 164.8 19.25 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 150' ' ' GLY . 6.6 ptp85 31.16 60.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.543 0.687 . . . . 0.0 110.228 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -70.37 131.47 44.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.1 tp -132.04 125.64 31.94 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.546 0.689 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -133.35 153.47 51.55 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.778 0.799 . . . . 0.0 110.052 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -69.38 -165.05 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.604 0.716 . . . . 0.0 110.185 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 158' ' ' HIS . 14.6 p80 -157.53 -169.19 2.8 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.88 0.847 . . . . 0.0 110.183 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.8 t60 58.52 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 156' ' ' HIS . 46.3 p-80 -91.99 127.08 37.32 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.02 0.914 . . . . 0.0 110.214 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.0 m-70 47.93 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.893 0.854 . . . . 0.0 110.496 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.822 -179.503 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.374 0.607 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 128' ' ' ALA . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.518 ' O ' ' CG ' ' A' ' 37' ' ' TRP . 14.6 p-90 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 112' ' ' SER . 44.1 tp . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 121.224 0.535 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 93' ' ' LEU . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 93' ' ' LEU . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 120' ' ' CYS . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 34.3 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' ' NH2' ' A' ' 13' ' ' ARG . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.361 0.6 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.538 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.468 ' NE2' HD21 ' A' ' 114' ' ' LEU . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 111' ' ' HIS . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.538 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 34' ' ' ILE . 15.3 p-90 . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.176 0.512 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.432 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.517 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 . . . . . 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.8 tp . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 107' ' ' LEU . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.552 ' N ' HD23 ' A' ' 107' ' ' LEU . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' CE1' ' HE1' ' A' ' 127' ' ' TRP . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.487 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.618 0.723 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' NH1' ' A' ' 13' ' ' ARG . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH1' HG11 ' A' ' 11' ' ' VAL . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 29' ' ' THR . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.521 0.677 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.583 ' N ' HD23 ' A' ' 109' ' ' LEU . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.207 0.527 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.735 HG21 ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.735 ' NE2' HG21 ' A' ' 11' ' ' VAL . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.77 ' OE2' HD12 ' A' ' 106' ' ' LEU . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.674 ' CE1' HD11 ' A' ' 106' ' ' LEU . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' CE3' ' O ' ' A' ' 37' ' ' TRP . 42.9 p-90 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 22.3 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 101' ' ' GLN . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' OE2' ' A' ' 14' ' ' GLU . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.611 ' C ' HD23 ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' O ' HG22 ' A' ' 29' ' ' THR . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 25' ' ' PHE . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' ILE . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' CD2' ' A' ' 37' ' ' TRP . 40.0 p-90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 109' ' ' LEU . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.486 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 37' ' ' TRP . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.104 0.478 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH2' HH21 ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 17' ' ' LEU . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.234 0.54 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 74' ' ' ARG . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HE ' HG21 ' A' ' 70' ' ' VAL . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.53 HH21 ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.598 ' NE2' HD21 ' A' ' 114' ' ' LEU . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.598 HD21 ' NE2' ' A' ' 111' ' ' HIS . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 87.6 m-85 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.322 0.582 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.572 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HG11 ' A' ' 137' ' ' VAL . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 67.6 p-90 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 97.6 mt-10 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.572 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG11 HH21 ' A' ' 36' ' ' ARG . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . . . . . . 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.617 0.723 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' ALA . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CE3' ' O ' ' A' ' 37' ' ' TRP . 45.4 p-90 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.288 0.565 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.645 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 107' ' ' LEU . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.51 ' N ' HD23 ' A' ' 107' ' ' LEU . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.632 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.592 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.548 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 111' ' ' HIS . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HH12 ' A' ' 133' ' ' ARG . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.408 HH12 ' HB3' ' A' ' 129' ' ' HIS . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.384 0.612 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.621 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 33' ' ' LYS . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HG2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.455 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.449 HG22 ' CD2' ' A' ' 111' ' ' HIS . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.449 ' CD2' HG22 ' A' ' 94' ' ' VAL . 28.1 t-80 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 32.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.41 HD23 ' OE2' ' A' ' 95' ' ' GLU . 55.8 tp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 93' ' ' LEU . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.47 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 31' ' ' PRO . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.501 ' O ' ' CD2' ' A' ' 37' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 72' ' ' VAL . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.597 0.713 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.665 ' N ' HD13 ' A' ' 93' ' ' LEU . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.43 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD13 ' SG ' ' A' ' 120' ' ' CYS . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 137' ' ' VAL . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' GLY . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 133' ' ' ARG . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 29' ' ' THR . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.557 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 29' ' ' THR . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.462 0.649 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.492 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.66 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.56 ' OE1' HD23 ' A' ' 106' ' ' LEU . 26.0 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.56 HD23 ' OE1' ' A' ' 101' ' ' GLN . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 107' ' ' LEU . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.493 ' N ' HD23 ' A' ' 107' ' ' LEU . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.467 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 . . . . . 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.333 0.587 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' OE2' ' A' ' 95' ' ' GLU . 37.0 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' OE2' HD21 ' A' ' 93' ' ' LEU . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.469 ' NE2' HD21 ' A' ' 114' ' ' LEU . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD21 ' NE2' ' A' ' 111' ' ' HIS . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 114' ' ' LEU . 3.2 p90 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.445 HG13 ' OG ' ' A' ' 112' ' ' SER . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.522 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.445 ' OG ' HG13 ' A' ' 10' ' ' VAL . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.702 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.522 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 8.9 p-90 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.468 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 111' ' ' HIS . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.616 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.541 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' CE1' HD21 ' A' ' 114' ' ' LEU . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 111' ' ' HIS . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.454 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.454 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 112' ' ' SER . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.54 HG11 ' NH2' ' A' ' 13' ' ' ARG . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' NH2' HG11 ' A' ' 11' ' ' VAL . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.405 0.621 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 77' ' ' TYR . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 75' ' ' LEU . 44.8 m-85 . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.658 ' C ' HD23 ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.426 ' CB ' HG22 ' A' ' 10' ' ' VAL . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.677 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -162.24 67.38 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.945 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -68.27 -104.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.357 -0.839 . . . . 0.0 110.545 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.55 149.15 36.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 110.683 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 mtt 43.43 76.92 0.48 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.613 -0.679 . . . . 0.0 110.168 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 7' ' ' GLU . 35.7 Cg_exo -59.69 144.57 99.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.665 2.243 . . . . 0.0 112.409 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.4 mm-40 44.46 -169.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.414 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 9' ' ' PHE . 87.2 p -121.87 -71.22 0.74 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.78 -0.575 . . . . 0.0 109.487 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 8' ' ' SER . 58.6 m-85 49.89 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.627 . . . . 0.0 109.38 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 128' ' ' ALA . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.518 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 14.6 p-90 -132.89 86.51 2.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.56 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 1.8 tpt 82.54 158.43 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.544 0.687 . . . . 0.0 110.309 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.98 113.69 1.97 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.5 m -95.86 -18.56 20.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -1.081 . . . . 0.0 108.588 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -157.33 119.02 3.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.17 146.18 40.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 109.45 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -150.7 126.41 10.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 108.598 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.77 156.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.019 -1.051 . . . . 0.0 109.728 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 41.43 56.19 8.88 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.716 -0.615 . . . . 0.0 110.466 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.56 -89.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.436 2.09 . . . . 0.0 112.218 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -79.88 157.85 73.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.613 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.08 137.73 28.77 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.017 1.811 . . . . 0.0 112.487 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 127.81 -19.82 5.8 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.24 122.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.94 112.76 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.24 . . . . 0.0 108.601 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.28 123.45 36.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 109.933 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.7 tp -164.83 129.31 2.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 108.888 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.99 137.2 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.234 -0.916 . . . . 0.0 109.128 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -86.67 86.4 7.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.89 -46.78 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.317 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -141.63 154.59 45.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.287 -0.883 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 42.99 -129.32 5.4 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.49 50.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -126.84 136.93 53.02 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.84 0.829 . . . . 0.0 110.202 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 63' ' ' ARG . 53.7 p90 -173.84 5.21 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.62 -81.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.908 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 61' ' ' PHE . 62.4 ttm-85 -141.57 141.78 33.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.227 -0.921 . . . . 0.0 109.654 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.7 164.79 54.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 m -159.76 89.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 108.85 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -73.39 136.89 44.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -103.74 -52.48 2.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -153.09 138.38 17.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -165.49 165.64 18.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 p -132.82 150.08 52.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 80' ' ' GLY . 16.5 p90 -169.83 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' ' CE2' ' A' ' 79' ' ' PHE . . . 84.11 160.95 31.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -89.96 -0.96 57.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.0 108.796 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.12 31.06 10.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.782 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.54 -8.65 76.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 85' ' ' GLU . 93.3 p -162.63 160.68 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.254 . . . . 0.0 109.738 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 84' ' ' SER . 96.4 mt-10 40.42 -105.58 0.06 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.623 0.725 . . . . 0.0 110.236 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.06 -33.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t 58.45 80.81 0.27 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -78.22 168.25 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.476 2.117 . . . . 0.0 111.942 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.67 136.99 59.13 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.202 1.935 . . . . 0.0 113.33 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.25 -27.84 10.89 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 80.8 p -68.62 -22.0 64.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.264 . . . . 0.0 109.527 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.5 p -156.99 162.51 39.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 108.523 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' OE2' ' A' ' 95' ' ' GLU . 44.1 tp -133.93 129.57 36.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.311 -0.868 . . . . 0.0 109.607 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 93' ' ' LEU . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 120' ' ' CYS . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 34.3 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' ' NH2' ' A' ' 13' ' ' ARG . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.56 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.48 126.08 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -70.57 -178.65 1.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -1.051 . . . . 0.0 111.021 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.7 OUTLIER 57.78 74.95 0.58 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 109.477 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.53 145.16 98.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.766 2.311 . . . . 0.0 112.365 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 145' ' ' PRO . . . -65.71 -44.01 93.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 144' ' ' GLY . 37.8 Cg_exo -60.65 148.81 90.27 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.776 2.317 . . . . 0.0 112.802 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 145' ' ' PRO . 76.6 m-20 -136.55 61.29 36.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 -38.07 38.25 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.003 1.802 . . . . 0.0 111.06 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -149.83 -53.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -80.13 140.61 36.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.299 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.06 65.12 0.05 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.11 135.38 55.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -1.036 . . . . 0.0 110.398 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 153' ' ' LEU . 12.2 tpp85 -161.27 71.53 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 108.8 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 152' ' ' ARG . 91.5 mt 39.93 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.433 0.635 . . . . 0.0 110.343 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.577 ' H ' ' CD ' ' A' ' 154' ' ' GLU . 2.0 pm0 -112.88 147.53 36.83 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.468 0.652 . . . . 0.0 109.367 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -63.24 175.36 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 110.496 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.73 165.45 30.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.316 -0.865 . . . . 0.0 109.391 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -73.23 133.91 44.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -78.02 150.42 33.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.301 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -67.76 141.75 56.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.464 -0.773 . . . . 0.0 110.133 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.022 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -65.36 140.41 58.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.432 -0.792 . . . . 0.0 110.232 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.4 143.0 40.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.71 . . . . 0.0 110.106 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.04 122.16 2.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.1 mtm 42.34 71.6 1.34 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.429 -0.794 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 7' ' ' GLU . 32.6 Cg_exo -58.99 143.76 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 0.0 112.71 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' PRO . 81.9 tt0 57.72 151.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.709 0.766 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 p -73.11 164.91 25.99 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -73.05 143.63 47.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 110.02 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.538 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.744 HH22 ' HE ' ' A' ' 141' ' ' ARG . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.525 ' O ' ' CB ' ' A' ' 38' ' ' MET . 30.8 p-90 -104.04 23.83 12.34 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER 90.69 147.33 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.495 0.664 . . . . 0.0 110.681 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.67 -163.57 27.42 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' GLU . 43.6 p -107.43 53.29 0.69 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.357 -1.084 . . . . 0.0 109.349 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' THR . 97.8 mt-10 58.58 140.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.446 0.641 . . . . 0.0 110.71 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.35 11.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.493 -0.755 . . . . 0.0 109.668 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.42 163.77 15.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.474 -0.766 . . . . 0.0 109.85 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.89 144.38 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.628 -0.67 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -166.37 155.29 10.05 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.167 -0.958 . . . . 0.0 108.883 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -43.4 -37.76 7.8 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.051 1.834 . . . . 0.0 112.186 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.27 112.12 61.34 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 109.115 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.55 136.72 33.33 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.799 1.666 . . . . 0.0 112.814 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.7 -40.95 1.06 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 52' ' ' TYR . . . 75.51 19.34 79.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.0 mt 55.18 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.91 . . . . 0.0 110.133 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' A' ' 50' ' ' GLY . 96.1 m-85 -75.74 157.17 33.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.971 . . . . 0.0 110.395 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 tp -75.75 125.61 29.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 109.742 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' ASN . 31.2 m -141.04 161.12 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.327 -0.858 . . . . 0.0 109.913 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' VAL . 39.6 p30 22.1 -142.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.678 0.751 . . . . 0.0 112.687 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.39 135.52 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.888 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 m -119.74 129.45 54.51 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.17 -125.53 5.41 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . -93.55 -166.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.0 110.643 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 55.31 3.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 59' ' ' ALA . 89.9 t80 -84.93 -68.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.338 -0.851 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.0 176.4 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.191 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -135.91 152.1 50.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.89 -47.46 0.64 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.0 p -107.81 0.04 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.934 . . . . 0.0 108.997 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -73.37 146.37 45.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -104.87 -30.74 9.65 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -161.4 131.63 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -157.79 162.23 38.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -137.69 142.61 41.08 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -151.03 127.27 10.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.888 -1.132 . . . . 0.0 109.283 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.51 -175.31 43.2 Favored Glycine 0 N--CA 1.498 2.802 0 O-C-N 121.149 -0.969 . . . . 0.0 110.805 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.423 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 65.7 p-90 -72.18 139.13 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.518 -0.989 . . . . 0.0 110.407 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 82.8 m-20 -145.62 72.86 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.47 -13.57 57.66 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' VAL . 13.9 m -84.76 158.37 20.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.1 -1.235 . . . . 0.0 110.266 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 86' ' ' VAL . 58.4 mp0 -58.93 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.9 m 31.21 89.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.09 0.472 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.4 m 29.21 75.32 0.37 Allowed Pre-proline 0 N--CA 1.5 2.068 0 CA-C-O 121.154 0.502 . . . . 0.0 111.593 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 12.1 Cg_exo -55.14 -44.13 52.39 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.034 1.822 . . . . 0.0 112.421 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 93.7 Cg_endo -84.66 -8.21 9.43 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.912 1.741 . . . . 0.0 111.116 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 97.9 -28.99 11.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 92' ' ' SER . 97.9 p 33.04 -90.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.034 -0.686 . . . . 0.0 110.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 90' ' ' GLY . 21.2 m 46.29 -113.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 109.62 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp -119.86 121.33 38.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.468 ' NE2' HD21 ' A' ' 114' ' ' LEU . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 111' ' ' HIS . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' CE1' ' O ' ' A' ' 89' ' ' PRO . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.538 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . -153.54 -134.79 2.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.744 ' HE ' HH22 ' A' ' 36' ' ' ARG . 80.2 mtp85 -42.71 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 110.714 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.84 81.46 58.27 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.703 . . . . 0.0 109.741 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.86 144.16 89.03 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.588 2.192 . . . . 0.0 112.365 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.61 177.31 0.23 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 158.11 57.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.824 2.349 . . . . 0.0 112.18 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.12 76.39 69.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 149' ' ' TYR . 49.2 Cg_exo -55.3 -36.68 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.636 2.224 . . . . 0.0 111.403 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 53.76 7.16 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 147' ' ' PRO . 90.6 t80 -63.01 -42.9 99.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 87.29 69.65 1.3 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.04 137.73 47.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 109.7 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -138.95 134.23 32.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 153' ' ' LEU . 3.8 mm? -87.79 -99.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.01 124.71 50.0 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.605 0.717 . . . . 0.0 109.624 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -92.79 -19.95 21.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -133.46 126.64 31.61 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.57 0.7 . . . . 0.0 109.744 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -155.67 -7.15 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.4 t-80 -74.86 138.51 42.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 110.486 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 158' ' ' HIS . 86.5 t60 46.74 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.16 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 160' ' ' HIS . 52.8 p-80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.109 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.19 140.89 58.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.454 -0.779 . . . . 0.0 109.958 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' ALA . 65.5 tttm -155.2 109.42 2.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' LYS . . . 60.5 130.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 5' ' ' MET . 0.4 OUTLIER -156.51 55.02 0.97 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 5' ' ' MET . 67.8 Cg_endo -71.49 152.46 60.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.841 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.91 58.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' PHE . 8.4 m -72.16 132.57 44.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.76 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' SER . 95.7 m-85 36.39 76.87 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 34' ' ' ILE . 15.3 p-90 -106.78 18.06 22.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 37' ' ' TRP . 96.8 mmm -141.51 -162.96 1.47 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.1 -1.0 . . . . 0.0 110.566 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.63 175.98 15.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.7 p -87.93 0.94 55.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.918 . . . . 0.0 108.991 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.54 131.01 27.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 109.103 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 55' ' ' ASN . . . -158.35 152.93 24.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.9 pm0 -132.06 148.21 52.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.46 132.81 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.742 . . . . 0.0 109.204 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -171.88 85.7 0.46 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.44 -34.7 62.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.058 1.839 . . . . 0.0 111.142 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -81.89 152.03 68.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.501 -0.749 . . . . 0.0 109.914 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.65 145.58 70.3 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.989 2.46 . . . . 0.0 112.918 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.25 0.94 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.9 92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.65 146.37 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 109.994 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -81.96 -11.37 58.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.569 -0.707 . . . . 0.0 109.147 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.29 148.37 39.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.034 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 56' ' ' VAL . 27.3 m -135.2 161.91 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.537 -0.727 . . . . 0.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ALA . 25.9 t-20 55.73 -77.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.256 0.551 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.9 t 58.85 129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.862 0.839 . . . . 0.0 110.757 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.4 p -101.93 -6.16 23.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -88.17 -13.32 64.18 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 61' ' ' PHE . . . 43.68 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.503 -0.998 . . . . 0.0 110.877 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' ALA . 95.6 mtt180 40.95 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.864 -0.522 . . . . 0.0 110.17 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 59' ' ' ALA . 50.5 t80 60.97 -70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.821 -0.549 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -100.21 147.06 26.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -143.41 149.07 37.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.466 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.69 89.83 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.0 m -91.38 -140.37 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.339 -1.095 . . . . 0.0 109.683 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 65' ' ' SER . 97.1 m-85 57.32 152.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.731 0.776 . . . . 0.0 110.535 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -86.11 -58.62 2.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.68 131.55 19.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.669 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.432 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -165.51 156.62 14.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 p -82.36 151.79 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.959 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 71.6 t80 -177.48 -58.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . 67.22 -142.61 41.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -106.65 121.83 45.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.361 -1.082 . . . . 0.0 109.143 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 67.4 t0 -66.4 141.91 57.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.668 0.747 . . . . 0.0 110.674 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 91.75 8.01 64.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -119.19 120.11 36.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.663 -0.904 . . . . 0.0 109.411 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 87' ' ' VAL . 79.6 mm-40 -101.54 -16.97 16.61 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.06 21.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 85' ' ' GLU . 17.0 t -140.2 67.31 32.61 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -59.38 -178.11 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.344 2.029 . . . . 0.0 111.657 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 145.03 98.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.51 2.14 . . . . 0.0 112.745 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.94 -28.23 5.61 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -63.69 -40.86 97.85 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.475 -1.014 . . . . 0.0 109.702 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -138.24 154.03 49.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp -149.1 128.71 13.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.432 -0.793 . . . . 0.0 109.026 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -175.48 -166.63 33.38 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 142' ' ' ASP . 87.7 mtm180 -144.22 161.58 38.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -1.008 . . . . 0.0 109.917 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 141' ' ' ARG . 3.7 p-10 41.76 69.08 2.24 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.782 -0.574 . . . . 0.0 110.286 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.57 -37.84 90.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.61 2.207 . . . . 0.0 111.237 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.84 -160.43 29.34 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.19 -163.91 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.848 2.365 . . . . 0.0 112.555 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -125.04 82.26 61.81 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.701 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 149' ' ' TYR . 17.2 Cg_exo -63.59 156.08 59.14 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.99 2.46 . . . . 0.0 112.063 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.5 t80 66.91 -61.56 0.33 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 147' ' ' PRO . 89.8 t80 -61.27 -44.58 97.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.12 174.53 3.39 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.036 -1.04 . . . . 0.0 110.787 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 153' ' ' LEU . 35.1 ptt180 -69.57 -10.39 57.95 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.516 -0.991 . . . . 0.0 109.114 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 59.38 -74.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.632 . . . . 0.0 109.69 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 151' ' ' ARG . 5.1 tp -140.07 -130.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.882 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 153' ' ' LEU . 98.1 mt-10 56.5 34.18 23.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -67.59 138.37 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 110.065 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -99.42 99.29 10.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.65 ' CG ' ' H ' ' A' ' 158' ' ' HIS . 48.3 t-80 49.55 179.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.79 0.805 . . . . 0.0 111.157 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 157' ' ' HIS . 80.8 m80 -74.96 135.2 41.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.453 -0.779 . . . . 0.0 110.102 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.91 128.1 34.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.386 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.065 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.459 0.647 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.4 -2.45 57.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.59 103.14 13.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.515 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.06 149.0 23.93 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.0 mtt -81.51 158.2 69.04 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.234 -0.917 . . . . 0.0 109.528 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 8' ' ' SER . 63.6 Cg_exo -47.16 -40.3 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.988 1.792 . . . . 0.0 112.144 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 6' ' ' PRO . 97.3 mt-10 38.26 -90.2 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.524 0.678 . . . . 0.0 110.561 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 6' ' ' PRO . 2.6 p 63.02 127.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.558 0.694 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -99.63 153.47 19.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.569 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 40' ' ' THR . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.517 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -110.28 40.95 1.84 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 tpt -150.46 -55.82 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.65 78.41 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 72.0 m -117.58 107.92 14.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.516 -0.991 . . . . 0.0 109.017 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 41' ' ' GLU . 57.8 mp0 -42.44 155.67 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.336 0.589 . . . . 0.0 110.255 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.32 152.87 32.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 109.918 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 96.8 mt-10 -82.93 163.54 21.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.96 140.36 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -100.86 148.53 35.17 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.4 -35.41 16.03 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.972 1.781 . . . . 0.0 112.276 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 mm-40 176.51 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.728 . . . . 0.0 109.082 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 92.6 Cg_endo -78.08 147.77 23.99 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.154 1.903 . . . . 0.0 112.712 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.06 95.04 0.5 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.51 157.27 3.02 Favored Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.51 -0.994 . . . . 0.0 110.618 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -50.26 -101.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.985 -0.715 . . . . 0.0 110.505 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' O ' ' CD2' ' A' ' 52' ' ' TYR . 55.6 t80 59.97 7.24 1.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -111.36 149.2 31.5 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' ASN . 98.7 t -134.98 157.41 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.627 -0.671 . . . . 0.0 109.655 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' THR . 24.0 m120 -81.18 -170.43 2.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 110.052 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' ASN . 16.0 m 32.64 35.77 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.88 0.848 . . . . 0.0 110.404 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ASN . 86.1 m -106.29 -11.81 15.9 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.38 21.73 64.05 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.1 153.53 35.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.186 -1.185 . . . . 0.0 109.584 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 61' ' ' PHE . 10.8 ptp85 -141.9 153.43 44.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.326 -0.859 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 62' ' ' ALA . 84.7 m-85 38.78 -102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.669 -0.644 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 49.92 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.629 -0.669 . . . . 0.0 109.429 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.8 148.02 50.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.382 -0.823 . . . . 0.0 109.106 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.38 -85.85 1.65 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -138.31 120.54 15.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.454 -1.027 . . . . 0.0 109.316 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -70.16 135.14 48.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -74.11 -79.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.944 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -147.4 134.94 20.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -125.06 129.01 49.4 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.5 117.87 33.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.404 -0.81 . . . . 0.0 109.537 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 85.9 t80 -161.38 132.29 5.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.088 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . -70.69 168.47 49.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.9 t90 -84.73 157.61 21.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -1.017 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.34 -83.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.421 -0.799 . . . . 0.0 109.48 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TRP . . . 176.27 -30.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -86.02 -175.28 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.497 -1.002 . . . . 0.0 109.975 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -70.26 3.1 3.09 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 84' ' ' SER . 22.9 m -68.85 138.58 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.84 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 m -150.1 68.02 8.59 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.401 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.514 ' O ' ' NE2' ' A' ' 119' ' ' GLN . 17.2 Cg_exo -54.64 -42.99 63.27 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.162 1.908 . . . . 0.0 112.26 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 45.0 Cg_endo -80.87 -4.44 12.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.465 1.443 . . . . 0.0 111.084 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.71 31.59 26.5 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 p -64.93 152.67 42.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.5 -1.0 . . . . 0.0 110.308 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 93' ' ' LEU . 1.8 t -176.4 -94.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' N ' ' OG ' ' A' ' 92' ' ' SER . 36.8 tp -111.57 120.51 42.33 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' C ' HD23 ' A' ' 107' ' ' LEU . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.552 ' N ' HD23 ' A' ' 107' ' ' LEU . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 88' ' ' PRO . 29.7 mm100 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 89' ' ' PRO . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.487 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.45 -115.97 0.62 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -172.34 54.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -1.068 . . . . 0.0 109.239 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.67 80.62 12.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.473 -0.767 . . . . 0.0 109.731 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.05 -37.3 78.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.378 2.052 . . . . 0.0 111.29 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 53.99 -176.57 0.31 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.67 13.91 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.512 2.141 . . . . 0.0 111.322 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.98 60.36 2.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.927 -0.483 . . . . 0.0 110.243 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.96 -17.14 41.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.298 1.999 . . . . 0.0 111.833 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.442 ' O ' ' CD2' ' A' ' 148' ' ' PHE . 82.5 t80 -84.27 59.34 5.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.32 -46.09 90.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.14 -46.12 0.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.72 134.09 38.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -1.225 . . . . 0.0 110.143 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -65.88 -42.62 90.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.533 -0.73 . . . . 0.0 109.977 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.52 129.1 56.47 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.405 -0.809 . . . . 0.0 109.909 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -110.38 159.57 17.34 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.734 -0.604 . . . . 0.0 109.497 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.8 114.16 22.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.739 . . . . 0.0 110.192 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.95 -11.67 32.72 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.49 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 20.1 t-80 -65.7 -43.81 88.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.598 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' ND1' ' O ' ' A' ' 157' ' ' HIS . 19.6 m-70 -146.55 150.47 35.6 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.88 89.56 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.048 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 5.1 mpp? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 59.12 62.24 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.443 0.64 . . . . 0.0 109.882 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 58.41 161.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.818 0.818 . . . . 0.0 110.861 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.71 58.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.774 -0.579 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -146.36 76.13 12.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 109.238 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.74 138.3 84.75 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.727 2.285 . . . . 0.0 112.011 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -175.19 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p 43.44 -128.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.664 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.1 152.0 21.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 110.268 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' NH1' ' A' ' 13' ' ' ARG . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH1' HG11 ' A' ' 11' ' ' VAL . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 29' ' ' THR . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -111.54 -26.98 8.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.505 ' SD ' ' OH ' ' A' ' 130' ' ' TYR . 1.2 tmm? -79.9 -71.12 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.166 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 35' ' ' LEU . . . 80.06 -165.47 49.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLU . 44.0 p 54.89 48.91 18.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.819 -0.812 . . . . 0.0 110.231 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 40' ' ' THR . 79.4 mm-40 56.65 144.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.779 0.799 . . . . 0.0 110.8 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.28 153.2 6.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -136.33 144.38 44.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.775 . . . . 0.0 109.067 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 44' ' ' VAL . 14.1 p -83.41 28.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.057 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLU . 28.6 tp10 -125.43 76.73 68.97 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.85 80.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.506 2.138 . . . . 0.0 112.148 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 45' ' ' GLU . 44.4 tt0 -174.04 83.02 0.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 136.28 61.65 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.315 2.01 . . . . 0.0 112.495 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.02 16.95 79.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.46 -109.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.196 -1.179 . . . . 0.0 110.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 51' ' ' LEU . 9.5 mp -84.02 -0.64 52.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.505 -0.997 . . . . 0.0 109.665 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 56.76 84.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.557 0.694 . . . . 0.0 109.968 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 pt? -165.39 140.33 5.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.335 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' VAL . 18.7 m -146.44 170.54 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.174 -0.954 . . . . 0.0 108.832 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 56' ' ' VAL . 17.7 t-20 54.34 -90.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 110.232 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 56' ' ' VAL . 14.5 p -63.05 121.67 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 110.271 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.2 m -133.89 132.37 40.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -0.826 . . . . 0.0 109.493 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.12 117.67 6.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 41.65 -111.26 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.596 -0.944 . . . . 0.0 110.449 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.4 105.48 3.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.186 -0.946 . . . . 0.0 108.791 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -73.66 131.78 42.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 0.0 109.917 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.29 120.79 9.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 109.072 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -146.03 145.23 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.115 -0.991 . . . . 0.0 109.542 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.32 120.49 5.59 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -164.78 -159.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 109.746 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER 62.54 176.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.757 0.789 . . . . 0.0 110.84 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.53 -51.75 67.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.354 0.597 . . . . 0.0 109.815 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.49 147.39 26.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.301 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.69 156.85 37.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 8.3 t -143.75 124.39 14.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.315 -0.866 . . . . 0.0 108.976 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 78' ' ' SER . 85.1 m-85 -157.95 96.5 1.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.61 111.75 4.24 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -108.97 138.0 46.01 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -1.012 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 54.78 46.7 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.764 . . . . 0.0 109.37 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -39.27 148.82 0.11 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 86' ' ' VAL . 4.9 m 49.98 -164.48 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 59.05 -70.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.326 0.584 . . . . 0.0 109.854 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 84' ' ' SER . 4.0 p -153.28 110.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 109.093 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.18 70.88 12.02 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 11.8 Cg_exo -56.74 -44.66 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.618 2.212 . . . . 0.0 113.186 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' SER . 72.2 Cg_endo -81.29 161.19 20.1 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.205 1.937 . . . . 0.0 112.673 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -51.64 85.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' PRO . 33.2 t -88.64 56.93 3.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -1.127 . . . . 0.0 108.966 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 113' ' ' GLY . 16.3 t -165.46 -130.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -0.905 . . . . 0.0 109.579 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -102.08 114.3 28.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.583 ' N ' HD23 ' A' ' 109' ' ' LEU . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.505 ' OH ' ' SD ' ' A' ' 38' ' ' MET . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -171.19 96.89 0.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -74.06 156.33 37.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -1.112 . . . . 0.0 110.145 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 60.45 60.84 3.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.637 -0.664 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.1 -4.22 14.84 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.447 2.098 . . . . 0.0 111.083 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' H ' ' HD3' ' A' ' 145' ' ' PRO . . . 104.21 58.64 0.7 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.468 ' HD3' ' H ' ' A' ' 144' ' ' GLY . 56.5 Cg_endo -69.82 155.41 65.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.758 2.306 . . . . 0.0 112.57 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.54 77.11 3.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.225 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.89 143.24 96.23 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.689 2.259 . . . . 0.0 112.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.55 83.86 4.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.799 . . . . 0.0 109.329 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -70.3 129.5 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.04 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.17 109.64 3.73 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.22 131.77 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.362 -1.081 . . . . 0.0 109.887 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -127.69 7.85 6.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 154' ' ' GLU . 4.6 tt -107.36 117.5 34.25 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.411 -0.806 . . . . 0.0 109.261 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.594 ' N ' HD23 ' A' ' 153' ' ' LEU . 40.9 tt0 -171.84 71.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -101.03 -2.84 30.6 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -57.65 112.1 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.733 . . . . 0.0 109.971 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -167.38 -9.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -62.71 -42.16 99.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.466 -0.772 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -64.38 -44.5 91.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.528 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.638 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.51 0.671 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.92 135.32 50.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.455 -0.778 . . . . 0.0 110.522 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -84.67 -78.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.565 0.697 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.45 48.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.887 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 tpt 44.76 58.87 14.23 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.623 -0.673 . . . . 0.0 110.126 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.53 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' SER . 17.1 pt-20 -98.12 -3.42 37.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.462 -0.774 . . . . 0.0 109.315 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' GLU . 91.4 p 52.22 169.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.719 . . . . 0.0 110.965 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -75.17 145.21 42.29 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.735 HG21 ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 141' ' ' ARG . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -123.35 21.61 9.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttm -139.82 -135.08 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.174 -0.954 . . . . 0.0 110.426 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.8 175.58 1.96 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.96 -14.73 15.86 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -147.88 118.66 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 109.067 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.29 153.19 5.22 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.41 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.0 pm0 -141.02 163.73 32.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.47 -0.769 . . . . 0.0 109.545 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.36 131.74 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.622 0.725 . . . . 0.0 109.216 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -163.14 81.75 1.55 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.2 -43.75 55.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.515 2.143 . . . . 0.0 111.9 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.681 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -111.15 -42.82 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.887 -0.508 . . . . 0.0 109.764 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 36.2 Cg_exo -59.16 157.76 28.71 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.598 2.199 . . . . 0.0 113.001 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.02 -15.21 65.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 38.43 -142.36 0.36 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.66 -0.906 . . . . 0.0 111.243 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.2 mt -86.42 -162.9 0.81 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.995 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 70.2 t80 -75.92 -101.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.565 0.697 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 32.9 tp -149.27 114.78 5.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 109.684 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 2.6 m -147.44 132.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' VAL . 1.7 p30 163.83 128.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.521 0.677 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' THR . 78.3 t -65.99 -42.21 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.637 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 56' ' ' VAL . 72.1 p -39.21 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.609 -0.682 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -160.04 -143.85 3.79 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.064 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -87.34 -159.39 0.51 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.628 -0.925 . . . . 0.0 110.689 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 59' ' ' ALA . 60.5 ttt85 58.26 154.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.494 0.664 . . . . 0.0 109.906 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CG ' ' OE2' ' A' ' 45' ' ' GLU . 53.4 m-85 -61.47 -43.72 98.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.577 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.81 -112.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' GLY . 88.2 mtm180 -142.9 140.89 31.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ARG . . . 36.69 -108.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 78' ' ' SER . 34.6 t -155.87 154.69 31.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -1.082 . . . . 0.0 109.619 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -71.02 141.58 50.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.797 . . . . 0.0 110.471 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HE ' ' CB ' ' A' ' 78' ' ' SER . 96.0 mtt-85 -134.86 -59.46 0.8 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -155.29 139.03 16.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 -146.56 150.52 35.67 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.535 ' CB ' ' HE ' ' A' ' 67' ' ' ARG . 5.4 p -81.12 -178.42 6.89 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.305 0.574 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -135.58 133.26 38.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.96 -132.57 11.18 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -171.03 148.61 2.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -1.094 . . . . 0.0 109.454 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 66.0 t0 -64.49 137.89 58.11 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 81.17 8.95 86.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p -78.02 164.41 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -1.067 . . . . 0.0 110.264 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 57.9 mp0 -120.78 -34.79 3.49 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 87' ' ' VAL . 27.7 m -66.54 -39.32 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' N ' HG23 ' A' ' 86' ' ' VAL . 64.3 t -148.92 78.79 8.76 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 109.255 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.7 158.12 4.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 123.132 2.555 . . . . 0.0 112.098 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.94 143.61 95.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.564 2.176 . . . . 0.0 112.711 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.04 -14.63 37.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t -68.88 -17.31 63.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.309 -1.113 . . . . 0.0 109.915 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 p -155.23 160.71 41.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.869 -1.144 . . . . 0.0 110.013 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.07 130.87 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.54 -0.725 . . . . 0.0 109.505 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.735 ' NE2' HG21 ' A' ' 11' ' ' VAL . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -135.85 -149.51 5.77 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.491 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 59.6 ttt85 -148.08 -32.06 0.27 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.544 -0.974 . . . . 0.0 109.681 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -153.56 70.09 6.64 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.048 -1.033 . . . . 0.0 110.572 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.13 155.89 60.52 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.299 1.999 . . . . 0.0 113.101 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.33 -166.33 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.25 -32.92 89.52 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.887 2.392 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 61.01 62.98 2.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.902 -0.499 . . . . 0.0 109.937 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.27 147.34 59.38 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.457 2.104 . . . . 0.0 112.359 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.45 20.79 0.29 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -70.92 138.7 50.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.546 -0.721 . . . . 0.0 110.228 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.92 -44.36 1.21 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -169.01 138.17 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -90.09 144.02 26.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.468 -0.77 . . . . 0.0 109.644 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -93.58 130.83 39.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.487 -0.758 . . . . 0.0 109.215 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.2 mp0 -121.95 109.12 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -92.61 128.9 38.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -130.49 133.47 46.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -91.18 -13.94 31.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.78 141.19 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -67.12 -39.45 86.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.566 -0.709 . . . . 0.0 109.773 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.834 -179.75 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -75.12 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.041 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' SD ' ' A' ' 5' ' ' MET . 68.1 mttm 56.2 50.25 13.83 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.634 0.73 . . . . 0.0 109.276 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' MET . . . -83.45 -2.82 56.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 109.201 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.564 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER 57.18 150.29 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 CA-C-O 121.177 0.513 . . . . 0.0 110.257 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 7' ' ' GLU . 57.0 Cg_endo -69.6 129.97 18.71 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.358 2.039 . . . . 0.0 112.99 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' PRO . 97.7 mt-10 56.56 142.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.121 0.962 . . . . 0.0 111.286 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' PHE . 93.3 p -79.75 167.05 21.13 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.642 0.734 . . . . 0.0 110.687 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.3 m-85 45.51 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.77 ' OE2' HD12 ' A' ' 106' ' ' LEU . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.674 ' CE1' HD11 ' A' ' 106' ' ' LEU . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' A' ' 44' ' ' VAL . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 42' ' ' ALA . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 42.9 p-90 -140.69 44.36 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.7 tpp -171.23 108.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.754 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.76 175.6 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 m -103.28 -15.87 15.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.891 . . . . 0.0 108.848 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -137.54 138.01 39.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.444 -0.785 . . . . 0.0 109.568 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 35' ' ' LEU . . . -171.04 148.7 2.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.384 -0.823 . . . . 0.0 109.269 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' H ' HG22 ' A' ' 54' ' ' VAL . 48.8 tp10 -150.97 102.58 2.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.131 -0.981 . . . . 0.0 109.429 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' GLU . 90.8 t -76.02 -79.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' VAL . 24.0 mt-10 56.3 153.68 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.851 -0.531 . . . . 0.0 109.918 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' GLU . 53.9 Cg_exo -34.34 141.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.644 2.229 . . . . 0.0 112.594 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE2' ' CE1' ' A' ' 66' ' ' PHE . 6.1 mt-10 -38.14 -63.86 0.51 Allowed Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.904 -0.498 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 40.1 Cg_endo -64.51 -22.31 65.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.213 1.942 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.22 32.26 4.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.95 85.71 0.56 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.27 149.03 31.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.557 -0.966 . . . . 0.0 110.384 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 52.91 -162.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.744 -0.597 . . . . 0.0 110.583 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD11 ' O ' ' A' ' 61' ' ' PHE . 22.6 tp -114.78 146.24 41.22 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 43' ' ' GLU . 43.3 t -110.45 122.35 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.833 0.825 . . . . 0.0 109.729 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -105.09 102.35 11.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.7 t -99.31 48.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.42 -0.8 . . . . 0.0 108.936 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.7 p 44.9 14.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' VAL . . . -89.23 -7.62 69.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 58' ' ' GLY . . . 69.84 -15.45 0.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.815 . . . . 0.0 109.621 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLY . 61.6 ttt85 -72.56 151.05 42.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.391 -0.818 . . . . 0.0 110.748 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' O ' HD11 ' A' ' 53' ' ' LEU . 96.4 m-85 -62.61 -45.35 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.852 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.76 168.18 28.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.942 -1.099 . . . . 0.0 110.211 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.421 HH21 ' HA3' ' A' ' 58' ' ' GLY . 95.3 mtt180 -132.89 153.7 51.09 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.906 0.86 . . . . 0.0 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.69 76.3 0.04 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' N ' ' OH ' ' A' ' 77' ' ' TYR . 60.3 p -130.4 30.53 4.71 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.577 -0.955 . . . . 0.0 108.846 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' OE2' ' A' ' 47' ' ' GLU . 49.7 p90 -59.28 135.51 57.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 110.274 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.54 HH11 HD13 ' A' ' 93' ' ' LEU . 83.0 mtp180 -107.13 -30.89 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -158.5 141.12 14.42 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 78' ' ' SER . 27.7 t80 -141.76 160.06 40.96 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 70.7 m -110.52 127.61 55.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 47.0 m-85 -129.3 151.68 49.69 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.803 0.811 . . . . 0.0 110.27 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.23 52.37 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -114.23 130.8 56.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 48.15 28.83 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.35 -128.92 0.18 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 85' ' ' GLU . 5.0 m -61.6 -172.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.546 -0.973 . . . . 0.0 110.446 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 56.8 mp0 -39.92 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.498 0.666 . . . . 0.0 110.286 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 87' ' ' VAL . 3.0 m -74.22 -109.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 109.987 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 86' ' ' VAL . 3.2 t 61.51 67.84 1.28 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.673 -0.642 . . . . 0.0 109.681 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.84 164.64 28.74 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.466 2.111 . . . . 0.0 111.727 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.67 139.92 92.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.05 -139.46 38.32 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p 46.06 23.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 109.57 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -144.93 144.71 31.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.336 -0.852 . . . . 0.0 109.464 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD13 HH11 ' A' ' 67' ' ' ARG . 37.8 tp -141.02 124.83 17.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.762 . . . . 0.0 109.357 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 22.3 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.502 ' O ' ' NE2' ' A' ' 101' ' ' GLN . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' OE2' ' A' ' 14' ' ' GLU . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.611 ' C ' HD23 ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CD2' HD21 ' A' ' 114' ' ' LEU . 15.6 t-160 -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 111' ' ' HIS . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.25 5.13 90.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.05 162.44 14.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.479 -1.012 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.17 141.82 62.94 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.586 -0.697 . . . . 0.0 109.641 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.4 145.98 60.96 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.495 2.13 . . . . 0.0 112.709 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.21 177.11 53.77 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.88 151.24 68.34 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.008 2.472 . . . . 0.0 112.476 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.92 74.43 76.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.94 -10.98 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.654 2.236 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -74.56 122.22 22.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -159.55 106.75 1.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.55 -0.718 . . . . 0.0 109.505 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . 77.0 0.25 69.0 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' GLY . 66.5 ttp85 60.73 137.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.993 . . . . 0.0 110.09 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -77.97 144.86 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.48 -0.762 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.0 tp -86.05 129.34 34.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.683 -0.636 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -125.59 139.33 53.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.571 0.701 . . . . 0.0 110.212 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.9 m80 56.05 87.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.711 0.767 . . . . 0.0 110.094 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 51.1 p-80 -148.88 114.1 5.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.572 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -147.84 144.65 28.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -157.01 156.21 32.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.418 -0.802 . . . . 0.0 109.518 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.5 p-80 -150.61 -45.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.523 -0.736 . . . . 0.0 109.106 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 52.9 p-80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.149 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ALA . 12.6 pt-20 -65.76 140.6 58.44 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.505 0.669 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt 53.74 6.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.671 -0.643 . . . . 0.0 109.585 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . . . -86.83 2.77 47.87 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.839 . . . . 0.0 108.908 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 5' ' ' MET . 0.2 OUTLIER -121.01 86.18 41.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.542 -0.724 . . . . 0.0 109.259 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.25 146.4 82.26 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.553 2.169 . . . . 0.0 111.73 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -55.22 135.13 49.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.678 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.6 p -160.39 165.56 30.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 57.57 23.38 9.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' O ' HG22 ' A' ' 29' ' ' THR . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 25' ' ' PHE . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' GLU . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 146' ' ' ASP . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' CD2' ' A' ' 37' ' ' TRP . 40.0 p-90 -111.14 57.63 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 13.2 ttt 79.87 163.46 0.18 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.777 0.799 . . . . 0.0 110.628 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 147.78 -20.3 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m 62.24 -69.88 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.692 -0.887 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 39' ' ' GLY . 96.0 mt-10 -141.27 149.05 40.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 109.632 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.778 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 80.7 tt0 -83.63 142.65 30.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.802 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' H ' ' H ' ' A' ' 45' ' ' GLU . 5.7 p -153.9 -9.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' H ' ' H ' ' A' ' 44' ' ' VAL . 4.1 mt-10 -99.76 148.48 34.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.282 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.92 159.32 53.71 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.538 2.159 . . . . 0.0 112.446 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 59.17 86.91 0.15 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.625 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.33 139.24 64.52 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.859 2.372 . . . . 0.0 112.645 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.72 -10.25 1.65 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.44 -73.33 0.98 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' LEU . 87.2 mt -77.48 -5.35 49.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.4 t80 54.11 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 110.028 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' LEU . 37.7 tp -93.66 127.61 39.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.66 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.01 138.05 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.486 0.66 . . . . 0.0 109.798 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 65.22 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.777 0.799 . . . . 0.0 110.711 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 57' ' ' THR . 12.3 p -63.54 -41.83 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 109.397 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 56' ' ' VAL . 79.0 m -120.63 127.78 52.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.599 -0.688 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.92 46.35 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . -111.02 126.72 55.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.61 -0.935 . . . . 0.0 109.78 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.6 mtt180 38.89 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.454 0.645 . . . . 0.0 110.261 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 55.9 m-85 55.77 13.58 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.616 -0.677 . . . . 0.0 109.331 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . 63.32 3.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.667 -0.645 . . . . 0.0 109.743 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 65' ' ' SER . 76.9 ttt180 -138.79 -26.56 0.86 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -74.66 28.93 1.06 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 63' ' ' ARG . 45.7 m -131.8 149.49 52.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.386 -1.067 . . . . 0.0 109.714 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -163.45 98.97 0.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -107.12 -41.88 5.03 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -164.4 128.81 2.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.451 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -124.4 128.86 49.69 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 79' ' ' PHE . 12.6 p -84.85 176.7 8.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.518 -0.739 . . . . 0.0 109.951 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 17.6 m-85 64.1 162.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.493 0.663 . . . . 0.0 109.823 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.14 109.34 0.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 78.8 t90 -109.2 139.25 44.37 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.48 -1.012 . . . . 0.0 109.574 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 72.2 m-20 -152.26 -166.37 2.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.732 . . . . 0.0 109.909 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 85' ' ' GLU . . . -65.9 159.58 46.13 Favored Glycine 0 N--CA 1.495 2.598 0 CA-C-O 121.923 0.735 . . . . 0.0 111.635 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 p 64.9 -5.24 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.824 -0.809 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 83' ' ' GLY . 96.7 mt-10 46.85 25.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.375 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 87' ' ' VAL . 11.4 p -73.63 3.83 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.396 -0.815 . . . . 0.0 109.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HG13 ' A' ' 86' ' ' VAL . 24.5 t -131.85 74.99 76.6 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.469 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 24.0 Cg_exo -58.98 -173.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.492 2.128 . . . . 0.0 111.453 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 35.6 Cg_exo -61.67 140.37 86.02 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.465 2.11 . . . . 0.0 112.675 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.82 0.38 2.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' PRO . 4.6 m -77.16 -8.3 57.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.507 -0.996 . . . . 0.0 109.371 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.0 p -149.98 160.25 43.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.114 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp -137.21 125.42 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.558 ' C ' HD23 ' A' ' 109' ' ' LEU . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.486 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 37' ' ' TRP . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -102.76 -73.87 1.0 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -166.66 -152.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.448 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -137.77 97.47 10.11 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.504 -0.747 . . . . 0.0 109.199 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 31.9 Cg_exo -51.02 108.47 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.307 2.005 . . . . 0.0 112.446 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 54.02 160.4 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.72 -93.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.312 2.008 . . . . 0.0 111.673 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.557 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.4 OUTLIER 60.35 68.05 1.48 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.68 -0.638 . . . . 0.0 109.915 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.25 144.88 29.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.523 2.149 . . . . 0.0 112.419 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' ' N ' ' A' ' 149' ' ' TYR . 76.2 t80 -81.48 -89.82 0.07 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.562 ' N ' ' CD2' ' A' ' 148' ' ' PHE . 95.2 m-85 39.22 66.51 0.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.845 0.831 . . . . 0.0 110.341 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.4 -176.5 51.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 60.15 33.97 21.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.564 -0.962 . . . . 0.0 108.716 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -137.77 128.4 26.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -158.74 -3.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 153' ' ' LEU . 17.4 pt-20 -121.52 133.98 55.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.655 0.74 . . . . 0.0 109.863 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -85.94 -67.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.436 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 24.6 p-80 -174.02 91.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.31 142.29 21.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 109.617 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.28 -56.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 44.03 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.519 -0.738 . . . . 0.0 109.973 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.695 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -90.18 -4.86 57.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -80.04 137.11 36.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.473 -0.767 . . . . 0.0 109.684 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.98 141.88 57.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.461 -0.774 . . . . 0.0 110.35 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.7 tpt -162.0 72.41 2.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.792 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.75 -93.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.742 2.295 . . . . 0.0 111.686 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -157.48 60.08 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -88.02 163.33 16.34 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.503 -0.748 . . . . 0.0 110.57 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 63.84 91.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.921 -0.487 . . . . 0.0 109.742 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH2' HH21 ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 17' ' ' LEU . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 41' ' ' GLU . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 -122.28 81.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.435 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 14.3 ttt 74.75 136.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.399 0.618 . . . . 0.0 110.123 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 40' ' ' THR . . . 141.64 -58.97 0.56 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' GLY . 4.4 p 41.09 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.792 -0.828 . . . . 0.0 110.016 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' N ' HD22 ' A' ' 35' ' ' LEU . 97.3 mt-10 55.03 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.686 -0.634 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 147.45 28.86 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.831 . . . . 0.0 109.94 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -94.97 164.11 13.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.662 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.3 p -56.03 122.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -174.23 79.04 0.36 Allowed Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.43 159.4 51.62 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.915 1.743 . . . . 0.0 112.133 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 64.29 89.15 0.11 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.288 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.1 137.9 53.83 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.736 2.291 . . . . 0.0 112.931 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.9 -17.45 2.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.15 -160.48 31.1 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' H ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -59.23 137.82 57.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.977 . . . . 0.0 109.559 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' H ' HD13 ' A' ' 51' ' ' LEU . 90.1 m-85 -39.03 135.84 0.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.31 0.576 . . . . 0.0 110.009 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 53' ' ' LEU . 10.0 mp -75.68 123.96 26.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.514 0.673 . . . . 0.0 110.255 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 m -155.07 150.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -93.54 14.28 19.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 109.342 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.48 -45.43 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.4 112.43 8.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.58 122.87 6.38 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 -70.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.473 -1.016 . . . . 0.0 109.056 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -159.73 -170.52 2.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 9.1 p90 -135.8 75.91 1.58 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.586 -0.696 . . . . 0.0 109.304 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.08 75.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 0.0 110.26 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' ' H ' ' A' ' 65' ' ' SER . 75.7 ttt180 -163.69 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.1 64.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.441 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 31.2 t -155.89 95.2 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -1.135 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -86.62 140.98 29.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.395 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -76.81 -78.83 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.526 -0.734 . . . . 0.0 109.591 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -145.61 135.5 23.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 74' ' ' ARG . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HE ' HG21 ' A' ' 70' ' ' VAL . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -122.29 135.38 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.407 ' H ' HH22 ' A' ' 63' ' ' ARG . 11.4 t -112.19 122.13 46.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 54.8 p90 -160.58 126.52 4.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 109.638 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.25 43.79 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.8 m95 65.61 156.77 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.617 -0.931 . . . . 0.0 110.868 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 t0 55.83 25.33 8.35 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.49 -174.83 49.66 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.4 p -79.44 174.74 11.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.905 . . . . 0.0 110.488 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -40.57 117.61 0.84 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 87' ' ' VAL . 43.7 t 46.83 82.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 86' ' ' VAL . 2.1 m -27.48 93.11 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 CA-C-O 120.795 0.331 . . . . 0.0 110.701 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 25.5 Cg_exo -53.39 -42.33 66.21 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.786 1.658 . . . . 0.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 98.1 Cg_endo -84.13 -9.84 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.671 1.581 . . . . 0.0 111.517 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 101.18 -30.0 11.31 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 33.03 95.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 122.222 -0.575 . . . . 0.0 110.756 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -155.85 -134.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 109.471 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -103.06 124.44 48.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.555 -0.716 . . . . 0.0 109.183 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.53 HH21 ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.598 ' NE2' HD21 ' A' ' 114' ' ' LEU . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.598 HD21 ' NE2' ' A' ' 111' ' ' HIS . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 162.26 133.37 1.46 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 90.6 mtm-85 -70.73 175.54 4.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.36 -1.083 . . . . 0.0 110.545 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 1.3 m-20 81.24 77.94 0.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 121.234 0.54 . . . . 0.0 110.196 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.93 145.86 89.32 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.809 2.34 . . . . 0.0 112.083 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.98 -64.34 1.67 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.66 141.21 75.75 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.778 1.652 . . . . 0.0 113.023 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.685 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.4 m-20 -104.18 -27.04 0.21 Allowed Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.206 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 59.6 Cg_endo -82.71 151.85 14.86 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.81 1.673 . . . . 0.0 112.491 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -99.46 134.82 41.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.452 -0.78 . . . . 0.0 109.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.6 t80 46.46 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.639 -0.663 . . . . 0.0 109.832 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.32 114.45 3.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.7 -14.0 35.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -1.096 . . . . 0.0 109.091 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -129.56 132.99 46.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.558 0.695 . . . . 0.0 110.007 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.7 mp -64.08 -40.4 96.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.573 -0.704 . . . . 0.0 109.301 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.1 mp0 -99.61 167.06 10.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.532 -0.73 . . . . 0.0 109.854 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -155.7 -165.22 1.91 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 156' ' ' HIS . 86.7 t60 41.23 44.78 2.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.708 -0.62 . . . . 0.0 109.833 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 46.33 84.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -148.73 137.44 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -170.96 48.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.179 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' GLU . 66.6 mtt . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 57.3 mp0 40.28 74.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.508 0.67 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -75.78 149.09 38.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' SD ' ' A' ' 5' ' ' MET . . . -164.43 -115.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.307 -0.871 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 5' ' ' MET . 2.1 mpt? -142.11 79.22 16.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.96 . . . . 0.0 109.158 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.9 146.75 92.41 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.676 2.251 . . . . 0.0 111.98 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.48 144.79 24.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.555 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' PHE . 98.9 p -65.1 -126.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.761 -0.587 . . . . 0.0 110.56 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 87.6 m-85 41.0 97.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.572 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HG11 ' A' ' 137' ' ' VAL . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CD2' ' N ' ' A' ' 38' ' ' MET . 67.6 p-90 -141.58 -50.21 0.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.492 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 4.3 ttt -64.17 -135.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.883 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.53 -168.35 0.41 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -141.22 28.28 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.944 . . . . 0.0 108.723 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -155.28 117.46 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 109.242 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.6 149.27 5.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.034 . . . . 0.0 109.184 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 58.8 mp0 -85.67 158.09 20.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.136 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.82 150.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 109.059 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -103.26 151.58 38.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.67 -42.22 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.893 1.729 . . . . 0.0 113.018 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 7.7 mm-40 -151.06 -63.89 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.809 -1.182 . . . . 0.0 110.863 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 21.0 Cg_endo -60.09 143.24 99.56 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.871 1.714 . . . . 0.0 112.872 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -85.99 38.32 3.06 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.47 34.02 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 49' ' ' GLY . 4.3 tp -120.61 -67.48 0.97 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -1.055 . . . . 0.0 109.123 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CZ ' ' O ' ' A' ' 49' ' ' GLY . 47.7 m-85 63.34 9.89 4.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.833 -0.542 . . . . 0.0 110.099 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.34 127.22 55.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' VAL . 4.9 t -135.76 133.53 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 68.41 -56.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 80' ' ' GLY . 23.1 m -66.68 141.13 18.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 110.1 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.7 p -126.14 159.59 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -157.19 11.48 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.34 39.99 3.77 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.47 -1.018 . . . . 0.0 109.285 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -148.0 141.29 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.014 -1.054 . . . . 0.0 109.966 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.48 -43.42 5.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.548 -0.72 . . . . 0.0 109.622 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.77 103.44 0.69 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.346 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -150.89 164.12 37.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 109.883 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.37 -128.0 27.13 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 p -149.21 147.69 28.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.265 . . . . 0.0 109.86 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -78.19 147.26 34.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.646 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.36 -77.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 97.6 mt-10 -143.2 132.54 23.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.907 . . . . 0.0 108.996 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.606 ' CD2' ' N ' ' A' ' 78' ' ' SER . 86.1 t80 -167.27 178.44 5.58 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.606 ' N ' ' CD2' ' A' ' 77' ' ' TYR . 99.9 p -88.99 99.81 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.672 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.44 -3.37 27.07 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.374 -0.829 . . . . 0.0 108.803 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -54.98 148.8 23.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -99.44 136.21 39.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.34 -1.094 . . . . 0.0 110.421 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 34.5 p-10 -94.41 -2.17 52.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.201 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.94 -89.27 0.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -66.23 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 123' ' ' HIS . 98.3 mt-10 -58.56 129.76 43.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.274 -0.891 . . . . 0.0 109.838 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.21 129.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.677 . . . . 0.0 109.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.8 t -154.88 88.13 3.27 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 34.2 Cg_exo -56.23 -173.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.347 2.032 . . . . 0.0 111.858 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 39.1 Cg_exo -58.1 -155.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.891 2.394 . . . . 0.0 112.794 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.65 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' PRO . 82.6 p -151.82 -55.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.454 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -80.86 162.99 23.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -154.89 127.26 7.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.595 -0.691 . . . . 0.0 109.249 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.443 ' CD2' ' OE1' ' A' ' 85' ' ' GLU . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.572 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG11 HH21 ' A' ' 36' ' ' ARG . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . 107.26 -10.73 39.81 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -75.38 153.5 37.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.019 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -141.58 74.75 23.01 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.309 -0.869 . . . . 0.0 109.113 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.34 158.5 44.62 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.433 2.088 . . . . 0.0 112.442 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.92 71.23 0.48 Allowed Glycine 0 N--CA 1.505 3.234 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.52 152.42 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.47 2.113 . . . . 0.0 112.449 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.27 60.67 2.12 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.12 -62.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.391 2.061 . . . . 0.0 111.653 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -100.6 -3.24 30.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 108.931 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.82 129.61 38.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.656 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.28 -176.11 31.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 106.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -1.009 . . . . 0.0 109.36 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -79.92 148.07 31.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.539 -0.725 . . . . 0.0 109.753 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 155' ' ' HIS . 0.1 OUTLIER -90.81 146.68 23.75 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.819 . . . . 0.0 109.701 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 53.1 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.384 -0.823 . . . . 0.0 110.254 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 86.3 t60 50.82 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.5 t60 50.17 81.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 110.322 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' HIS . 11.5 p80 -67.7 -45.38 75.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 0.0 109.597 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 157' ' ' HIS . 53.1 t-80 -170.8 -73.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -124.13 124.09 41.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.556 -0.715 . . . . 0.0 109.812 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 33.7 m170 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.041 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.1 -37.77 81.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.739 0.781 . . . . 0.0 109.565 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.84 130.11 34.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.134 -0.979 . . . . 0.0 110.04 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 95.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 158.37 40.26 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.71 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.55 143.39 28.24 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.522 2.148 . . . . 0.0 112.897 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.79 -21.29 17.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.187 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 t -77.22 154.61 32.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.646 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -75.37 142.97 43.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.91 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' ALA . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 38' ' ' MET . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 45.4 p-90 -118.6 62.85 0.77 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.482 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 3.8 ttt 81.35 150.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.082 0.944 . . . . 0.0 110.91 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 139.03 -25.21 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 41' ' ' GLU . 6.3 p 60.01 -70.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.847 -0.796 . . . . 0.0 109.676 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 39' ' ' GLY . 80.0 mm-40 -131.84 145.21 51.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.871 0.843 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 124.47 6.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' H ' HG23 ' A' ' 54' ' ' VAL . 95.7 mt-10 -144.68 113.84 6.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.285 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -125.67 132.54 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -134.65 154.97 79.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -42.75 139.06 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.805 2.337 . . . . 0.0 113.093 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.03 156.49 0.15 Allowed Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.92 145.09 84.99 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.1 63.12 0.44 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.15 149.85 51.7 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.463 -1.022 . . . . 0.0 110.663 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.27 145.26 44.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.691 -0.888 . . . . 0.0 109.814 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 42.65 -161.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.843 0.83 . . . . 0.0 110.585 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.7 mm? -75.57 145.53 41.14 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.759 0.79 . . . . 0.0 110.12 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG23 ' H ' ' A' ' 43' ' ' GLU . 2.7 p -138.89 138.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.825 0.821 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -89.23 85.2 6.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.552 0.691 . . . . 0.0 109.471 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.81 -153.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.738 . . . . 0.0 110.39 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -116.06 130.63 56.9 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.821 0.82 . . . . 0.0 110.273 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.81 -8.4 79.86 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 -147.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.348 -1.09 . . . . 0.0 109.94 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' PHE . 30.3 ptt85 -155.45 115.89 3.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.229 -0.919 . . . . 0.0 110.017 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 62' ' ' ALA . 80.6 t80 53.14 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.842 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 61' ' ' PHE . . . 69.05 -17.5 0.2 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' PHE . 13.2 mmp_? -129.67 156.03 44.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 0.0 109.812 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.74 83.87 0.97 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' PHE . 81.1 p -102.82 -0.01 32.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.253 -1.146 . . . . 0.0 108.55 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' SER . 96.9 m-85 39.7 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.883 0.849 . . . . 0.0 110.627 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 77.8 ttt-85 -67.39 -42.41 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.246 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -151.49 129.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.04 -1.038 . . . . 0.0 109.599 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.645 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 67' ' ' ARG . 48.6 p90 -149.37 150.76 32.95 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 96.3 p -82.06 161.49 22.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.445 0.64 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -134.19 153.16 52.01 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.725 0.774 . . . . 0.0 109.61 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' H ' ' HD3' ' A' ' 63' ' ' ARG . . . 88.07 -116.5 4.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' GLY . 11.4 m0 58.23 121.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.936 0.874 . . . . 0.0 110.418 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 55.99 28.73 13.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.576 0.703 . . . . 0.0 109.458 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.95 148.72 25.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -110.4 123.22 49.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -1.043 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 51.84 27.18 4.03 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.485 0.66 . . . . 0.0 109.584 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 86' ' ' VAL . 14.2 p -159.14 115.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.115 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t 49.9 91.62 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.759 -0.588 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -52.89 161.78 3.01 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.618 2.212 . . . . 0.0 111.492 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.89 135.78 58.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.83 2.353 . . . . 0.0 113.196 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.89 -176.96 52.2 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m 58.92 -159.41 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.92 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.7 p 42.93 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.453 0.644 . . . . 0.0 109.982 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp -122.68 127.32 49.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 107' ' ' LEU . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.51 ' N ' HD23 ' A' ' 107' ' ' LEU . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.632 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.592 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.548 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 111' ' ' HIS . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HH12 ' A' ' 133' ' ' ARG . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.542 ' HE ' ' CG ' ' A' ' 145' ' ' PRO . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -158.94 -150.47 5.81 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -148.25 16.16 1.04 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.547 -0.973 . . . . 0.0 108.724 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -119.24 89.57 40.08 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.347 -0.845 . . . . 0.0 109.664 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.16 145.52 75.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.751 2.301 . . . . 0.0 111.954 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.88 -81.32 0.14 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.542 ' CG ' ' HE ' ' A' ' 133' ' ' ARG . 38.2 Cg_endo -63.66 147.9 92.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.503 2.135 . . . . 0.0 112.474 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 16.3 p-10 -158.1 62.89 2.53 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.92 -89.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.83 2.353 . . . . 0.0 112.034 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 149' ' ' TYR . 98.5 m-85 -138.62 4.22 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 148' ' ' PHE . 97.9 m-85 42.58 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.031 0.92 . . . . 0.0 110.496 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 85.29 164.37 38.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -82.68 -15.92 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.973 . . . . 0.0 109.24 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -92.25 132.3 36.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.734 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.4 mp -64.39 -40.44 95.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.589 -0.694 . . . . 0.0 109.807 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 153' ' ' LEU . 71.9 mm-40 58.66 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.751 0.786 . . . . 0.0 110.53 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -135.63 159.24 42.23 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.743 0.782 . . . . 0.0 109.927 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 158' ' ' HIS . 50.6 t60 42.8 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.901 0.858 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 157' ' ' HIS . 18.7 t-80 -78.67 17.34 0.71 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 156' ' ' HIS . 80.7 m80 55.92 10.39 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.643 0.735 . . . . 0.0 109.648 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.519 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 44.4 t-80 52.44 -111.34 0.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.561 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.519 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 86.7 m-70 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.113 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.578 0.704 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 3' ' ' LYS . 97.9 mt-10 -73.65 159.58 32.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.808 0.813 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 88.7 tttt 60.01 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.897 0.856 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 66.82 166.79 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.782 0.801 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.9 tpt 64.8 51.77 1.02 Allowed Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 121.83 -0.544 . . . . 0.0 110.029 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 5' ' ' MET . 50.9 Cg_endo -67.39 142.54 60.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.1 -13.71 16.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.472 -0.767 . . . . 0.0 109.604 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.7 m -107.9 31.59 5.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 -66.41 145.0 56.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 109.844 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.621 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 33' ' ' LYS . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HG2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 41' ' ' GLU . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -146.48 9.64 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.3 ttm -160.55 100.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.51 157.75 32.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -109.57 -20.93 12.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.673 -0.898 . . . . 0.0 108.786 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' N ' HD22 ' A' ' 35' ' ' LEU . 81.6 tt0 -156.59 126.39 6.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.148 -0.97 . . . . 0.0 109.782 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.34 151.59 5.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -141.27 127.72 20.0 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.843 0.83 . . . . 0.0 109.373 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.33 -77.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 54.07 68.23 2.92 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.576 -0.703 . . . . 0.0 109.753 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.64 0.7 3.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.233 1.955 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.4 tt0 -178.87 -45.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 24.3 Cg_exo -63.82 132.83 36.4 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.488 2.125 . . . . 0.0 112.479 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . 36.0 92.74 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.67 84.64 1.52 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 51' ' ' LEU . 10.4 mp -95.64 -172.84 2.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.63 -0.923 . . . . 0.0 110.051 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -72.88 133.42 44.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.749 0.785 . . . . 0.0 110.022 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -95.14 155.26 16.81 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.601 0.715 . . . . 0.0 109.617 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 55' ' ' ASN . 44.7 t -131.08 162.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.622 0.725 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.0 m120 55.91 -175.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.872 0.844 . . . . 0.0 110.707 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t 61.93 124.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.841 0.829 . . . . 0.0 110.381 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 81' ' ' TRP . 15.1 t -101.77 176.58 5.17 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.823 0.82 . . . . 0.0 109.998 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.1 -16.25 61.47 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.18 129.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -1.14 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -118.72 -36.79 3.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.621 -0.674 . . . . 0.0 109.697 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.81 -45.94 91.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.99 . . . . 0.0 109.435 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.09 -172.86 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 109.693 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -104.97 0.44 27.77 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.68 -125.59 23.14 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 t -134.96 141.09 46.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.551 -0.97 . . . . 0.0 109.819 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -73.89 147.29 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.708 0.766 . . . . 0.0 110.401 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -73.11 -74.61 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.481 0.658 . . . . 0.0 109.658 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.2 136.03 37.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.467 -0.771 . . . . 0.0 109.168 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.455 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.636 ' CG ' ' N ' ' A' ' 78' ' ' SER . 60.7 t80 -169.38 176.96 4.89 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.636 ' N ' ' CG ' ' A' ' 77' ' ' TYR . 14.7 p -85.77 155.41 21.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.831 0.824 . . . . 0.0 110.551 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -156.61 101.72 2.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.18 -171.35 47.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.481 ' O ' HG22 ' A' ' 57' ' ' THR . 95.8 m95 -91.93 149.38 21.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.988 . . . . 0.0 110.292 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 48.6 p-10 -66.37 -25.85 66.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 110.065 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -60.32 -126.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 t -138.8 8.96 2.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.391 -1.064 . . . . 0.0 109.458 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.57 139.42 57.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 87' ' ' VAL . 9.7 t -80.53 121.3 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.715 0.769 . . . . 0.0 110.222 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 86' ' ' VAL . 60.1 t -155.22 85.77 3.44 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -54.05 156.11 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.987 2.458 . . . . 0.0 112.145 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.88 -22.78 42.05 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.324 2.016 . . . . 0.0 111.453 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.18 -23.49 29.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -69.29 -34.05 74.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.995 . . . . 0.0 109.711 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -140.28 148.65 41.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp -124.11 130.38 52.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 32.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.81 119.79 0.08 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -171.32 -132.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -1.088 . . . . 0.0 109.847 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -148.34 80.0 8.69 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 144' ' ' GLY . 52.7 Cg_exo -50.93 -174.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.637 2.225 . . . . 0.0 112.639 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -48.01 179.28 0.01 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.2 -40.28 86.58 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.399 2.066 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.1 OUTLIER 173.38 -48.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.583 -0.698 . . . . 0.0 109.52 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 73.4 Cg_endo -83.82 178.16 5.65 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.659 2.239 . . . . 0.0 112.816 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.434 ' CZ ' ' OD2' ' A' ' 82' ' ' ASP . 77.6 m-85 -72.18 143.45 48.9 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.874 0.845 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 49.06 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.955 0.884 . . . . 0.0 110.301 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.56 -7.81 60.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -64.6 -42.95 95.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.14 -1.212 . . . . 0.0 109.418 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -168.03 140.71 3.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.7 mp -78.28 144.69 35.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.2 127.79 56.28 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.675 0.75 . . . . 0.0 109.455 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 155' ' ' HIS . 57.5 t-80 -84.33 24.07 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.711 0.767 . . . . 0.0 109.209 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.08 -43.97 98.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.69 7.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.029 -1.044 . . . . 0.0 108.6 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -85.96 127.87 34.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.432 ' O ' ' OXT' ' A' ' 160' ' ' HIS . 72.9 t60 -139.84 133.82 30.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 0.0 109.954 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.432 ' OXT' ' O ' ' A' ' 159' ' ' HIS . 26.9 m170 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 59.2 mp0 -68.36 135.8 52.38 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.841 0.829 . . . . 0.0 110.111 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 5' ' ' MET . 99.4 mttt -66.6 -81.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 42.34 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.986 0.898 . . . . 0.0 109.027 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' LYS . 21.3 ptt? -82.84 147.42 54.81 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.479 -0.763 . . . . 0.0 109.41 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.05 -69.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.464 2.109 . . . . 0.0 112.218 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.29 137.2 0.51 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.651 -0.656 . . . . 0.0 109.556 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t 75.51 -167.57 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.988 0.899 . . . . 0.0 111.474 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -75.59 149.36 38.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -124.07 51.88 1.52 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.7 tpp -158.39 -74.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.59 -140.01 3.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.66 -1.257 . . . . 0.0 109.981 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -116.17 7.57 14.18 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.94 148.2 40.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.396 -0.815 . . . . 0.0 109.048 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.45 132.93 12.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 109.605 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -106.19 121.07 43.43 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' VAL . 59.3 t -139.78 -1.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 5.7 mp0 -81.28 150.16 67.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 47' ' ' GLU . 56.7 Cg_endo -71.04 -85.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 111.555 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mt-10 -156.19 -63.12 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 73.2 Cg_exo -31.45 96.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.786 2.324 . . . . 0.0 112.923 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.22 37.25 46.64 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.41 97.63 0.15 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.7 tp -157.13 -57.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -1.074 . . . . 0.0 109.073 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' CG ' ' O ' ' A' ' 52' ' ' TYR . 90.1 t80 -78.99 4.1 15.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.2 mt -92.04 132.22 36.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' VAL . 27.2 m -136.86 161.56 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.7 t-20 69.64 -53.05 0.61 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.913 -0.492 . . . . 0.0 109.701 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 55' ' ' ASN . 35.8 m 35.08 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.642 0.734 . . . . 0.0 111.166 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 58' ' ' GLY . 2.5 t -167.58 -128.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -74.26 165.76 54.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.17 17.61 3.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.844 . . . . 0.0 109.335 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -64.54 152.13 42.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 0.0 110.884 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.96 126.23 36.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 110.094 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.41 27.68 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -139.15 144.77 38.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.323 -0.861 . . . . 0.0 109.661 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -110.61 0.45 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -87.29 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.328 -1.101 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -64.54 134.89 55.33 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.818 0.818 . . . . 0.0 110.299 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -64.03 -64.6 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 109.383 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -159.14 137.38 10.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.074 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -140.22 164.25 30.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 11.9 p -153.5 159.6 42.3 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.639 0.733 . . . . 0.0 109.857 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 78' ' ' SER . 44.1 m-85 -158.18 -151.2 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.89 119.51 0.51 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.4 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 66.2 t-105 -67.99 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.53 -0.982 . . . . 0.0 109.94 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 80.1 m-20 -63.7 140.62 58.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.881 0.848 . . . . 0.0 110.187 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.7 91.44 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 86' ' ' VAL . 27.3 t -154.75 99.37 2.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -1.174 . . . . 0.0 109.21 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 84' ' ' SER . 80.2 mm-40 38.9 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.711 0.767 . . . . 0.0 110.502 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' SER . 3.9 p -158.52 115.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.481 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 87' ' ' VAL . 47.1 t -153.93 74.16 6.33 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 109.414 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 24.4 Cg_exo -64.75 -173.67 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.944 2.43 . . . . 0.0 111.617 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 50.0 Cg_exo -55.05 -35.58 90.68 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.705 2.27 . . . . 0.0 111.265 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.22 -13.07 60.79 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 69.98 33.02 2.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.827 -0.808 . . . . 0.0 110.319 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 m -158.05 -172.36 3.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 0.0 110.128 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.41 HD23 ' OE2' ' A' ' 95' ' ' GLU . 55.8 tp -100.98 131.55 46.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.469 -0.77 . . . . 0.0 109.207 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 93' ' ' LEU . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.47 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -172.62 100.1 0.15 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' PRO . 83.1 mmt-85 -35.95 -67.55 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.038 -0.684 . . . . 0.0 110.416 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 15.2 p-10 -25.99 89.34 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 CA-C-O 121.056 0.455 . . . . 0.0 110.574 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' ARG . 36.3 Cg_exo -57.06 158.87 16.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.642 2.228 . . . . 0.0 112.452 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 146' ' ' ASP . . . -45.14 177.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.54 12.42 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.32 2.013 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 144' ' ' GLY . 23.0 t0 56.36 55.81 8.91 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.514 -0.742 . . . . 0.0 109.647 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 34.6 Cg_endo -64.58 149.76 89.34 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 0.0 113.19 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -71.95 137.24 47.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.973 0.892 . . . . 0.0 110.485 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -145.97 -6.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.93 -144.63 9.35 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 55.36 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.614 -0.933 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -77.61 145.42 36.79 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.85 0.833 . . . . 0.0 110.76 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.3 mp -76.29 145.57 39.52 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.747 0.784 . . . . 0.0 110.168 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.94 167.08 17.29 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.683 0.754 . . . . 0.0 110.371 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -95.33 135.88 36.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.801 0.81 . . . . 0.0 110.292 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.502 ' O ' ' CE1' ' A' ' 159' ' ' HIS . 77.6 m80 -72.81 135.73 45.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -85.65 -14.09 46.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.217 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 159' ' ' HIS . 86.4 t60 -65.49 -41.44 93.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.248 -0.907 . . . . 0.0 109.376 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 156' ' ' HIS . 67.5 m80 46.37 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.766 0.793 . . . . 0.0 110.93 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.226 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.691 0.757 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -67.4 142.3 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.526 -0.734 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.08 -54.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.28 144.04 55.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.991 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.3 mtt 49.84 58.02 17.66 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.524 -0.735 . . . . 0.0 109.906 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.09 150.2 42.52 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.87 2.38 . . . . 0.0 113.033 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.29 73.98 0.82 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.341 -0.85 . . . . 0.0 108.876 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -157.06 -61.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.55 -5.64 38.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.436 -0.79 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 31' ' ' PRO . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 38' ' ' MET . 43.2 p-90 -118.26 72.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 6.0 tpt 82.94 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.72 0.771 . . . . 0.0 110.208 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 40' ' ' THR . . . 156.76 -58.31 0.37 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 34.07 95.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.432 0.634 . . . . 0.0 110.67 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 60.0 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.53 140.93 51.81 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.618 0.723 . . . . 0.0 109.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.5 150.68 21.95 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.735 0.779 . . . . 0.0 110.25 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.63 142.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -119.53 88.08 37.96 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.54 -0.725 . . . . 0.0 109.146 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.19 -37.13 87.63 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.647 2.231 . . . . 0.0 111.967 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.711 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -173.61 -38.53 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.711 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 45.9 Cg_exo -59.05 142.84 99.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.325 2.017 . . . . 0.0 113.107 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.49 67.84 0.56 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . 89.5 130.57 4.04 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.486 -1.008 . . . . 0.0 110.711 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 52' ' ' TYR . 3.7 tt -156.64 114.51 3.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -1.064 . . . . 0.0 108.276 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' N ' HD23 ' A' ' 51' ' ' LEU . 73.7 t80 -46.63 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.648 0.737 . . . . 0.0 109.943 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 51' ' ' LEU . 6.2 tt -147.97 112.08 5.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.352 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.77 150.21 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.31 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.501 ' CG ' ' H ' ' A' ' 56' ' ' VAL . 24.1 t-20 72.68 -162.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.799 0.809 . . . . 0.0 111.263 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' H ' ' CG ' ' A' ' 55' ' ' ASN . 12.7 p -59.46 126.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.843 0.83 . . . . 0.0 110.644 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.9 p -88.64 169.89 11.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.624 0.726 . . . . 0.0 110.567 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.85 -35.66 92.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -144.44 -168.73 2.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.971 -1.311 . . . . 0.0 109.857 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 61' ' ' PHE . 95.4 mtt-85 -64.76 -48.39 74.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 53.0 m-85 38.83 -166.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.818 0.818 . . . . 0.0 111.159 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.48 55.51 4.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -131.48 137.24 48.48 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.802 0.811 . . . . 0.0 109.927 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.24 -1.11 51.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 m -89.38 -148.25 0.18 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -1.111 . . . . 0.0 110.372 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 59.12 164.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.838 0.828 . . . . 0.0 110.802 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CD ' HD21 ' A' ' 93' ' ' LEU . 95.3 mtt-85 -64.96 -45.03 87.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.638 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.44 132.67 3.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 108.874 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 72' ' ' VAL . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 78' ' ' SER . 68.7 t80 -167.33 162.03 14.57 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 31.4 t -107.86 123.59 48.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.503 -0.748 . . . . 0.0 109.343 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.34 -61.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.81 -136.85 46.46 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -119.4 105.2 11.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.892 . . . . 0.0 109.213 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.45 -11.22 60.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -3.93 63.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 85' ' ' GLU . 42.5 m -127.39 119.24 25.74 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.89 . . . . 0.0 109.717 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 84' ' ' SER . 97.9 mt-10 41.97 -167.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.899 0.856 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.45 129.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.452 0.644 . . . . 0.0 109.698 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.7 t -137.92 76.49 39.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 17.7 Cg_exo -65.92 -174.39 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 33.4 Cg_exo -61.11 143.31 98.83 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.323 2.015 . . . . 0.0 112.487 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.43 -39.16 3.04 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.2 p -70.95 -15.43 62.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -1.057 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.0 p -154.49 161.71 41.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.871 -1.143 . . . . 0.0 109.583 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER -147.13 124.03 11.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.278 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.665 ' N ' HD13 ' A' ' 93' ' ' LEU . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.43 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD13 ' SG ' ' A' ' 120' ' ' CYS . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.59 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' OE1' ' OD2' ' A' ' 142' ' ' ASP . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 133' ' ' ARG . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 142.43 150.35 5.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -52.75 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.568 -0.96 . . . . 0.0 110.465 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.2 OUTLIER 176.25 -60.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 142' ' ' ASP . 22.0 Cg_endo -59.55 145.7 97.28 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.218 1.946 . . . . 0.0 112.921 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.453 ' H ' ' HD3' ' A' ' 145' ' ' PRO . . . 160.81 58.26 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.453 ' HD3' ' H ' ' A' ' 144' ' ' GLY . 39.2 Cg_endo -67.35 -12.93 37.61 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.438 2.092 . . . . 0.0 111.411 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.611 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER 174.95 -45.15 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 32.8 Cg_exo -56.61 141.76 90.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.873 2.382 . . . . 0.0 113.258 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 149' ' ' TYR . 53.3 p90 -144.29 -12.88 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 148' ' ' PHE . 89.9 m-85 58.93 129.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -176.97 163.9 33.01 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -64.39 -34.37 78.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.941 . . . . 0.0 109.566 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 150' ' ' GLY . 89.9 mtm-85 58.34 173.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.733 0.778 . . . . 0.0 110.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.01 -42.61 94.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 47.56 -166.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.938 0.875 . . . . 0.0 110.8 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.402 ' O ' ' ND1' ' A' ' 157' ' ' HIS . 74.6 m80 51.14 -171.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.906 0.86 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.556 ' CG ' ' N ' ' A' ' 157' ' ' HIS . 51.2 t-80 57.09 -120.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.409 0.623 . . . . 0.0 110.336 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.556 ' N ' ' CG ' ' A' ' 156' ' ' HIS . 69.7 m80 46.99 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.887 0.851 . . . . 0.0 109.981 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -68.33 133.38 48.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.704 0.764 . . . . 0.0 110.536 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -76.48 134.51 39.49 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.755 0.788 . . . . 0.0 110.148 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.748 -1.12 . . . . 0.0 108.961 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.618 0.723 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.1 138.02 57.72 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.674 0.75 . . . . 0.0 109.864 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.77 132.05 36.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.572 0.701 . . . . 0.0 109.88 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.58 146.97 46.32 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.792 0.806 . . . . 0.0 110.307 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -82.79 153.07 67.24 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-O 121.158 0.504 . . . . 0.0 109.849 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.29 143.39 76.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.808 2.339 . . . . 0.0 111.617 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -101.53 -9.75 20.73 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 t -63.77 149.94 45.71 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.704 0.764 . . . . 0.0 109.994 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -91.14 -0.94 57.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 29' ' ' THR . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -107.01 -19.44 13.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.4 tpt -95.17 -56.78 2.61 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.819 -1.176 . . . . 0.0 109.382 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' H ' ' HA ' ' A' ' 35' ' ' LEU . . . 76.63 -163.03 52.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 m 62.09 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.549 0.69 . . . . 0.0 109.907 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' GLY . 81.3 tt0 -167.56 149.56 5.73 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.849 0.833 . . . . 0.0 109.882 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.49 119.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.989 0.899 . . . . 0.0 109.725 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -140.15 119.05 12.53 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.898 0.856 . . . . 0.0 109.377 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.61 -38.56 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 0.0 109.239 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 54.81 81.6 0.26 Allowed Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.466 -0.772 . . . . 0.0 109.533 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.84 -36.97 76.24 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.629 2.219 . . . . 0.0 111.727 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -43.82 155.73 0.32 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.955 -0.466 . . . . 0.0 110.542 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -50.86 136.82 43.59 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.027 1.818 . . . . 0.0 112.27 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLY . . . 77.19 -76.98 1.58 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 48.02 -177.65 0.01 OUTLIER Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.7 140.64 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.624 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -97.69 1.03 48.13 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.345 0.593 . . . . 0.0 109.438 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.1 mt -111.06 136.29 50.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.291 -0.881 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.52 135.89 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.116 0.96 . . . . 0.0 109.76 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 56' ' ' VAL . 62.4 t30 47.9 -130.05 1.66 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.129 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.49 ' H ' ' CG ' ' A' ' 55' ' ' ASN . 21.9 t 48.35 -108.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.483 0.659 . . . . 0.0 109.462 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 56' ' ' VAL . 14.5 t -150.97 146.46 26.26 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.98 0.895 . . . . 0.0 109.305 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.5 93.17 1.69 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.12 18.66 0.08 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.137 -0.977 . . . . 0.0 110.231 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -84.42 -30.49 25.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.493 0.663 . . . . 0.0 109.795 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.14 152.17 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.412 HH22 ' H ' ' A' ' 82' ' ' ASP . 79.4 ttt180 -150.16 -83.62 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.559 0.695 . . . . 0.0 109.722 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.39 112.82 4.36 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -82.14 166.6 19.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.727 0.775 . . . . 0.0 110.131 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -97.16 120.42 37.49 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.718 0.77 . . . . 0.0 109.235 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -81.48 -74.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -141.55 138.75 32.91 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -166.14 152.64 9.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 153.78 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.631 0.729 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 86.9 t80 -170.11 163.0 9.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.912 0.863 . . . . 0.0 109.898 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 177.74 174.51 44.14 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -110.45 125.77 53.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.487 -1.008 . . . . 0.0 109.7 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' H ' HH22 ' A' ' 63' ' ' ARG . 64.0 t0 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.662 0.744 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' SER . . . -42.76 102.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 83' ' ' GLY . 4.3 m 56.71 149.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.867 0.842 . . . . 0.0 110.343 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' SER . 82.3 tt0 46.88 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.446 0.641 . . . . 0.0 109.944 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.49 133.97 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.625 0.726 . . . . 0.0 109.191 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.84 82.64 10.85 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.53 164.99 31.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.598 2.199 . . . . 0.0 111.471 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.67 137.53 26.49 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.632 2.222 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.92 -40.44 2.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.6 t -64.14 -43.3 95.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -1.017 . . . . 0.0 109.767 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.55 ' OG ' ' NE2' ' A' ' 111' ' ' HIS . 35.3 t -145.81 143.52 29.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.007 0.908 . . . . 0.0 110.144 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -129.31 134.39 47.9 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.55 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' NH2' ' C ' ' A' ' 144' ' ' GLY . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.557 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . 53.52 107.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -159.12 -110.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.806 0.812 . . . . 0.0 109.6 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 25.5 p-10 -147.32 77.83 10.5 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.417 -0.802 . . . . 0.0 109.311 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 146.86 64.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.967 2.445 . . . . 0.0 112.412 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' C ' ' NH2' ' A' ' 133' ' ' ARG . . . -88.93 -161.47 37.5 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.41 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.182 2.588 . . . . 0.0 112.979 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -122.4 85.11 47.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.179 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.97 148.95 73.67 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.397 2.731 . . . . 0.0 112.483 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.29 148.74 3.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.665 0.745 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -61.25 -42.71 99.09 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.61 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -85.78 103.58 2.77 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -95.12 -9.34 33.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.801 -0.823 . . . . 0.0 109.072 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 95.3 mtt-85 -67.75 -38.9 84.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.14 9.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ARG . 49.1 tp10 -152.83 88.84 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.909 0.862 . . . . 0.0 108.961 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -85.55 154.71 21.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.024 0.916 . . . . 0.0 110.386 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -69.09 95.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.681 0.753 . . . . 0.0 109.964 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.4 -43.72 85.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 45.8 p-80 -160.14 74.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.737 0.779 . . . . 0.0 109.266 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.52 -42.1 87.77 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.199 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -149.76 -21.89 0.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -77.61 145.02 37.02 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.697 0.761 . . . . 0.0 110.286 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.38 171.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.873 0.844 . . . . 0.0 110.574 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.552 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.4 mtm 175.43 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.638 -0.664 . . . . 0.0 109.415 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 5' ' ' MET . 27.0 Cg_exo -59.43 145.04 99.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.95 1.767 . . . . 0.0 111.749 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -125.44 -28.23 3.36 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -77.96 168.08 20.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 110.631 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.42 106.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 29' ' ' THR . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -111.75 22.82 14.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttp -157.61 120.31 3.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.686 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.1 91.85 1.67 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.3 m -164.16 103.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -1.027 . . . . 0.0 109.438 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -48.99 138.01 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.373 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.1 153.68 26.29 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.767 0.794 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -150.22 104.75 3.29 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.48 136.77 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.466 -0.771 . . . . 0.0 109.677 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -95.37 152.38 39.28 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' O ' ' CD ' ' A' ' 47' ' ' GLU . 84.1 Cg_exo -44.55 -54.92 3.63 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 1.8 mp0 -142.34 -64.45 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.561 -0.712 . . . . 0.0 109.271 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 18.4 Cg_endo -59.23 145.64 97.16 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.775 1.65 . . . . 0.0 112.436 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.0 -66.9 0.23 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.08 13.56 83.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.91 143.66 49.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.666 -0.902 . . . . 0.0 110.488 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -157.46 84.83 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.7 mt -118.12 136.84 53.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.583 0.706 . . . . 0.0 109.667 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 55' ' ' ASN . 30.0 m -127.58 134.62 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.48 0.657 . . . . 0.0 109.374 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' OD1' ' A' ' 82' ' ' ASP . 96.8 m-20 35.31 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.407 0.622 . . . . 0.0 111.258 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.32 132.95 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 110.395 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -113.13 160.28 18.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.783 0.801 . . . . 0.0 109.721 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 146.69 38.88 0.05 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . 55.81 -156.55 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.597 -0.943 . . . . 0.0 110.643 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 64.94 -12.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.355 0.598 . . . . 0.0 109.592 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' H ' ' C ' ' A' ' 59' ' ' ALA . 61.3 m-85 -78.09 143.58 37.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.145 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB2' ' OH ' ' A' ' 77' ' ' TYR . . . 45.46 -174.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.737 0.78 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -109.15 -1.89 18.43 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.84 -11.26 66.26 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.3 m -137.99 147.37 44.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -1.122 . . . . 0.0 110.12 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -76.55 143.22 40.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.736 0.779 . . . . 0.0 110.376 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -77.55 -75.89 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 109.554 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -147.44 129.46 15.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.301 -0.874 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.66 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' A' ' 62' ' ' ALA . 85.8 t80 -167.18 145.58 4.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 77' ' ' TYR . 95.8 p -76.3 150.8 36.89 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.65 0.738 . . . . 0.0 110.667 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 91.2 t80 -173.39 169.8 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.704 . . . . 0.0 109.766 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.585 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 152.43 -3.07 0.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -81.49 177.28 9.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.4 -1.059 . . . . 0.0 110.641 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.476 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 42.3 t0 63.19 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.792 0.806 . . . . 0.0 111.002 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.74 -21.79 7.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -84.22 154.75 22.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.514 -0.991 . . . . 0.0 110.52 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -100.93 -19.75 15.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.539 -0.726 . . . . 0.0 110.015 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 86' ' ' VAL . 11.7 p -154.46 124.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.988 -1.07 . . . . 0.0 109.709 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.1 t -150.87 88.53 4.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 19.0 Cg_exo -59.32 -173.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.531 2.154 . . . . 0.0 111.588 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 35.8 Cg_exo -61.81 145.72 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.632 2.221 . . . . 0.0 112.7 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 81.96 -22.52 5.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' GLY . 81.0 p 34.85 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.772 0.796 . . . . 0.0 111.463 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.4 m -90.54 -177.6 5.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.743 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp -120.27 129.12 53.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.56 ' OE1' HD23 ' A' ' 106' ' ' LEU . 26.0 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.56 HD23 ' OE1' ' A' ' 101' ' ' GLN . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 107' ' ' LEU . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.493 ' N ' HD23 ' A' ' 107' ' ' LEU . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.467 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.82 -144.82 6.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -172.28 87.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -1.044 . . . . 0.0 109.549 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.31 56.9 0.23 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 109.866 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.46 154.14 50.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.763 2.309 . . . . 0.0 112.637 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.0 57.43 0.12 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.3 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.567 2.178 . . . . 0.0 111.662 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -156.24 57.41 1.46 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.22 147.17 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.544 2.163 . . . . 0.0 112.672 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.39 16.08 26.17 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 54.27 -98.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.604 -0.685 . . . . 0.0 110.585 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 54.77 80.37 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -70.45 138.18 50.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.987 . . . . 0.0 110.081 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -104.99 140.36 38.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.852 0.834 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.67 131.46 34.94 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.67 0.747 . . . . 0.0 110.002 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -143.69 119.11 10.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 155' ' ' HIS . 57.1 p-80 -89.74 114.35 26.02 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.625 0.726 . . . . 0.0 109.739 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.449 ' CD2' ' H ' ' A' ' 156' ' ' HIS . 10.5 p80 -94.31 118.57 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.57 -0.706 . . . . 0.0 109.365 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 80.5 m80 41.92 85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.313 0.578 . . . . 0.0 109.977 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -113.37 122.16 46.53 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.522 0.677 . . . . 0.0 109.347 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -108.01 132.46 53.51 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.539 0.685 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.99 -179.705 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' LYS . 15.8 ptp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 52.71 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.533 0.682 . . . . 0.0 110.177 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' O ' ' SD ' ' A' ' 5' ' ' MET . 17.3 mmmt 52.83 179.0 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 122.029 0.919 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.78 151.96 37.44 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.967 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -146.39 74.3 12.79 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 108.997 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 49.6 Cg_exo -55.38 -159.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.993 2.462 . . . . 0.0 112.475 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.94 160.93 37.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' PHE . 8.0 t -149.45 121.73 8.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 90.1 m-85 56.82 147.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -105.5 -21.11 13.28 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.425 ' HG3' ' H ' ' A' ' 40' ' ' THR . 13.8 tpp -84.55 -74.54 0.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.53 89.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.425 ' H ' ' HG3' ' A' ' 38' ' ' MET . 93.0 m -85.41 -75.53 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.41 -1.053 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -171.76 149.76 2.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.555 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.0 131.81 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.94 . . . . 0.0 109.055 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -86.55 151.09 23.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.927 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.25 143.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 5.1 mp0 -97.36 153.78 38.27 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 109.717 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -15.74 38.77 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.572 2.181 . . . . 0.0 111.38 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -178.34 -47.69 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.223 -0.923 . . . . 0.0 110.818 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 51.9 Cg_exo -52.25 139.45 53.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 112.757 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.57 77.56 0.04 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . -136.92 42.31 1.32 Allowed Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.7 -7.16 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.035 . . . . 0.0 109.031 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.86 38.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.7 mt -105.11 130.64 53.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 110.031 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.7 156.24 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.646 -0.659 . . . . 0.0 109.399 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HA ' HD21 ' A' ' 55' ' ' ASN . 8.2 m120 -107.92 19.12 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 57' ' ' THR . 7.2 p -62.69 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 56' ' ' VAL . 3.2 m -131.84 -15.52 3.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.98 -165.39 54.79 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.875 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 56.23 -117.75 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.015 -0.697 . . . . 0.0 110.486 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 59' ' ' ALA . 99.6 mtt180 40.22 -98.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.432 0.634 . . . . 0.0 110.48 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 63' ' ' ARG . 37.6 t80 -62.14 -45.85 91.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.6 -0.687 . . . . 0.0 109.494 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 40.91 -91.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.317 0.58 . . . . 0.0 110.27 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 61' ' ' PHE . 77.7 ttt-85 -144.31 143.71 31.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.96 110.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 66' ' ' PHE . 19.5 p -159.98 -141.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.452 -1.028 . . . . 0.0 109.917 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' N ' ' OG ' ' A' ' 65' ' ' SER . 35.1 t80 58.18 119.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.862 0.839 . . . . 0.0 110.552 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 78' ' ' SER . 20.0 ptp180 -138.21 -34.64 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.3 128.06 7.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.007 -1.058 . . . . 0.0 109.981 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.52 ' O ' ' CB ' ' A' ' 78' ' ' SER . 5.5 p90 -166.94 179.43 5.26 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 77' ' ' TYR . 3.5 p 86.37 159.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.73 0.776 . . . . 0.0 110.204 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -54.53 -167.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.8 0.809 . . . . 0.0 110.755 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.45 125.69 0.03 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.533 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 24.9 t90 -175.02 171.61 3.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.672 -0.899 . . . . 0.0 109.96 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 98.6 m-20 55.19 108.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.731 0.777 . . . . 0.0 110.373 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 108.39 2.54 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 m -160.59 -112.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -1.078 . . . . 0.0 109.561 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.3 -169.13 0.37 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.009 0.909 . . . . 0.0 110.928 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 87' ' ' VAL . 8.8 p -86.72 168.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.678 0.752 . . . . 0.0 110.891 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.701 ' O ' HG23 ' A' ' 87' ' ' VAL . 34.5 m -108.97 98.44 30.09 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 35.7 Cg_exo -52.53 -44.57 46.27 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.887 1.725 . . . . 0.0 111.958 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 91' ' ' SER . 71.5 Cg_endo -81.79 163.46 18.48 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.133 1.889 . . . . 0.0 113.098 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' SER . . . -59.21 2.97 0.21 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.566 ' H ' ' C ' ' A' ' 89' ' ' PRO . 10.4 m -39.61 126.9 1.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.638 -0.919 . . . . 0.0 110.215 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.1 m -134.48 150.55 50.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.729 -0.607 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' OE2' ' A' ' 95' ' ' GLU . 37.0 tp -113.72 125.13 53.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' OE2' HD21 ' A' ' 93' ' ' LEU . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.469 ' NE2' HD21 ' A' ' 114' ' ' LEU . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD21 ' NE2' ' A' ' 111' ' ' HIS . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.89 -122.38 1.12 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -156.34 109.26 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -1.1 . . . . 0.0 109.103 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 35.0 t0 -169.75 48.21 0.12 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 37.8 Cg_endo -65.62 128.19 19.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.314 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 39.61 -164.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 144' ' ' GLY . 50.8 Cg_exo -56.12 -135.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.903 2.402 . . . . 0.0 111.975 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -121.62 55.43 5.55 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 109.456 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.08 145.4 96.53 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.48 2.12 . . . . 0.0 111.644 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -90.27 77.95 6.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.681 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -156.98 113.11 2.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.16 -168.99 44.09 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -66.21 -92.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.492 -1.004 . . . . 0.0 110.119 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -88.19 9.48 22.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.532 -0.73 . . . . 0.0 109.318 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 153' ' ' LEU . 3.8 mm? -73.05 137.68 45.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.507 -0.745 . . . . 0.0 110.177 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.05 -123.39 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -138.64 29.23 2.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 108.72 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.474 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 55.4 p-80 -69.8 70.25 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.678 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -67.11 -39.93 86.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.632 -0.668 . . . . 0.0 109.288 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -153.11 160.24 42.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 109.76 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -83.97 128.18 34.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.432 -0.793 . . . . 0.0 110.367 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.474 ' ND1' ' OXT' ' A' ' 160' ' ' HIS . 59.3 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.955 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.783 0.801 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.35 141.8 55.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.45 -9.47 52.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.349 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.18 54.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 ptt? -154.86 51.74 0.65 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 109.135 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 5' ' ' MET . 47.6 Cg_endo -67.32 150.15 81.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.815 2.343 . . . . 0.0 112.94 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.16 -40.68 86.68 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.783 0.801 . . . . 0.0 109.074 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' C ' ' CG ' ' A' ' 9' ' ' PHE . 18.5 m -154.96 57.32 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.226 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CG ' ' C ' ' A' ' 8' ' ' SER . 3.2 p90 36.75 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.445 HG13 ' OG ' ' A' ' 112' ' ' SER . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.522 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CH2' ' SD ' ' A' ' 38' ' ' MET . 27.4 p-90 -104.11 8.2 36.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.524 ' SD ' ' CH2' ' A' ' 37' ' ' TRP . 7.5 ptm -157.98 84.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.914 -1.116 . . . . 0.0 109.069 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.11 89.22 1.61 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' GLU . 7.4 m -156.45 51.86 0.52 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 108.35 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' THR . 82.7 tt0 53.84 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.624 0.726 . . . . 0.0 110.194 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.062 -1.024 . . . . 0.0 110.334 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -150.71 112.7 4.55 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.65 -86.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 108.968 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' GLU . 70.6 mt-10 -157.3 76.08 4.08 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.7 18.44 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.248 1.965 . . . . 0.0 110.591 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' GLU . 1.3 pp20? -174.93 150.54 1.31 Allowed Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.81 135.6 28.39 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.357 2.038 . . . . 0.0 113.153 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.59 17.46 79.89 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.59 145.91 47.78 Favored Glycine 0 N--CA 1.494 2.525 0 O-C-N 121.347 -1.09 . . . . 0.0 110.536 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -103.76 147.69 26.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.355 -1.085 . . . . 0.0 110.039 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -82.16 128.26 33.97 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.823 0.82 . . . . 0.0 110.5 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 tp -157.79 120.7 3.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.48 -0.762 . . . . 0.0 108.994 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 54' ' ' VAL . 25.6 m -133.09 129.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.374 -0.829 . . . . 0.0 109.822 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' VAL . 28.9 t-20 36.77 -103.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 110.776 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 5.3 p -42.71 144.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.898 0.856 . . . . 0.0 110.492 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.6 t -143.49 158.1 43.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.95 136.47 3.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.44 -143.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.893 . . . . 0.0 110.332 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 20.9 tpt85 -128.23 131.21 48.81 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.739 0.78 . . . . 0.0 109.768 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 62' ' ' ALA . 69.5 m-85 -81.18 -6.29 58.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.721 0.772 . . . . 0.0 109.413 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' H ' ' HG3' ' A' ' 60' ' ' ARG . . . -59.91 -148.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 62' ' ' ALA . 95.3 mtt-85 55.81 158.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.01 0.909 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.12 -176.95 36.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.7 p -156.85 164.01 38.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -1.025 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -65.57 151.42 46.5 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.57 -0.706 . . . . 0.0 110.106 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -102.36 -27.75 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -158.18 137.16 11.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.639 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 1.7 t80 -118.61 129.41 55.3 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.5 t -101.19 132.68 46.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.639 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 50.0 m-85 -131.23 152.36 50.57 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.916 0.865 . . . . 0.0 109.749 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 75.69 -117.98 5.33 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.407 ' HE1' ' HB2' ' A' ' 93' ' ' LEU . 98.2 m95 46.94 17.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -1.033 . . . . 0.0 109.305 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' GLY . 63.3 t0 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.91 . . . . 0.0 109.296 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.82 -30.73 8.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 m -105.19 -52.76 2.78 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -1.028 . . . . 0.0 109.73 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.63 125.56 28.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -48.71 176.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.771 0.796 . . . . 0.0 110.608 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.55 79.11 72.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 109.598 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 40.5 Cg_exo -55.54 -174.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.395 2.063 . . . . 0.0 111.014 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 34.8 Cg_exo -60.13 143.19 99.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.637 2.225 . . . . 0.0 113.072 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.11 -23.67 1.77 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 89' ' ' PRO . 19.3 m -85.61 100.43 11.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -1.174 . . . . 0.0 110.216 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 93' ' ' LEU . 8.0 p -175.25 -140.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 92' ' ' SER . 53.1 tp -109.92 120.9 43.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.716 . . . . 0.0 109.558 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.481 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.445 ' OG ' HG13 ' A' ' 10' ' ' VAL . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.702 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.522 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . 96.94 147.9 23.34 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HE ' ' H ' ' A' ' 142' ' ' ASP . 8.2 tpm_? 59.61 139.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.809 -0.819 . . . . 0.0 110.422 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.782 ' H ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER 160.68 -39.02 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 36.0 Cg_exo -57.78 142.9 96.3 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.14 1.893 . . . . 0.0 112.451 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 154.36 -69.77 0.29 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.51 152.06 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.375 2.05 . . . . 0.0 112.699 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 20.0 p-10 -159.33 54.43 0.66 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.725 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 41.5 Cg_endo -67.05 150.61 82.57 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.963 2.442 . . . . 0.0 112.318 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -74.98 135.49 41.33 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.001 0.905 . . . . 0.0 110.199 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -62.98 -45.4 92.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.726 0.774 . . . . 0.0 109.831 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . -62.17 148.71 48.28 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 150' ' ' GLY . 88.2 mtm180 51.4 171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.649 -0.912 . . . . 0.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -138.64 144.22 39.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 109.633 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.25 78.12 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.6 mp0 -119.31 122.81 42.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.87 133.7 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.48 -0.763 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 157' ' ' HIS . 8.1 t60 -66.54 -42.83 86.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.642 0.734 . . . . 0.0 109.675 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 93.8 m-70 -148.7 -59.39 0.23 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.189 -0.945 . . . . 0.0 109.205 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.66 130.38 55.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.828 0.823 . . . . 0.0 110.297 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.37 -42.87 87.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.9 0.857 . . . . 0.0 109.621 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.5 t60 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.683 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.614 0.721 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.56 139.31 57.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.77 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -92.81 -9.03 41.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 109.25 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 43.5 65.27 1.02 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.915 0.864 . . . . 0.0 109.353 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.1 ttt -89.69 131.48 39.65 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 148.5 64.23 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.066 1.844 . . . . 0.0 112.518 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' PHE . 6.4 pt-20 -162.95 123.91 2.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.918 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m 58.38 -0.68 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.513 -0.742 . . . . 0.0 110.103 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' GLU . 65.5 m-85 -99.76 7.66 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 108.648 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CG ' ' N ' ' A' ' 38' ' ' MET . 8.9 p-90 -110.31 -65.39 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.576 ' SD ' ' CE1' ' A' ' 130' ' ' TYR . 23.1 ttt -142.1 154.55 45.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.827 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . 139.18 127.19 2.43 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.0 p -98.04 -17.58 19.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -1.21 . . . . 0.0 108.922 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 97.0 mt-10 -145.76 146.03 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.988 -1.07 . . . . 0.0 110.013 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.18 113.89 1.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 0.0 109.21 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 54' ' ' VAL . 27.9 tp10 -85.97 160.66 19.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.759 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.3 p -123.89 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.724 0.774 . . . . 0.0 109.53 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -176.71 148.75 0.83 Allowed Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' GLY . 37.4 Cg_endo -65.39 152.17 82.81 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -40.5 -62.24 1.0 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.638 -0.664 . . . . 0.0 110.049 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 29.1 Cg_endo -62.33 -18.92 65.31 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.135 1.89 . . . . 0.0 110.883 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 46' ' ' PRO . . . -42.16 -78.03 0.07 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.7 -26.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt 47.05 85.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.965 . . . . 0.0 109.563 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.75 -119.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.673 -0.642 . . . . 0.0 110.327 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.98 132.29 54.08 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.53 0.681 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 43' ' ' GLU . 31.6 m -132.34 145.56 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.567 -0.708 . . . . 0.0 109.996 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.75 129.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.048 0.928 . . . . 0.0 111.287 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 57' ' ' THR . 18.8 m -65.62 -39.03 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 110.427 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.424 ' N ' HG23 ' A' ' 56' ' ' VAL . 20.9 p 49.92 16.02 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.027 -1.046 . . . . 0.0 109.909 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 56' ' ' VAL . . . 152.19 -64.2 0.37 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.81 141.76 5.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -1.131 . . . . 0.0 109.818 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' NH2' ' OE2' ' A' ' 41' ' ' GLU . 42.4 ttm180 -71.17 135.62 47.68 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.585 0.707 . . . . 0.0 110.415 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -99.92 -102.93 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.451 -0.78 . . . . 0.0 109.891 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -169.68 -18.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 109.318 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -140.78 151.11 44.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.981 -1.074 . . . . 0.0 109.985 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.66 124.96 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 18.2 m -140.46 26.58 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . 53.7 m-85 56.79 151.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.355 1.074 . . . . 0.0 111.439 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -80.76 -74.84 0.3 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.914 0.864 . . . . 0.0 108.92 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -146.17 142.49 28.49 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 78' ' ' SER . 91.1 t80 -125.46 127.09 45.96 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 17.0 p -76.89 162.51 27.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 110.017 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -147.6 136.9 22.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 80.36 -101.82 2.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 26.2 t90 50.75 -88.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.551 -0.97 . . . . 0.0 110.364 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' GLY . 48.6 p-10 -69.33 140.2 54.3 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -0.912 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.19 43.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p 63.16 178.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.933 0.873 . . . . 0.0 110.334 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.73 -54.37 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.679 0.752 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 87' ' ' VAL . 8.3 m -90.79 3.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 109.56 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 86' ' ' VAL . 22.1 t -130.15 78.28 74.92 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.169 -0.957 . . . . 0.0 109.802 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 27.1 Cg_exo -59.69 -173.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.689 2.26 . . . . 0.0 111.603 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 91' ' ' SER . 40.3 Cg_exo -58.65 140.31 94.36 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.916 2.411 . . . . 0.0 113.664 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 41.62 17.3 0.02 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 89' ' ' PRO . 93.7 p -74.49 -15.44 60.88 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.094 -1.239 . . . . 0.0 108.654 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 p -148.06 155.7 41.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 110.11 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp -161.04 129.14 4.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 111' ' ' HIS . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.616 ' C ' HD23 ' A' ' 109' ' ' LEU . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.541 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' CE1' HD21 ' A' ' 114' ' ' LEU . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 111' ' ' HIS . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.454 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.454 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.576 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CZ ' ' O ' ' A' ' 143' ' ' PRO . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.68 -109.69 0.42 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -144.07 107.35 4.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -1.1 . . . . 0.0 109.395 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -165.81 68.91 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.56 -0.713 . . . . 0.0 109.079 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 31.2 Cg_exo -56.91 -30.28 85.27 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.646 2.23 . . . . 0.0 110.405 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.74 172.04 24.66 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.95 144.88 78.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.892 2.395 . . . . 0.0 112.351 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 4.1 p30 -158.37 54.97 0.79 Allowed Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.508 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 25.3 Cg_endo -61.69 106.57 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.533 2.155 . . . . 0.0 111.409 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 150' ' ' GLY . 76.0 m-85 -84.0 144.57 29.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.05 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -54.23 88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.822 0.82 . . . . 0.0 109.803 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 148' ' ' PHE . . . -67.6 110.59 3.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.412 HH21 ' CD1' ' A' ' 153' ' ' LEU . 16.7 ptm180 -84.49 132.54 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.459 -1.024 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.87 -35.32 74.57 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.851 0.834 . . . . 0.0 109.711 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 154' ' ' GLU . 5.8 tp 47.25 -131.08 1.41 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.713 0.768 . . . . 0.0 110.376 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 153' ' ' LEU . 97.5 mt-10 41.5 -168.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.015 0.912 . . . . 0.0 110.877 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.49 151.24 32.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.6 t60 41.54 47.87 3.36 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.899 0.857 . . . . 0.0 109.758 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.44 -44.1 97.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.54 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 86.2 t60 -164.12 77.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.459 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 77.9 m80 54.99 84.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.889 0.852 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 158' ' ' HIS . 97.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.036 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 56.62 27.04 11.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.14 131.06 45.29 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.742 0.782 . . . . 0.0 110.213 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.41 22.17 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.755 0.788 . . . . 0.0 109.82 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.1 tpt -172.1 73.0 0.47 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.12 141.14 96.26 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.761 2.308 . . . . 0.0 112.349 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' CB ' HG21 ' A' ' 10' ' ' VAL . 97.5 mt-10 -88.43 156.21 19.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.725 0.774 . . . . 0.0 110.055 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 8.5 p -74.26 130.82 40.46 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.342 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 5.2 p90 28.55 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' SER . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.54 HG11 ' NH2' ' A' ' 13' ' ' ARG . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' NH2' HG11 ' A' ' 11' ' ' VAL . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' N ' ' OE1' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HB2' HG11 ' A' ' 44' ' ' VAL . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 -109.84 -18.41 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.8 ttp -129.24 74.76 1.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.66 68.4 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -92.57 -88.43 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -1.007 . . . . 0.0 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -169.73 138.62 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.762 0.791 . . . . 0.0 110.633 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.06 153.79 2.62 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.486 0.66 . . . . 0.0 109.849 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 44' ' ' VAL . 46.4 tp10 -92.57 98.83 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.543 0.687 . . . . 0.0 110.075 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 43' ' ' GLU . 2.3 m -161.87 24.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.722 -0.611 . . . . 0.0 109.695 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -142.35 69.9 21.83 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.0 109.664 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 -37.35 79.42 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.701 2.267 . . . . 0.0 111.441 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -46.27 150.39 1.13 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.91 -0.493 . . . . 0.0 109.841 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.4 -18.27 38.77 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.858 2.372 . . . . 0.0 111.893 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.82 95.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 52' ' ' TYR . . . -97.69 -101.17 2.11 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TYR . 5.5 tp 51.44 7.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.765 . . . . 0.0 109.748 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 6.3 p90 -59.7 -144.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.738 0.78 . . . . 0.0 109.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 3.6 mm? -68.77 136.64 53.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.393 -0.817 . . . . 0.0 109.784 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 163.04 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.764 0.792 . . . . 0.0 109.716 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.6 78.93 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.781 0.8 . . . . 0.0 110.192 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 57' ' ' THR . 13.4 p -65.13 -32.02 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.658 -0.651 . . . . 0.0 109.397 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER 74.45 69.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.858 0.837 . . . . 0.0 109.717 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.48 158.44 19.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 44.8 -158.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.85 0.833 . . . . 0.0 110.858 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' C ' ' N ' ' A' ' 62' ' ' ALA . 85.5 mtp180 -72.8 -167.98 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.56 0.695 . . . . 0.0 109.901 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 49.75 16.87 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 60' ' ' ARG . . . -102.71 95.68 6.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 109.284 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -110.01 -29.56 8.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.18 147.01 42.04 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -157.61 176.12 13.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.655 -0.909 . . . . 0.0 109.839 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -151.06 59.36 0.91 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.01 -46.17 88.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.786 -1.196 . . . . 0.0 109.434 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -164.98 140.7 5.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.788 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 77' ' ' TYR . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 75' ' ' LEU . 44.8 m-85 -122.37 153.82 38.5 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.3 p -93.08 6.47 47.85 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 62.0 t80 56.74 -105.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.596 0.712 . . . . 0.0 110.262 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . -88.53 -74.98 1.29 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 74.1 t90 60.52 0.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.979 -0.718 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 47.9 p-10 -66.88 -33.99 76.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.476 -0.765 . . . . 0.0 109.771 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 80.06 21.05 66.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -59.32 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -1.152 . . . . 0.0 109.928 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.08 -81.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -140.66 76.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.332 -0.855 . . . . 0.0 109.155 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 5.4 t -144.4 54.95 2.98 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.495 -0.753 . . . . 0.0 109.471 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 87' ' ' VAL . 18.8 Cg_endo -58.19 166.01 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.724 2.282 . . . . 0.0 111.646 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.35 131.24 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.212 1.941 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.94 -24.86 26.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 t -74.55 151.85 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -1.024 . . . . 0.0 110.493 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 113' ' ' GLY . 22.2 p 46.65 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.739 0.781 . . . . 0.0 110.674 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp -123.4 128.91 50.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.658 ' C ' HD23 ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.426 ' CB ' HG22 ' A' ' 10' ' ' VAL . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.677 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -146.02 -150.56 5.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 59.2 ttt85 -173.08 154.99 2.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.828 . . . . 0.0 109.852 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 3.9 t70 77.59 58.82 0.21 Allowed Pre-proline 0 N--CA 1.494 1.77 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.231 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 144' ' ' GLY . 43.8 Cg_endo -68.69 152.91 74.14 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.141 1.894 . . . . 0.0 112.351 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -46.86 176.82 0.01 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.22 141.6 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.295 1.997 . . . . 0.0 112.246 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.721 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 23.1 t70 -129.22 23.72 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.997 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 51.9 Cg_exo -47.65 77.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 111.971 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 149' ' ' TYR . 86.6 t80 48.98 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.971 0.891 . . . . 0.0 111.001 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 47.1 m-85 -64.94 -73.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.518 -0.739 . . . . 0.0 110.016 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 151' ' ' ARG . . . 163.33 164.8 19.25 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 150' ' ' GLY . 6.6 ptp85 31.16 60.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.543 0.687 . . . . 0.0 110.228 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -70.37 131.47 44.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.1 tp -132.04 125.64 31.94 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.546 0.689 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -133.35 153.47 51.55 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.778 0.799 . . . . 0.0 110.052 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -69.38 -165.05 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.604 0.716 . . . . 0.0 110.185 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 158' ' ' HIS . 14.6 p80 -157.53 -169.19 2.8 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.88 0.847 . . . . 0.0 110.183 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.8 t60 58.52 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 156' ' ' HIS . 46.3 p-80 -91.99 127.08 37.32 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.02 0.914 . . . . 0.0 110.214 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.0 m-70 47.93 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.893 0.854 . . . . 0.0 110.496 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.822 -179.503 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.374 0.607 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 128' ' ' ALA . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 16' ' ' HIS . 5.4 p80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.518 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 14.6 p-90 . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.664 ' O ' HG22 ' A' ' 72' ' ' VAL . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' N ' ' HG ' ' A' ' 112' ' ' SER . 44.1 tp . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 121.224 0.535 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 93' ' ' LEU . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.411 HE22 HD22 ' A' ' 106' ' ' LEU . 86.3 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 HE22 ' A' ' 101' ' ' GLN . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 93' ' ' LEU . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 120' ' ' CYS . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 77.9 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' ' NH2' ' A' ' 13' ' ' ARG . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.361 0.6 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.538 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 . . . . . 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.66 ' O ' HG22 ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.468 ' NE2' HD21 ' A' ' 114' ' ' LEU . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 111' ' ' HIS . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.538 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 34' ' ' ILE . 15.3 p-90 . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.176 0.512 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.432 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.517 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 . . . . . 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.8 tp . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 107' ' ' LEU . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.552 ' N ' HD23 ' A' ' 107' ' ' LEU . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.487 ' CE1' ' HE1' ' A' ' 127' ' ' TRP . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.487 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.618 0.723 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' NH1' ' A' ' 13' ' ' ARG . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH1' HG11 ' A' ' 11' ' ' VAL . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 29' ' ' THR . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 . . . . . 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.521 0.677 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.583 ' N ' HD23 ' A' ' 109' ' ' LEU . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.207 0.527 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.735 HG21 ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 . . . . . 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.735 ' NE2' HG21 ' A' ' 11' ' ' VAL . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.77 ' OE2' HD12 ' A' ' 106' ' ' LEU . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.674 ' CE1' HD11 ' A' ' 106' ' ' LEU . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 42.9 p-90 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 27.7 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.8 tp . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.392 0.615 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 103' ' ' GLY . 2.6 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' OE2' ' A' ' 14' ' ' GLU . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CD2' HD21 ' A' ' 114' ' ' LEU . 15.6 t-160 -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 111' ' ' HIS . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.427 HE21 ' CE1' ' A' ' 123' ' ' HIS . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CE1' HE21 ' A' ' 119' ' ' GLN . 32.2 m170 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' O ' HG22 ' A' ' 29' ' ' THR . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 25' ' ' PHE . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 34' ' ' ILE . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' CD2' ' O ' ' A' ' 37' ' ' TRP . 40.0 p-90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.647 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 109' ' ' LEU . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.486 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 37' ' ' TRP . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.104 0.478 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH2' HH21 ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 17' ' ' LEU . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 35' ' ' LEU . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.234 0.54 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 74' ' ' ARG . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HE ' HG21 ' A' ' 70' ' ' VAL . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.53 HH21 ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.598 ' NE2' HD21 ' A' ' 114' ' ' LEU . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.598 HD21 ' NE2' ' A' ' 111' ' ' HIS . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 117' ' ' ALA . 87.6 m-85 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.322 0.582 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.572 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.425 ' CG ' ' O ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HG11 ' A' ' 137' ' ' VAL . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 67.6 p-90 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 97.6 mt-10 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.572 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG11 HH21 ' A' ' 36' ' ' ARG . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . . . . . . 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.617 0.723 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' ALA . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 45.4 p-90 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.288 0.565 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.645 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.6 p90 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD23 ' A' ' 106' ' ' LEU . 75.3 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD23 ' NE2' ' A' ' 101' ' ' GLN . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 107' ' ' LEU . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.51 ' N ' HD23 ' A' ' 107' ' ' LEU . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.592 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.548 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 111' ' ' HIS . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HH12 ' A' ' 133' ' ' ARG . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.408 HH12 ' HB3' ' A' ' 129' ' ' HIS . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.384 0.612 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.621 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 33' ' ' LYS . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HG2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.701 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.455 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 76.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.621 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.41 HD23 ' OE2' ' A' ' 95' ' ' GLU . 55.8 tp . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 93' ' ' LEU . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.47 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 31' ' ' PRO . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.501 ' CD2' ' O ' ' A' ' 37' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 72' ' ' VAL . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 68.7 t80 . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.597 0.713 . . . . 0.0 109.278 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.665 ' N ' HD13 ' A' ' 93' ' ' LEU . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.43 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD13 ' SG ' ' A' ' 120' ' ' CYS . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 137' ' ' VAL . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' GLY . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 133' ' ' ARG . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 29' ' ' THR . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 . . . . . 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.557 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 29' ' ' THR . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.462 0.649 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.492 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.66 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.756 HE22 HD23 ' A' ' 106' ' ' LEU . 97.6 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.756 HD23 HE22 ' A' ' 101' ' ' GLN . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.493 ' N ' HD23 ' A' ' 107' ' ' LEU . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.467 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 . . . . . 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.333 0.587 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' OE2' ' A' ' 95' ' ' GLU . 37.0 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' OE2' HD21 ' A' ' 93' ' ' LEU . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.469 ' NE2' HD21 ' A' ' 114' ' ' LEU . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD21 ' NE2' ' A' ' 111' ' ' HIS . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 114' ' ' LEU . 3.2 p90 . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.445 HG13 ' OG ' ' A' ' 112' ' ' SER . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.522 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 27.4 p-90 . . . . . 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.445 ' OG ' HG13 ' A' ' 10' ' ' VAL . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.702 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.522 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 8.9 p-90 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.468 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 t80 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 111' ' ' HIS . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.541 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.48 ' CE1' HD21 ' A' ' 114' ' ' LEU . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 111' ' ' HIS . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.454 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.454 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 112' ' ' SER . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.54 HG11 ' NH2' ' A' ' 13' ' ' ARG . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' NH2' HG11 ' A' ' 11' ' ' VAL . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.685 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 4.6 p80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.405 0.621 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 77' ' ' TYR . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 75' ' ' LEU . 44.8 m-85 . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.426 ' CB ' HG22 ' A' ' 10' ' ' VAL . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.677 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . . . . . . 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -162.24 67.38 0.24 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 108.945 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -68.27 -104.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.357 -0.839 . . . . 0.0 110.545 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.55 149.15 36.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.0 110.683 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 mtt 43.43 76.92 0.48 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.613 -0.679 . . . . 0.0 110.168 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 7' ' ' GLU . 35.7 Cg_exo -59.69 144.57 99.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.665 2.243 . . . . 0.0 112.409 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' PRO . 79.4 mm-40 44.46 -169.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 0.0 110.414 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 9' ' ' PHE . 87.2 p -121.87 -71.22 0.74 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.78 -0.575 . . . . 0.0 109.487 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.513 ' N ' ' OG ' ' A' ' 8' ' ' SER . 58.6 m-85 49.89 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.697 -0.627 . . . . 0.0 109.38 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.37 135.32 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.52 -0.737 . . . . 0.0 109.218 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.94 131.89 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.41 140.77 51.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.442 -0.786 . . . . 0.0 108.934 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' NH2' ' HB2' ' A' ' 128' ' ' ALA . 80.7 mtp85 -139.51 156.24 47.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 109.1 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -136.52 157.07 47.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.433 -0.792 . . . . 0.0 109.388 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.91 30.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.165 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.502 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 5.4 p80 -105.5 122.79 46.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -114.11 136.19 53.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.608 -0.683 . . . . 0.0 109.164 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.33 -0.44 49.76 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.685 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.61 153.42 38.19 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.273 -0.892 . . . . 0.0 109.487 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.71 162.36 37.65 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.616 2.211 . . . . 0.0 112.067 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.09 -29.99 81.96 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.784 2.322 . . . . 0.0 111.742 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.48 94.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.746 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.53 89.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.201 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.8 -46.24 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.714 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -61.25 -43.08 99.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.927 . . . . 0.0 109.474 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.69 70.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.381 -0.824 . . . . 0.0 109.839 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.2 mt -63.19 -42.29 99.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.69 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.8 mtm -83.05 -7.06 59.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.913 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -100.35 -14.96 18.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 0.0 108.898 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.27 124.04 37.73 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.51 -0.744 . . . . 0.0 109.176 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.19 -22.99 13.93 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.957 1.771 . . . . 0.0 112.442 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -84.66 -39.48 18.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.172 -0.955 . . . . 0.0 110.235 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -62.23 -32.6 73.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.44 -42.02 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.988 -1.07 . . . . 0.0 109.952 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -55.44 -29.21 58.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.705 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.56 -34.64 74.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 0.0 108.762 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.518 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 14.6 p-90 -132.89 86.51 2.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.625 -0.672 . . . . 0.0 109.686 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.56 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 1.8 tpt 82.54 158.43 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.544 0.687 . . . . 0.0 110.309 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.98 113.69 1.97 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.5 m -95.86 -18.56 20.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -1.081 . . . . 0.0 108.588 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -157.33 119.02 3.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.17 146.18 40.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 109.45 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -150.7 126.41 10.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.255 -0.903 . . . . 0.0 108.598 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.77 156.24 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.019 -1.051 . . . . 0.0 109.728 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 41.43 56.19 8.88 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.716 -0.615 . . . . 0.0 110.466 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.56 -89.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.436 2.09 . . . . 0.0 112.218 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -79.88 157.85 73.51 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.175 -0.953 . . . . 0.0 109.613 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.08 137.73 28.77 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.017 1.811 . . . . 0.0 112.487 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 127.81 -19.82 5.8 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.24 122.07 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.94 112.76 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.24 . . . . 0.0 108.601 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -93.28 123.45 36.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 109.933 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.7 tp -164.83 129.31 2.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 108.888 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.99 137.2 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.234 -0.916 . . . . 0.0 109.128 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -86.67 86.4 7.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.89 -46.78 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.317 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -141.63 154.59 45.48 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.287 -0.883 . . . . 0.0 109.885 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 42.99 -129.32 5.4 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.49 50.34 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -126.84 136.93 53.02 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.84 0.829 . . . . 0.0 110.202 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.519 ' O ' ' N ' ' A' ' 63' ' ' ARG . 53.7 p90 -173.84 5.21 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.62 -81.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.908 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 61' ' ' PHE . 62.4 ttm-85 -141.57 141.78 33.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.227 -0.921 . . . . 0.0 109.654 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.7 164.79 54.83 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 m -159.76 89.63 0.89 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.245 -1.15 . . . . 0.0 108.85 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -73.39 136.89 44.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -103.74 -52.48 2.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -153.09 138.38 17.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.401 -0.812 . . . . 0.0 109.146 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.48 129.81 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.447 -0.783 . . . . 0.0 109.726 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 t -143.5 95.21 5.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 73' ' ' HIS . 52.0 Cg_exo -54.18 152.39 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.176 1.917 . . . . 0.0 112.601 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.2 p 36.93 38.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-O 121.518 0.675 . . . . 0.0 110.324 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' CD2' ' O ' ' A' ' 71' ' ' PRO . 75.0 m-70 -151.65 -71.01 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 109.691 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -163.31 159.96 23.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.013 -1.054 . . . . 0.0 110.126 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -138.62 145.99 41.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.359 -0.838 . . . . 0.0 109.624 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.09 120.22 16.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.362 -0.837 . . . . 0.0 108.816 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -165.49 165.64 18.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 p -132.82 150.08 52.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 80' ' ' GLY . 16.5 p90 -169.83 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' ' CE2' ' A' ' 79' ' ' PHE . . . 84.11 160.95 31.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -89.96 -0.96 57.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.0 108.796 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.12 31.06 10.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.782 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.54 -8.65 76.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 85' ' ' GLU . 93.3 p -162.63 160.68 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.068 -1.254 . . . . 0.0 109.738 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 84' ' ' SER . 96.4 mt-10 40.42 -105.58 0.06 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.623 0.725 . . . . 0.0 110.236 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -153.06 -33.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t 58.45 80.81 0.27 Allowed Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -78.22 168.25 22.01 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.476 2.117 . . . . 0.0 111.942 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -52.67 136.99 59.13 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.202 1.935 . . . . 0.0 113.33 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.25 -27.84 10.89 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 80.8 p -68.62 -22.0 64.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.051 -1.264 . . . . 0.0 109.527 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.5 p -156.99 162.51 39.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -0.959 . . . . 0.0 108.523 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' OE2' ' A' ' 95' ' ' GLU . 44.1 tp -133.93 129.57 36.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.311 -0.868 . . . . 0.0 109.607 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.9 131.56 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 93' ' ' LEU . 96.3 mt-10 -139.74 138.98 36.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.001 . . . . 0.0 109.741 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.75 129.19 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -126.46 134.99 50.81 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.375 -0.828 . . . . 0.0 109.838 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.43 129.46 54.93 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.46 125.47 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.31 -0.869 . . . . 0.0 109.167 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -73.49 137.92 44.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.555 -0.716 . . . . 0.0 109.788 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.411 HE22 HD22 ' A' ' 106' ' ' LEU . 86.3 mt-30 -144.75 155.63 43.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.263 -0.898 . . . . 0.0 109.278 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.09 -42.46 99.53 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.84 84.17 0.87 Allowed Glycine 0 N--CA 1.497 2.733 0 O-C-N 121.005 -1.291 . . . . 0.0 110.092 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.14 -165.9 54.74 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 121.151 -1.205 . . . . 0.0 110.397 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 83.5 m -121.57 133.77 55.01 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.639 -0.918 . . . . 0.0 109.212 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 HE22 ' A' ' 101' ' ' GLN . 52.9 tp -92.4 128.37 38.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.356 -0.84 . . . . 0.0 109.285 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.55 124.42 51.84 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.464 -0.773 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -105.19 135.59 46.27 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.12 125.55 39.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.507 -0.746 . . . . 0.0 109.135 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.3 m -124.45 128.66 49.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.564 -0.71 . . . . 0.0 109.141 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -125.96 106.75 9.86 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 p -91.07 168.39 11.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.83 -114.29 4.47 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 120' ' ' CYS . 15.2 mt 57.82 70.85 1.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.335 -1.097 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.3 -9.41 21.74 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.417 2.078 . . . . 0.0 111.472 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.1 p -137.6 152.39 49.33 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.0 109.868 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.58 -36.13 81.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.45 -0.781 . . . . 0.0 109.844 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -56.78 -44.62 82.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 108.93 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.45 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 77.9 mt-30 -65.86 -37.54 86.45 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.397 -0.814 . . . . 0.0 109.211 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.3 t -64.38 -51.49 63.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.24 89.77 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.02 79.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 3.0 m80 -66.87 -43.6 83.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -1.118 . . . . 0.0 109.657 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -57.67 -47.98 80.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.126 -0.984 . . . . 0.0 109.236 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -70.6 -37.21 73.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.432 -0.793 . . . . 0.0 109.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.78 -47.99 70.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -64.38 -38.42 90.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.111 -1.229 . . . . 0.0 110.141 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HB2' ' NH2' ' A' ' 13' ' ' ARG . . . -58.96 -48.62 80.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.127 -0.983 . . . . 0.0 109.899 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.89 -42.17 85.99 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.409 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -61.06 -49.9 75.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.337 -0.852 . . . . 0.0 109.337 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.32 -41.3 94.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.566 -0.709 . . . . 0.0 109.509 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.47 99.18 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.56 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 43.4 ttm180 -65.34 -41.31 94.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.288 -1.125 . . . . 0.0 109.417 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.7 tp -61.8 -40.18 94.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.5 m -58.87 -43.27 90.85 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.34 -45.76 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -0.892 . . . . 0.0 109.25 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 69.6 t -65.22 -44.29 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 109.522 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.46 85.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.98 -4.88 59.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.162 -0.961 . . . . 0.0 109.542 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.48 126.08 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -70.57 -178.65 1.86 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -1.051 . . . . 0.0 111.021 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.7 OUTLIER 57.78 74.95 0.58 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.703 -0.623 . . . . 0.0 109.477 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.53 145.16 98.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.766 2.311 . . . . 0.0 112.365 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.586 ' N ' ' CD ' ' A' ' 145' ' ' PRO . . . -65.71 -44.01 93.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 144' ' ' GLY . 37.8 Cg_exo -60.65 148.81 90.27 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.776 2.317 . . . . 0.0 112.802 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 145' ' ' PRO . 76.6 m-20 -136.55 61.29 36.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.96 -38.07 38.25 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.003 1.802 . . . . 0.0 111.06 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -149.83 -53.81 0.16 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -80.13 140.61 36.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.299 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 174.06 65.12 0.05 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.11 135.38 55.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.438 -1.036 . . . . 0.0 110.398 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 153' ' ' LEU . 12.2 tpp85 -161.27 71.53 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 108.8 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 152' ' ' ARG . 91.5 mt 39.93 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.433 0.635 . . . . 0.0 110.343 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 154' ' ' GLU . 2.0 pm0 -112.88 147.53 36.83 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.468 0.652 . . . . 0.0 109.367 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -63.24 175.36 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.791 . . . . 0.0 110.496 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -147.73 165.45 30.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.316 -0.865 . . . . 0.0 109.391 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -73.23 133.91 44.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.268 -0.895 . . . . 0.0 110.06 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -78.02 150.42 33.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 110.301 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.76 141.75 56.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.464 -0.773 . . . . 0.0 110.133 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.022 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.304 0.573 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -65.36 140.41 58.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.432 -0.792 . . . . 0.0 110.232 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.4 143.0 40.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.563 -0.71 . . . . 0.0 110.106 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.04 122.16 2.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.873 . . . . 0.0 109.308 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.1 mtm 42.34 71.6 1.34 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.429 -0.794 . . . . 0.0 110.438 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 7' ' ' GLU . 32.6 Cg_exo -58.99 143.76 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.731 2.287 . . . . 0.0 112.71 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' PRO . 81.9 tt0 57.72 151.93 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.709 0.766 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 p -73.11 164.91 25.99 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.127 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -73.05 143.63 47.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.492 -0.755 . . . . 0.0 110.02 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.3 t -125.74 134.92 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -114.12 132.38 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -125.04 136.28 53.54 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.538 HH21 ' CG ' ' A' ' 124' ' ' GLU . 22.0 mmt180 -137.14 153.67 50.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.382 -0.824 . . . . 0.0 109.793 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 97.6 mt-10 -139.69 150.37 44.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 0.0 109.143 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.32 150.3 28.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.107 -0.995 . . . . 0.0 109.274 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 49.1 p-80 -103.59 113.43 26.93 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.367 -0.833 . . . . 0.0 108.875 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.11 128.46 54.7 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.421 -0.799 . . . . 0.0 109.361 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.71 76.62 10.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.66 151.93 1.06 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.958 . . . . 0.0 108.825 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.03 162.57 16.13 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.115 1.877 . . . . 0.0 111.696 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.42 -31.03 81.03 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.678 2.252 . . . . 0.0 111.634 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.26 93.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.66 -41.85 95.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.56 -46.15 95.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.302 -0.874 . . . . 0.0 109.83 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -61.43 -43.16 99.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 109.539 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.42 -42.57 64.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.134 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.98 -42.04 99.73 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.316 -0.865 . . . . 0.0 109.082 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 62.8 mtt -65.6 -40.91 93.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 110.215 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 m -91.96 54.56 2.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.978 -1.076 . . . . 0.0 109.566 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -163.66 89.99 1.16 Allowed Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.14 -39.23 71.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.271 1.981 . . . . 0.0 112.182 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -66.44 -45.04 81.16 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.56 -0.713 . . . . 0.0 109.891 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.36 -37.96 88.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 110.049 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.05 -46.02 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.496 -1.377 . . . . 0.0 109.636 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.54 -16.03 63.35 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.38 -0.825 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.744 HH22 ' HE ' ' A' ' 141' ' ' ARG . 3.1 tmt_? -63.19 -43.12 99.08 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.462 -0.774 . . . . 0.0 109.28 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.525 ' O ' ' CB ' ' A' ' 38' ' ' MET . 30.8 p-90 -104.04 23.83 12.34 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.525 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER 90.69 147.33 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 121.495 0.664 . . . . 0.0 110.681 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.67 -163.57 27.42 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' GLU . 43.6 p -107.43 53.29 0.69 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.357 -1.084 . . . . 0.0 109.349 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' THR . 97.8 mt-10 58.58 140.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.446 0.641 . . . . 0.0 110.71 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.35 11.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.493 -0.755 . . . . 0.0 109.668 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.42 163.77 15.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.474 -0.766 . . . . 0.0 109.85 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.89 144.38 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.628 -0.67 . . . . 0.0 109.509 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -166.37 155.29 10.05 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.167 -0.958 . . . . 0.0 108.883 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -43.4 -37.76 7.8 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.051 1.834 . . . . 0.0 112.186 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -98.27 112.12 61.34 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 109.115 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.55 136.72 33.33 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.799 1.666 . . . . 0.0 112.814 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.7 -40.95 1.06 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 52' ' ' TYR . . . 75.51 19.34 79.38 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.0 mt 55.18 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.91 . . . . 0.0 110.133 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.561 ' N ' ' O ' ' A' ' 50' ' ' GLY . 96.1 m-85 -75.74 157.17 33.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.147 -0.971 . . . . 0.0 110.395 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 tp -75.75 125.61 29.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 109.742 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' ASN . 31.2 m -141.04 161.12 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.327 -0.858 . . . . 0.0 109.913 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' VAL . 39.6 p30 22.1 -142.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.678 0.751 . . . . 0.0 112.687 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.39 135.52 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.49 -0.756 . . . . 0.0 109.888 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 m -119.74 129.45 54.51 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.17 -125.53 5.41 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . -93.55 -166.91 1.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.0 110.643 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 55.31 3.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' H ' ' C ' ' A' ' 59' ' ' ALA . 89.9 t80 -84.93 -68.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.338 -0.851 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -177.0 176.4 1.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.489 -0.757 . . . . 0.0 109.191 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -135.91 152.1 50.66 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.89 -47.46 0.64 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.0 p -107.81 0.04 21.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.934 . . . . 0.0 108.997 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -73.37 146.37 45.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -104.87 -30.74 9.65 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -161.4 131.63 4.98 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.54 124.63 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.328 -0.857 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.6 t -147.68 96.43 4.11 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.9 147.0 19.86 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.239 1.959 . . . . 0.0 113.723 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 72' ' ' VAL . 7.7 p 37.53 41.98 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.631 ' NE2' ' NH1' ' A' ' 74' ' ' ARG . 39.8 t60 -155.09 -73.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 108.892 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.631 ' NH1' ' NE2' ' A' ' 73' ' ' HIS . 83.5 mtt85 -144.84 141.35 29.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 0.0 109.748 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.8 137.15 41.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.78 126.17 12.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.072 -1.018 . . . . 0.0 108.676 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -157.79 162.23 38.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.023 -1.048 . . . . 0.0 109.96 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -137.69 142.61 41.08 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -151.03 127.27 10.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.888 -1.132 . . . . 0.0 109.283 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.51 -175.31 43.2 Favored Glycine 0 N--CA 1.498 2.802 0 O-C-N 121.149 -0.969 . . . . 0.0 110.805 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.423 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 65.7 p-90 -72.18 139.13 48.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.518 -0.989 . . . . 0.0 110.407 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 82.8 m-20 -145.62 72.86 1.33 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.47 -13.57 57.66 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' VAL . 13.9 m -84.76 158.37 20.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.1 -1.235 . . . . 0.0 110.266 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 86' ' ' VAL . 58.4 mp0 -58.93 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 0.0 109.497 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.9 m 31.21 89.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.09 0.472 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 86' ' ' VAL . 7.4 m 29.21 75.32 0.37 Allowed Pre-proline 0 N--CA 1.5 2.068 0 CA-C-O 121.154 0.502 . . . . 0.0 111.593 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 12.1 Cg_exo -55.14 -44.13 52.39 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 122.034 1.822 . . . . 0.0 112.421 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 93.7 Cg_endo -84.66 -8.21 9.43 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.912 1.741 . . . . 0.0 111.116 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 97.9 -28.99 11.95 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 92' ' ' SER . 97.9 p 33.04 -90.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.034 -0.686 . . . . 0.0 110.665 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 90' ' ' GLY . 21.2 m 46.29 -113.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 109.62 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.0 tp -119.86 121.33 38.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.587 -0.696 . . . . 0.0 109.278 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.78 130.82 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.98 131.5 27.06 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 98.8 mt -129.35 132.55 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -0.826 . . . . 0.0 109.403 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -126.93 134.9 50.32 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.5 mt -109.7 129.67 55.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.468 -0.77 . . . . 0.0 109.201 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.46 128.79 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -88.74 137.03 32.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.361 -0.837 . . . . 0.0 110.358 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -138.12 30.99 2.43 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 79.0 163.3 24.91 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.66 -95.44 0.01 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -82.35 175.28 53.63 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.5 m -122.73 130.88 53.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.655 -0.909 . . . . 0.0 109.183 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.4 tp -84.88 128.85 34.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.042 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.76 122.29 46.65 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' NH1' ' OE2' ' A' ' 14' ' ' GLU . 95.6 mtt-85 -104.73 130.91 52.72 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.29 125.46 53.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 92.5 m -123.71 127.79 48.67 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.468 ' NE2' HD21 ' A' ' 114' ' ' LEU . 13.6 t60 -135.92 139.74 43.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.376 -0.828 . . . . 0.0 109.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.0 p -139.05 157.51 45.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.331 -0.856 . . . . 0.0 109.234 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.76 -113.4 3.08 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.468 HD21 ' NE2' ' A' ' 111' ' ' HIS . 9.6 mt 50.17 77.06 0.48 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.182 -1.187 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.03 -22.28 62.97 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.889 2.392 . . . . 0.0 111.508 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 p -107.31 134.29 50.61 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.676 0.75 . . . . 0.0 109.973 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.53 78.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.601 -0.687 . . . . 0.0 109.98 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.04 -42.85 86.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.37 -0.831 . . . . 0.0 109.426 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.66 -35.96 82.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.19 -46.74 82.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.52 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.03 90.56 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.322 -0.861 . . . . 0.0 109.321 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.28 92.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' CE1' ' O ' ' A' ' 89' ' ' PRO . 2.0 m-70 -66.23 -43.63 86.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -1.069 . . . . 0.0 109.195 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.538 ' CG ' HH21 ' A' ' 13' ' ' ARG . 80.7 tt0 -56.9 -50.54 72.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -71.57 -35.26 70.52 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.666 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.92 -49.88 60.81 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.054 -1.07 . . . . 0.0 110.553 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -63.64 -41.21 98.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -1.232 . . . . 0.0 109.796 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.95 97.3 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.183 -0.948 . . . . 0.0 109.487 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.54 -45.7 74.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -62.24 -46.0 90.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.557 -0.715 . . . . 0.0 109.832 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.0 mt -63.16 -40.65 98.18 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.94 -49.77 74.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -65.49 -40.52 93.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.373 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.84 -42.11 99.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.209 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 81.7 m -61.2 -43.91 98.13 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -0.794 . . . . 0.0 109.485 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.6 mm-40 -62.18 -42.29 99.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.465 -0.772 . . . . 0.0 110.119 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.23 -46.95 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.397 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.72 -38.45 80.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.99 22.47 10.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.279 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . -153.54 -134.79 2.04 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.744 ' HE ' HH22 ' A' ' 36' ' ' ARG . 80.2 mtp85 -42.71 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 110.714 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.84 81.46 58.27 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.703 . . . . 0.0 109.741 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -56.86 144.16 89.03 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.588 2.192 . . . . 0.0 112.365 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.61 177.31 0.23 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 158.11 57.68 Favored 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.824 2.349 . . . . 0.0 112.18 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -133.12 76.39 69.65 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.486 -0.759 . . . . 0.0 109.388 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 149' ' ' TYR . 49.2 Cg_exo -55.3 -36.68 94.14 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.636 2.224 . . . . 0.0 111.403 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 53.76 7.16 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 147' ' ' PRO . 90.6 t80 -63.01 -42.9 99.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 87.29 69.65 1.3 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -72.04 137.73 47.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -1.128 . . . . 0.0 109.7 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -138.95 134.23 32.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 153' ' ' LEU . 3.8 mm? -87.79 -99.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.01 124.71 50.0 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.605 0.717 . . . . 0.0 109.624 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -92.79 -19.95 21.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 109.409 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -133.46 126.64 31.61 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.57 0.7 . . . . 0.0 109.744 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -155.67 -7.15 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.4 t-80 -74.86 138.51 42.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 110.486 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 158' ' ' HIS . 86.5 t60 46.74 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.16 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 160' ' ' HIS . 52.8 p-80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.109 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.19 140.89 58.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.454 -0.779 . . . . 0.0 109.958 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' ALA . 65.5 tttm -155.2 109.42 2.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.425 -0.797 . . . . 0.0 109.276 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' LYS . . . 60.5 130.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.631 -0.668 . . . . 0.0 110.424 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 5' ' ' MET . 0.4 OUTLIER -156.51 55.02 0.97 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.741 179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 5' ' ' MET . 67.8 Cg_endo -71.49 152.46 60.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.027 2.485 . . . . 0.0 112.841 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -174.91 58.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 9' ' ' PHE . 8.4 m -72.16 132.57 44.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.76 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 8' ' ' SER . 95.7 m-85 36.39 76.87 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.082 0.467 . . . . 0.0 110.21 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.06 137.45 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.526 -0.734 . . . . 0.0 109.127 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.2 t -113.84 132.67 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -118.91 137.92 53.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.706 -0.621 . . . . 0.0 109.477 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.24 152.63 46.11 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.29 152.44 47.25 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.512 0.672 . . . . 0.0 109.643 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.99 25.96 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -104.87 121.93 44.71 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 110.197 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.6 131.05 57.05 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.93 80.68 9.2 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.93 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 179.46 152.75 0.56 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 108.834 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.52 160.35 32.34 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.412 2.075 . . . . 0.0 111.643 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -66.42 -24.97 49.04 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.387 2.058 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.23 -47.16 83.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -39.58 82.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 79.3 t -64.7 -44.78 96.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.422 -0.799 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.87 -44.56 96.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.452 -0.78 . . . . 0.0 109.923 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -57.61 -45.32 85.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 88.6 mt -63.39 -38.15 90.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.393 -0.817 . . . . 0.0 109.451 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.8 mmm -77.64 -8.35 57.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 109.838 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 m -119.59 76.2 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.454 -0.779 . . . . 0.0 109.084 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.7 OUTLIER 169.22 120.77 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.86 -14.92 29.78 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.166 1.91 . . . . 0.0 111.395 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -85.3 -52.0 6.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.623 -0.673 . . . . 0.0 110.57 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -65.27 -40.22 93.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.285 -0.884 . . . . 0.0 109.963 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 55.7 mt -50.95 -27.55 5.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.256 -0.903 . . . . 0.0 109.501 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.01 -21.68 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -62.82 -41.98 99.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 110.503 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 34' ' ' ILE . 15.3 p-90 -106.78 18.06 22.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.328 -0.857 . . . . 0.0 110.173 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 37' ' ' TRP . 96.8 mmm -141.51 -162.96 1.47 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.1 -1.0 . . . . 0.0 110.566 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.63 175.98 15.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.7 p -87.93 0.94 55.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.639 -0.918 . . . . 0.0 108.991 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.54 131.01 27.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.314 -0.866 . . . . 0.0 109.103 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 55' ' ' ASN . . . -158.35 152.93 24.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.9 pm0 -132.06 148.21 52.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.46 132.81 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.742 . . . . 0.0 109.204 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -171.88 85.7 0.46 Allowed Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.44 -34.7 62.67 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.058 1.839 . . . . 0.0 111.142 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -81.89 152.03 68.28 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.501 -0.749 . . . . 0.0 109.914 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.65 145.58 70.3 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.989 2.46 . . . . 0.0 112.918 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.25 0.94 Allowed Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.9 92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.65 146.37 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 109.994 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -81.96 -11.37 58.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.569 -0.707 . . . . 0.0 109.147 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.29 148.37 39.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.034 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 56' ' ' VAL . 27.3 m -135.2 161.91 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.537 -0.727 . . . . 0.0 109.301 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 42' ' ' ALA . 25.9 t-20 55.73 -77.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.256 0.551 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 54' ' ' VAL . 4.9 t 58.85 129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.862 0.839 . . . . 0.0 110.757 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.4 p -101.93 -6.16 23.81 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.413 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -88.17 -13.32 64.18 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 61' ' ' PHE . . . 43.68 -151.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.503 -0.998 . . . . 0.0 110.877 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' ALA . 95.6 mtt180 40.95 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.864 -0.522 . . . . 0.0 110.17 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 59' ' ' ALA . 50.5 t80 60.97 -70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.821 -0.549 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -100.21 147.06 26.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -143.41 149.07 37.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.466 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.69 89.83 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.0 m -91.38 -140.37 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.339 -1.095 . . . . 0.0 109.683 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 65' ' ' SER . 97.1 m-85 57.32 152.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.731 0.776 . . . . 0.0 110.535 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -86.11 -58.62 2.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.523 -0.735 . . . . 0.0 109.212 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.68 131.55 19.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.669 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.89 131.79 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.432 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.5 t -145.73 97.43 4.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 58.3 Cg_exo -51.94 151.92 14.97 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.459 2.106 . . . . 0.0 113.268 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 34.72 43.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.463 0.649 . . . . 0.0 110.615 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -156.74 -81.96 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.438 -0.789 . . . . 0.0 109.84 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 62.1 ttp180 -143.72 152.71 41.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.0 tp -142.03 133.32 26.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.435 -0.79 . . . . 0.0 109.45 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.58 138.64 23.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.042 -1.036 . . . . 0.0 109.66 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -165.51 156.62 14.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 109.573 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 p -82.36 151.79 26.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.959 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 71.6 t80 -177.48 -58.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . 67.22 -142.61 41.49 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -106.65 121.83 45.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.361 -1.082 . . . . 0.0 109.143 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 67.4 t0 -66.4 141.91 57.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.668 0.747 . . . . 0.0 110.674 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 91.75 8.01 64.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.9 m -119.19 120.11 36.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.663 -0.904 . . . . 0.0 109.411 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 87' ' ' VAL . 79.6 mm-40 -101.54 -16.97 16.61 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.06 21.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 85' ' ' GLU . 17.0 t -140.2 67.31 32.61 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.278 -0.888 . . . . 0.0 109.656 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -59.38 -178.11 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.344 2.029 . . . . 0.0 111.657 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 145.03 98.92 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.51 2.14 . . . . 0.0 112.745 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.94 -28.23 5.61 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -63.69 -40.86 97.85 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.475 -1.014 . . . . 0.0 109.702 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -138.24 154.03 49.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.263 -0.898 . . . . 0.0 109.768 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 tp -149.1 128.71 13.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.432 -0.793 . . . . 0.0 109.026 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -90.31 132.86 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.67 140.7 42.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.46 -0.775 . . . . 0.0 109.081 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 99.3 mt -134.12 141.05 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.249 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -126.1 123.31 38.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.556 -0.715 . . . . 0.0 109.518 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.3 mt -101.53 132.07 47.37 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.375 -0.828 . . . . 0.0 109.005 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.76 129.49 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -0.776 . . . . 0.0 109.356 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -78.77 136.31 37.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.472 -0.768 . . . . 0.0 109.773 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -144.75 160.67 40.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.258 -0.902 . . . . 0.0 110.097 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.56 -40.73 98.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.83 91.39 1.72 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.21 -141.99 46.95 Favored Glycine 0 N--CA 1.488 2.147 0 O-C-N 121.374 -1.074 . . . . 0.0 110.588 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 m -128.07 132.06 49.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.635 -0.92 . . . . 0.0 109.627 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -89.27 127.38 35.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 109.09 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.758 -0.589 . . . . 0.0 109.6 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -113.36 133.5 55.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.98 126.09 52.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.555 -0.715 . . . . 0.0 109.595 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -121.13 124.57 45.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -136.32 139.46 42.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -128.65 152.47 48.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.335 -0.853 . . . . 0.0 109.541 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.9 -122.46 4.7 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.9 mt 40.02 84.26 0.19 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.746 -0.855 . . . . 0.0 110.299 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.32 10.23 3.33 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.529 2.153 . . . . 0.0 111.716 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m -128.03 146.44 50.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.938 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.08 79.58 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 109.994 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -65.61 -41.62 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.7 -38.39 89.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 109.638 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.96 -43.56 87.58 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.416 1.103 . . . . 0.0 108.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.61 -50.84 67.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.144 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.06 -40.49 83.39 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -65.85 -44.17 86.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.339 -1.095 . . . . 0.0 109.654 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.9 -49.82 74.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.318 -0.864 . . . . 0.0 109.601 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.32 -36.35 76.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.048 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' O ' ' CD2' ' A' ' 130' ' ' TYR . . . -64.42 -49.73 63.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -56.06 -40.18 73.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.08 . . . . 0.0 109.642 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.54 88.41 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.233 -0.917 . . . . 0.0 109.358 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.23 -51.45 24.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.877 . . . . 0.0 109.726 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 126' ' ' GLY . 52.4 m-85 -62.86 -38.34 90.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.68 -0.637 . . . . 0.0 109.674 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.8 mt -61.73 -39.73 92.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.93 -41.11 97.67 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -63.93 -40.67 96.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -1.084 . . . . 0.0 109.451 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.97 -40.4 95.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.547 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -61.06 -42.98 99.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.375 -0.828 . . . . 0.0 110.096 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 140' ' ' GLY . 94.6 mt-10 -62.97 -34.69 78.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.808 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.16 -43.91 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.186 -0.946 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.18 -38.31 88.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.984 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.2 22.04 15.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -175.48 -166.63 33.38 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 142' ' ' ASP . 87.7 mtm180 -144.22 161.58 38.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.487 -1.008 . . . . 0.0 109.917 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 141' ' ' ARG . 3.7 p-10 41.76 69.08 2.24 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.782 -0.574 . . . . 0.0 110.286 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.57 -37.84 90.53 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.61 2.207 . . . . 0.0 111.237 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.84 -160.43 29.34 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.19 -163.91 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.848 2.365 . . . . 0.0 112.555 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -125.04 82.26 61.81 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.578 -0.701 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 149' ' ' TYR . 17.2 Cg_exo -63.59 156.08 59.14 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.99 2.46 . . . . 0.0 112.063 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.5 t80 66.91 -61.56 0.33 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 147' ' ' PRO . 89.8 t80 -61.27 -44.58 97.01 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.732 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.12 174.53 3.39 Favored Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.036 -1.04 . . . . 0.0 110.787 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 153' ' ' LEU . 35.1 ptt180 -69.57 -10.39 57.95 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.516 -0.991 . . . . 0.0 109.114 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 59.38 -74.16 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.632 . . . . 0.0 109.69 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 151' ' ' ARG . 5.1 tp -140.07 -130.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.882 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 153' ' ' LEU . 98.1 mt-10 56.5 34.18 23.87 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -67.59 138.37 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.494 -0.754 . . . . 0.0 110.065 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -99.42 99.29 10.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.65 ' CG ' ' H ' ' A' ' 158' ' ' HIS . 73.8 t60 49.55 179.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.79 0.805 . . . . 0.0 111.157 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.65 ' H ' ' CG ' ' A' ' 157' ' ' HIS . 80.8 m80 -74.96 135.2 41.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.453 -0.779 . . . . 0.0 110.102 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -84.91 128.1 34.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.386 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.065 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.459 0.647 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.4 -2.45 57.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 109.417 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.59 103.14 13.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.515 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.06 149.0 23.93 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.0 mtt -81.51 158.2 69.04 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.234 -0.917 . . . . 0.0 109.528 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 8' ' ' SER . 63.6 Cg_exo -47.16 -40.3 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.988 1.792 . . . . 0.0 112.144 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 6' ' ' PRO . 97.3 mt-10 38.26 -90.2 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.524 0.678 . . . . 0.0 110.561 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 6' ' ' PRO . 2.6 p 63.02 127.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.558 0.694 . . . . 0.0 109.636 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -99.63 153.47 19.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 109.569 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.63 135.12 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 51.9 t -114.83 132.28 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.64 133.63 53.89 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 152.06 50.56 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.34 -0.85 . . . . 0.0 109.519 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.96 147.86 49.86 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.89 142.98 28.2 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 0.0 109.152 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -100.13 115.14 29.12 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.46 132.98 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.462 -0.774 . . . . 0.0 109.729 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.38 70.51 10.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.21 151.9 1.16 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.834 . . . . 0.0 109.25 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.95 162.94 33.0 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.526 2.151 . . . . 0.0 112.095 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.57 -26.74 76.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.51 2.14 . . . . 0.0 111.337 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.1 98.22 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.547 -0.721 . . . . 0.0 109.384 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -46.12 79.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.69 -46.78 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.105 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -61.55 -43.73 98.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.645 -0.66 . . . . 0.0 109.459 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.75 -42.7 75.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -0.788 . . . . 0.0 109.889 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.11 -42.96 99.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 0.0 109.489 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.4 mtt -67.0 -38.96 86.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.394 -0.816 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -81.2 1.22 33.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 109.621 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -118.99 85.46 29.06 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.545 -0.722 . . . . 0.0 109.135 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.45 -37.99 73.58 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.584 2.189 . . . . 0.0 112.107 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.98 -42.36 89.93 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.1 -31.95 73.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.908 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.3 mt -62.27 -42.91 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.12 -0.987 . . . . 0.0 109.496 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 40' ' ' THR . 76.3 mt -57.99 -12.88 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.759 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.517 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -65.3 -43.36 91.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -110.28 40.95 1.84 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.453 -0.779 . . . . 0.0 109.842 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.8 tpt -150.46 -55.82 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.65 78.41 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 72.0 m -117.58 107.92 14.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.516 -0.991 . . . . 0.0 109.017 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 41' ' ' GLU . 57.8 mp0 -42.44 155.67 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.336 0.589 . . . . 0.0 110.255 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -152.32 152.87 32.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.334 -0.854 . . . . 0.0 109.918 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 96.8 mt-10 -82.93 163.54 21.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.425 -0.797 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -130.96 140.36 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -100.86 148.53 35.17 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.4 -35.41 16.03 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.972 1.781 . . . . 0.0 112.276 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 mm-40 176.51 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.728 . . . . 0.0 109.082 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 47' ' ' GLU . 92.6 Cg_endo -78.08 147.77 23.99 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.154 1.903 . . . . 0.0 112.712 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.06 95.04 0.5 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.51 157.27 3.02 Favored Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.51 -0.994 . . . . 0.0 110.618 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 51' ' ' LEU . 4.2 mm? -50.26 -101.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.985 -0.715 . . . . 0.0 110.505 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 52' ' ' TYR . 55.6 t80 59.97 7.24 1.1 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -111.36 149.2 31.5 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' ASN . 98.7 t -134.98 157.41 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.627 -0.671 . . . . 0.0 109.655 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 57' ' ' THR . 72.4 m-20 -81.18 -170.43 2.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.432 -0.793 . . . . 0.0 110.052 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 55' ' ' ASN . 16.0 m 32.64 35.77 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.88 0.848 . . . . 0.0 110.404 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' ASN . 86.1 m -106.29 -11.81 15.9 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.38 21.73 64.05 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.1 153.53 35.22 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.186 -1.185 . . . . 0.0 109.584 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 61' ' ' PHE . 10.8 ptp85 -141.9 153.43 44.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.326 -0.859 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 62' ' ' ALA . 84.7 m-85 38.78 -102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.669 -0.644 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 49.92 98.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.629 -0.669 . . . . 0.0 109.429 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -134.8 148.02 50.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.382 -0.823 . . . . 0.0 109.106 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.38 -85.85 1.65 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.7 m -138.31 120.54 15.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.454 -1.027 . . . . 0.0 109.316 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -70.16 135.14 48.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.867 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -74.11 -79.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.944 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -147.4 134.94 20.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -125.17 127.32 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 ' HE ' ' A' ' 74' ' ' ARG . 2.4 t -146.83 132.11 9.11 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.291 -0.88 . . . . 0.0 108.893 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 72' ' ' VAL . 61.8 Cg_endo -72.97 158.49 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 121.604 1.536 . . . . 0.0 112.392 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 26.71 43.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-O 121.221 0.534 . . . . 0.0 111.876 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.468 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 48.4 m80 -152.91 -79.71 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.226 -0.921 . . . . 0.0 109.773 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HE ' HG21 ' A' ' 70' ' ' VAL . 36.4 ptt180 -145.41 151.39 38.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.0 110.163 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.1 tp -137.93 133.49 33.82 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.31 115.58 12.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -125.06 129.01 49.4 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 t -112.5 117.87 33.55 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.404 -0.81 . . . . 0.0 109.537 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 80' ' ' GLY . 85.9 t80 -161.38 132.29 5.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 109.088 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 79' ' ' PHE . . . -70.69 168.47 49.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.52 ' O ' ' N ' ' A' ' 83' ' ' GLY . 19.9 t90 -84.73 157.61 21.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.471 -1.017 . . . . 0.0 109.725 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.4 t0 56.34 -83.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.421 -0.799 . . . . 0.0 109.48 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' TRP . . . 176.27 -30.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 86' ' ' VAL . 11.0 p -86.02 -175.28 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.497 -1.002 . . . . 0.0 109.975 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -70.26 3.1 3.09 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 84' ' ' SER . 22.9 m -68.85 138.58 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.444 -0.785 . . . . 0.0 109.84 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.7 m -150.1 68.02 8.59 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.44 -0.787 . . . . 0.0 109.401 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 17.2 Cg_exo -54.64 -42.99 63.27 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.162 1.908 . . . . 0.0 112.26 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 45.0 Cg_endo -80.87 -4.44 12.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.465 1.443 . . . . 0.0 111.084 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.71 31.59 26.5 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 p -64.93 152.67 42.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.5 -1.0 . . . . 0.0 110.308 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 93' ' ' LEU . 1.8 t -176.4 -94.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' N ' ' OG ' ' A' ' 92' ' ' SER . 36.8 tp -111.57 120.51 42.33 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.09 121.39 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -127.64 131.39 49.87 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 108.825 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.14 130.13 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.555 -0.716 . . . . 0.0 109.09 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -125.66 139.78 53.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.46 -0.775 . . . . 0.0 109.173 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.05 127.05 53.44 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.48 -0.762 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.32 131.45 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.494 -0.753 . . . . 0.0 109.297 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.56 138.89 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.47 -0.769 . . . . 0.0 110.535 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 102' ' ' GLY . 50.9 tt0 -147.85 116.0 6.52 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 38.54 -138.52 0.77 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.02 98.68 2.07 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.07 -173.15 21.15 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -125.74 130.17 50.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.669 -0.901 . . . . 0.0 108.954 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.6 tp -88.2 130.35 35.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 108.882 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 107' ' ' LEU . 6.5 tt -109.97 121.3 44.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.552 ' N ' HD23 ' A' ' 107' ' ' LEU . 77.7 ttt-85 -109.6 123.06 48.81 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -115.15 124.36 51.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.537 ' OG1' ' NH1' ' A' ' 108' ' ' ARG . 99.3 m -125.45 130.18 51.31 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -129.98 139.99 50.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.473 -0.767 . . . . 0.0 108.932 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 t -138.43 148.75 44.77 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.41 46.81 0.96 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.443 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 19.6 mt -95.99 146.62 31.63 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.263 -1.14 . . . . 0.0 109.821 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.44 -46.61 3.84 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.132 1.888 . . . . 0.0 112.059 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.6 p -156.54 169.15 25.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.318 -0.864 . . . . 0.0 109.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.05 -35.54 80.58 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.593 -0.692 . . . . 0.0 109.562 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -50.66 -56.36 12.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.479 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.31 -29.57 69.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 109.158 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.542 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 8.6 t -62.97 -44.3 96.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.417 -0.802 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.15 -48.62 79.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -40.7 90.16 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 89' ' ' PRO . 62.1 t60 -65.96 -41.96 90.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -1.043 . . . . 0.0 109.528 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.62 -38.38 89.99 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.488 -0.758 . . . . 0.0 109.469 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -66.14 -35.3 80.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -44.83 97.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.487 ' HE1' ' CE1' ' A' ' 123' ' ' HIS . 88.9 m95 -62.16 -37.95 87.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.348 -1.089 . . . . 0.0 109.579 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.32 89.05 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.288 -0.882 . . . . 0.0 109.295 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.49 -48.74 68.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.336 -0.852 . . . . 0.0 109.662 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -63.22 -44.68 94.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 58.9 mt -62.76 -41.71 99.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.679 -0.638 . . . . 0.0 109.64 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.27 -47.23 86.89 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -64.86 -42.19 95.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -1.118 . . . . 0.0 109.522 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.19 -40.4 95.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.495 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.6 m -59.24 -44.04 92.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.244 -0.91 . . . . 0.0 109.038 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.52 -42.5 95.73 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.414 -0.803 . . . . 0.0 109.791 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.517 ' CG1' HH21 ' A' ' 36' ' ' ARG . 79.0 t -64.59 -45.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.97 -29.55 70.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.0 109.422 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.11 0.8 43.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.408 -0.807 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.45 -115.97 0.62 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -172.34 54.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.385 -1.068 . . . . 0.0 109.239 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.67 80.62 12.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.473 -0.767 . . . . 0.0 109.731 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.05 -37.3 78.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.378 2.052 . . . . 0.0 111.29 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 53.99 -176.57 0.31 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.67 13.91 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.512 2.141 . . . . 0.0 111.322 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 62.98 60.36 2.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.927 -0.483 . . . . 0.0 110.243 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.96 -17.14 41.36 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.298 1.999 . . . . 0.0 111.833 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.442 ' CD2' ' O ' ' A' ' 148' ' ' PHE . 82.5 t80 -84.27 59.34 5.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.32 -46.09 90.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 177.14 -46.12 0.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -77.72 134.09 38.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.117 -1.225 . . . . 0.0 110.143 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -65.88 -42.62 90.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.533 -0.73 . . . . 0.0 109.977 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.52 129.1 56.47 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.405 -0.809 . . . . 0.0 109.909 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -110.38 159.57 17.34 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.734 -0.604 . . . . 0.0 109.497 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -85.8 114.16 22.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.739 . . . . 0.0 110.192 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.95 -11.67 32.72 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 73.9 t60 -65.7 -43.81 88.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.598 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.503 ' CD2' ' CD2' ' A' ' 157' ' ' HIS . 19.6 m-70 -146.55 150.47 35.6 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.212 -0.93 . . . . 0.0 110.118 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.88 89.56 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.425 -0.797 . . . . 0.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.048 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 5.1 mpp? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.453 0.644 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 59.12 62.24 1.89 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.443 0.64 . . . . 0.0 109.882 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 58.41 161.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.818 0.818 . . . . 0.0 110.861 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.71 58.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.774 -0.579 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -146.36 76.13 12.23 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 109.238 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.74 138.3 84.75 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.727 2.285 . . . . 0.0 112.011 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -175.19 -66.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.562 -0.711 . . . . 0.0 109.149 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p 43.44 -128.2 0.82 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.648 -0.658 . . . . 0.0 110.664 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.1 152.0 21.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.505 -0.747 . . . . 0.0 110.268 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 84.7 t -118.14 133.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG11 ' NH1' ' A' ' 13' ' ' ARG . 55.3 t -119.49 133.72 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -127.3 141.16 51.78 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' NH1' HG11 ' A' ' 11' ' ' VAL . 92.8 mtm-85 -138.65 153.56 48.6 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.443 -0.786 . . . . 0.0 109.214 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -137.3 146.12 44.28 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.87 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.84 . . . . 0.0 108.96 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -107.29 122.15 45.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.562 -0.711 . . . . 0.0 109.089 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.21 129.24 56.2 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.52 81.99 8.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.366 -0.833 . . . . 0.0 109.715 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.64 152.47 0.91 Allowed Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.39 162.54 35.96 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.395 2.063 . . . . 0.0 111.789 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.86 -31.37 85.05 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.709 2.273 . . . . 0.0 111.756 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.47 -41.01 93.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.534 -0.729 . . . . 0.0 110.04 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -41.67 90.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.04 -44.64 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.342 -0.849 . . . . 0.0 109.78 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' O ' ' OG1' ' A' ' 29' ' ' THR . 85.9 t80 -61.0 -45.13 96.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.398 -0.813 . . . . 0.0 110.166 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.39 -42.53 82.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.43 -41.48 98.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.479 -0.763 . . . . 0.0 109.728 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mmm -82.38 -6.65 59.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.781 . . . . 0.0 109.899 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 29' ' ' THR . 89.1 m -96.49 -6.65 36.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.477 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.86 127.96 25.78 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.411 -0.806 . . . . 0.0 109.493 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.16 -32.49 4.1 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.863 1.708 . . . . 0.0 111.487 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -67.91 -43.39 79.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.644 -0.66 . . . . 0.0 109.876 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -64.61 -38.06 89.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.705 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.45 -42.92 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 109.132 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 71.4 mt -63.29 -9.57 12.32 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.372 -0.83 . . . . 0.0 109.821 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.03 -44.03 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.846 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -111.54 -26.98 8.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.509 -0.745 . . . . 0.0 109.912 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.505 ' SD ' ' OH ' ' A' ' 130' ' ' TYR . 1.2 tmm? -79.9 -71.12 0.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.166 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 35' ' ' LEU . . . 80.06 -165.47 49.06 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 41' ' ' GLU . 44.0 p 54.89 48.91 18.94 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.819 -0.812 . . . . 0.0 110.231 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 40' ' ' THR . 79.4 mm-40 56.65 144.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.779 0.799 . . . . 0.0 110.8 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.28 153.2 6.45 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.289 -0.882 . . . . 0.0 109.731 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -136.33 144.38 44.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.775 . . . . 0.0 109.067 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.595 ' O ' HG22 ' A' ' 44' ' ' VAL . 14.1 p -83.41 28.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.057 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLU . 28.6 tp10 -125.43 76.73 68.97 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -46.85 80.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.506 2.138 . . . . 0.0 112.148 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 45' ' ' GLU . 44.4 tt0 -174.04 83.02 0.36 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 136.28 61.65 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.315 2.01 . . . . 0.0 112.495 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.02 16.95 79.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.46 -109.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.202 0 O-C-N 121.196 -1.179 . . . . 0.0 110.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 51' ' ' LEU . 9.5 mp -84.02 -0.64 52.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.505 -0.997 . . . . 0.0 109.665 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 56.76 84.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.557 0.694 . . . . 0.0 109.968 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.3 pt? -165.39 140.33 5.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.335 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 56' ' ' VAL . 18.7 m -146.44 170.54 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.174 -0.954 . . . . 0.0 108.832 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 56' ' ' VAL . 17.7 t-20 54.34 -90.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 110.232 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 56' ' ' VAL . 14.5 p -63.05 121.67 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.217 -0.927 . . . . 0.0 110.271 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.2 m -133.89 132.37 40.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -0.826 . . . . 0.0 109.493 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.12 117.67 6.95 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 41.65 -111.26 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.596 -0.944 . . . . 0.0 110.449 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -147.4 105.48 3.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.186 -0.946 . . . . 0.0 108.791 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -73.66 131.78 42.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 0.0 109.917 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.29 120.79 9.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.316 -0.865 . . . . 0.0 109.072 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -146.03 145.23 30.51 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.115 -0.991 . . . . 0.0 109.542 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.32 120.49 5.59 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -164.78 -159.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 109.746 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER 62.54 176.81 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.757 0.789 . . . . 0.0 110.84 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.53 -51.75 67.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.354 0.597 . . . . 0.0 109.815 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -151.49 147.39 26.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 109.301 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 t -140.09 108.73 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -115.93 127.62 26.63 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 73' ' ' HIS . 65.2 Cg_endo -73.35 154.5 51.08 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.848 1.699 . . . . 0.0 112.748 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 71' ' ' PRO . 28.4 m 28.52 37.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 CA-C-O 121.532 0.682 . . . . 0.0 111.287 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 71' ' ' PRO . 32.8 m80 -141.93 -80.98 0.22 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.472 -0.767 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -152.84 156.53 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -0.818 . . . . 0.0 109.741 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -133.33 149.15 51.91 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.384 -0.822 . . . . 0.0 109.527 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.16 127.47 14.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.345 -0.847 . . . . 0.0 109.087 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -154.69 156.85 37.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.448 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 8.3 t -143.75 124.39 14.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.315 -0.866 . . . . 0.0 108.976 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' A' ' 78' ' ' SER . 85.1 m-85 -157.95 96.5 1.48 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.326 -0.859 . . . . 0.0 109.063 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.61 111.75 4.24 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -108.97 138.0 46.01 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.48 -1.012 . . . . 0.0 109.508 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 54.78 46.7 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.764 . . . . 0.0 109.37 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -39.27 148.82 0.11 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 86' ' ' VAL . 4.9 m 49.98 -164.48 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.547 -0.972 . . . . 0.0 110.04 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 59.05 -70.99 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.326 0.584 . . . . 0.0 109.854 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 84' ' ' SER . 4.0 p -153.28 110.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.0 109.093 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.18 70.88 12.02 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 11.8 Cg_exo -56.74 -44.66 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.618 2.212 . . . . 0.0 113.186 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' SER . 72.2 Cg_endo -81.29 161.19 20.1 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.205 1.937 . . . . 0.0 112.673 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -51.64 85.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 89' ' ' PRO . 33.2 t -88.64 56.93 3.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -1.127 . . . . 0.0 108.966 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 113' ' ' GLY . 16.3 t -165.46 -130.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.251 -0.905 . . . . 0.0 109.579 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -102.08 114.3 28.3 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.5 130.65 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -138.25 131.82 30.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 109.337 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.5 mt -125.51 130.78 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -126.21 129.5 49.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.489 -0.757 . . . . 0.0 109.416 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.44 125.12 48.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.53 130.08 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.798 . . . . 0.0 109.45 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.1 142.71 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.498 -0.751 . . . . 0.0 110.302 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.27 158.66 43.44 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.333 -0.854 . . . . 0.0 109.365 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.42 128.2 8.33 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.39 82.5 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.5 -170.76 35.82 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.0 m -121.79 129.84 52.96 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.754 -0.851 . . . . 0.0 109.146 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.7 tp -85.65 130.0 34.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -0.82 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 tt -113.37 122.55 47.7 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -107.2 132.53 52.95 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.4 tt -124.49 120.2 31.33 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.583 ' N ' HD23 ' A' ' 109' ' ' LEU . 87.4 m -118.04 131.0 56.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -133.19 140.97 47.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.474 -0.766 . . . . 0.0 109.02 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 p -157.5 165.05 36.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.064 -1.022 . . . . 0.0 110.069 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.428 ' O ' ' OG ' ' A' ' 92' ' ' SER . . . 84.74 33.05 20.0 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.83 155.38 61.52 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.236 . . . . 0.0 109.608 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.33 -44.67 37.84 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.016 1.811 . . . . 0.0 112.702 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -160.04 173.65 15.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.107 -0.995 . . . . 0.0 110.47 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.316 0.579 . . . . 0.0 109.572 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.78 -40.46 72.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.397 -0.814 . . . . 0.0 109.484 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.6 mm-40 -65.98 -37.13 85.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 82.3 m -61.26 -40.86 95.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.688 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.81 88.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.82 82.38 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 46.0 m80 -66.56 -39.78 88.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.516 -0.991 . . . . 0.0 109.504 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.17 -44.89 83.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.705 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -68.26 -39.99 82.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.494 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.78 -49.99 60.81 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.453 ' CD1' ' NH2' ' A' ' 13' ' ' ARG . 74.9 m95 -63.32 -35.48 80.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.45 -45.12 89.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.387 -0.821 . . . . 0.0 109.651 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -66.69 -42.14 86.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.897 . . . . 0.0 109.684 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.505 ' OH ' ' SD ' ' A' ' 38' ' ' MET . 5.6 m-85 -61.55 -46.6 89.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.56 -41.17 98.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.18 -46.99 89.52 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -64.89 -41.34 95.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.172 -1.193 . . . . 0.0 109.29 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.58 -39.82 95.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.7 m -59.88 -44.38 94.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.467 -0.77 . . . . 0.0 109.627 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 140' ' ' GLY . 83.7 tt0 -62.86 -38.85 92.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.3 t -63.24 -46.07 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -0.888 . . . . 0.0 109.516 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.85 92.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.955 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.19 -3.86 56.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.931 . . . . 0.0 109.352 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -171.19 96.89 0.11 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -74.06 156.33 37.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -1.112 . . . . 0.0 110.145 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 60.45 60.84 3.64 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.637 -0.664 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.1 -4.22 14.84 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.447 2.098 . . . . 0.0 111.083 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' H ' ' HD3' ' A' ' 145' ' ' PRO . . . 104.21 58.64 0.7 Allowed Glycine 0 N--CA 1.5 2.925 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.468 ' HD3' ' H ' ' A' ' 144' ' ' GLY . 56.5 Cg_endo -69.82 155.41 65.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.758 2.306 . . . . 0.0 112.57 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -158.54 77.11 3.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.225 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -57.89 143.24 96.23 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.689 2.259 . . . . 0.0 112.186 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.55 83.86 4.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.421 -0.799 . . . . 0.0 109.329 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -70.3 129.5 39.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 110.04 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -91.17 109.64 3.73 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -76.22 131.77 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.362 -1.081 . . . . 0.0 109.887 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -127.69 7.85 6.29 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 154' ' ' GLU . 4.6 tt -107.36 117.5 34.25 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.411 -0.806 . . . . 0.0 109.261 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.594 ' N ' HD23 ' A' ' 153' ' ' LEU . 40.9 tt0 -171.84 71.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -101.03 -2.84 30.6 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -57.65 112.1 1.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.528 -0.733 . . . . 0.0 109.971 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -167.38 -9.34 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -62.71 -42.16 99.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.466 -0.772 . . . . 0.0 109.367 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -64.38 -44.5 91.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.528 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.638 -179.782 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.51 0.671 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -68.92 135.32 50.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.455 -0.778 . . . . 0.0 110.522 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -84.67 -78.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.565 0.697 . . . . 0.0 110.042 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.45 48.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 110.887 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.3 tpt 44.76 58.87 14.23 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.623 -0.673 . . . . 0.0 110.126 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.95 143.53 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.576 2.184 . . . . 0.0 112.538 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' SER . 17.1 pt-20 -98.12 -3.42 37.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.462 -0.774 . . . . 0.0 109.315 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' GLU . 91.4 p 52.22 169.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.549 -0.719 . . . . 0.0 110.965 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -75.17 145.21 42.29 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 0.0 109.813 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.46 134.76 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.735 HG21 ' NE2' ' A' ' 123' ' ' HIS . 59.1 t -100.76 132.29 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 0.0 108.996 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -123.45 124.59 43.22 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -132.85 153.6 51.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.553 -0.717 . . . . 0.0 109.651 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -140.02 152.43 46.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.49 0.662 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 153.02 29.07 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -109.25 122.31 47.05 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.388 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.39 131.93 54.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.538 -0.726 . . . . 0.0 109.796 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.89 77.35 10.11 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.508 -0.745 . . . . 0.0 109.73 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.98 153.54 1.09 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -62.73 162.43 25.07 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.502 2.135 . . . . 0.0 111.746 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.42 -29.15 62.62 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.662 2.241 . . . . 0.0 111.399 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.41 93.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.797 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.56 82.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.255 -0.903 . . . . 0.0 109.824 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.02 -46.9 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.581 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.66 -43.77 97.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.443 -0.786 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.56 73.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 109.303 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.77 -41.95 97.87 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.412 -0.805 . . . . 0.0 109.604 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.3 mtm -81.41 -6.77 59.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.197 -0.94 . . . . 0.0 109.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.463 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 11.4 m -111.08 70.33 0.71 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.526 0.679 . . . . 0.0 109.441 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 162.72 138.14 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.16 -35.94 2.74 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.514 2.143 . . . . 0.0 112.274 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -70.57 -43.94 68.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.063 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.99 -38.77 92.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -62.73 -42.08 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.218 -0.926 . . . . 0.0 109.726 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.27 -21.97 62.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 110.55 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 141' ' ' ARG . 85.0 mtp180 -62.94 -38.89 92.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.889 -1.132 . . . . 0.0 110.168 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -123.35 21.61 9.48 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.301 -0.875 . . . . 0.0 110.114 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttm -139.82 -135.08 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.174 -0.954 . . . . 0.0 110.426 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.8 175.58 1.96 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.96 -14.73 15.86 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -147.88 118.66 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.315 -0.865 . . . . 0.0 109.067 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.29 153.19 5.22 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.41 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 43' ' ' GLU . 2.0 pm0 -141.02 163.73 32.2 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.47 -0.769 . . . . 0.0 109.545 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.36 131.74 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.622 0.725 . . . . 0.0 109.216 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -163.14 81.75 1.55 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.2 -43.75 55.92 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.515 2.143 . . . . 0.0 111.9 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.681 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 2.7 tt0 -111.15 -42.82 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.887 -0.508 . . . . 0.0 109.764 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 36.2 Cg_exo -59.16 157.76 28.71 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.598 2.199 . . . . 0.0 113.001 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.02 -15.21 65.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 38.43 -142.36 0.36 Allowed Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.66 -0.906 . . . . 0.0 111.243 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.2 mt -86.42 -162.9 0.81 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.995 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 70.2 t80 -75.92 -101.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.565 0.697 . . . . 0.0 110.348 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 32.9 tp -149.27 114.78 5.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 109.684 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 2.6 m -147.44 132.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 54' ' ' VAL . 1.7 p30 163.83 128.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.521 0.677 . . . . 0.0 109.919 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 57' ' ' THR . 78.3 t -65.99 -42.21 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 109.637 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 56' ' ' VAL . 72.1 p -39.21 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.609 -0.682 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -160.04 -143.85 3.79 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.064 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 60' ' ' ARG . . . -87.34 -159.39 0.51 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.628 -0.925 . . . . 0.0 110.689 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 59' ' ' ALA . 60.5 ttt85 58.26 154.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.494 0.664 . . . . 0.0 109.906 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CG ' ' OE2' ' A' ' 45' ' ' GLU . 53.4 m-85 -61.47 -43.72 98.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.577 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.81 -112.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.43 -0.794 . . . . 0.0 110.139 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 64' ' ' GLY . 88.2 mtm180 -142.9 140.89 31.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.374 -0.829 . . . . 0.0 109.448 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ARG . . . 36.69 -108.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 78' ' ' SER . 34.6 t -155.87 154.69 31.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -1.082 . . . . 0.0 109.619 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -71.02 141.58 50.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.426 -0.797 . . . . 0.0 110.471 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HE ' ' CB ' ' A' ' 78' ' ' SER . 96.0 mtt-85 -134.86 -59.46 0.8 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -155.29 139.03 16.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -124.05 127.96 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -138.97 96.45 9.17 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 72' ' ' VAL . 54.4 Cg_exo -50.98 143.33 31.33 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.498 2.132 . . . . 0.0 113.316 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 71' ' ' PRO . 24.7 m 34.2 53.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-O 121.68 0.752 . . . . 0.0 110.513 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' HE ' ' A' ' 74' ' ' ARG . 42.0 t-80 -161.64 -75.06 0.05 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.727 -0.608 . . . . 0.0 109.403 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 85.9 mtm180 -148.77 161.2 42.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.443 -0.786 . . . . 0.0 110.346 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.75 135.54 22.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.414 -0.804 . . . . 0.0 108.935 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 77' ' ' TYR . . . -133.16 130.63 39.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.403 -0.81 . . . . 0.0 109.694 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 15.9 m-85 -146.56 150.52 35.67 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.907 0.86 . . . . 0.0 109.898 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.535 ' CB ' ' HE ' ' A' ' 67' ' ' ARG . 5.4 p -81.12 -178.42 6.89 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.305 0.574 . . . . 0.0 109.754 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -135.58 133.26 38.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.534 -0.729 . . . . 0.0 109.566 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.96 -132.57 11.18 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -171.03 148.61 2.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -1.094 . . . . 0.0 109.454 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 66.0 t0 -64.49 137.89 58.11 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 81.17 8.95 86.7 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p -78.02 164.41 25.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.386 -1.067 . . . . 0.0 110.264 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 57.9 mp0 -120.78 -34.79 3.49 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 87' ' ' VAL . 27.7 m -66.54 -39.32 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' N ' HG23 ' A' ' 86' ' ' VAL . 64.3 t -148.92 78.79 8.76 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.275 -0.891 . . . . 0.0 109.255 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.7 158.12 4.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 123.132 2.555 . . . . 0.0 112.098 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.94 143.61 95.59 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.564 2.176 . . . . 0.0 112.711 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.04 -14.63 37.33 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t -68.88 -17.31 63.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.309 -1.113 . . . . 0.0 109.915 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 p -155.23 160.71 41.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.869 -1.144 . . . . 0.0 110.013 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.9 tp -142.07 130.87 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.54 -0.725 . . . . 0.0 109.505 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.2 t -114.47 132.46 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.81 138.83 39.58 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.51 -0.743 . . . . 0.0 109.669 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -125.96 130.1 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -119.77 142.47 48.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.665 -0.647 . . . . 0.0 109.749 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.6 mt -107.02 126.37 52.24 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.1 129.56 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.557 0.694 . . . . 0.0 109.665 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 142.09 53.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.678 -0.638 . . . . 0.0 110.028 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -156.53 87.2 1.02 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.816 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 37.19 -119.84 0.66 Allowed Glycine 0 N--CA 1.496 2.669 0 CA-C-O 121.727 0.626 . . . . 0.0 111.657 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.57 130.81 15.61 Favored Glycine 0 N--CA 1.487 2.096 0 O-C-N 121.488 -1.007 . . . . 0.0 110.668 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.63 -178.75 49.99 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.0 m -127.62 133.3 49.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.626 -0.926 . . . . 0.0 109.454 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -84.17 128.64 34.69 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.486 -0.759 . . . . 0.0 109.166 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 tt -117.32 124.9 50.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -108.03 136.82 47.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.752 -0.592 . . . . 0.0 109.65 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -123.32 127.98 49.29 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 99.0 m -124.04 128.28 49.1 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.314 0.578 . . . . 0.0 109.452 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -132.07 132.95 43.8 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.1 m -130.01 154.71 47.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.669 -0.644 . . . . 0.0 109.571 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 121.85 -103.01 0.83 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 mt 61.38 70.56 0.89 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.926 . . . . 0.0 109.677 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.52 -36.52 80.43 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.689 2.259 . . . . 0.0 111.476 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -137.05 167.69 21.03 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.63 0.729 . . . . 0.0 110.006 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.61 67.16 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.503 0.668 . . . . 0.0 109.487 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.87 -45.94 85.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.404 -0.81 . . . . 0.0 109.649 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -68.81 -29.28 67.6 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.393 -0.817 . . . . 0.0 109.439 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.492 ' O ' ' CE1' ' A' ' 123' ' ' HIS . 6.0 t -57.88 -62.31 1.9 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.17 -28.88 67.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.636 -0.665 . . . . 0.0 109.416 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.0 -48.58 59.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.735 ' NE2' HG21 ' A' ' 11' ' ' VAL . 6.7 p-80 -67.92 -46.95 70.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.919 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.645 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 14.2 tm-20 -58.59 -47.61 83.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 0.0 109.507 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -71.55 -39.06 70.9 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.71 -53.09 33.31 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -65.02 -38.34 90.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -1.007 . . . . 0.0 109.899 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.5 -50.03 75.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.0 109.898 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -73.01 -42.07 63.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 110.009 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -62.16 -46.77 87.48 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.272 -0.892 . . . . 0.0 109.387 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.78 -40.34 96.44 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.353 -0.842 . . . . 0.0 109.401 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -59.4 -40.76 96.5 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -65.98 -40.93 91.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -1.21 . . . . 0.0 109.419 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 tp -64.19 -40.56 96.35 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -60.75 -43.13 98.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.5 mm-40 -63.02 -42.79 99.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.904 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.57 -44.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.84 -38.13 89.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 108.935 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.33 -0.25 57.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -135.85 -149.51 5.77 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.491 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 59.6 ttt85 -148.08 -32.06 0.27 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.544 -0.974 . . . . 0.0 109.681 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -153.56 70.09 6.64 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.048 -1.033 . . . . 0.0 110.572 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.13 155.89 60.52 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.299 1.999 . . . . 0.0 113.101 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 47.33 -166.33 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.25 -32.92 89.52 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.887 2.392 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 61.01 62.98 2.66 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.902 -0.499 . . . . 0.0 109.937 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.27 147.34 59.38 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.457 2.104 . . . . 0.0 112.359 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.45 20.79 0.29 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -70.92 138.7 50.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.546 -0.721 . . . . 0.0 110.228 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -107.92 -44.36 1.21 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -169.01 138.17 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -1.139 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -90.09 144.02 26.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.468 -0.77 . . . . 0.0 109.644 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -93.58 130.83 39.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.487 -0.758 . . . . 0.0 109.215 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.2 mp0 -121.95 109.12 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -92.61 128.9 38.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.459 -0.776 . . . . 0.0 109.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -130.49 133.47 46.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.543 -0.723 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.7 ' H ' ' CD2' ' A' ' 157' ' ' HIS . 5.8 p80 -91.18 -13.94 31.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 109.022 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.439 ' NE2' ' CE1' ' A' ' 157' ' ' HIS . 95.1 m-70 -71.78 141.19 49.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 110.307 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -67.12 -39.45 86.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.566 -0.709 . . . . 0.0 109.773 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.834 -179.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -75.12 -125.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.603 -0.685 . . . . 0.0 110.041 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' SD ' ' A' ' 5' ' ' MET . 68.1 mttm 56.2 50.25 13.83 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.634 0.73 . . . . 0.0 109.276 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' MET . . . -83.45 -2.82 56.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 109.201 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.564 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER 57.18 150.29 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 CA-C-O 121.177 0.513 . . . . 0.0 110.257 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 7' ' ' GLU . 57.0 Cg_endo -69.6 129.97 18.71 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.358 2.039 . . . . 0.0 112.99 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' PRO . 97.7 mt-10 56.56 142.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.121 0.962 . . . . 0.0 111.286 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 9' ' ' PHE . 93.3 p -79.75 167.05 21.13 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.642 0.734 . . . . 0.0 110.687 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' SER . 92.3 m-85 45.51 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.726 0.774 . . . . 0.0 110.078 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.7 t -125.62 135.24 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.519 0.676 . . . . 0.0 109.195 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.81 132.3 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.77 133.9 48.23 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 30.3 mmt180 -136.19 155.75 49.69 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.759 0.79 . . . . 0.0 110.039 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.77 ' OE2' HD12 ' A' ' 106' ' ' LEU . 82.6 tt0 -138.37 153.64 48.94 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.458 0.647 . . . . 0.0 109.388 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.7 151.02 39.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.57 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.674 ' CE1' HD11 ' A' ' 106' ' ' LEU . 95.0 m-70 -103.29 121.63 43.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.623 -0.673 . . . . 0.0 109.606 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.6 mp -117.12 131.86 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.723 0.773 . . . . 0.0 109.749 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 4.28 32.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.72 151.85 37.61 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.468 -0.77 . . . . 0.0 109.311 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.88 162.45 34.94 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 122.641 2.227 . . . . 0.0 112.197 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.71 -32.81 86.71 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.587 2.191 . . . . 0.0 111.521 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.69 88.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.52 -0.737 . . . . 0.0 109.674 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.1 91.91 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 109.686 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -63.15 -47.62 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.658 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -64.24 -44.43 91.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 0.0 109.616 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.71 -37.41 81.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 109.193 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.57 -40.57 97.33 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.5 mtt -83.53 -5.69 59.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.487 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.0 m -98.67 -53.9 3.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 108.996 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.71 130.88 94.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.788 . . . . 0.0 110.21 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HB3' ' H ' ' A' ' 44' ' ' VAL . 72.7 Cg_endo -76.39 -33.68 3.15 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.61 2.207 . . . . 0.0 112.348 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -70.45 -42.75 71.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.654 . . . . 0.0 110.794 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.54 -36.99 86.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.233 -0.917 . . . . 0.0 110.524 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.7 -24.5 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.973 -1.079 . . . . 0.0 109.468 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 42' ' ' ALA . 69.9 mt -68.96 -14.48 63.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.542 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -64.47 -35.87 82.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.389 -0.819 . . . . 0.0 109.993 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 42.9 p-90 -140.69 44.36 1.83 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.095 -1.003 . . . . 0.0 109.968 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.7 tpp -171.23 108.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.754 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.76 175.6 0.03 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 m -103.28 -15.87 15.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.685 -0.891 . . . . 0.0 108.848 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -137.54 138.01 39.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.444 -0.785 . . . . 0.0 109.568 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 35' ' ' LEU . . . -171.04 148.7 2.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.384 -0.823 . . . . 0.0 109.269 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' H ' HG22 ' A' ' 54' ' ' VAL . 48.8 tp10 -150.97 102.58 2.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.131 -0.981 . . . . 0.0 109.429 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' GLU . 90.8 t -76.02 -79.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.543 -0.723 . . . . 0.0 109.637 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 44' ' ' VAL . 24.0 mt-10 56.3 153.68 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.851 -0.531 . . . . 0.0 109.918 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' GLU . 53.9 Cg_exo -34.34 141.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.644 2.229 . . . . 0.0 112.594 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' OE2' ' CE1' ' A' ' 66' ' ' PHE . 6.1 mt-10 -38.14 -63.86 0.51 Allowed Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.904 -0.498 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 40.1 Cg_endo -64.51 -22.31 65.39 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.213 1.942 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.22 32.26 4.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.95 85.71 0.56 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -79.27 149.03 31.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.557 -0.966 . . . . 0.0 110.384 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 52.91 -162.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.744 -0.597 . . . . 0.0 110.583 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD11 ' O ' ' A' ' 61' ' ' PHE . 22.6 tp -114.78 146.24 41.22 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 43' ' ' GLU . 43.3 t -110.45 122.35 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 CA-C-O 121.833 0.825 . . . . 0.0 109.729 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -105.09 102.35 11.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 58' ' ' GLY . 3.7 t -99.31 48.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.42 -0.8 . . . . 0.0 108.936 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.7 p 44.9 14.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.632 -0.668 . . . . 0.0 109.919 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 56' ' ' VAL . . . -89.23 -7.62 69.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 58' ' ' GLY . . . 69.84 -15.45 0.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.815 . . . . 0.0 109.621 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLY . 61.6 ttt85 -72.56 151.05 42.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.391 -0.818 . . . . 0.0 110.748 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' O ' HD11 ' A' ' 53' ' ' LEU . 96.4 m-85 -62.61 -45.35 93.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.516 -0.74 . . . . 0.0 109.852 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.76 168.18 28.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.942 -1.099 . . . . 0.0 110.211 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.421 HH21 ' HA3' ' A' ' 58' ' ' GLY . 95.3 mtt180 -132.89 153.7 51.09 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.906 0.86 . . . . 0.0 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.69 76.3 0.04 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' N ' ' OH ' ' A' ' 77' ' ' TYR . 60.3 p -130.4 30.53 4.71 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.577 -0.955 . . . . 0.0 108.846 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' OE2' ' A' ' 47' ' ' GLU . 49.7 p90 -59.28 135.51 57.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 110.274 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.54 HH11 HD13 ' A' ' 93' ' ' LEU . 83.0 mtp180 -107.13 -30.89 8.51 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -158.5 141.12 14.42 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.5 t -131.16 129.38 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 109.703 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -142.48 96.6 6.26 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 72' ' ' VAL . 50.5 Cg_exo -51.9 153.14 12.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.527 2.151 . . . . 0.0 113.656 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.9 m 31.81 38.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 121.397 0.617 . . . . 0.0 111.148 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' PRO . 51.8 t-80 -152.27 -76.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 0.0 109.732 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 82.6 mtp180 -144.25 161.74 38.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.2 tp -149.6 134.54 17.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.027 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.68 30.74 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.66 -0.65 . . . . 0.0 109.492 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 78' ' ' SER . 27.7 t80 -141.76 160.06 40.96 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 70.7 m -110.52 127.61 55.26 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 47.0 m-85 -129.3 151.68 49.69 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.803 0.811 . . . . 0.0 110.27 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.23 52.37 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -114.23 130.8 56.63 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 48.15 28.83 1.63 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.35 -128.92 0.18 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 85' ' ' GLU . 5.0 m -61.6 -172.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.546 -0.973 . . . . 0.0 110.446 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 56.8 mp0 -39.92 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.498 0.666 . . . . 0.0 110.286 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 87' ' ' VAL . 3.0 m -74.22 -109.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 109.987 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 86' ' ' VAL . 3.2 t 61.51 67.84 1.28 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.673 -0.642 . . . . 0.0 109.681 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -66.84 164.64 28.74 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.466 2.111 . . . . 0.0 111.727 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -58.67 139.92 92.76 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.616 2.21 . . . . 0.0 112.263 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.05 -139.46 38.32 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 p 46.06 23.69 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.697 -0.884 . . . . 0.0 109.57 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.6 t -144.93 144.71 31.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.336 -0.852 . . . . 0.0 109.464 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD13 HH11 ' A' ' 67' ' ' ARG . 37.8 tp -141.02 124.83 17.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.762 . . . . 0.0 109.357 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.64 132.68 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -133.35 144.85 49.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 0.0 109.839 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.76 133.29 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.96 120.74 31.14 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.479 0.657 . . . . 0.0 109.561 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.3 mt -97.54 127.35 43.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.621 -0.674 . . . . 0.0 109.479 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.82 124.03 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.677 0.751 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 57.2 mp0 -85.74 106.33 16.91 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.575 0.702 . . . . 0.0 109.894 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 103' ' ' GLY . 2.6 pt20 -92.68 -165.26 1.31 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.752 0.787 . . . . 0.0 110.43 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.56 -35.87 91.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 101' ' ' GLN . . . -151.27 116.95 0.79 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.93 176.52 32.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -127.85 129.44 46.94 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.612 -0.934 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' OE2' ' A' ' 14' ' ' GLU . 4.4 mm? -88.21 138.13 31.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.495 0.664 . . . . 0.0 109.238 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -120.55 108.43 14.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -101.4 135.38 42.99 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.29 125.65 44.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.637 -0.664 . . . . 0.0 109.277 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 76.7 m -116.48 126.67 53.71 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.411 ' CD2' HD21 ' A' ' 114' ' ' LEU . 15.6 t-160 -123.97 122.53 38.17 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.3 p -139.99 168.19 20.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 110.209 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.06 18.55 50.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 111' ' ' HIS . 13.7 mt -71.54 145.87 90.67 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.991 . . . . 0.0 110.287 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.24 -32.15 27.43 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.737 2.291 . . . . 0.0 112.101 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -166.28 171.02 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 110.136 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -22.18 66.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.688 -0.633 . . . . 0.0 109.627 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.67 -45.0 93.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.289 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.427 HE21 ' CE1' ' A' ' 123' ' ' HIS . 51.7 tt0 -70.43 -38.62 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.509 -0.745 . . . . 0.0 109.67 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 1.2 p -62.77 -42.62 99.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 109.928 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -62.23 -46.67 87.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.432 -0.792 . . . . 0.0 109.533 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.22 -44.19 91.43 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CE1' HE21 ' A' ' 119' ' ' GLN . 32.2 m170 -68.4 -41.28 80.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -1.084 . . . . 0.0 110.096 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.7 tt0 -52.32 -48.23 65.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.458 -0.776 . . . . 0.0 109.357 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.82 -37.59 82.13 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.539 0.685 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.66 -43.71 95.99 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 74.2 m95 -62.16 -37.36 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.579 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.34 -47.38 85.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.416 -0.802 . . . . 0.0 110.099 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -67.16 -42.75 83.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -62.0 -46.04 90.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.419 -0.801 . . . . 0.0 109.495 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.05 -41.4 97.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.571 -0.706 . . . . 0.0 109.679 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.88 -42.47 99.74 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -66.09 -39.69 90.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -1.108 . . . . 0.0 109.603 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.53 -41.76 98.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -0.891 . . . . 0.0 109.631 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -61.02 -45.63 94.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.354 -0.841 . . . . 0.0 109.756 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.73 -46.07 89.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.845 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.4 t -66.63 -43.63 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.46 84.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.601 -0.687 . . . . 0.0 109.745 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.33 1.85 7.1 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.398 -0.814 . . . . 0.0 109.041 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.25 5.13 90.27 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.05 162.44 14.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.479 -1.012 . . . . 0.0 110.346 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.17 141.82 62.94 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.586 -0.697 . . . . 0.0 109.641 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.4 145.98 60.96 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.495 2.13 . . . . 0.0 112.709 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.21 177.11 53.77 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.88 151.24 68.34 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.008 2.472 . . . . 0.0 112.476 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.92 74.43 76.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.94 -10.98 19.86 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.654 2.236 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -74.56 122.22 22.79 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -159.55 106.75 1.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.55 -0.718 . . . . 0.0 109.505 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . 77.0 0.25 69.0 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' GLY . 66.5 ttp85 60.73 137.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.512 -0.993 . . . . 0.0 110.09 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -77.97 144.86 36.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.48 -0.762 . . . . 0.0 110.46 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.0 tp -86.05 129.34 34.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.683 -0.636 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -125.59 139.33 53.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.571 0.701 . . . . 0.0 110.212 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.9 m80 56.05 87.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.711 0.767 . . . . 0.0 110.094 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 51.1 p-80 -148.88 114.1 5.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.163 -0.961 . . . . 0.0 109.572 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -147.84 144.65 28.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.473 -0.767 . . . . 0.0 109.641 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -157.01 156.21 32.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.418 -0.802 . . . . 0.0 109.518 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.5 p-80 -150.61 -45.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.523 -0.736 . . . . 0.0 109.106 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 52.9 p-80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.149 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ALA . 12.6 pt-20 -65.76 140.6 58.44 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.505 0.669 . . . . 0.0 110.348 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt 53.74 6.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.671 -0.643 . . . . 0.0 109.585 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . . . -86.83 2.77 47.87 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.839 . . . . 0.0 108.908 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 5' ' ' MET . 0.2 OUTLIER -121.01 86.18 41.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.542 -0.724 . . . . 0.0 109.259 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.25 146.4 82.26 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.553 2.169 . . . . 0.0 111.73 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -55.22 135.13 49.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.678 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.6 p -160.39 165.56 30.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 57.57 23.38 9.2 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -118.25 135.68 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' CG2' ' SG ' ' A' ' 120' ' ' CYS . 47.0 t -101.87 127.0 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.402 -0.811 . . . . 0.0 109.498 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -109.92 134.21 52.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.46 144.75 38.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.013 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.88 152.01 48.62 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.53 0.681 . . . . 0.0 110.025 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.13 139.35 22.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.564 -0.71 . . . . 0.0 109.149 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -94.76 118.02 31.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.443 -0.786 . . . . 0.0 109.341 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.2 mp -111.34 134.6 52.81 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.665 0.745 . . . . 0.0 109.564 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.7 -0.41 53.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.9 147.57 34.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 109.095 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.39 165.24 27.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.995 1.797 . . . . 0.0 112.378 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.4 -40.32 71.43 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.34 2.027 . . . . 0.0 111.599 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.38 96.3 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.704 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.25 87.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.39 -45.83 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.359 -0.838 . . . . 0.0 109.599 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' O ' HG22 ' A' ' 29' ' ' THR . 74.5 t80 -61.4 -44.16 97.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.354 -0.841 . . . . 0.0 109.558 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.25 -47.11 75.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 0.0 109.827 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.19 -41.1 97.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 109.967 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.7 mtp -65.7 -40.24 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 110.004 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 25' ' ' PHE . 10.9 t -93.92 53.28 1.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.08 -1.012 . . . . 0.0 108.909 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 29' ' ' THR . 55.7 m-20 -161.72 83.11 1.79 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' GLU . 55.9 Cg_exo -52.17 -41.49 65.0 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.563 2.175 . . . . 0.0 112.35 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -71.01 -43.25 68.32 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -0.766 . . . . 0.0 110.634 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -65.52 -32.21 73.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.915 -1.116 . . . . 0.0 110.022 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' ARG . 79.6 mt -62.56 -42.88 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.99 -1.068 . . . . 0.0 109.808 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -49.03 -15.33 0.1 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.85 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG ' ' A' ' 146' ' ' ASP . 83.7 mtt-85 -66.71 -40.93 88.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.471 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' CD2' ' A' ' 37' ' ' TRP . 40.0 p-90 -111.14 57.63 0.62 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.691 -0.631 . . . . 0.0 109.478 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.469 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 13.2 ttt 79.87 163.46 0.18 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.777 0.799 . . . . 0.0 110.628 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 147.78 -20.3 1.46 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m 62.24 -69.88 0.06 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.692 -0.887 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 39' ' ' GLY . 96.0 mt-10 -141.27 149.05 40.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.354 -0.841 . . . . 0.0 109.632 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.93 150.62 31.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.778 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 80.7 tt0 -83.63 142.65 30.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.802 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' H ' ' H ' ' A' ' 45' ' ' GLU . 5.7 p -153.9 -9.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' H ' ' H ' ' A' ' 44' ' ' VAL . 4.1 mt-10 -99.76 148.48 34.83 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.497 -0.752 . . . . 0.0 109.282 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.92 159.32 53.71 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.538 2.159 . . . . 0.0 112.446 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 59.17 86.91 0.15 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.625 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -53.33 139.24 64.52 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.859 2.372 . . . . 0.0 112.645 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.72 -10.25 1.65 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.44 -73.33 0.98 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' LEU . 87.2 mt -77.48 -5.35 49.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.4 t80 54.11 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.596 -0.69 . . . . 0.0 110.028 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' LEU . 37.7 tp -93.66 127.61 39.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.0 109.66 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.01 138.05 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.486 0.66 . . . . 0.0 109.798 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 65.22 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.777 0.799 . . . . 0.0 110.711 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 57' ' ' THR . 12.3 p -63.54 -41.83 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 109.397 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.525 ' N ' HG13 ' A' ' 56' ' ' VAL . 79.0 m -120.63 127.78 52.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.599 -0.688 . . . . 0.0 109.616 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 173.89 -176.92 46.35 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . -111.02 126.72 55.09 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.61 -0.935 . . . . 0.0 109.78 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.6 mtt180 38.89 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.454 0.645 . . . . 0.0 110.261 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 55.9 m-85 55.77 13.58 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.616 -0.677 . . . . 0.0 109.331 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . 63.32 3.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.667 -0.645 . . . . 0.0 109.743 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 65' ' ' SER . 76.9 ttt180 -138.79 -26.56 0.86 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 60' ' ' ARG . . . -74.66 28.93 1.06 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' H ' ' C ' ' A' ' 63' ' ' ARG . 45.7 m -131.8 149.49 52.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.386 -1.067 . . . . 0.0 109.714 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -163.45 98.97 0.91 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -107.12 -41.88 5.03 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -164.4 128.81 2.64 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.451 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.1 t -126.19 130.09 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.87 124.73 21.79 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.5 Cg_exo -40.82 109.87 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.932 1.754 . . . . 0.0 112.113 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.3 p 31.59 69.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 121.613 0.721 . . . . 0.0 110.654 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -161.39 -50.2 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.262 -0.899 . . . . 0.0 109.489 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -153.88 132.35 12.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.055 -1.028 . . . . 0.0 110.34 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.3 mt -128.63 139.49 52.24 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.49 130.97 15.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -0.816 . . . . 0.0 108.927 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -124.4 128.86 49.69 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.429 ' OG ' ' CE2' ' A' ' 79' ' ' PHE . 12.6 p -84.85 176.7 8.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.518 -0.739 . . . . 0.0 109.951 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CE2' ' OG ' ' A' ' 78' ' ' SER . 17.6 m-85 64.1 162.58 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.493 0.663 . . . . 0.0 109.823 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.14 109.34 0.31 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.437 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 78.8 t90 -109.2 139.25 44.37 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.48 -1.012 . . . . 0.0 109.574 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 81' ' ' TRP . 72.2 m-20 -152.26 -166.37 2.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.529 -0.732 . . . . 0.0 109.909 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 85' ' ' GLU . . . -65.9 159.58 46.13 Favored Glycine 0 N--CA 1.495 2.598 0 CA-C-O 121.923 0.735 . . . . 0.0 111.635 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 p 64.9 -5.24 0.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.824 -0.809 . . . . 0.0 109.324 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 83' ' ' GLY . 96.7 mt-10 46.85 25.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.375 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 87' ' ' VAL . 11.4 p -73.63 3.83 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.396 -0.815 . . . . 0.0 109.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.519 HG23 HG13 ' A' ' 86' ' ' VAL . 24.5 t -131.85 74.99 76.6 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.469 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 24.0 Cg_exo -58.98 -173.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.492 2.128 . . . . 0.0 111.453 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 35.6 Cg_exo -61.67 140.37 86.02 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.465 2.11 . . . . 0.0 112.675 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.82 0.38 2.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 89' ' ' PRO . 4.6 m -77.16 -8.3 57.3 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.507 -0.996 . . . . 0.0 109.371 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.0 p -149.98 160.25 43.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.178 -0.951 . . . . 0.0 109.114 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.5 tp -137.21 125.42 23.12 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 t -107.65 131.39 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 109.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -136.83 135.04 37.59 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.413 -0.804 . . . . 0.0 109.211 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.03 129.69 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -120.23 142.06 49.37 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.462 0.649 . . . . 0.0 109.651 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.4 126.9 51.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.23 125.24 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.849 0.833 . . . . 0.0 109.597 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -73.25 136.83 44.66 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.335 0.588 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -149.05 153.47 37.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 109.191 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 134.62 12.83 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.28 11.49 84.22 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.64 177.72 32.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.9 m -126.56 130.57 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.506 -0.996 . . . . 0.0 109.613 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.9 tp -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 tt -112.59 130.02 56.17 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.546 0.688 . . . . 0.0 109.998 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -104.24 133.64 48.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.68 -0.637 . . . . 0.0 109.299 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 109' ' ' LEU . 7.2 tt -123.53 122.4 38.11 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.497 -0.752 . . . . 0.0 109.202 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.486 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.6 p -123.73 136.18 54.29 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.521 0.677 . . . . 0.0 109.461 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 p -132.16 160.45 36.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.529 0.68 . . . . 0.0 109.596 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.62 71.96 1.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.29 82.39 65.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.544 -0.974 . . . . 0.0 108.932 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.35 -25.81 49.59 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.874 2.383 . . . . 0.0 111.92 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -130.83 142.26 50.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.473 -0.767 . . . . 0.0 109.898 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.51 78.57 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.473 0.654 . . . . 0.0 109.58 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -52.57 -41.69 63.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -67.07 -37.89 84.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.211 -0.931 . . . . 0.0 109.174 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.457 ' SG ' ' CG2' ' A' ' 11' ' ' VAL . 12.4 t -63.59 -45.6 89.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.86 94.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.398 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.7 -49.55 48.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.02 -45.18 74.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -1.088 . . . . 0.0 109.841 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.95 -44.93 91.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.867 . . . . 0.0 109.504 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -69.29 -38.15 78.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.34 -54.3 30.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -57.8 -35.56 71.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -1.058 . . . . 0.0 109.769 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.17 -45.52 90.8 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -67.71 -45.39 75.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 109.724 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -62.72 -45.99 90.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 110.001 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 15.5 mt -63.69 -41.85 98.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.75 65.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -67.44 -38.58 84.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -1.038 . . . . 0.0 109.352 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 37' ' ' TRP . 65.1 tp -59.43 -42.92 92.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.6 m -68.07 -30.0 69.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.595 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 140' ' ' GLY . 46.4 tp10 -61.52 -53.56 54.81 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 109.886 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -66.11 -44.4 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 109.561 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.6 -39.01 93.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.521 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -93.93 -4.63 49.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.292 -0.88 . . . . 0.0 109.029 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -102.76 -73.87 1.0 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -166.66 -152.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -1.19 . . . . 0.0 109.448 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -137.77 97.47 10.11 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.504 -0.747 . . . . 0.0 109.199 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' O ' ' NH1' ' A' ' 36' ' ' ARG . 31.9 Cg_exo -51.02 108.47 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.307 2.005 . . . . 0.0 112.446 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 54.02 160.4 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.72 -93.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.312 2.008 . . . . 0.0 111.673 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.557 ' CG ' HH21 ' A' ' 36' ' ' ARG . 0.4 OUTLIER 60.35 68.05 1.48 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.68 -0.638 . . . . 0.0 109.915 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.25 144.88 29.96 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.523 2.149 . . . . 0.0 112.419 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.562 ' CD2' ' N ' ' A' ' 149' ' ' TYR . 76.2 t80 -81.48 -89.82 0.07 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.587 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.562 ' N ' ' CD2' ' A' ' 148' ' ' PHE . 95.2 m-85 39.22 66.51 0.54 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.845 0.831 . . . . 0.0 110.341 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.4 -176.5 51.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 60.15 33.97 21.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.564 -0.962 . . . . 0.0 108.716 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -137.77 128.4 26.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.349 -0.844 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -158.74 -3.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 153' ' ' LEU . 17.4 pt-20 -121.52 133.98 55.04 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.655 0.74 . . . . 0.0 109.863 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -85.94 -67.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 109.436 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 156' ' ' HIS . 24.6 p-80 -174.02 91.18 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.483 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -153.31 142.29 21.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 0.0 109.617 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.28 -56.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 44.03 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.519 -0.738 . . . . 0.0 109.973 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.121 -0.943 . . . . 0.0 109.695 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -90.18 -4.86 57.0 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -80.04 137.11 36.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.473 -0.767 . . . . 0.0 109.684 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.98 141.88 57.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.461 -0.774 . . . . 0.0 110.35 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.7 tpt -162.0 72.41 2.35 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.792 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -81.75 -93.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.742 2.295 . . . . 0.0 111.686 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -157.48 60.08 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -88.02 163.33 16.34 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.503 -0.748 . . . . 0.0 110.57 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 63.84 91.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.921 -0.487 . . . . 0.0 109.742 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.56 136.4 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 52.0 t -116.13 132.57 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.53 ' NH2' HH21 ' A' ' 108' ' ' ARG . 84.3 mtp180 -128.37 137.63 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NH2' ' OE2' ' A' ' 124' ' ' GLU . 28.0 mmt180 -138.71 153.67 48.53 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -138.11 147.81 44.35 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.71 125.97 7.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 108.707 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 16' ' ' HIS . 20.3 p-80 -90.7 111.33 22.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 17' ' ' LEU . 10.2 mp -101.33 132.24 46.98 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.504 -0.747 . . . . 0.0 109.179 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.98 9.42 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.576 -0.702 . . . . 0.0 109.862 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.64 151.83 39.93 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.44 -0.787 . . . . 0.0 109.262 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.78 161.89 37.11 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.307 2.005 . . . . 0.0 112.15 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.37 -26.02 63.6 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.706 2.271 . . . . 0.0 111.395 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.99 -39.97 94.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.556 -0.715 . . . . 0.0 109.264 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.53 -42.27 83.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.466 -0.771 . . . . 0.0 109.887 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.82 -46.42 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -61.11 -44.17 97.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.53 -0.731 . . . . 0.0 109.379 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.31 -41.3 88.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.45 -0.781 . . . . 0.0 109.916 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.81 -42.86 99.54 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.356 -0.84 . . . . 0.0 109.873 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.9 mtt -67.29 -35.09 78.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 109.77 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.5 p -93.46 -0.2 56.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -107.77 98.09 23.43 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.323 -0.861 . . . . 0.0 109.223 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.95 -20.34 25.74 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.783 1.655 . . . . 0.0 111.8 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.68 -40.77 16.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.635 -0.666 . . . . 0.0 109.508 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -64.8 -34.69 78.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.788 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 36' ' ' ARG . 90.5 mt -61.59 -41.41 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 109.152 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 41' ' ' GLU . 56.6 mt -43.84 -21.51 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.142 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 34' ' ' ILE . 99.7 mtt180 -63.58 -41.62 98.35 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CG ' ' O ' ' A' ' 37' ' ' TRP . 25.9 p-90 -122.28 81.0 1.78 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.416 0.627 . . . . 0.0 109.676 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.435 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 14.3 ttt 74.75 136.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.399 0.618 . . . . 0.0 110.123 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 40' ' ' THR . . . 141.64 -58.97 0.56 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' GLY . 4.4 p 41.09 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.792 -0.828 . . . . 0.0 110.016 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' N ' HD22 ' A' ' 35' ' ' LEU . 97.3 mt-10 55.03 95.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.686 -0.634 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.73 147.45 28.86 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.371 -0.831 . . . . 0.0 109.94 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -94.97 164.11 13.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.662 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 44' ' ' VAL . 11.3 p -56.03 122.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -174.23 79.04 0.36 Allowed Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.43 159.4 51.62 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.915 1.743 . . . . 0.0 112.133 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 64.29 89.15 0.11 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.288 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.1 137.9 53.83 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.736 2.291 . . . . 0.0 112.931 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 142.9 -17.45 2.37 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.15 -160.48 31.1 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.656 HD13 ' H ' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -59.23 137.82 57.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.538 -0.977 . . . . 0.0 109.559 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.656 ' H ' HD13 ' A' ' 51' ' ' LEU . 90.1 m-85 -39.03 135.84 0.87 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.31 0.576 . . . . 0.0 110.009 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 53' ' ' LEU . 10.0 mp -75.68 123.96 26.43 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.514 0.673 . . . . 0.0 110.255 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.0 m -155.07 150.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -93.54 14.28 19.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.253 -0.904 . . . . 0.0 109.342 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.48 -45.43 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.4 112.43 8.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.22 -0.925 . . . . 0.0 109.512 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.58 122.87 6.38 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 -70.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.473 -1.016 . . . . 0.0 109.056 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -159.73 -170.52 2.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -0.784 . . . . 0.0 109.346 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 9.1 p90 -135.8 75.91 1.58 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.586 -0.696 . . . . 0.0 109.304 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.08 75.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.224 0.535 . . . . 0.0 110.26 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' ' H ' ' A' ' 65' ' ' SER . 75.7 ttt180 -163.69 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.13 31.1 64.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.441 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 31.2 t -155.89 95.2 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.27 -1.135 . . . . 0.0 109.428 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -86.62 140.98 29.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.436 -0.79 . . . . 0.0 110.395 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -76.81 -78.83 0.12 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.526 -0.734 . . . . 0.0 109.591 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -145.61 135.5 23.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.375 -0.828 . . . . 0.0 109.578 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 84.9 t -127.56 130.85 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 109.74 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG21 ' HE ' ' A' ' 74' ' ' ARG . 1.6 t -135.59 94.59 15.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.502 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 50.0 Cg_exo -52.25 151.48 17.24 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.553 2.168 . . . . 0.0 113.648 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.4 m 34.91 34.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.386 0.612 . . . . 0.0 110.959 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.502 ' ND1' ' O ' ' A' ' 71' ' ' PRO . 44.0 m80 -144.37 -74.69 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HE ' HG21 ' A' ' 70' ' ' VAL . 37.9 ptt180 -156.16 157.14 35.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.452 -0.78 . . . . 0.0 109.694 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -133.62 148.37 51.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.573 -0.704 . . . . 0.0 109.57 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.03 116.04 6.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.473 -0.767 . . . . 0.0 109.021 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -122.29 135.38 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.849 -0.532 . . . . 0.0 109.626 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.407 ' H ' HH22 ' A' ' 63' ' ' ARG . 11.4 t -112.19 122.13 46.87 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 79' ' ' PHE . 54.8 p90 -160.58 126.52 4.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 109.638 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.6 -174.25 43.79 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 12.8 m95 65.61 156.77 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.617 -0.931 . . . . 0.0 110.868 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.4 t0 55.83 25.33 8.35 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.49 -174.83 49.66 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 93.4 p -79.44 174.74 11.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.662 -0.905 . . . . 0.0 110.488 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -40.57 117.61 0.84 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' ' C ' ' A' ' 87' ' ' VAL . 43.7 t 46.83 82.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 86' ' ' VAL . 2.1 m -27.48 93.11 0.05 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 CA-C-O 120.795 0.331 . . . . 0.0 110.701 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 25.5 Cg_exo -53.39 -42.33 66.21 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.786 1.658 . . . . 0.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 88' ' ' PRO . 98.1 Cg_endo -84.13 -9.84 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.671 1.581 . . . . 0.0 111.517 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 101.18 -30.0 11.31 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER 33.03 95.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 122.222 -0.575 . . . . 0.0 110.756 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 t -155.85 -134.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 0.0 109.471 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -103.06 124.44 48.54 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.555 -0.716 . . . . 0.0 109.183 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -114.91 131.56 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -134.19 127.39 31.87 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.76 132.0 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -122.13 135.01 54.75 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.743 . . . . 0.0 109.371 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.74 129.13 55.06 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.79 127.86 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -84.8 135.64 34.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.564 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.64 124.87 16.43 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.226 -0.921 . . . . 0.0 110.181 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 56.07 29.72 56.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.43 -23.47 12.2 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.65 179.24 53.26 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 89.0 m -123.05 129.08 51.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.743 -0.857 . . . . 0.0 109.038 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.74 123.98 45.7 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.4 tt -99.09 125.86 44.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 0.0 109.054 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.53 HH21 ' NH2' ' A' ' 12' ' ' ARG . 73.9 ttt180 -121.35 124.05 43.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.71 126.86 52.84 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 95.4 m -125.13 130.75 52.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.598 ' NE2' HD21 ' A' ' 114' ' ' LEU . 9.1 t60 -130.3 137.14 49.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.423 -0.798 . . . . 0.0 109.163 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -154.01 169.78 22.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.202 -0.937 . . . . 0.0 110.187 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.14 28.22 26.06 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.598 HD21 ' NE2' ' A' ' 111' ' ' HIS . 55.5 mt -82.46 145.8 52.37 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.251 . . . . 0.0 110.064 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.52 -23.19 27.6 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.347 2.032 . . . . 0.0 111.533 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.9 p -157.73 157.5 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 110.01 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -71.34 -35.85 71.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.705 -0.622 . . . . 0.0 110.253 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -51.05 -39.72 56.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.331 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -67.68 -38.01 83.11 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.379 -0.826 . . . . 0.0 109.14 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.47 -42.32 98.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.586 -0.696 . . . . 0.0 109.657 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.534 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -61.04 -51.07 70.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 110.09 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.12 -39.24 83.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.469 ' NE2' ' NE1' ' A' ' 127' ' ' TRP . 80.2 t60 -65.75 -41.2 92.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -1.056 . . . . 0.0 109.55 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 80.4 tt0 -62.05 -39.02 90.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 109.359 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.95 -37.89 88.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.68 99.86 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.469 ' NE1' ' NE2' ' A' ' 123' ' ' HIS . 78.0 m95 -66.15 -33.77 76.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.45 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.07 84.16 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.346 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -66.09 -47.59 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.401 -0.812 . . . . 0.0 110.031 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CE1' ' NH2' ' A' ' 133' ' ' ARG . 10.2 m-85 -62.15 -46.85 87.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.507 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.11 -41.79 99.42 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.123 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.92 83.51 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.537 ' NH2' ' CE1' ' A' ' 130' ' ' TYR . 88.3 mtm180 -66.55 -39.33 88.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.47 -1.018 . . . . 0.0 109.273 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.73 -42.93 99.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.554 -0.716 . . . . 0.0 109.717 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.6 m -59.54 -43.43 93.5 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 0.0 109.102 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 140' ' ' GLY . 97.4 mt-10 -59.38 -45.25 92.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.415 -0.803 . . . . 0.0 109.199 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 82.3 t -64.73 -44.02 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.531 -0.731 . . . . 0.0 109.603 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.67 83.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.713 . . . . 0.0 109.727 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.4 -6.11 58.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 162.26 133.37 1.46 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 90.6 mtm-85 -70.73 175.54 4.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.36 -1.083 . . . . 0.0 110.545 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 1.3 m-20 81.24 77.94 0.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 CA-C-O 121.234 0.54 . . . . 0.0 110.196 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.93 145.86 89.32 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.809 2.34 . . . . 0.0 112.083 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.98 -64.34 1.67 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.66 141.21 75.75 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.778 1.652 . . . . 0.0 113.023 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.685 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 1.4 m-20 -104.18 -27.04 0.21 Allowed Pre-proline 0 C--N 1.3 -1.576 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.206 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 59.6 Cg_endo -82.71 151.85 14.86 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 C-N-CA 121.81 1.673 . . . . 0.0 112.491 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -99.46 134.82 41.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.452 -0.78 . . . . 0.0 109.894 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 88.6 t80 46.46 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.639 -0.663 . . . . 0.0 109.832 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -84.32 114.45 3.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.7 -14.0 35.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -1.096 . . . . 0.0 109.091 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -129.56 132.99 46.96 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.558 0.695 . . . . 0.0 110.007 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.7 mp -64.08 -40.4 96.17 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.573 -0.704 . . . . 0.0 109.301 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.1 mp0 -99.61 167.06 10.82 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.532 -0.73 . . . . 0.0 109.854 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -155.7 -165.22 1.91 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.289 -0.882 . . . . 0.0 110.067 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' O ' ' CG ' ' A' ' 156' ' ' HIS . 86.7 t60 41.23 44.78 2.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.708 -0.62 . . . . 0.0 109.833 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 46.33 84.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -148.73 137.44 21.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -170.96 48.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.179 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' GLU . 66.6 mtt . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 57.3 mp0 40.28 74.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.508 0.67 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -75.78 149.09 38.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.722 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.448 ' C ' ' SD ' ' A' ' 5' ' ' MET . . . -164.43 -115.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.307 -0.871 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 5' ' ' MET . 2.1 mpt? -142.11 79.22 16.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.165 -0.96 . . . . 0.0 109.158 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.9 146.75 92.41 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.676 2.251 . . . . 0.0 111.98 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -55.48 144.79 24.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 110.555 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 9' ' ' PHE . 98.9 p -65.1 -126.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.761 -0.587 . . . . 0.0 110.56 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 87.6 m-85 41.0 97.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.759 -0.588 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.44 136.72 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.48 131.92 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -121.59 134.87 55.02 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.654 -0.653 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.572 HH21 ' CG ' ' A' ' 124' ' ' GLU . 90.7 mtt-85 -146.93 155.9 42.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.854 . . . . 0.0 109.192 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -139.93 153.76 47.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.355 -0.841 . . . . 0.0 108.981 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.04 144.82 26.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.908 -1.12 . . . . 0.0 108.888 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.425 ' O ' ' CG ' ' A' ' 16' ' ' HIS . 32.3 p80 -102.08 124.93 48.53 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.218 -0.926 . . . . 0.0 109.539 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -110.85 139.23 46.35 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.01 3.27 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.0 109.768 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -99.93 147.65 33.74 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.352 -0.843 . . . . 0.0 109.375 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.32 165.84 29.09 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.177 1.918 . . . . 0.0 112.289 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.02 -37.61 68.25 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.162 1.908 . . . . 0.0 111.755 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.76 93.38 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -62.43 -46.99 86.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.36 -46.07 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.242 -0.911 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' O ' ' OG1' ' A' ' 29' ' ' THR . 79.9 t80 -61.22 -44.16 97.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.67 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.41 73.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -64.13 -42.4 96.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.797 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -82.83 -3.27 56.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.724 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 95.7 m -95.07 -14.93 23.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.163 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.35 129.42 25.25 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.515 -0.741 . . . . 0.0 109.196 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.79 -20.95 16.87 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.812 1.675 . . . . 0.0 111.844 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -81.78 -41.34 21.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 110.012 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -64.49 -33.18 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.947 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.1 -42.57 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.024 -1.048 . . . . 0.0 110.173 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.1 mt -67.59 -5.17 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.871 -1.143 . . . . 0.0 109.602 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.496 HH21 HG11 ' A' ' 137' ' ' VAL . 62.3 ttp180 -71.17 -19.63 62.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.099 -1.0 . . . . 0.0 108.846 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.492 ' CD2' ' N ' ' A' ' 38' ' ' MET . 67.6 p-90 -141.58 -50.21 0.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.492 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 4.3 ttt -64.17 -135.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.124 -0.985 . . . . 0.0 110.883 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.53 -168.35 0.41 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -141.22 28.28 1.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.944 . . . . 0.0 108.723 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -155.28 117.46 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 109.242 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.6 149.27 5.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.046 -1.034 . . . . 0.0 109.184 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 43' ' ' GLU . 58.8 mp0 -85.67 158.09 20.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.136 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -137.82 150.23 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.256 -0.903 . . . . 0.0 109.059 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -103.26 151.58 38.57 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.322 -0.861 . . . . 0.0 109.363 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -46.67 -42.22 24.07 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.893 1.729 . . . . 0.0 113.018 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 7.7 mm-40 -151.06 -63.89 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 120.809 -1.182 . . . . 0.0 110.863 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 21.0 Cg_endo -60.09 143.24 99.56 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.871 1.714 . . . . 0.0 112.872 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -85.99 38.32 3.06 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.47 34.02 0.45 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 49' ' ' GLY . 4.3 tp -120.61 -67.48 0.97 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.406 -1.055 . . . . 0.0 109.123 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CZ ' ' O ' ' A' ' 49' ' ' GLY . 47.7 m-85 63.34 9.89 4.37 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.833 -0.542 . . . . 0.0 110.099 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.34 127.22 55.94 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.221 -0.925 . . . . 0.0 109.242 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 56' ' ' VAL . 4.9 t -135.76 133.53 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m120 68.41 -56.48 0.5 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.581 -0.699 . . . . 0.0 109.58 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 80' ' ' GLY . 23.1 m -66.68 141.13 18.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 110.1 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.7 p -126.14 159.59 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -157.19 11.48 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.34 39.99 3.77 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.47 -1.018 . . . . 0.0 109.285 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -148.0 141.29 25.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.014 -1.054 . . . . 0.0 109.966 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.48 -43.42 5.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.548 -0.72 . . . . 0.0 109.622 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.77 103.44 0.69 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.346 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -150.89 164.12 37.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.952 -1.093 . . . . 0.0 109.883 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.37 -128.0 27.13 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 p -149.21 147.69 28.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.265 . . . . 0.0 109.86 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -78.19 147.26 34.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.456 -0.778 . . . . 0.0 110.646 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.36 -77.57 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 97.6 mt-10 -143.2 132.54 23.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.25 -0.907 . . . . 0.0 108.996 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -149.56 111.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.157 -0.965 . . . . 0.0 109.244 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.31 132.27 15.55 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 73' ' ' HIS . 73.3 Cg_endo -72.58 154.68 55.0 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.672 1.581 . . . . 0.0 112.87 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.5 m 28.57 41.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 CA-C-O 121.449 0.642 . . . . 0.0 111.391 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 71' ' ' PRO . 47.0 t-80 -151.51 -79.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.437 -0.79 . . . . 0.0 109.334 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -141.54 148.4 39.29 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.088 -1.007 . . . . 0.0 110.123 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.6 tp -147.5 132.17 17.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 108.768 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 68' ' ' GLU . . . -148.29 130.29 15.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 109.177 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.606 ' CD2' ' N ' ' A' ' 78' ' ' SER . 86.1 t80 -167.27 178.44 5.58 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.479 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.606 ' N ' ' CD2' ' A' ' 77' ' ' TYR . 99.9 p -88.99 99.81 12.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 109.672 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -102.44 -3.37 27.07 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.374 -0.829 . . . . 0.0 108.803 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -54.98 148.8 23.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -99.44 136.21 39.71 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.34 -1.094 . . . . 0.0 110.421 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 34.5 p-10 -94.41 -2.17 52.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.201 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.94 -89.27 0.56 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.9 m -66.23 -80.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 123' ' ' HIS . 98.3 mt-10 -58.56 129.76 43.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.274 -0.891 . . . . 0.0 109.838 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.4 t -65.21 129.08 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.677 . . . . 0.0 109.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.8 t -154.88 88.13 3.27 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 34.2 Cg_exo -56.23 -173.02 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.347 2.032 . . . . 0.0 111.858 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 39.1 Cg_exo -58.1 -155.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.891 2.394 . . . . 0.0 112.794 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.13 95.65 0.01 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' PRO . 82.6 p -151.82 -55.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.454 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -80.86 162.99 23.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 110.251 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.6 tp -154.89 127.26 7.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.595 -0.691 . . . . 0.0 109.249 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.66 130.65 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.402 -0.811 . . . . 0.0 108.814 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -116.76 127.62 54.53 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.12 131.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.465 -0.772 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -133.74 129.2 36.34 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.371 -0.831 . . . . 0.0 109.097 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.18 128.15 45.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.348 -0.845 . . . . 0.0 108.931 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -127.96 128.84 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.422 -0.798 . . . . 0.0 109.525 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.02 141.57 54.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.409 -0.807 . . . . 0.0 110.326 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -150.74 88.05 1.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.923 . . . . 0.0 109.311 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 46.05 90.71 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.79 -71.16 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 O-C-N 121.175 -1.191 . . . . 0.0 110.816 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . -59.66 165.57 10.63 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 m -120.81 128.82 53.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.635 -0.921 . . . . 0.0 109.168 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.5 tp -87.01 128.81 35.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 108.714 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.8 tt -113.18 127.83 56.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.701 . . . . 0.0 109.372 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -111.97 124.73 53.02 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.7 123.93 43.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.9 m -125.93 128.48 47.6 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -106.45 123.59 48.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 t -138.78 154.58 48.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.044 -1.035 . . . . 0.0 110.103 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.94 27.96 24.82 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -69.01 150.46 97.58 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.237 -1.155 . . . . 0.0 109.811 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.0 -30.92 38.46 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.362 2.042 . . . . 0.0 111.777 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 40.2 t -164.38 166.71 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 110.029 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.421 ' O ' ' SG ' ' A' ' 120' ' ' CYS . . . -65.12 -37.16 86.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.742 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -59.23 -38.4 79.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.249 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -66.21 -32.16 73.42 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.224 -0.923 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -63.23 -43.48 97.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.901 . . . . 0.0 109.389 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.546 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -63.68 -41.52 98.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.404 -0.81 . . . . 0.0 109.602 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.64 -44.34 71.73 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.443 ' CD2' ' OE1' ' A' ' 85' ' ' GLU . 37.0 m170 -67.08 -40.1 86.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.539 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.572 ' CG ' HH21 ' A' ' 13' ' ' ARG . 83.2 tt0 -55.72 -45.73 77.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.554 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -66.91 -39.37 87.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.174 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.44 82.57 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.06 -41.15 97.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.26 . . . . 0.0 109.766 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.64 98.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 109.039 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -67.65 -45.14 76.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.32 -0.863 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -62.54 -46.45 88.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.586 -0.696 . . . . 0.0 109.54 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 65.5 mt -63.01 -40.12 96.8 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.444 -0.785 . . . . 0.0 109.705 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.13 -43.85 98.9 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.114 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.418 ' CZ ' ' O ' ' A' ' 37' ' ' TRP . 83.4 mtp180 -65.34 -41.11 94.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.948 -1.325 . . . . 0.0 109.976 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.5 tp -63.04 -43.37 98.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.088 -1.007 . . . . 0.0 109.993 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 87.6 m -62.51 -43.86 97.79 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.137 -0.977 . . . . 0.0 109.782 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -59.49 -46.76 87.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.851 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG11 HH21 ' A' ' 36' ' ' ARG . 74.1 t -64.69 -44.27 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 0.0 109.633 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 140' ' ' GLY . . . -60.93 -22.41 64.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.297 -0.877 . . . . 0.0 109.391 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.21 2.82 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.608 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 138' ' ' ALA . . . 107.26 -10.73 39.81 Favored Glycine 0 N--CA 1.501 3.026 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -75.38 153.5 37.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -1.152 . . . . 0.0 110.019 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -141.58 74.75 23.01 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.309 -0.869 . . . . 0.0 109.113 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.34 158.5 44.62 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.433 2.088 . . . . 0.0 112.442 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.92 71.23 0.48 Allowed Glycine 0 N--CA 1.505 3.234 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.52 152.42 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.47 2.113 . . . . 0.0 112.449 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -157.27 60.67 2.12 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.12 -62.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.391 2.061 . . . . 0.0 111.653 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -100.6 -3.24 30.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 108.931 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -73.82 129.61 38.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 109.656 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 153.28 -176.11 31.45 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 106.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.484 -1.009 . . . . 0.0 109.36 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -79.92 148.07 31.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.539 -0.725 . . . . 0.0 109.753 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 155' ' ' HIS . 0.1 OUTLIER -90.81 146.68 23.75 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.389 -0.819 . . . . 0.0 109.701 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 53.1 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.384 -0.823 . . . . 0.0 110.254 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.556 ' N ' ' O ' ' A' ' 153' ' ' LEU . 86.3 t60 50.82 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.332 -0.855 . . . . 0.0 109.721 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.5 t60 50.17 81.39 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 110.322 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 158' ' ' HIS . 11.5 p80 -67.7 -45.38 75.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.388 -0.82 . . . . 0.0 109.597 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.536 ' N ' ' CG ' ' A' ' 157' ' ' HIS . 53.1 t-80 -170.8 -73.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.293 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.44 ' NE2' ' CD2' ' A' ' 160' ' ' HIS . 74.1 t60 -124.13 124.09 41.74 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.556 -0.715 . . . . 0.0 109.812 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' CD2' ' NE2' ' A' ' 159' ' ' HIS . 60.0 m-70 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.041 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.1 -37.77 81.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.739 0.781 . . . . 0.0 109.565 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.84 130.11 34.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.134 -0.979 . . . . 0.0 110.04 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -178.35 95.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.74 158.37 40.26 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.71 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.55 143.39 28.24 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.522 2.148 . . . . 0.0 112.897 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.79 -21.29 17.63 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.394 -0.816 . . . . 0.0 109.187 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 t -77.22 154.61 32.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.646 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -75.37 142.97 43.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.91 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.14 135.7 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.505 -0.747 . . . . 0.0 109.379 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.18 131.49 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.626 0.727 . . . . 0.0 109.446 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 88.6 mtm180 -125.35 141.68 51.93 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 12' ' ' ARG . 5.8 mmp_? -133.92 149.3 51.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.787 0.803 . . . . 0.0 110.261 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.7 mp0 -136.4 146.16 46.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.592 0.71 . . . . 0.0 109.371 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.42 140.44 22.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.388 -0.82 . . . . 0.0 109.241 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -97.25 115.4 27.55 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.333 -0.854 . . . . 0.0 109.8 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.5 mp -108.24 130.74 55.15 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.796 0.808 . . . . 0.0 109.65 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.82 6.19 32.87 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 138' ' ' ALA . . . -100.06 153.05 37.96 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.96 162.65 28.28 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.777 2.318 . . . . 0.0 112.078 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.94 -31.74 76.99 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.513 2.142 . . . . 0.0 111.668 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.34 -38.23 87.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -0.781 . . . . 0.0 109.733 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.2 85.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.86 -46.81 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.085 -1.01 . . . . 0.0 110.164 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CZ ' ' OG1' ' A' ' 29' ' ' THR . 87.8 t80 -63.67 -42.74 98.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.175 -0.953 . . . . 0.0 109.721 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.99 72.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.9 -42.88 97.33 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.89 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.2 mtt -68.02 -39.08 83.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.409 ' OG1' ' CZ ' ' A' ' 25' ' ' PHE . 87.2 m -77.08 -78.9 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.19 112.36 1.2 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 110.315 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.4 -22.91 13.66 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.466 2.111 . . . . 0.0 111.728 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -70.19 -36.98 75.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -66.0 -32.63 74.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.334 -0.853 . . . . 0.0 109.814 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 38' ' ' MET . 90.4 mt -62.7 -42.02 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.3 mt -57.9 -26.5 62.24 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -60.59 -41.97 95.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.192 -0.942 . . . . 0.0 109.878 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 37' ' ' TRP . 45.4 p-90 -118.6 62.85 0.77 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.361 -0.837 . . . . 0.0 110.146 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.482 ' CB ' ' O ' ' A' ' 37' ' ' TRP . 3.8 ttt 81.35 150.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.082 0.944 . . . . 0.0 110.91 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 41' ' ' GLU . . . 139.03 -25.21 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 41' ' ' GLU . 6.3 p 60.01 -70.67 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.847 -0.796 . . . . 0.0 109.676 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 39' ' ' GLY . 80.0 mm-40 -131.84 145.21 51.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.871 0.843 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 124.47 6.49 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' H ' HG23 ' A' ' 54' ' ' VAL . 95.7 mt-10 -144.68 113.84 6.96 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.239 -0.913 . . . . 0.0 109.285 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -125.67 132.54 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -134.65 154.97 79.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -42.75 139.06 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.805 2.337 . . . . 0.0 113.093 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 70.03 156.49 0.15 Allowed Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.92 145.09 84.99 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.522 2.148 . . . . 0.0 112.281 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.1 63.12 0.44 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.15 149.85 51.7 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.463 -1.022 . . . . 0.0 110.663 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.27 145.26 44.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.691 -0.888 . . . . 0.0 109.814 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 42.65 -161.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.843 0.83 . . . . 0.0 110.585 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.7 mm? -75.57 145.53 41.14 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.759 0.79 . . . . 0.0 110.12 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG23 ' H ' ' A' ' 43' ' ' GLU . 2.7 p -138.89 138.65 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.825 0.821 . . . . 0.0 109.772 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -89.23 85.2 6.57 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.552 0.691 . . . . 0.0 109.471 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.81 -153.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.518 -0.738 . . . . 0.0 110.39 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 t -116.06 130.63 56.9 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.821 0.82 . . . . 0.0 110.273 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.81 -8.4 79.86 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 -147.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.348 -1.09 . . . . 0.0 109.94 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' PHE . 30.3 ptt85 -155.45 115.89 3.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.229 -0.919 . . . . 0.0 110.017 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' A' ' 62' ' ' ALA . 80.6 t80 53.14 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.842 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' N ' ' CG ' ' A' ' 61' ' ' PHE . . . 69.05 -17.5 0.2 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' PHE . 13.2 mmp_? -129.67 156.03 44.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.371 -0.831 . . . . 0.0 109.812 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.74 83.87 0.97 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' PHE . 81.1 p -102.82 -0.01 32.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.253 -1.146 . . . . 0.0 108.55 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' SER . 96.9 m-85 39.7 79.08 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.883 0.849 . . . . 0.0 110.627 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 77.8 ttt-85 -67.39 -42.41 83.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.427 -0.796 . . . . 0.0 109.246 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -151.49 129.01 11.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.04 -1.038 . . . . 0.0 109.599 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.6 t -128.21 130.23 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 121.83 0.824 . . . . 0.0 109.501 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -142.45 97.5 6.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' O ' ' C ' ' A' ' 72' ' ' VAL . 84.2 Cg_exo -49.45 148.85 10.46 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.875 2.383 . . . . 0.0 112.643 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 71' ' ' PRO . 10.6 m 33.18 57.37 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.261 0 CA-C-O 122.008 0.909 . . . . 0.0 109.825 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -170.16 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.602 -0.686 . . . . 0.0 109.572 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -154.63 144.07 21.34 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.099 . . . . 0.0 110.243 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.645 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.1 tt -137.64 121.35 17.43 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.645 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -136.64 141.79 43.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.368 -0.832 . . . . 0.0 109.263 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 67' ' ' ARG . 48.6 p90 -149.37 150.76 32.95 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.721 0.772 . . . . 0.0 109.792 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 96.3 p -82.06 161.49 22.91 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.445 0.64 . . . . 0.0 109.871 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -134.19 153.16 52.01 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.725 0.774 . . . . 0.0 109.61 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' H ' ' HD3' ' A' ' 63' ' ' ARG . . . 88.07 -116.5 4.59 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' GLY . 11.4 m0 58.23 121.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.936 0.874 . . . . 0.0 110.418 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 55.99 28.73 13.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.576 0.703 . . . . 0.0 109.458 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.95 148.72 25.98 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -110.4 123.22 49.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -1.043 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 51.84 27.18 4.03 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.485 0.66 . . . . 0.0 109.584 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 86' ' ' VAL . 14.2 p -159.14 115.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.15 -0.969 . . . . 0.0 110.115 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.9 t 49.9 91.62 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.759 -0.588 . . . . 0.0 110.474 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -52.89 161.78 3.01 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.618 2.212 . . . . 0.0 111.492 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.89 135.78 58.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.83 2.353 . . . . 0.0 113.196 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.89 -176.96 52.2 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m 58.92 -159.41 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.92 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.7 p 42.93 88.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.453 0.644 . . . . 0.0 109.982 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.1 tp -122.68 127.32 49.12 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.725 0.774 . . . . 0.0 109.531 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.7 t -103.78 132.03 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.42 139.06 50.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.731 0.776 . . . . 0.0 109.716 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.56 129.9 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.73 137.73 53.29 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.577 -0.702 . . . . 0.0 109.43 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.2 mt -105.59 125.06 50.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.513 -0.742 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.89 127.17 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.71 0.767 . . . . 0.0 109.184 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -83.59 139.09 33.06 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.626 0.727 . . . . 0.0 109.996 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD23 ' A' ' 106' ' ' LEU . 75.3 mt-30 -146.15 -164.91 2.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.333 -0.855 . . . . 0.0 109.797 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.25 97.66 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.0 95.5 2.11 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 39.58 -121.55 1.49 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.6 m -123.03 128.71 50.54 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.507 -0.996 . . . . 0.0 109.529 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD23 ' NE2' ' A' ' 101' ' ' GLN . 40.3 tp -88.81 131.78 34.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.45 -0.781 . . . . 0.0 109.265 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 107' ' ' LEU . 6.6 tt -107.96 122.15 46.24 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.51 ' N ' HD23 ' A' ' 107' ' ' LEU . 70.7 ttt180 -111.01 129.28 55.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.486 0.66 . . . . 0.0 109.531 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.6 tt -124.88 121.04 33.37 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.592 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.3 m -118.66 126.35 51.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.594 -0.692 . . . . 0.0 109.362 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.548 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.8 t-80 -119.85 126.7 51.59 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.0 t -135.42 146.89 48.71 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.85 0.833 . . . . 0.0 109.563 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.59 50.74 0.95 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' CE1' ' A' ' 111' ' ' HIS . 51.4 mt -114.26 89.74 18.37 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.459 -1.024 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.05 -6.84 18.53 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.855 2.37 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 p -123.39 132.88 54.1 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.17 80.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.582 0.706 . . . . 0.0 109.883 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -58.81 -41.14 86.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.082 -1.011 . . . . 0.0 109.429 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -66.39 -35.05 79.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.317 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 88.1 m -66.85 -45.25 78.77 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -41.64 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.109 -0.994 . . . . 0.0 109.449 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.6 -42.52 80.3 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -67.79 -43.33 79.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.099 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.73 -45.63 77.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.344 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.05 -38.21 72.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.407 -0.808 . . . . 0.0 109.711 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.68 -48.4 67.76 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -64.87 -40.4 95.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -1.084 . . . . 0.0 109.801 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.86 -50.12 73.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.943 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' HB3' HH12 ' A' ' 133' ' ' ARG . 69.2 m80 -69.55 -41.37 76.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.562 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -61.59 -49.52 76.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.16 -37.78 86.48 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.763 0.792 . . . . 0.0 109.499 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.32 -45.56 92.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.542 ' HE ' ' CG ' ' A' ' 145' ' ' PRO . 83.5 mtt85 -66.19 -41.61 89.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.155 -1.203 . . . . 0.0 109.791 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.94 -42.31 97.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.897 . . . . 0.0 109.87 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.03 -46.41 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.285 -0.884 . . . . 0.0 109.736 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 140' ' ' GLY . 80.7 tt0 -66.62 -45.94 77.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.242 -0.911 . . . . 0.0 109.94 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 140' ' ' GLY . 77.6 t -66.93 -43.12 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.223 -0.923 . . . . 0.0 109.71 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -72.68 -27.82 62.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.923 . . . . 0.0 109.551 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.21 -5.67 36.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -158.94 -150.47 5.81 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -148.25 16.16 1.04 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.547 -0.973 . . . . 0.0 108.724 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 0.5 OUTLIER -119.24 89.57 40.08 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.347 -0.845 . . . . 0.0 109.664 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.16 145.52 75.82 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.751 2.301 . . . . 0.0 111.954 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.88 -81.32 0.14 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.542 ' CG ' ' HE ' ' A' ' 133' ' ' ARG . 38.2 Cg_endo -63.66 147.9 92.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.503 2.135 . . . . 0.0 112.474 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 16.3 p-10 -158.1 62.89 2.53 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.92 -89.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.83 2.353 . . . . 0.0 112.034 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 149' ' ' TYR . 98.5 m-85 -138.62 4.22 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 148' ' ' PHE . 97.9 m-85 42.58 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.031 0.92 . . . . 0.0 110.496 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 85.29 164.37 38.68 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -82.68 -15.92 50.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.546 -0.973 . . . . 0.0 109.24 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -92.25 132.3 36.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.734 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.4 mp -64.39 -40.44 95.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.589 -0.694 . . . . 0.0 109.807 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 153' ' ' LEU . 71.9 mm-40 58.66 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.751 0.786 . . . . 0.0 110.53 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -135.63 159.24 42.23 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.743 0.782 . . . . 0.0 109.927 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 158' ' ' HIS . 12.3 t-80 42.8 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.901 0.858 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 157' ' ' HIS . 18.7 t-80 -78.67 17.34 0.71 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.16 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 156' ' ' HIS . 80.7 m80 55.92 10.39 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.643 0.735 . . . . 0.0 109.648 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.537 ' CD2' ' H ' ' A' ' 160' ' ' HIS . 86.4 t60 52.44 -111.34 0.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.478 -0.764 . . . . 0.0 110.561 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.537 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 86.7 m-70 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.113 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.578 0.704 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 3' ' ' LYS . 97.9 mt-10 -73.65 159.58 32.83 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.808 0.813 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 88.7 tttt 60.01 133.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.897 0.856 . . . . 0.0 110.755 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 66.82 166.79 0.22 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.782 0.801 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.9 tpt 64.8 51.77 1.02 Allowed Pre-proline 0 N--CA 1.485 1.31 0 O-C-N 121.83 -0.544 . . . . 0.0 110.029 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 5' ' ' MET . 50.9 Cg_endo -67.39 142.54 60.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -104.1 -13.71 16.16 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.472 -0.767 . . . . 0.0 109.604 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.7 m -107.9 31.59 5.39 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.334 -0.854 . . . . 0.0 108.799 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.8 t80 -66.41 145.0 56.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 109.844 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.42 137.39 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.553 0.692 . . . . 0.0 109.519 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.5 t -109.55 132.51 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.573 0.701 . . . . 0.0 109.642 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -129.42 139.68 51.57 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.503 0.668 . . . . 0.0 109.321 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.621 HH21 ' CA ' ' A' ' 124' ' ' GLU . 18.3 mmt180 -137.7 153.73 49.75 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.668 0.747 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.6 mp0 -139.81 150.5 44.78 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.626 0.727 . . . . 0.0 109.777 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.14 154.04 24.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 109.601 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -103.86 132.29 50.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.503 -0.748 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.57 141.32 47.9 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.757 0.789 . . . . 0.0 109.975 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.16 68.99 8.28 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.532 0.682 . . . . 0.0 109.548 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -177.0 153.79 1.1 Allowed Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.89 162.2 26.41 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.805 2.336 . . . . 0.0 112.261 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.45 -29.73 71.61 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.528 2.152 . . . . 0.0 111.454 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.24 -40.18 95.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.304 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.81 86.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.1 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.25 -43.31 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 109.154 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.73 -42.5 99.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.428 -0.795 . . . . 0.0 109.296 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.67 79.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.497 -0.752 . . . . 0.0 109.394 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 33' ' ' LYS . 8.7 mt -62.89 -41.62 99.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.312 -0.868 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.15 -3.83 59.09 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.507 -0.746 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.3 m -124.58 59.69 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.813 0.816 . . . . 0.0 109.14 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 32' ' ' GLU . 6.5 t0 -176.12 127.04 0.35 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.55 -35.87 2.54 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.449 2.1 . . . . 0.0 112.349 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 97.3 mt-10 -72.45 -42.6 64.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HG2' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -65.16 -40.0 93.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 110.146 -179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.49 -42.12 94.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 121.44 -0.788 . . . . 0.0 109.547 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 41' ' ' GLU . 56.3 mt -73.24 -5.39 39.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.848 . . . . 0.0 109.776 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -78.19 -19.89 52.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.8 p-90 -146.48 9.64 1.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.3 ttm -160.55 100.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.51 157.75 32.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.4 m -109.57 -20.93 12.69 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.673 -0.898 . . . . 0.0 108.786 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' N ' HD22 ' A' ' 35' ' ' LEU . 81.6 tt0 -156.59 126.39 6.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.148 -0.97 . . . . 0.0 109.782 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.34 151.59 5.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.581 -0.699 . . . . 0.0 109.352 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -141.27 127.72 20.0 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.843 0.83 . . . . 0.0 109.373 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.33 -77.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 54.07 68.23 2.92 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.576 -0.703 . . . . 0.0 109.753 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.64 0.7 3.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.233 1.955 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 1.4 tt0 -178.87 -45.86 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 47' ' ' GLU . 24.3 Cg_exo -63.82 132.83 36.4 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.488 2.125 . . . . 0.0 112.479 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' PRO . . . 36.0 92.74 0.01 OUTLIER Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.67 84.64 1.52 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.4 mp -95.64 -172.84 2.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.63 -0.923 . . . . 0.0 110.051 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -72.88 133.42 44.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.749 0.785 . . . . 0.0 110.022 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -95.14 155.26 16.81 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.601 0.715 . . . . 0.0 109.617 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 55' ' ' ASN . 44.7 t -131.08 162.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.622 0.725 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 54' ' ' VAL . 9.0 m120 55.91 -175.85 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.872 0.844 . . . . 0.0 110.707 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 t 61.93 124.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.841 0.829 . . . . 0.0 110.381 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 81' ' ' TRP . 15.1 t -101.77 176.58 5.17 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.823 0.82 . . . . 0.0 109.998 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.1 -16.25 61.47 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.18 129.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -1.14 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -118.72 -36.79 3.39 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.621 -0.674 . . . . 0.0 109.697 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.81 -45.94 91.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.115 -0.99 . . . . 0.0 109.435 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.09 -172.86 2.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 109.693 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -104.97 0.44 27.77 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.68 -125.59 23.14 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 t -134.96 141.09 46.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.551 -0.97 . . . . 0.0 109.819 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -73.89 147.29 43.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.708 0.766 . . . . 0.0 110.401 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -73.11 -74.61 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.481 0.658 . . . . 0.0 109.658 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -137.2 136.03 37.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.467 -0.771 . . . . 0.0 109.168 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.24 132.05 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.643 0.735 . . . . 0.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.3 t -130.35 105.7 16.1 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' VAL . 53.2 Cg_exo -48.03 134.69 23.98 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.354 2.036 . . . . 0.0 112.929 -178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.8 p 32.42 61.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -164.82 -72.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.405 -0.809 . . . . 0.0 109.511 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.455 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 71.7 ttp85 -147.6 143.58 27.83 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 110.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.2 mt -130.77 137.4 49.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.525 0.679 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.12 113.7 13.03 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.617 0.723 . . . . 0.0 109.229 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.636 ' CG ' ' N ' ' A' ' 78' ' ' SER . 60.7 t80 -169.38 176.96 4.89 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.774 0.797 . . . . 0.0 109.86 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.636 ' N ' ' CG ' ' A' ' 77' ' ' TYR . 14.7 p -85.77 155.41 21.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.831 0.824 . . . . 0.0 110.551 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -156.61 101.72 2.01 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.18 -171.35 47.83 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.481 ' O ' HG22 ' A' ' 57' ' ' THR . 95.8 m95 -91.93 149.38 21.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.521 -0.988 . . . . 0.0 110.292 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 48.6 p-10 -66.37 -25.85 66.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 110.065 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . -60.32 -126.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 t -138.8 8.96 2.59 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.391 -1.064 . . . . 0.0 109.458 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.57 139.42 57.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 87' ' ' VAL . 9.7 t -80.53 121.3 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.715 0.769 . . . . 0.0 110.222 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 86' ' ' VAL . 60.1 t -155.22 85.77 3.44 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -54.05 156.11 13.63 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.987 2.458 . . . . 0.0 112.145 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.88 -22.78 42.05 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.324 2.016 . . . . 0.0 111.453 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.18 -23.49 29.39 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -69.29 -34.05 74.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.995 . . . . 0.0 109.711 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.6 m -140.28 148.65 41.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.3 tp -124.11 130.38 52.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.7 t -115.91 132.33 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -130.61 143.51 50.8 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.4 0.619 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.83 132.21 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.416 0.627 . . . . 0.0 109.416 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -120.84 127.87 52.31 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.6 0.714 . . . . 0.0 109.432 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.6 mt -100.39 124.37 45.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.491 -0.756 . . . . 0.0 109.055 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.4 mt -127.94 128.92 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.678 0.751 . . . . 0.0 109.481 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.58 133.2 35.74 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.696 0.76 . . . . 0.0 109.903 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' GLY . 83.7 mt-30 -145.99 109.94 4.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.581 -0.699 . . . . 0.0 109.253 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 101' ' ' GLN . . . 37.14 -131.78 1.07 Allowed Glycine 0 N--CA 1.495 2.585 0 CA-C-O 121.922 0.734 . . . . 0.0 111.44 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.88 28.6 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.11 49.02 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 95.2 m -125.97 131.22 52.29 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.686 -0.891 . . . . 0.0 109.287 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.12 128.72 34.74 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.613 -0.679 . . . . 0.0 109.329 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 tt -112.71 127.17 56.06 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.521 0.677 . . . . 0.0 109.746 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -113.52 131.71 55.96 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.9 tp -115.92 128.27 55.64 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.7 m -121.29 129.27 53.03 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.681 0.753 . . . . 0.0 109.721 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -133.26 129.62 37.9 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.2 m -139.06 154.92 48.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.671 0.748 . . . . 0.0 110.047 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.95 57.82 1.66 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 57.3 mt -86.28 116.53 66.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.933 . . . . 0.0 109.793 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -49.89 -35.35 39.94 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.411 2.074 . . . . 0.0 111.711 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.8 t -150.85 155.22 38.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.705 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.8 -33.05 74.39 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.513 0.673 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -53.99 -41.62 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.933 . . . . 0.0 109.404 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 123' ' ' HIS . 76.8 mt-30 -66.12 -30.86 71.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.699 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.502 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.7 t -60.29 -49.03 79.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 109.848 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.74 -44.67 89.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 109.858 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.46 -36.14 92.21 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.427 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 37.9 m170 -64.86 -45.01 87.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -1.082 . . . . 0.0 109.724 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.621 ' CA ' HH21 ' A' ' 13' ' ' ARG . 20.6 mm-40 -55.56 -47.8 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.177 -0.952 . . . . 0.0 109.412 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -68.49 -37.08 79.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.33 -48.63 57.18 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -63.01 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.445 -1.032 . . . . 0.0 110.213 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.51 76.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.302 -0.874 . . . . 0.0 109.771 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -69.7 -42.84 73.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.282 -0.886 . . . . 0.0 110.08 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -62.36 -44.38 96.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.254 -0.904 . . . . 0.0 109.596 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.3 mt -62.62 -40.58 97.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 109.639 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.81 99.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -66.73 -38.53 86.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.398 -1.06 . . . . 0.0 109.61 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.44 -41.3 93.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.9 m -60.63 -42.79 97.61 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.288 -0.883 . . . . 0.0 109.566 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -45.06 87.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 109.687 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.56 -43.14 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.384 -0.822 . . . . 0.0 110.062 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.55 -35.2 78.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.745 . . . . 0.0 110.17 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.61 -4.42 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 73.81 119.79 0.08 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -171.32 -132.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.351 -1.088 . . . . 0.0 109.847 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -148.34 80.0 8.69 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 144' ' ' GLY . 52.7 Cg_exo -50.93 -174.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.637 2.225 . . . . 0.0 112.639 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -48.01 179.28 0.01 OUTLIER Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -55.2 -40.28 86.58 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.399 2.066 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.1 OUTLIER 173.38 -48.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.583 -0.698 . . . . 0.0 109.52 -179.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 73.4 Cg_endo -83.82 178.16 5.65 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.659 2.239 . . . . 0.0 112.816 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.434 ' CZ ' ' OD2' ' A' ' 82' ' ' ASP . 77.6 m-85 -72.18 143.45 48.9 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.874 0.845 . . . . 0.0 110.371 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 49.06 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.955 0.884 . . . . 0.0 110.301 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -94.56 -7.81 60.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -64.6 -42.95 95.23 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.14 -1.212 . . . . 0.0 109.418 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -168.03 140.71 3.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.298 -0.876 . . . . 0.0 109.735 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.7 mp -78.28 144.69 35.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.2 127.79 56.28 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.675 0.75 . . . . 0.0 109.455 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 155' ' ' HIS . 57.5 t-80 -84.33 24.07 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.711 0.767 . . . . 0.0 109.209 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.08 -43.97 98.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.69 7.66 1.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.029 -1.044 . . . . 0.0 108.6 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -85.96 127.87 34.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.472 ' NE2' ' CD2' ' A' ' 160' ' ' HIS . 72.9 t60 -139.84 133.82 30.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.385 -0.822 . . . . 0.0 109.954 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.472 ' CD2' ' NE2' ' A' ' 159' ' ' HIS . 46.8 m-70 . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.469 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 ttp . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 59.2 mp0 -68.36 135.8 52.38 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.841 0.829 . . . . 0.0 110.111 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 5' ' ' MET . 99.4 mttt -66.6 -81.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.604 -0.685 . . . . 0.0 109.561 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 42.34 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.986 0.898 . . . . 0.0 109.027 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 3' ' ' LYS . 21.3 ptt? -82.84 147.42 54.81 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.479 -0.763 . . . . 0.0 109.41 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.05 -69.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.464 2.109 . . . . 0.0 112.218 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -174.29 137.2 0.51 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.651 -0.656 . . . . 0.0 109.556 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 t 75.51 -167.57 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.988 0.899 . . . . 0.0 111.474 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -75.59 149.36 38.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.652 0.739 . . . . 0.0 110.378 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -123.07 136.45 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.77 131.3 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.713 0.768 . . . . 0.0 109.437 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -120.8 138.64 53.92 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.507 0.67 . . . . 0.0 109.254 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 124' ' ' GLU . 21.2 mmt180 -138.27 155.12 48.91 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.624 0.726 . . . . 0.0 109.681 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -135.75 145.36 46.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.545 0.688 . . . . 0.0 109.244 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.49 151.6 31.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -107.11 122.77 47.15 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.488 0.661 . . . . 0.0 109.591 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 mt -112.28 127.55 56.01 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.649 0.738 . . . . 0.0 109.53 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.37 75.94 9.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.589 0.709 . . . . 0.0 109.679 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -179.72 149.23 0.52 Allowed Pre-proline 0 C--N 1.303 -1.441 0 O-C-N 121.502 -0.749 . . . . 0.0 109.174 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -41.98 157.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.507 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.14 -33.38 31.54 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.477 2.118 . . . . 0.0 111.469 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.44 -36.79 76.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.478 -0.764 . . . . 0.0 109.87 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.35 -49.19 76.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.948 . . . . 0.0 109.61 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.25 -44.1 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.18 -43.05 99.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 109.626 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.71 -41.02 80.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.13 -43.12 99.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.19 -0.944 . . . . 0.0 109.785 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -69.22 -39.09 78.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 109.788 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 m -87.7 53.59 2.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 109.431 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -172.9 89.69 0.39 Allowed Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 -37.32 64.5 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.937 2.425 . . . . 0.0 112.719 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.18 -45.99 82.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.282 -0.886 . . . . 0.0 110.877 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -65.73 -38.21 88.54 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.886 -1.134 . . . . 0.0 109.681 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.4 mt -57.56 -24.21 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.72 -19.66 65.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.811 -1.18 . . . . 0.0 109.743 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -63.81 -37.19 86.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.931 -1.105 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -124.07 51.88 1.52 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.863 0.839 . . . . 0.0 109.287 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.7 tpp -158.39 -74.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.59 -140.01 3.28 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.66 -1.257 . . . . 0.0 109.981 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -116.17 7.57 14.18 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -140.94 148.2 40.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.396 -0.815 . . . . 0.0 109.048 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.45 132.93 12.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.039 -1.038 . . . . 0.0 109.605 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -106.19 121.07 43.43 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 44' ' ' VAL . 59.3 t -139.78 -1.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 5.7 mp0 -81.28 150.16 67.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 47' ' ' GLU . 56.7 Cg_endo -71.04 -85.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 111.555 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 6.1 mt-10 -156.19 -63.12 0.02 OUTLIER Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 73.2 Cg_exo -31.45 96.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 122.786 2.324 . . . . 0.0 112.923 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 52.22 37.25 46.64 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.41 97.63 0.15 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 44.7 tp -157.13 -57.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.373 -1.074 . . . . 0.0 109.073 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' O ' ' CG ' ' A' ' 52' ' ' TYR . 90.1 t80 -78.99 4.1 15.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.2 mt -92.04 132.22 36.73 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' VAL . 27.2 m -136.86 161.56 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.7 t-20 69.64 -53.05 0.61 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.913 -0.492 . . . . 0.0 109.701 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 55' ' ' ASN . 35.8 m 35.08 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.642 0.734 . . . . 0.0 111.166 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 58' ' ' GLY . 2.5 t -167.58 -128.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.248 -0.907 . . . . 0.0 109.643 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' N ' ' OG1' ' A' ' 57' ' ' THR . . . -74.26 165.76 54.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 57.17 17.61 3.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.765 -0.844 . . . . 0.0 109.335 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -64.54 152.13 42.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.383 -0.823 . . . . 0.0 110.884 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -91.96 126.23 36.96 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 110.094 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.41 27.68 3.1 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -139.15 144.77 38.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.323 -0.861 . . . . 0.0 109.661 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.93 -110.61 0.45 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -87.29 36.55 0.74 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.328 -1.101 . . . . 0.0 109.22 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -64.54 134.89 55.33 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.818 0.818 . . . . 0.0 110.299 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -64.03 -64.6 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 109.383 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -159.14 137.38 10.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.017 -1.052 . . . . 0.0 109.074 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -125.48 124.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.279 -0.888 . . . . 0.0 109.132 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.1 t -147.52 94.21 4.49 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.9 Cg_exo -52.46 149.36 23.79 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.652 2.234 . . . . 0.0 113.257 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.2 m 36.5 46.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.862 0.839 . . . . 0.0 110.441 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -164.02 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.572 0.701 . . . . 0.0 109.365 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' A' ' 97' ' ' ASP . 93.7 mtt-85 -143.79 150.88 39.22 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.129 -0.982 . . . . 0.0 110.651 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.98 133.99 20.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.72 133.58 21.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.126 -0.984 . . . . 0.0 109.309 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -140.22 164.25 30.59 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.684 0.754 . . . . 0.0 109.644 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 79' ' ' PHE . 11.9 p -153.5 159.6 42.3 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.639 0.733 . . . . 0.0 109.857 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' CG ' ' O ' ' A' ' 78' ' ' SER . 44.1 m-85 -158.18 -151.2 0.28 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.492 -0.755 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.89 119.51 0.51 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.4 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 66.2 t-105 -67.99 -91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.53 -0.982 . . . . 0.0 109.94 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 80.1 m-20 -63.7 140.62 58.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.881 0.848 . . . . 0.0 110.187 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.7 91.44 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 86' ' ' VAL . 27.3 t -154.75 99.37 2.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -1.174 . . . . 0.0 109.21 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 84' ' ' SER . 80.2 mm-40 38.9 -90.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.711 0.767 . . . . 0.0 110.502 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 84' ' ' SER . 3.9 p -158.52 115.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.235 -0.915 . . . . 0.0 109.481 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 87' ' ' VAL . 47.1 t -153.93 74.16 6.33 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.376 -0.827 . . . . 0.0 109.414 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 24.4 Cg_exo -64.75 -173.67 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.944 2.43 . . . . 0.0 111.617 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 50.0 Cg_exo -55.05 -35.58 90.68 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.705 2.27 . . . . 0.0 111.265 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -90.22 -13.07 60.79 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 69.98 33.02 2.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.827 -0.808 . . . . 0.0 110.319 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.8 m -158.05 -172.36 3.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 0.0 110.128 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.41 HD23 ' OE2' ' A' ' 95' ' ' GLU . 55.8 tp -100.98 131.55 46.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.469 -0.77 . . . . 0.0 109.207 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.7 t -86.69 123.21 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.68 0.752 . . . . 0.0 110.53 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' OE2' HD23 ' A' ' 93' ' ' LEU . 96.2 mt-10 -140.59 118.76 12.0 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -124.36 132.17 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.45 -0.781 . . . . 0.0 110.098 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' A' ' 74' ' ' ARG . 97.4 m-20 -116.42 135.5 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.15 127.77 51.78 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.436 -0.79 . . . . 0.0 109.427 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.43 127.66 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.572 0.701 . . . . 0.0 109.169 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -73.7 138.0 44.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.415 -0.803 . . . . 0.0 110.154 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.71 158.47 43.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.939 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.76 -41.95 84.27 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.72 92.8 1.75 Allowed Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.033 -1.274 . . . . 0.0 110.203 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.71 -135.09 47.05 Favored Glycine 0 N--CA 1.49 2.279 0 O-C-N 121.478 -1.013 . . . . 0.0 110.573 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -126.96 131.88 50.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.992 . . . . 0.0 109.58 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 tp -90.86 122.74 33.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.59 -0.694 . . . . 0.0 109.25 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.27 128.46 56.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.483 0.659 . . . . 0.0 109.311 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -115.62 129.68 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.33 125.81 54.69 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.672 0.749 . . . . 0.0 109.381 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.4 m -116.08 129.29 56.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.93 136.92 55.04 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.379 0.609 . . . . 0.0 109.549 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.7 t -127.33 127.55 44.47 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.704 0.764 . . . . 0.0 109.847 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 141.21 -126.55 3.1 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 mt 52.01 68.51 3.12 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.925 . . . . 0.0 109.977 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.63 -32.56 83.89 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.502 2.135 . . . . 0.0 111.704 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.4 m -98.07 141.2 31.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.43 77.99 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.565 0.698 . . . . 0.0 109.744 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.77 -38.28 84.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.174 -0.954 . . . . 0.0 108.906 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -65.58 -39.3 91.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.783 . . . . 0.0 109.446 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 83.3 m -60.65 -42.33 96.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 0.0 109.738 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -40.04 84.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.87 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.01 -44.44 67.35 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -67.95 -41.42 82.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.357 -1.084 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.47 ' CG ' HH21 ' A' ' 13' ' ' ARG . 81.7 tt0 -54.51 -52.29 62.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.401 -0.812 . . . . 0.0 110.387 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.2 -34.22 72.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 0.0 109.622 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.21 -46.74 92.43 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -62.86 -37.28 86.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -1.08 . . . . 0.0 109.831 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.81 82.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.851 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -67.62 -42.74 81.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 109.803 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.49 -43.28 99.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.287 -0.883 . . . . 0.0 109.624 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -67.17 -42.47 91.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -67.29 -40.66 86.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.242 -1.152 . . . . 0.0 109.613 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.9 tp -62.12 -40.48 96.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.659 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.9 m -61.12 -42.18 98.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.6 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 140' ' ' GLY . 82.3 tt0 -58.7 -39.77 81.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.333 -0.854 . . . . 0.0 109.354 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.82 -43.7 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.309 -0.87 . . . . 0.0 109.675 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.42 95.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.85 -4.32 54.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -172.62 100.1 0.15 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' PRO . 83.1 mmt-85 -35.95 -67.55 0.16 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.038 -0.684 . . . . 0.0 110.416 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 15.2 p-10 -25.99 89.34 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 CA-C-O 121.056 0.455 . . . . 0.0 110.574 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' ARG . 36.3 Cg_exo -57.06 158.87 16.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.642 2.228 . . . . 0.0 112.452 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 146' ' ' ASP . . . -45.14 177.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.54 12.42 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.32 2.013 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 144' ' ' GLY . 23.0 t0 56.36 55.81 8.91 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.514 -0.742 . . . . 0.0 109.647 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 34.6 Cg_endo -64.58 149.76 89.34 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 0.0 113.19 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -71.95 137.24 47.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.973 0.892 . . . . 0.0 110.485 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -145.97 -6.06 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.93 -144.63 9.35 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 55.36 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.614 -0.933 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -77.61 145.42 36.79 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.85 0.833 . . . . 0.0 110.76 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 153' ' ' LEU . 10.3 mp -76.29 145.57 39.52 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.747 0.784 . . . . 0.0 110.168 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.94 167.08 17.29 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.683 0.754 . . . . 0.0 110.371 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -95.33 135.88 36.39 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.801 0.81 . . . . 0.0 110.292 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.502 ' O ' ' CE1' ' A' ' 159' ' ' HIS . 77.6 m80 -72.81 135.73 45.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -85.65 -14.09 46.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.444 -0.785 . . . . 0.0 109.217 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' A' ' 159' ' ' HIS . 86.4 t60 -65.49 -41.44 93.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.248 -0.907 . . . . 0.0 109.376 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 156' ' ' HIS . 67.5 m80 46.37 -175.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.766 0.793 . . . . 0.0 110.93 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.846 -1.073 . . . . 0.0 109.226 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.691 0.757 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -67.4 142.3 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.526 -0.734 . . . . 0.0 110.582 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -135.08 -54.3 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.28 144.04 55.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.397 -0.814 . . . . 0.0 110.991 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 30.3 mtt 49.84 58.02 17.66 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.524 -0.735 . . . . 0.0 109.906 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.09 150.2 42.52 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.87 2.38 . . . . 0.0 113.033 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.29 73.98 0.82 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.341 -0.85 . . . . 0.0 108.876 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -157.06 -61.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.383 -0.823 . . . . 0.0 109.568 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.55 -5.64 38.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.436 -0.79 . . . . 0.0 109.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -131.12 134.79 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.91 132.25 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.611 -0.68 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -124.49 122.53 37.88 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -143.32 157.11 44.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.331 -0.856 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 59.0 mp0 -135.2 161.14 36.21 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.555 0.693 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.77 155.1 37.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.412 -0.805 . . . . 0.0 109.177 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -110.73 121.24 44.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.597 -0.69 . . . . 0.0 109.423 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.47 135.14 54.4 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.769 0.795 . . . . 0.0 109.644 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' ALA . . . -84.08 82.51 8.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.604 0.716 . . . . 0.0 109.582 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . 171.95 153.36 0.22 Allowed Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.95 160.29 30.26 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.484 2.123 . . . . 0.0 111.92 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.97 -24.38 45.74 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.561 2.174 . . . . 0.0 111.41 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.81 -47.57 82.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.0 -41.13 82.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.423 -0.798 . . . . 0.0 109.405 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.23 -44.99 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 109.572 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.49 -45.53 93.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.09 82.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 109.496 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.85 -40.7 95.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.403 -0.811 . . . . 0.0 109.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.7 mmm -74.7 -6.39 48.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.523 -0.735 . . . . 0.0 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -123.24 49.41 1.68 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.506 -0.746 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -162.38 97.87 1.15 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.258 -0.901 . . . . 0.0 109.728 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HA ' HD12 ' A' ' 34' ' ' ILE . 74.9 Cg_exo -50.89 -34.16 44.42 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.643 2.229 . . . . 0.0 111.753 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.93 -41.48 82.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.733 -0.605 . . . . 0.0 109.894 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -66.79 -29.51 69.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.461 -0.775 . . . . 0.0 109.882 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 31' ' ' PRO . 90.2 mt -62.05 -41.81 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.322 -0.861 . . . . 0.0 109.073 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 57.8 mt -55.7 -30.22 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.412 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.86 -44.36 97.13 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.185 -0.947 . . . . 0.0 109.598 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 38' ' ' MET . 43.2 p-90 -118.26 72.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.59 ' SD ' ' NH1' ' A' ' 133' ' ' ARG . 6.0 tpt 82.94 127.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.72 0.771 . . . . 0.0 110.208 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 40' ' ' THR . . . 156.76 -58.31 0.37 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 34.07 95.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.432 0.634 . . . . 0.0 110.67 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 60.0 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.53 140.93 51.81 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.618 0.723 . . . . 0.0 109.908 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -99.5 150.68 21.95 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.735 0.779 . . . . 0.0 110.25 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -136.63 142.36 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -119.53 88.08 37.96 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.54 -0.725 . . . . 0.0 109.146 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -54.19 -37.13 87.63 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.647 2.231 . . . . 0.0 111.967 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.711 ' H ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -173.61 -38.53 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.442 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.711 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 45.9 Cg_exo -59.05 142.84 99.81 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.325 2.017 . . . . 0.0 113.107 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.49 67.84 0.56 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . 89.5 130.57 4.04 Favored Glycine 0 N--CA 1.492 2.41 0 O-C-N 121.486 -1.008 . . . . 0.0 110.711 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 52' ' ' TYR . 3.7 tt -156.64 114.51 3.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.392 -1.064 . . . . 0.0 108.276 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' N ' HD23 ' A' ' 51' ' ' LEU . 73.7 t80 -46.63 90.49 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.648 0.737 . . . . 0.0 109.943 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 51' ' ' LEU . 6.2 tt -147.97 112.08 5.18 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.352 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.2 p -145.77 150.21 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.79 . . . . 0.0 109.31 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.635 ' ND2' ' H ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER 72.68 -162.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.799 0.809 . . . . 0.0 111.263 179.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.635 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 12.7 p -59.46 126.38 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-O 121.843 0.83 . . . . 0.0 110.644 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.9 p -88.64 169.89 11.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.624 0.726 . . . . 0.0 110.567 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.85 -35.66 92.3 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -144.44 -168.73 2.97 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.971 -1.311 . . . . 0.0 109.857 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 61' ' ' PHE . 95.4 mtt-85 -64.76 -48.39 74.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 109.917 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 59' ' ' ALA . 53.0 m-85 38.83 -166.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.818 0.818 . . . . 0.0 111.159 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.48 55.51 4.11 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.512 -0.742 . . . . 0.0 109.751 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -131.48 137.24 48.48 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.802 0.811 . . . . 0.0 109.927 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.24 -1.11 51.09 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 m -89.38 -148.25 0.18 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -1.111 . . . . 0.0 110.372 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 59.12 164.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.838 0.828 . . . . 0.0 110.802 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' CD ' HD21 ' A' ' 93' ' ' LEU . 95.3 mtt-85 -64.96 -45.03 87.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 109.638 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.44 132.67 3.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 108.874 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.8 t -125.54 131.47 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.373 -0.829 . . . . 0.0 109.313 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 4.0 t -124.75 131.19 24.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 72' ' ' VAL . 31.9 Cg_exo -47.39 129.15 15.85 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.237 1.958 . . . . 0.0 112.689 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 72' ' ' VAL . 9.8 p 17.59 60.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 CA-C-O 121.639 0.733 . . . . 0.0 111.755 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -154.2 -70.58 0.13 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.468 -0.77 . . . . 0.0 109.708 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 61.1 ttp180 -139.78 143.07 36.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.291 -0.881 . . . . 0.0 110.629 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.83 139.39 43.4 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.45 129.56 43.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.531 -0.73 . . . . 0.0 109.706 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.514 ' CE2' ' O ' ' A' ' 78' ' ' SER . 68.7 t80 -167.33 162.03 14.57 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.514 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 31.4 t -107.86 123.59 48.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.503 -0.748 . . . . 0.0 109.343 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.34 -61.76 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.81 -136.85 46.46 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -119.4 105.2 11.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.683 -0.892 . . . . 0.0 109.213 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.45 -11.22 60.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -3.93 63.68 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 85' ' ' GLU . 42.5 m -127.39 119.24 25.74 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.89 . . . . 0.0 109.717 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 84' ' ' SER . 97.9 mt-10 41.97 -167.16 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.899 0.856 . . . . 0.0 110.634 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.45 129.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.452 0.644 . . . . 0.0 109.698 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.7 t -137.92 76.49 39.98 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.55 -0.719 . . . . 0.0 109.438 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 17.7 Cg_exo -65.92 -174.39 0.39 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.912 2.408 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 33.4 Cg_exo -61.11 143.31 98.83 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.323 2.015 . . . . 0.0 112.487 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.43 -39.16 3.04 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.2 p -70.95 -15.43 62.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.403 -1.057 . . . . 0.0 110.051 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.0 p -154.49 161.71 41.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.871 -1.143 . . . . 0.0 109.583 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 94' ' ' VAL . 0.3 OUTLIER -147.13 124.03 11.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.278 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.665 ' N ' HD13 ' A' ' 93' ' ' LEU . 53.8 t -120.58 134.01 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -133.08 136.82 46.11 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.47 129.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.388 0.613 . . . . 0.0 109.38 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -112.92 137.93 50.55 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -106.89 125.47 51.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.441 -0.787 . . . . 0.0 109.172 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.06 129.97 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.452 0.644 . . . . 0.0 109.688 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 101' ' ' GLN . 8.9 tm-20 -69.4 137.87 53.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.606 -0.683 . . . . 0.0 109.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 49.8 tt0 -148.8 154.98 40.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.836 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.07 140.21 33.84 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.47 -13.51 66.48 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.44 -134.5 3.75 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.7 m -131.17 133.37 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.453 -1.028 . . . . 0.0 109.716 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -88.69 128.11 35.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.521 -0.737 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 tt -114.47 130.8 56.75 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.548 0.69 . . . . 0.0 109.817 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -114.0 127.59 56.02 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.2 tt -116.6 126.4 53.22 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.366 0.603 . . . . 0.0 109.543 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 93.7 m -126.76 130.99 51.4 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.354 0.597 . . . . 0.0 109.403 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 112' ' ' SER . 17.3 t-80 -125.45 138.01 53.99 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.43 ' N ' ' ND1' ' A' ' 111' ' ' HIS . 34.3 t -151.44 166.07 32.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.88 . . . . 0.0 109.796 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.55 3.71 74.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD13 ' SG ' ' A' ' 120' ' ' CYS . 25.7 mt -42.21 116.93 1.85 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.638 -0.919 . . . . 0.0 110.53 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -50.33 -37.03 49.46 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.194 1.929 . . . . 0.0 111.747 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.2 t -153.6 168.49 26.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.99 76.75 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.58 0.705 . . . . 0.0 109.324 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -58.49 -36.66 74.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 0.0 109.122 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.1 -32.5 74.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.282 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 114' ' ' LEU . 1.8 t -64.46 -48.39 75.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.348 -0.845 . . . . 0.0 110.094 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.2 -41.5 94.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 109.616 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.89 -42.24 79.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -67.15 -40.7 86.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -1.072 . . . . 0.0 109.588 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -58.22 -43.34 87.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 0.0 109.566 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.34 -38.98 78.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 109.455 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.74 -50.34 59.15 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -64.08 -36.4 83.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -1.077 . . . . 0.0 109.829 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.21 -47.13 79.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.838 . . . . 0.0 109.88 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -44.33 79.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.287 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -62.79 -43.31 99.14 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 69.6 mt -63.71 -42.42 97.96 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.05 -1.031 . . . . 0.0 109.489 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -69.61 -46.17 55.93 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.59 ' NH1' ' SD ' ' A' ' 38' ' ' MET . 99.0 mtt180 -65.19 -38.79 91.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.013 . . . . 0.0 109.335 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.47 -36.87 79.58 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.673 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 96.8 m -60.69 -48.57 81.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.926 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' OE1' ' OD2' ' A' ' 142' ' ' ASP . 20.6 pt-20 -66.9 -35.77 80.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 133' ' ' ARG . 29.6 t -62.22 -43.73 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -57.83 -35.91 71.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.618 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.27 -4.94 58.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.454 -0.779 . . . . 0.0 109.259 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 136' ' ' GLU . . . 142.43 150.35 5.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -52.75 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.568 -0.96 . . . . 0.0 110.465 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 0.2 OUTLIER 176.25 -60.05 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 142' ' ' ASP . 22.0 Cg_endo -59.55 145.7 97.28 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.218 1.946 . . . . 0.0 112.921 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.453 ' H ' ' HD3' ' A' ' 145' ' ' PRO . . . 160.81 58.26 0.02 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.453 ' HD3' ' H ' ' A' ' 144' ' ' GLY . 39.2 Cg_endo -67.35 -12.93 37.61 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 122.438 2.092 . . . . 0.0 111.411 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.611 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER 174.95 -45.15 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.229 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 32.8 Cg_exo -56.61 141.76 90.94 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.873 2.382 . . . . 0.0 113.258 -177.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.445 ' O ' ' O ' ' A' ' 149' ' ' TYR . 53.3 p90 -144.29 -12.88 0.61 Allowed 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.445 ' O ' ' O ' ' A' ' 148' ' ' PHE . 89.9 m-85 58.93 129.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.704 0.764 . . . . 0.0 110.308 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -176.97 163.9 33.01 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -64.39 -34.37 78.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.941 . . . . 0.0 109.566 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 150' ' ' GLY . 89.9 mtm-85 58.34 173.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.733 0.778 . . . . 0.0 110.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.01 -42.61 94.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.61 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 47.56 -166.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.938 0.875 . . . . 0.0 110.8 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.402 ' O ' ' ND1' ' A' ' 157' ' ' HIS . 74.6 m80 51.14 -171.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.906 0.86 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.556 ' CG ' ' N ' ' A' ' 157' ' ' HIS . 51.2 t-80 57.09 -120.28 1.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.409 0.623 . . . . 0.0 110.336 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.556 ' N ' ' CG ' ' A' ' 156' ' ' HIS . 69.7 m80 46.99 99.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.887 0.851 . . . . 0.0 109.981 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -68.33 133.38 48.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.704 0.764 . . . . 0.0 110.536 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -76.48 134.51 39.49 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.755 0.788 . . . . 0.0 110.148 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.748 -1.12 . . . . 0.0 108.961 179.723 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttm . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.618 0.723 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.1 138.02 57.72 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.674 0.75 . . . . 0.0 109.864 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -78.77 132.05 36.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.572 0.701 . . . . 0.0 109.88 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.58 146.97 46.32 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.792 0.806 . . . . 0.0 110.307 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -82.79 153.07 67.24 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-O 121.158 0.504 . . . . 0.0 109.849 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.29 143.39 76.84 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.808 2.339 . . . . 0.0 111.617 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -101.53 -9.75 20.73 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.4 t -63.77 149.94 45.71 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.704 0.764 . . . . 0.0 109.994 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -91.14 -0.94 57.81 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.42 133.47 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.276 -0.89 . . . . 0.0 109.347 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -122.05 133.04 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.787 0.803 . . . . 0.0 109.481 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -124.76 132.44 53.36 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.002 0.906 . . . . 0.0 110.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -133.23 152.26 51.94 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.023 0.916 . . . . 0.0 109.642 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -137.07 149.14 47.2 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.914 0.864 . . . . 0.0 109.803 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.63 150.84 29.92 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.949 0.88 . . . . 0.0 109.845 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -103.98 118.36 36.49 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.783 0.801 . . . . 0.0 109.297 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.27 130.57 56.21 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.924 0.868 . . . . 0.0 109.929 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.55 75.87 9.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.885 0.85 . . . . 0.0 109.419 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 179.37 150.18 0.48 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.68 161.57 41.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.841 2.361 . . . . 0.0 112.145 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.14 -29.75 81.29 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.697 2.265 . . . . 0.0 111.505 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -40.17 89.86 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.49 0.662 . . . . 0.0 109.283 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.33 85.83 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.506 0.67 . . . . 0.0 109.194 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.9 t -64.38 -45.74 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.406 0.622 . . . . 0.0 109.488 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' HG21 ' A' ' 29' ' ' THR . 68.2 t80 -62.28 -42.49 99.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.47 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.42 77.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.4 mt -63.84 -41.25 97.87 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.0 mtt -65.92 -36.93 84.74 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.354 0.597 . . . . 0.0 110.298 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 30' ' ' ASP . 46.7 p -82.3 -77.61 0.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.51 -0.744 . . . . 0.0 109.419 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER -31.41 95.74 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.85 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 77.9 Cg_exo -52.57 -38.13 75.0 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.603 2.202 . . . . 0.0 111.568 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -62.82 -39.11 93.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.912 -0.492 . . . . 0.0 110.637 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -64.14 -33.75 76.49 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 110.025 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.17 -43.17 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.364 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 91.2 mt -61.23 -20.63 63.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.549 -0.72 . . . . 0.0 110.077 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.557 HH21 ' CG1' ' A' ' 137' ' ' VAL . 62.0 ttp180 -60.98 -43.93 98.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.907 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -107.01 -19.44 13.62 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.006 -1.059 . . . . 0.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 1.4 tpt -95.17 -56.78 2.61 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.819 -1.176 . . . . 0.0 109.382 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' H ' ' HA ' ' A' ' 35' ' ' LEU . . . 76.63 -163.03 52.46 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 m 62.09 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.549 0.69 . . . . 0.0 109.907 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 39' ' ' GLY . 81.3 tt0 -167.56 149.56 5.73 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.849 0.833 . . . . 0.0 109.882 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.49 119.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.989 0.899 . . . . 0.0 109.725 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -140.15 119.05 12.53 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.898 0.856 . . . . 0.0 109.377 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.61 -38.56 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.55 -0.719 . . . . 0.0 109.239 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 54.81 81.6 0.26 Allowed Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.466 -0.772 . . . . 0.0 109.533 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.84 -36.97 76.24 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.629 2.219 . . . . 0.0 111.727 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -43.82 155.73 0.32 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.955 -0.466 . . . . 0.0 110.542 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -50.86 136.82 43.59 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.027 1.818 . . . . 0.0 112.27 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 50' ' ' GLY . . . 77.19 -76.98 1.58 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 49' ' ' GLY . . . 48.02 -177.65 0.01 OUTLIER Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.7 140.64 42.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.648 0.737 . . . . 0.0 109.624 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -97.69 1.03 48.13 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.345 0.593 . . . . 0.0 109.438 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.1 mt -111.06 136.29 50.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.291 -0.881 . . . . 0.0 109.658 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.52 135.89 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 122.116 0.96 . . . . 0.0 109.76 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 56' ' ' VAL . 62.4 t30 47.9 -130.05 1.66 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.129 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.49 ' H ' ' CG ' ' A' ' 55' ' ' ASN . 21.9 t 48.35 -108.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.483 0.659 . . . . 0.0 109.462 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.415 ' N ' HG12 ' A' ' 56' ' ' VAL . 14.5 t -150.97 146.46 26.26 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 121.98 0.895 . . . . 0.0 109.305 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.5 93.17 1.69 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.12 18.66 0.08 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.137 -0.977 . . . . 0.0 110.231 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -84.42 -30.49 25.3 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.493 0.663 . . . . 0.0 109.795 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -165.14 152.17 10.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.806 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.412 HH22 ' H ' ' A' ' 82' ' ' ASP . 79.4 ttt180 -150.16 -83.62 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.559 0.695 . . . . 0.0 109.722 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.39 112.82 4.36 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 p -82.14 166.6 19.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.727 0.775 . . . . 0.0 110.131 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -97.16 120.42 37.49 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.718 0.77 . . . . 0.0 109.235 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -81.48 -74.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -141.55 138.75 32.91 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.811 0.815 . . . . 0.0 109.458 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.03 130.95 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.203 1.002 . . . . 0.0 109.344 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.04 95.95 5.55 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.05 155.09 12.05 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.64 2.227 . . . . 0.0 112.485 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.2 m 35.58 42.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.317 0.58 . . . . 0.0 110.582 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -157.35 -75.54 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.568 -0.707 . . . . 0.0 109.905 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -156.29 147.8 22.64 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.995 0.902 . . . . 0.0 110.361 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -126.95 143.57 51.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.002 0.906 . . . . 0.0 109.673 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.94 129.62 16.07 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.899 0.857 . . . . 0.0 109.276 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -166.14 152.64 9.3 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.929 0.871 . . . . 0.0 110.18 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 153.78 28.52 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.631 0.729 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 86.9 t80 -170.11 163.0 9.12 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.912 0.863 . . . . 0.0 109.898 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.468 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 177.74 174.51 44.14 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -110.45 125.77 53.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.487 -1.008 . . . . 0.0 109.7 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' H ' HH22 ' A' ' 63' ' ' ARG . 64.0 t0 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.662 0.744 . . . . 0.0 109.4 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' SER . . . -42.76 102.77 0.03 OUTLIER Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 83' ' ' GLY . 4.3 m 56.71 149.97 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.867 0.842 . . . . 0.0 110.343 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' SER . 82.3 tt0 46.88 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.446 0.641 . . . . 0.0 109.944 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.49 133.97 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.625 0.726 . . . . 0.0 109.191 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.84 82.64 10.85 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.53 164.99 31.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.598 2.199 . . . . 0.0 111.471 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.67 137.53 26.49 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.632 2.222 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.92 -40.44 2.42 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.6 t -64.14 -43.3 95.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -1.017 . . . . 0.0 109.767 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.55 ' OG ' ' NE2' ' A' ' 111' ' ' HIS . 35.3 t -145.81 143.52 29.71 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.007 0.908 . . . . 0.0 110.144 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -129.31 134.39 47.9 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.746 0.784 . . . . 0.0 109.615 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.9 t -106.18 131.46 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 121.915 0.864 . . . . 0.0 109.486 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.34 142.87 39.69 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.97 0.89 . . . . 0.0 109.786 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 97.2 mt -131.54 131.96 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 121.695 0.76 . . . . 0.0 109.691 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -111.98 138.69 48.27 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.979 0.895 . . . . 0.0 110.151 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.4 mt -107.53 126.01 52.0 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.614 0.721 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -131.78 127.16 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.094 0.949 . . . . 0.0 109.944 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.52 137.26 46.18 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.634 0.731 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -148.95 102.15 3.24 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.421 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 59.99 -143.75 46.99 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.51 -41.7 83.75 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.65 179.89 52.26 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.7 m -122.96 130.9 53.4 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.971 0.891 . . . . 0.0 109.929 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.0 tp -86.62 125.03 33.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.766 0.793 . . . . 0.0 109.833 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.3 125.98 54.5 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.898 0.856 . . . . 0.0 109.846 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -115.33 134.67 54.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.99 0.9 . . . . 0.0 109.779 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.04 126.44 55.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.106 0.955 . . . . 0.0 109.821 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 91.1 m -120.46 130.52 54.34 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.876 0.846 . . . . 0.0 109.096 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.55 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 8.8 t60 -128.27 140.3 51.96 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 109.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.0 t -131.75 139.39 48.95 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.089 0.947 . . . . 0.0 109.706 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 129.63 -104.13 0.61 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.0 mt 42.68 74.55 0.75 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 122.092 -0.652 . . . . 0.0 110.191 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.18 -9.17 17.75 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.772 2.314 . . . . 0.0 111.614 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.4 m -127.7 149.72 50.09 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.006 0.908 . . . . 0.0 109.694 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.99 -36.6 80.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.543 0.687 . . . . 0.0 109.585 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -60.7 -37.68 82.51 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.478 0.656 . . . . 0.0 109.386 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -66.77 -35.0 79.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.76 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 99.6 m -64.63 -44.24 91.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.486 -0.759 . . . . 0.0 109.293 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.58 -40.69 93.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.542 -0.724 . . . . 0.0 109.405 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.33 -45.89 75.74 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -68.93 -44.99 71.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.728 -0.866 . . . . 0.0 109.548 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.81 -61.16 2.38 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.478 0.656 . . . . 0.0 109.628 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.49 -33.29 71.06 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.51 0.671 . . . . 0.0 109.82 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.88 -54.64 35.86 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -63.72 -36.71 84.76 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.763 -0.845 . . . . 0.0 109.717 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.09 -40.4 81.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.684 -0.635 . . . . 0.0 109.695 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -67.32 -45.61 75.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.644 -0.66 . . . . 0.0 109.818 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -64.53 -44.03 92.14 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 0.0 109.598 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.04 -43.49 98.53 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.426 0.631 . . . . 0.0 109.728 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.3 58.16 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.473 ' NH2' ' C ' ' A' ' 144' ' ' GLY . 14.3 tpt180 -68.74 -42.23 77.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.619 -0.93 . . . . 0.0 109.641 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.4 tp -64.02 -39.2 93.57 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.554 0.693 . . . . 0.0 109.311 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.5 m -59.48 -44.11 93.12 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.259 0.552 . . . . 0.0 109.947 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.06 -41.89 90.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.744 -0.597 . . . . 0.0 110.296 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.557 ' CG1' HH21 ' A' ' 36' ' ' ARG . 70.0 t -66.95 -42.47 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.387 -0.821 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.23 -25.01 45.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 109.4 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 140' ' ' GLY . . . -84.58 -3.36 58.42 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.574 0.702 . . . . 0.0 109.391 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 139' ' ' ALA . . . 53.52 107.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -159.12 -110.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.806 0.812 . . . . 0.0 109.6 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 25.5 p-10 -147.32 77.83 10.5 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.417 -0.802 . . . . 0.0 109.311 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 146.86 64.26 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.967 2.445 . . . . 0.0 112.412 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' C ' ' NH2' ' A' ' 133' ' ' ARG . . . -88.93 -161.47 37.5 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.41 -169.32 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.182 2.588 . . . . 0.0 112.979 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -122.4 85.11 47.63 Favored Pre-proline 0 N--CA 1.497 1.919 0 CA-C-O 121.494 0.664 . . . . 0.0 110.179 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.97 148.95 73.67 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.397 2.731 . . . . 0.0 112.483 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.29 148.74 3.36 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.665 0.745 . . . . 0.0 110.156 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -61.25 -42.71 99.09 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.61 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -85.78 103.58 2.77 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -95.12 -9.34 33.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.801 -0.823 . . . . 0.0 109.072 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 154' ' ' GLU . 95.3 mtt-85 -67.75 -38.9 84.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.401 -0.812 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.1 mp 52.14 9.28 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ARG . 49.1 tp10 -152.83 88.84 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.909 0.862 . . . . 0.0 108.961 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -85.55 154.71 21.56 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.024 0.916 . . . . 0.0 110.386 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -69.09 95.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.681 0.753 . . . . 0.0 109.964 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -66.4 -43.72 85.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 45.8 p-80 -160.14 74.49 0.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.737 0.779 . . . . 0.0 109.266 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -66.52 -42.1 87.77 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.199 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -149.76 -21.89 0.27 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -77.61 145.02 37.02 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.697 0.761 . . . . 0.0 110.286 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.38 171.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.873 0.844 . . . . 0.0 110.574 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.552 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.4 mtm 175.43 -45.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.638 -0.664 . . . . 0.0 109.415 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 5' ' ' MET . 27.0 Cg_exo -59.43 145.04 99.11 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.95 1.767 . . . . 0.0 111.749 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -125.44 -28.23 3.36 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.0 p -77.96 168.08 20.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 110.631 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.42 106.66 0.48 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.701 0.762 . . . . 0.0 110.305 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.19 136.29 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.2 131.74 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.553 0.692 . . . . 0.0 109.384 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -122.64 137.12 55.0 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -135.02 157.5 46.76 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.583 0.706 . . . . 0.0 110.171 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.5 mp0 -136.37 150.44 48.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.766 0.794 . . . . 0.0 109.596 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.13 127.8 9.44 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -92.39 128.86 38.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.616 -0.678 . . . . 0.0 109.319 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.74 140.71 49.11 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.743 0.782 . . . . 0.0 109.522 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.1 2.79 37.72 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.55 33.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.643 -0.661 . . . . 0.0 109.23 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.33 164.69 29.6 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.254 1.969 . . . . 0.0 112.425 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -51.43 -39.05 64.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.312 2.008 . . . . 0.0 111.54 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.56 95.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.741 -0.6 . . . . 0.0 109.924 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.97 96.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 109.733 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.88 -45.0 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.408 -0.807 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.94 -43.87 97.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.515 -0.741 . . . . 0.0 109.618 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.31 82.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 110.138 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.48 -41.69 98.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.159 -0.963 . . . . 0.0 109.855 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtm -83.3 -8.48 59.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 109.936 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 29' ' ' THR . 63.5 m -101.98 -4.03 26.77 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.397 -0.815 . . . . 0.0 109.362 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -115.75 92.7 34.92 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.67 -41.28 46.0 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.742 2.295 . . . . 0.0 112.592 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.29 -39.61 82.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.512 -0.742 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -64.99 -35.69 82.0 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -62.92 -43.33 98.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.07 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.04 -16.04 27.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.294 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -68.06 -44.23 76.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.674 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -111.75 22.82 14.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.598 -0.689 . . . . 0.0 109.981 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttp -157.61 120.31 3.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.686 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.1 91.85 1.67 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.412 ' HA ' HD21 ' A' ' 55' ' ' ASN . 88.3 m -164.16 103.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -1.027 . . . . 0.0 109.438 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.508 ' OE1' ' ND2' ' A' ' 55' ' ' ASN . 59.4 mp0 -48.99 138.01 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.666 0.746 . . . . 0.0 110.373 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.1 153.68 26.29 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.767 0.794 . . . . 0.0 109.71 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -150.22 104.75 3.29 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.48 136.77 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.466 -0.771 . . . . 0.0 109.677 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -95.37 152.38 39.28 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.563 -0.711 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' O ' ' CD ' ' A' ' 47' ' ' GLU . 84.1 Cg_exo -44.55 -54.92 3.63 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 1.8 mp0 -142.34 -64.45 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.561 -0.712 . . . . 0.0 109.271 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 18.4 Cg_endo -59.23 145.64 97.16 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.775 1.65 . . . . 0.0 112.436 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.0 -66.9 0.23 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.08 13.56 83.22 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.91 143.66 49.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.666 -0.902 . . . . 0.0 110.488 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -157.46 84.83 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.7 mt -118.12 136.84 53.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.583 0.706 . . . . 0.0 109.667 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 55' ' ' ASN . 30.0 m -127.58 134.62 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.48 0.657 . . . . 0.0 109.374 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' ND2' ' OE1' ' A' ' 41' ' ' GLU . 8.7 m120 35.31 -100.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.407 0.622 . . . . 0.0 111.258 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.32 132.95 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 110.395 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -113.13 160.28 18.38 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.783 0.801 . . . . 0.0 109.721 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 146.69 38.88 0.05 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' C ' ' H ' ' A' ' 61' ' ' PHE . . . 55.81 -156.55 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.597 -0.943 . . . . 0.0 110.643 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 64.94 -12.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.355 0.598 . . . . 0.0 109.592 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' H ' ' C ' ' A' ' 59' ' ' ALA . 61.3 m-85 -78.09 143.58 37.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 110.145 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB2' ' OH ' ' A' ' 77' ' ' TYR . . . 45.46 -174.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.737 0.78 . . . . 0.0 110.721 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -109.15 -1.89 18.43 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.84 -11.26 66.26 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.3 m -137.99 147.37 44.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -1.122 . . . . 0.0 110.12 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -76.55 143.22 40.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.736 0.779 . . . . 0.0 110.376 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.6 ttm-85 -77.55 -75.89 0.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.687 -0.633 . . . . 0.0 109.554 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -147.44 129.46 15.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.301 -0.874 . . . . 0.0 109.796 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.5 t -128.86 133.04 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.732 0.777 . . . . 0.0 109.484 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 2.0 t -142.29 98.03 6.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' HIS . 76.2 Cg_exo -51.61 156.27 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 113.607 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 71' ' ' PRO . 16.5 m 33.32 37.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.711 0.767 . . . . 0.0 110.715 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' PRO . 49.8 m80 -154.37 -83.34 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.466 -0.771 . . . . 0.0 109.873 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.6 mtm180 -141.52 155.2 45.82 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.777 0.798 . . . . 0.0 110.721 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 76' ' ' ALA . 5.0 tt -143.65 121.45 11.94 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.66 ' N ' HD23 ' A' ' 75' ' ' LEU . . . -117.45 131.77 56.68 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.575 0.702 . . . . 0.0 109.634 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' A' ' 62' ' ' ALA . 85.8 t80 -167.18 145.58 4.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.564 0.697 . . . . 0.0 109.634 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 77' ' ' TYR . 95.8 p -76.3 150.8 36.89 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.65 0.738 . . . . 0.0 110.667 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 91.2 t80 -173.39 169.8 4.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.573 -0.704 . . . . 0.0 109.766 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.585 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . 152.43 -3.07 0.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -81.49 177.28 9.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.4 -1.059 . . . . 0.0 110.641 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.3 t0 63.19 122.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.792 0.806 . . . . 0.0 111.002 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.74 -21.79 7.29 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -84.22 154.75 22.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.514 -0.991 . . . . 0.0 110.52 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -100.93 -19.75 15.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.539 -0.726 . . . . 0.0 110.015 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 86' ' ' VAL . 11.7 p -154.46 124.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.988 -1.07 . . . . 0.0 109.709 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.1 t -150.87 88.53 4.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 19.0 Cg_exo -59.32 -173.69 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.531 2.154 . . . . 0.0 111.588 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 35.8 Cg_exo -61.81 145.72 96.99 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.632 2.221 . . . . 0.0 112.7 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 91' ' ' SER . . . 81.96 -22.52 5.83 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' GLY . 81.0 p 34.85 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.772 0.796 . . . . 0.0 111.463 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.4 m -90.54 -177.6 5.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.743 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.7 tp -120.27 129.12 53.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.42 0.629 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.5 t -118.42 132.71 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.572 0.701 . . . . 0.0 109.624 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -132.74 143.7 49.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.71 132.19 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.642 -0.661 . . . . 0.0 109.842 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -123.49 136.31 54.51 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.487 0.661 . . . . 0.0 109.483 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.3 mt -109.51 131.21 55.27 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.8 mt -117.07 130.22 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.745 0.783 . . . . 0.0 109.663 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -79.76 110.57 15.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.406 0.622 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.756 HE22 HD23 ' A' ' 106' ' ' LEU . 97.6 mt-30 -105.42 -8.44 18.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.96 -67.64 1.78 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -2.09 87.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.2 -178.52 48.36 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.7 m -126.89 129.51 48.35 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.47 -1.018 . . . . 0.0 110.211 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.756 HD23 HE22 ' A' ' 101' ' ' GLN . 0.1 OUTLIER -84.56 134.27 34.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.695 -0.628 . . . . 0.0 109.4 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 107' ' ' LEU . 5.7 tt -117.89 115.6 25.28 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.493 ' N ' HD23 ' A' ' 107' ' ' LEU . 90.3 mtm180 -105.05 133.88 49.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.616 -0.678 . . . . 0.0 109.377 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 tt -117.97 125.87 51.24 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.338 0.589 . . . . 0.0 109.765 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 122.39 44.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -120.26 117.22 27.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.0 t -138.03 152.58 48.99 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.614 0.721 . . . . 0.0 109.76 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.52 28.99 12.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.6 150.97 97.5 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.59 -0.947 . . . . 0.0 110.153 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.21 -68.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.484 2.122 . . . . 0.0 112.153 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.5 m -130.23 164.76 23.83 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.746 0.784 . . . . 0.0 109.726 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.96 -35.28 79.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.688 -0.632 . . . . 0.0 110.132 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -54.04 -47.84 71.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.852 . . . . 0.0 109.725 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' O ' ' ND1' ' A' ' 123' ' ' HIS . 99.0 mm-40 -70.53 -31.24 68.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 109.464 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 59.2 m -61.86 -44.27 97.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 109.372 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.17 86.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -0.812 . . . . 0.0 109.702 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.1 -37.5 93.13 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 119' ' ' GLN . 1.6 m80 -66.48 -44.91 81.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.419 -1.048 . . . . 0.0 109.905 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -55.9 -47.96 76.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -68.52 -36.51 78.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.311 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.43 -49.58 60.0 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -59.41 -38.66 81.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.65 -0.912 . . . . 0.0 110.13 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.21 93.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.446 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.467 ' CE1' ' HE ' ' A' ' 133' ' ' ARG . 86.3 t60 -67.43 -46.29 73.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.439 -0.788 . . . . 0.0 109.863 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -65.46 -40.22 92.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.396 -0.815 . . . . 0.0 109.481 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.92 -41.32 99.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.47 -0.769 . . . . 0.0 109.257 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.91 -40.81 99.73 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 129' ' ' HIS . 37.9 mmt180 -66.6 -38.48 87.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.516 -0.991 . . . . 0.0 109.529 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.15 -42.47 99.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.392 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 90.9 m -62.48 -44.94 95.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.533 -0.73 . . . . 0.0 109.607 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -67.39 -42.61 83.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.471 -0.768 . . . . 0.0 109.683 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.37 -43.82 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.325 -0.859 . . . . 0.0 109.142 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.04 -36.76 84.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.568 -0.707 . . . . 0.0 109.687 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.39 22.24 12.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.558 -0.714 . . . . 0.0 109.096 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 177.82 -144.82 6.75 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -172.28 87.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.425 -1.044 . . . . 0.0 109.549 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -172.31 56.9 0.23 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 109.866 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.46 154.14 50.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.763 2.309 . . . . 0.0 112.637 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -175.0 57.43 0.12 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.3 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.567 2.178 . . . . 0.0 111.662 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -156.24 57.41 1.46 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.743 . . . . 0.0 109.435 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.22 147.17 95.48 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.544 2.163 . . . . 0.0 112.672 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.39 16.08 26.17 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 54.27 -98.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.604 -0.685 . . . . 0.0 110.585 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 54.77 80.37 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -70.45 138.18 50.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.987 . . . . 0.0 110.081 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -104.99 140.36 38.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.852 0.834 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pp -83.67 131.46 34.94 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.67 0.747 . . . . 0.0 110.002 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -143.69 119.11 10.28 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.458 ' O ' ' CG ' ' A' ' 155' ' ' HIS . 57.1 p-80 -89.74 114.35 26.02 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.625 0.726 . . . . 0.0 109.739 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.449 ' CD2' ' H ' ' A' ' 156' ' ' HIS . 10.5 p80 -94.31 118.57 31.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.57 -0.706 . . . . 0.0 109.365 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 80.5 m80 41.92 85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.313 0.578 . . . . 0.0 109.977 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -113.37 122.16 46.53 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.522 0.677 . . . . 0.0 109.347 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -108.01 132.46 53.51 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.539 0.685 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.415 ' H ' ' CD2' ' A' ' 160' ' ' HIS . 9.0 p80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.99 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' LYS . 15.8 ptp . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 52.71 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.533 0.682 . . . . 0.0 110.177 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' O ' ' SD ' ' A' ' 5' ' ' MET . 17.3 mmmt 52.83 179.0 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 122.029 0.919 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.78 151.96 37.44 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.603 0.716 . . . . 0.0 109.967 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -146.39 74.3 12.79 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 108.997 179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 49.6 Cg_exo -55.38 -159.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.993 2.462 . . . . 0.0 112.475 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.94 160.93 37.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' PHE . 8.0 t -149.45 121.73 8.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 90.1 m-85 56.82 147.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.683 0.754 . . . . 0.0 110.587 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.81 135.78 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.404 -0.81 . . . . 0.0 109.734 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.52 132.09 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.46 134.96 54.65 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 109.736 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.64 151.94 49.87 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 56.8 mp0 -141.07 146.98 37.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.41 -0.806 . . . . 0.0 109.953 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.03 146.94 25.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -104.26 120.59 41.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.509 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -111.95 128.75 56.25 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.722 0.773 . . . . 0.0 109.492 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.22 74.53 7.03 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -175.61 153.9 1.49 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.484 -0.76 . . . . 0.0 109.025 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.22 160.06 32.36 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.703 2.268 . . . . 0.0 112.116 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.85 -29.84 67.86 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.735 2.29 . . . . 0.0 111.35 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.36 89.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.74 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.33 87.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.39 -0.819 . . . . 0.0 109.242 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.47 -46.05 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.679 0.752 . . . . 0.0 109.187 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' O ' ' OG1' ' A' ' 29' ' ' THR . 87.1 t80 -62.37 -44.44 96.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.682 -0.636 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.12 70.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.308 -0.87 . . . . 0.0 109.365 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.62 -41.6 98.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 109.743 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -84.94 -7.39 59.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.838 . . . . 0.0 110.073 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 25' ' ' PHE . 3.9 m -106.47 42.24 1.31 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.343 -0.848 . . . . 0.0 109.432 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -172.55 133.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.447 -0.783 . . . . 0.0 109.384 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.47 -32.86 5.88 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.638 2.225 . . . . 0.0 111.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.55 -42.59 74.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 0.0 110.039 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -65.51 -39.57 92.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.368 -0.833 . . . . 0.0 109.445 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -63.45 -44.19 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.354 -0.841 . . . . 0.0 109.168 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.05 -5.34 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.425 -0.797 . . . . 0.0 109.302 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 109.861 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -105.5 -21.11 13.28 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.425 ' HG3' ' H ' ' A' ' 40' ' ' THR . 13.8 tpp -84.55 -74.54 0.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -0.923 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.53 89.29 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.425 ' H ' ' HG3' ' A' ' 38' ' ' MET . 93.0 m -85.41 -75.53 0.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.41 -1.053 . . . . 0.0 109.412 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' CD ' ' ND2' ' A' ' 55' ' ' ASN . 84.6 tt0 -171.76 149.76 2.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.555 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.0 131.81 8.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.94 . . . . 0.0 109.055 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -86.55 151.09 23.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.927 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.25 143.53 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 5.1 mp0 -97.36 153.78 38.27 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 109.717 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -15.74 38.77 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.572 2.181 . . . . 0.0 111.38 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' H ' ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -178.34 -47.69 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.223 -0.923 . . . . 0.0 110.818 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 47' ' ' GLU . 51.9 Cg_exo -52.25 139.45 53.87 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.711 1.607 . . . . 0.0 112.757 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.57 77.56 0.04 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 48' ' ' PRO . . . -136.92 42.31 1.32 Allowed Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.6 mt -87.7 -7.16 57.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.035 . . . . 0.0 109.031 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.86 38.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.541 -0.724 . . . . 0.0 109.504 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.7 mt -105.11 130.64 53.24 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.332 -0.855 . . . . 0.0 110.031 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.1 m -137.7 156.24 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.646 -0.659 . . . . 0.0 109.399 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' ND2' ' CD ' ' A' ' 41' ' ' GLU . 98.4 m-20 -107.92 19.12 20.45 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 57' ' ' THR . 7.2 p -62.69 -45.79 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.455 -0.778 . . . . 0.0 109.271 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.591 ' N ' HG13 ' A' ' 56' ' ' VAL . 3.2 m -131.84 -15.52 3.03 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.98 -165.39 54.79 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.875 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 60' ' ' ARG . . . 56.23 -117.75 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.015 -0.697 . . . . 0.0 110.486 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 59' ' ' ALA . 99.6 mtt180 40.22 -98.37 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.432 0.634 . . . . 0.0 110.48 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 63' ' ' ARG . 37.6 t80 -62.14 -45.85 91.61 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.6 -0.687 . . . . 0.0 109.494 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 40.91 -91.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.317 0.58 . . . . 0.0 110.27 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 61' ' ' PHE . 77.7 ttt-85 -144.31 143.71 31.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -0.892 . . . . 0.0 110.127 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.96 110.57 0.01 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 66' ' ' PHE . 19.5 p -159.98 -141.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.452 -1.028 . . . . 0.0 109.917 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' N ' ' OG ' ' A' ' 65' ' ' SER . 35.1 t80 58.18 119.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.862 0.839 . . . . 0.0 110.552 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' NH2' ' O ' ' A' ' 78' ' ' SER . 20.0 ptp180 -138.21 -34.64 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.3 128.06 7.31 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.007 -1.058 . . . . 0.0 109.981 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.5 t -125.94 129.87 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.09 94.91 4.5 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 72' ' ' VAL . 52.5 Cg_exo -53.95 152.53 23.27 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.521 2.147 . . . . 0.0 113.03 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' PRO . 31.3 m 35.27 44.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.813 0.816 . . . . 0.0 110.392 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.599 ' CE1' ' NH1' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -160.25 -72.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.538 -0.726 . . . . 0.0 109.067 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.599 ' NH1' ' CE1' ' A' ' 73' ' ' HIS . 83.2 mtt85 -147.57 155.99 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.602 HD13 ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -145.36 121.85 11.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.235 -0.915 . . . . 0.0 108.563 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' N ' HD13 ' A' ' 75' ' ' LEU . . . -139.03 131.24 28.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.841 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.52 ' O ' ' CB ' ' A' ' 78' ' ' SER . 5.5 p90 -166.94 179.43 5.26 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 77' ' ' TYR . 3.5 p 86.37 159.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.73 0.776 . . . . 0.0 110.204 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -54.53 -167.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.8 0.809 . . . . 0.0 110.755 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.45 125.69 0.03 OUTLIER Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.533 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 24.9 t90 -175.02 171.61 3.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.672 -0.899 . . . . 0.0 109.96 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' N ' ' CG ' ' A' ' 81' ' ' TRP . 98.6 m-20 55.19 108.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.731 0.777 . . . . 0.0 110.373 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.07 108.39 2.54 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 m -160.59 -112.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -1.078 . . . . 0.0 109.561 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.3 -169.13 0.37 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 122.009 0.909 . . . . 0.0 110.928 -178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.581 HG22 ' N ' ' A' ' 87' ' ' VAL . 8.8 p -86.72 168.31 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.678 0.752 . . . . 0.0 110.891 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 87' ' ' VAL . 34.5 m -108.97 98.44 30.09 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' N ' ' CD ' ' A' ' 89' ' ' PRO . 35.7 Cg_exo -52.53 -44.57 46.27 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.887 1.725 . . . . 0.0 111.958 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 91' ' ' SER . 71.5 Cg_endo -81.79 163.46 18.48 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 122.133 1.889 . . . . 0.0 113.098 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' SER . . . -59.21 2.97 0.21 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.566 ' H ' ' C ' ' A' ' 89' ' ' PRO . 10.4 m -39.61 126.9 1.93 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.638 -0.919 . . . . 0.0 110.215 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.1 m -134.48 150.55 50.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.729 -0.607 . . . . 0.0 109.374 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD21 ' OE2' ' A' ' 95' ' ' GLU . 37.0 tp -113.72 125.13 53.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.08 126.27 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' OE2' HD21 ' A' ' 93' ' ' LEU . 95.8 mt-10 -135.77 140.77 44.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.636 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.37 125.73 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -110.53 133.18 53.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.33 129.06 55.24 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.591 -0.693 . . . . 0.0 109.454 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.62 128.98 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.493 0.663 . . . . 0.0 109.509 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.39 138.59 57.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.746 -0.596 . . . . 0.0 109.421 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -136.58 145.34 44.84 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.832 0.825 . . . . 0.0 110.233 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 -37.06 93.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.67 -2.59 89.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.98 -110.44 0.46 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -152.58 124.0 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.301 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.9 tp -87.08 128.24 35.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.0 109.412 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.46 128.03 56.13 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.636 0.732 . . . . 0.0 109.88 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -113.79 133.09 55.6 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.6 tt -114.29 126.91 55.56 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.65 0.738 . . . . 0.0 109.738 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 97.6 m -120.67 126.99 51.62 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.469 ' NE2' HD21 ' A' ' 114' ' ' LEU . 5.7 t60 -127.8 127.28 43.25 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -131.4 157.72 42.67 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.584 0.707 . . . . 0.0 109.997 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.28 35.36 5.02 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD21 ' NE2' ' A' ' 111' ' ' HIS . 33.2 mt -114.7 81.22 6.99 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.414 -1.05 . . . . 0.0 109.765 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.53 -9.06 19.91 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.566 2.177 . . . . 0.0 111.338 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 94.3 p -110.74 138.42 47.16 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.638 0.732 . . . . 0.0 109.63 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.49 -34.29 76.84 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.443 0.639 . . . . 0.0 109.507 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.28 -45.79 83.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.434 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.07 -39.18 89.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.56 -46.22 76.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.228 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.99 -41.71 81.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.531 -0.731 . . . . 0.0 109.609 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -69.33 -41.05 79.91 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -43.63 82.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -1.099 . . . . 0.0 109.791 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -47.77 80.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -70.21 -38.31 75.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.523 -0.736 . . . . 0.0 109.641 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.05 -50.08 66.46 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -67.44 -33.09 74.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -1.009 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.17 68.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.63 ' ND1' ' N ' ' A' ' 130' ' ' TYR . 4.8 p80 -73.4 -32.33 64.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 109.519 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.63 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 31.8 t80 -61.64 -48.29 81.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.41 -0.806 . . . . 0.0 109.681 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.6 mt -64.4 -42.09 96.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.362 -0.836 . . . . 0.0 109.294 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.89 -46.8 88.36 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -63.5 -44.11 95.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.32 -1.106 . . . . 0.0 109.79 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.66 -38.57 91.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 0.0 109.526 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 75.7 m -59.75 -43.73 94.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.416 -0.803 . . . . 0.0 109.611 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.47 -45.73 88.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.345 -0.847 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.32 -46.43 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 109.657 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.41 77.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 0.0 109.39 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.32 11.12 1.3 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.464 -0.773 . . . . 0.0 109.395 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.89 -122.38 1.12 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -156.34 109.26 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -1.1 . . . . 0.0 109.103 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 35.0 t0 -169.75 48.21 0.12 Allowed Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 37.8 Cg_endo -65.62 128.19 19.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.48 2.12 . . . . 0.0 112.314 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . 39.61 -164.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 144' ' ' GLY . 50.8 Cg_exo -56.12 -135.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.903 2.402 . . . . 0.0 111.975 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -121.62 55.43 5.55 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.715 -0.616 . . . . 0.0 109.456 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.08 145.4 96.53 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.48 2.12 . . . . 0.0 111.644 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -90.27 77.95 6.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.681 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -156.98 113.11 2.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.42 -0.8 . . . . 0.0 109.261 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -83.16 -168.99 44.09 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -66.21 -92.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.492 -1.004 . . . . 0.0 110.119 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -88.19 9.48 22.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.532 -0.73 . . . . 0.0 109.318 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 153' ' ' LEU . 3.8 mm? -73.05 137.68 45.47 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.507 -0.745 . . . . 0.0 110.177 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -112.05 -123.39 0.28 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -138.64 29.23 2.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.902 . . . . 0.0 108.72 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 156' ' ' HIS . 55.4 p-80 -69.8 70.25 0.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.678 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -67.11 -39.93 86.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.632 -0.668 . . . . 0.0 109.288 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -153.11 160.24 42.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 109.76 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -83.97 128.18 34.37 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.432 -0.793 . . . . 0.0 110.367 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.474 ' ND1' ' OXT' ' A' ' 160' ' ' HIS . 59.3 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.955 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.783 0.801 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -60.35 141.8 55.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.45 -9.47 52.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.349 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.14 142.18 54.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.971 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.0 ptt? -154.86 51.74 0.65 Allowed Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 109.135 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 5' ' ' MET . 47.6 Cg_endo -67.32 150.15 81.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.815 2.343 . . . . 0.0 112.94 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.16 -40.68 86.68 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.783 0.801 . . . . 0.0 109.074 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' C ' ' CG ' ' A' ' 9' ' ' PHE . 18.5 m -154.96 57.32 0.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.226 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' CG ' ' C ' ' A' ' 8' ' ' SER . 3.2 p90 36.75 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.66 0.743 . . . . 0.0 110.387 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.445 HG13 ' OG ' ' A' ' 112' ' ' SER . 55.5 t -126.54 136.6 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -115.51 132.44 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.43 -0.794 . . . . 0.0 109.528 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -129.55 123.2 30.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.77 155.04 37.33 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.124 0.964 . . . . 0.0 109.879 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.15 145.14 39.03 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.748 0.785 . . . . 0.0 109.833 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.78 146.42 23.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 109.296 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.53 118.72 37.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.421 -0.799 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.25 133.31 52.66 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.77 72.51 3.39 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.626 0.726 . . . . 0.0 109.623 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 23' ' ' ALA . . . -174.4 148.34 1.27 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.88 165.51 25.75 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.531 2.154 . . . . 0.0 112.521 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.39 -38.5 63.23 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.182 1.921 . . . . 0.0 111.324 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.27 99.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.517 -0.74 . . . . 0.0 109.301 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . . . -64.39 -49.45 71.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.417 -0.802 . . . . 0.0 109.857 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.28 -44.24 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.19 -0.944 . . . . 0.0 109.626 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.65 -45.0 95.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.141 -0.974 . . . . 0.0 109.653 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OD2' ' A' ' 30' ' ' ASP . . . -59.24 -47.29 85.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.374 -0.828 . . . . 0.0 109.868 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 11.7 mt -63.95 -39.95 95.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -77.16 -7.14 55.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.539 -0.725 . . . . 0.0 109.112 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 23.9 m -122.36 83.27 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.963 0.887 . . . . 0.0 108.682 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 0.8 OUTLIER 161.5 119.94 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.85 -35.87 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.991 1.794 . . . . 0.0 111.882 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.59 -43.61 69.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.792 . . . . 0.0 110.128 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -65.87 -42.42 90.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.018 -1.051 . . . . 0.0 109.99 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 36' ' ' ARG . 90.3 mt -63.93 -42.52 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 109.328 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.85 -5.54 0.98 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.36 -0.837 . . . . 0.0 109.546 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.522 HH21 ' CG1' ' A' ' 137' ' ' VAL . 61.1 ttp180 -68.21 -43.75 77.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.231 -0.918 . . . . 0.0 110.337 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.524 ' CH2' ' SD ' ' A' ' 38' ' ' MET . 27.4 p-90 -104.11 8.2 36.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.206 -0.934 . . . . 0.0 109.77 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.524 ' SD ' ' CH2' ' A' ' 37' ' ' TRP . 7.5 ptm -157.98 84.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.914 -1.116 . . . . 0.0 109.069 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.11 89.22 1.61 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 41' ' ' GLU . 7.4 m -156.45 51.86 0.52 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 108.35 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' THR . 82.7 tt0 53.84 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.624 0.726 . . . . 0.0 110.194 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.062 -1.024 . . . . 0.0 110.334 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -150.71 112.7 4.55 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.65 -86.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 108.968 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 47' ' ' GLU . 70.6 mt-10 -157.3 76.08 4.08 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.7 18.44 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.248 1.965 . . . . 0.0 110.591 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 45' ' ' GLU . 1.3 pp20? -174.93 150.54 1.31 Allowed Pre-proline 0 C--N 1.302 -1.464 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.81 135.6 28.39 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.357 2.038 . . . . 0.0 113.153 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.59 17.46 79.89 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.59 145.91 47.78 Favored Glycine 0 N--CA 1.494 2.525 0 O-C-N 121.347 -1.09 . . . . 0.0 110.536 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -103.76 147.69 26.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.355 -1.085 . . . . 0.0 110.039 -179.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -82.16 128.26 33.97 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.823 0.82 . . . . 0.0 110.5 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.5 tp -157.79 120.7 3.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.48 -0.762 . . . . 0.0 108.994 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 54' ' ' VAL . 25.6 m -133.09 129.31 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.374 -0.829 . . . . 0.0 109.822 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' VAL . 28.9 t-20 36.77 -103.28 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 110.776 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 5.3 p -42.71 144.85 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.898 0.856 . . . . 0.0 110.492 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.6 t -143.49 158.1 43.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.774 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.95 136.47 3.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 50.44 -143.75 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.682 -0.893 . . . . 0.0 110.332 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 20.9 tpt85 -128.23 131.21 48.81 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.739 0.78 . . . . 0.0 109.768 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 62' ' ' ALA . 69.5 m-85 -81.18 -6.29 58.68 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.721 0.772 . . . . 0.0 109.413 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' H ' ' HG3' ' A' ' 60' ' ' ARG . . . -59.91 -148.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.13 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 62' ' ' ALA . 95.3 mtt-85 55.81 158.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.01 0.909 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 71.12 -176.95 36.46 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.7 p -156.85 164.01 38.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.457 -1.025 . . . . 0.0 109.614 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -65.57 151.42 46.5 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.57 -0.706 . . . . 0.0 110.106 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -102.36 -27.75 12.64 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -158.18 137.16 11.45 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -143.65 109.54 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.126 -0.984 . . . . 0.0 109.23 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.25 131.48 11.19 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' O ' ' C ' ' A' ' 72' ' ' VAL . 60.6 Cg_endo -73.06 159.16 48.31 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.444 2.096 . . . . 0.0 113.175 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.0 m 29.88 40.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 121.811 0.815 . . . . 0.0 110.991 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 71' ' ' PRO . 86.4 t60 -151.27 -81.75 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.41 -0.806 . . . . 0.0 109.576 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -146.1 140.82 26.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.939 . . . . 0.0 109.716 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -139.8 133.04 29.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 109.367 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.5 117.94 6.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 109.058 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.639 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 1.7 t80 -118.61 129.41 55.3 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.536 0.684 . . . . 0.0 109.366 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.5 t -101.19 132.68 46.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.0 109.493 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.639 ' CZ ' ' CD1' ' A' ' 77' ' ' TYR . 50.0 m-85 -131.23 152.36 50.57 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.916 0.865 . . . . 0.0 109.749 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 75.69 -117.98 5.33 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.407 ' HE1' ' HB2' ' A' ' 93' ' ' LEU . 98.2 m95 46.94 17.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -1.033 . . . . 0.0 109.305 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 80' ' ' GLY . 63.3 t0 -65.17 -38.3 90.09 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.91 . . . . 0.0 109.296 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.82 -30.73 8.83 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 m -105.19 -52.76 2.78 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -1.028 . . . . 0.0 109.73 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.63 125.56 28.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.111 -0.993 . . . . 0.0 110.15 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -48.71 176.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.771 0.796 . . . . 0.0 110.608 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.55 79.11 72.84 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 109.598 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 40.5 Cg_exo -55.54 -174.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.395 2.063 . . . . 0.0 111.014 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 88' ' ' PRO . 34.8 Cg_exo -60.13 143.19 99.55 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.637 2.225 . . . . 0.0 113.072 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.11 -23.67 1.77 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 89' ' ' PRO . 19.3 m -85.61 100.43 11.95 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.205 -1.174 . . . . 0.0 110.216 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 93' ' ' LEU . 8.0 p -175.25 -140.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 92' ' ' SER . 53.1 tp -109.92 120.9 43.93 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.555 -0.716 . . . . 0.0 109.558 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.7 t -117.69 131.56 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.485 -0.759 . . . . 0.0 110.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -132.02 136.34 47.18 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.1 mt -128.69 128.32 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.472 -0.768 . . . . 0.0 109.638 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -126.76 135.85 51.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.529 -0.732 . . . . 0.0 109.036 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.8 mt -107.7 126.73 52.95 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.36 -0.837 . . . . 0.0 109.474 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.5 mt -129.86 130.41 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.568 -0.707 . . . . 0.0 109.859 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -77.51 123.28 26.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.578 -0.702 . . . . 0.0 109.806 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -167.54 148.45 5.43 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.367 -0.833 . . . . 0.0 109.781 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 104' ' ' GLY . . . 74.18 17.83 79.65 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.27 -22.25 2.09 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 102' ' ' GLY . . . -97.45 -118.67 3.77 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -153.08 122.94 6.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -1.189 . . . . 0.0 109.658 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.6 tp -91.19 128.28 36.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 108.992 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.4 tt -112.45 126.84 55.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.567 -0.708 . . . . 0.0 109.52 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -113.21 125.26 54.13 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.587 0.708 . . . . 0.0 109.541 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.1 tt -120.07 127.8 52.9 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 98.6 m -122.79 126.57 47.71 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.525 -0.735 . . . . 0.0 109.857 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.481 ' NE2' ' OG ' ' A' ' 92' ' ' SER . 2.8 t60 -117.61 115.98 26.18 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.445 ' OG ' HG13 ' A' ' 10' ' ' VAL . 68.4 m -133.76 158.48 43.23 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.686 0.755 . . . . 0.0 109.613 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.68 35.32 6.91 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 48.0 mt -94.74 149.43 36.41 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.224 -1.162 . . . . 0.0 109.972 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -45.78 -51.2 8.57 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.623 2.215 . . . . 0.0 112.86 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.3 m -158.05 168.11 28.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.038 -1.039 . . . . 0.0 109.989 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.87 67.12 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.815 0.816 . . . . 0.0 109.579 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -53.04 62.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -0.914 . . . . 0.0 109.865 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -67.66 -35.92 79.76 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 121' ' ' ALA . 0.7 OUTLIER -62.4 -41.89 99.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 109.212 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 120' ' ' CYS . . . -57.91 -49.23 77.43 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.907 0.86 . . . . 0.0 109.427 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.85 -35.6 92.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.702 ' CD2' ' HE1' ' A' ' 127' ' ' TRP . 1.3 t60 -67.34 -39.57 85.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -1.058 . . . . 0.0 109.402 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.39 -44.23 75.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.11 -0.994 . . . . 0.0 109.016 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.8 -41.61 97.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 109.062 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.35 -42.27 99.22 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.702 ' HE1' ' CD2' ' A' ' 123' ' ' HIS . 59.0 m95 -61.4 -37.37 83.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.09 . . . . 0.0 109.523 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.22 91.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.698 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -66.37 -48.15 71.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.899 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -63.9 -45.94 87.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.323 -0.86 . . . . 0.0 110.063 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.45 -42.59 98.66 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.221 -0.925 . . . . 0.0 109.683 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -66.74 -47.02 70.12 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -69.64 -40.77 76.32 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.251 -1.146 . . . . 0.0 110.178 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.42 -39.54 93.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.314 -0.866 . . . . 0.0 109.962 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.4 m -60.5 -43.81 96.65 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.145 -0.972 . . . . 0.0 109.914 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -64.4 -34.92 79.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.522 ' CG1' HH21 ' A' ' 36' ' ' ARG . 72.9 t -63.76 -44.03 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.019 -1.051 . . . . 0.0 109.585 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.02 -34.52 71.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.135 -0.978 . . . . 0.0 109.552 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.39 -5.79 57.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 108.968 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 141' ' ' ARG . . . 96.94 147.9 23.34 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.782 ' HE ' ' H ' ' A' ' 142' ' ' ASP . 8.2 tpm_? 59.61 139.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.809 -0.819 . . . . 0.0 110.422 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.782 ' H ' ' HE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER 160.68 -39.02 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' ASP . 36.0 Cg_exo -57.78 142.9 96.3 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.14 1.893 . . . . 0.0 112.451 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 154.36 -69.77 0.29 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.51 152.06 65.19 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.375 2.05 . . . . 0.0 112.699 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 20.0 p-10 -159.33 54.43 0.66 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.285 -0.884 . . . . 0.0 109.725 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 41.5 Cg_endo -67.05 150.61 82.57 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.963 2.442 . . . . 0.0 112.318 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -74.98 135.49 41.33 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 122.001 0.905 . . . . 0.0 110.199 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -62.98 -45.4 92.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.726 0.774 . . . . 0.0 109.831 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 151' ' ' ARG . . . -62.17 148.71 48.28 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 150' ' ' GLY . 88.2 mtm180 51.4 171.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.649 -0.912 . . . . 0.0 110.335 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -138.64 144.22 39.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 109.633 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.25 78.12 1.09 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 58.6 mp0 -119.31 122.81 42.71 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.347 -0.846 . . . . 0.0 109.577 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -145.87 133.7 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.48 -0.763 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 157' ' ' HIS . 8.1 t60 -66.54 -42.83 86.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.642 0.734 . . . . 0.0 109.675 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.527 ' CD2' ' CD2' ' A' ' 156' ' ' HIS . 93.8 m-70 -148.7 -59.39 0.23 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.189 -0.945 . . . . 0.0 109.205 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -111.66 130.38 55.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.828 0.823 . . . . 0.0 110.297 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.37 -42.87 87.38 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.9 0.857 . . . . 0.0 109.621 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.5 t60 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.683 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.614 0.721 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -66.56 139.31 57.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.77 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -92.81 -9.03 41.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.54 -0.725 . . . . 0.0 109.25 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 43.5 65.27 1.02 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.915 0.864 . . . . 0.0 109.353 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.1 ttt -89.69 131.48 39.65 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.524 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.91 148.5 64.23 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.066 1.844 . . . . 0.0 112.518 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 9' ' ' PHE . 6.4 pt-20 -162.95 123.91 2.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.918 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m 58.38 -0.68 0.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.513 -0.742 . . . . 0.0 110.103 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 7' ' ' GLU . 65.5 m-85 -99.76 7.66 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 108.648 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.77 134.31 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.508 -0.745 . . . . 0.0 109.138 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.9 t -116.27 132.45 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-O 121.53 0.681 . . . . 0.0 109.296 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -124.82 136.41 53.8 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.7 mmp_? -134.17 149.38 51.03 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.591 0.71 . . . . 0.0 109.326 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -139.88 151.73 45.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.658 0.742 . . . . 0.0 109.788 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -154.04 148.93 26.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.268 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -97.6 122.64 40.9 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.233 -0.917 . . . . 0.0 109.422 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -116.39 126.43 53.45 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.746 0.784 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.62 76.22 8.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.759 0.79 . . . . 0.0 109.398 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -176.8 153.82 1.16 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.427 -0.795 . . . . 0.0 108.906 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.5 162.51 30.6 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.691 2.261 . . . . 0.0 111.763 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.89 -26.68 51.65 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.464 2.11 . . . . 0.0 110.935 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.95 88.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.0 81.31 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.83 -45.13 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.224 -0.923 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -61.73 -44.62 96.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.551 -0.718 . . . . 0.0 110.001 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.28 97.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.819 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.84 -42.81 97.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 110.523 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.1 mtp -69.24 -36.29 77.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 110.724 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 71.3 m -102.11 97.08 7.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.121 -0.987 . . . . 0.0 110.173 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.7 OUTLIER 166.63 148.84 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -59.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.696 2.264 . . . . 0.0 113.079 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -66.95 -36.22 81.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 110.545 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -62.82 -43.31 99.13 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.934 -1.104 . . . . 0.0 110.304 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HA ' ' HE1' ' A' ' 37' ' ' TRP . 93.9 mt -66.33 -44.45 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.764 -1.21 . . . . 0.0 109.872 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' CD2' ' O ' ' A' ' 39' ' ' GLY . 90.8 mt -71.4 -2.87 18.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 109.679 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -66.91 -40.18 87.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.306 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CG ' ' N ' ' A' ' 38' ' ' MET . 8.9 p-90 -110.31 -65.39 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.365 -0.835 . . . . 0.0 109.607 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.576 ' SD ' ' CE1' ' A' ' 130' ' ' TYR . 23.1 ttt -142.1 154.55 45.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.827 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' O ' ' CD2' ' A' ' 35' ' ' LEU . . . 139.18 127.19 2.43 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.0 p -98.04 -17.58 19.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -1.21 . . . . 0.0 108.922 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' OE2' ' NH2' ' A' ' 60' ' ' ARG . 97.0 mt-10 -145.76 146.03 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.988 -1.07 . . . . 0.0 110.013 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.18 113.89 1.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.354 -0.841 . . . . 0.0 109.21 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 54' ' ' VAL . 27.9 tp10 -85.97 160.66 19.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.759 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.3 p -123.89 132.56 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.724 0.774 . . . . 0.0 109.53 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -176.71 148.75 0.83 Allowed Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' GLY . 37.4 Cg_endo -65.39 152.17 82.81 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -40.5 -62.24 1.0 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.638 -0.664 . . . . 0.0 110.049 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 47' ' ' GLU . 29.1 Cg_endo -62.33 -18.92 65.31 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.135 1.89 . . . . 0.0 110.883 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 46' ' ' PRO . . . -42.16 -78.03 0.07 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 176.7 -26.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt 47.05 85.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.559 -0.965 . . . . 0.0 109.563 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.75 -119.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.673 -0.642 . . . . 0.0 110.327 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.98 132.29 54.08 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.53 0.681 . . . . 0.0 109.982 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.64 HG12 ' H ' ' A' ' 43' ' ' GLU . 31.6 m -132.34 145.56 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.567 -0.708 . . . . 0.0 109.996 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.75 129.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 122.048 0.928 . . . . 0.0 111.287 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 57' ' ' THR . 18.8 m -65.62 -39.03 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.538 -0.726 . . . . 0.0 110.427 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.424 ' N ' HG23 ' A' ' 56' ' ' VAL . 20.9 p 49.92 16.02 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.027 -1.046 . . . . 0.0 109.909 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 56' ' ' VAL . . . 152.19 -64.2 0.37 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.81 141.76 5.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -1.131 . . . . 0.0 109.818 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' NH2' ' OE2' ' A' ' 41' ' ' GLU . 42.4 ttm180 -71.17 135.62 47.68 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.585 0.707 . . . . 0.0 110.415 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -99.92 -102.93 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.451 -0.78 . . . . 0.0 109.891 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -169.68 -18.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.919 . . . . 0.0 109.318 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -140.78 151.11 44.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.981 -1.074 . . . . 0.0 109.985 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.66 124.96 0.99 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 18.2 m -140.46 26.58 2.14 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . 53.7 m-85 56.79 151.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.355 1.074 . . . . 0.0 111.439 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -80.76 -74.84 0.3 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.914 0.864 . . . . 0.0 108.92 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -146.17 142.49 28.49 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.4 t -135.25 131.25 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 11.8 t -126.82 115.34 22.39 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 72' ' ' VAL . 57.0 Cg_exo -47.89 136.93 22.55 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.311 2.007 . . . . 0.0 112.855 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 73' ' ' HIS . 12.4 m 33.13 59.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.676 0.751 . . . . 0.0 110.644 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 72' ' ' VAL . 45.0 m-70 -163.05 -98.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -0.776 . . . . 0.0 110.02 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 72.8 ttp85 -138.04 139.07 39.41 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.963 0.887 . . . . 0.0 110.823 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.64 149.73 39.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.06 147.09 50.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.592 -0.692 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.431 ' CE2' ' O ' ' A' ' 78' ' ' SER . 91.1 t80 -125.46 127.09 45.96 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.623 0.725 . . . . 0.0 109.682 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' O ' ' CE2' ' A' ' 77' ' ' TYR . 17.0 p -76.89 162.51 27.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 110.017 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -147.6 136.9 22.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 82' ' ' ASP . . . 80.36 -101.82 2.02 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 26.2 t90 50.75 -88.5 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.551 -0.97 . . . . 0.0 110.364 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 80' ' ' GLY . 48.6 p-10 -69.33 140.2 54.3 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.241 -0.912 . . . . 0.0 110.946 -179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.19 43.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.1 p 63.16 178.9 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.933 0.873 . . . . 0.0 110.334 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -141.73 -54.37 0.45 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.679 0.752 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 87' ' ' VAL . 8.3 m -90.79 3.19 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.434 -0.791 . . . . 0.0 109.56 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 HG23 ' A' ' 86' ' ' VAL . 22.1 t -130.15 78.28 74.92 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.169 -0.957 . . . . 0.0 109.802 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . 27.1 Cg_exo -59.69 -173.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.689 2.26 . . . . 0.0 111.603 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.582 ' O ' ' N ' ' A' ' 91' ' ' SER . 40.3 Cg_exo -58.65 140.31 94.36 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.916 2.411 . . . . 0.0 113.664 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 41.62 17.3 0.02 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 89' ' ' PRO . 93.7 p -74.49 -15.44 60.88 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.094 -1.239 . . . . 0.0 108.654 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.5 p -148.06 155.7 41.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 110.11 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.1 tp -161.04 129.14 4.38 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' CD2' ' A' ' 111' ' ' HIS . 16.7 t -101.0 133.88 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.528 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -126.76 137.63 53.25 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.599 0.714 . . . . 0.0 110.004 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.94 129.56 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -126.63 141.07 51.97 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.383 -0.823 . . . . 0.0 110.04 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.61 125.63 51.21 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.7 129.59 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.818 0.818 . . . . 0.0 110.051 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -70.57 126.41 29.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.568 0.699 . . . . 0.0 109.805 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -171.63 141.39 1.46 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.485 -0.76 . . . . 0.0 109.824 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.57 10.86 84.74 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.78 4.2 87.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -125.74 -115.75 2.05 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.7 m -155.47 114.68 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.132 -1.217 . . . . 0.0 109.668 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.8 tp -87.05 130.57 34.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.497 0.665 . . . . 0.0 109.421 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.56 125.39 51.78 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.538 0.685 . . . . 0.0 109.691 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -111.78 126.03 54.63 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 109' ' ' LEU . 6.9 tt -117.1 121.35 41.04 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.541 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.4 m -119.55 127.67 53.21 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.19 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.48 ' CE1' HD21 ' A' ' 114' ' ' LEU . 12.2 t-80 -123.5 131.85 53.75 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.7 t -125.54 150.25 47.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.512 -0.743 . . . . 0.0 109.851 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.14 71.06 1.21 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 111' ' ' HIS . 37.1 mt -131.64 68.22 80.65 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.366 -1.079 . . . . 0.0 109.226 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.31 -9.31 21.65 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.859 2.373 . . . . 0.0 111.712 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.1 m -110.24 126.47 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 109.498 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.94 -37.5 87.85 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.617 0.722 . . . . 0.0 109.89 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.54 -43.26 94.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.138 -0.976 . . . . 0.0 109.65 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.454 HE21 ' CD2' ' A' ' 123' ' ' HIS . 68.2 tp60 -67.79 -39.25 84.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -0.979 . . . . 0.0 109.613 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 6.7 t -64.89 -42.68 94.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.226 -0.921 . . . . 0.0 109.75 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.5 -39.35 94.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.13 93.34 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.454 ' CD2' HE21 ' A' ' 119' ' ' GLN . 35.1 m170 -66.11 -45.63 80.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.228 -1.16 . . . . 0.0 110.172 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.93 -47.28 87.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.342 -0.849 . . . . 0.0 110.053 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.5 -38.67 74.35 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.094 -1.004 . . . . 0.0 109.913 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.65 -51.65 40.02 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -67.11 -39.35 86.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.353 -1.087 . . . . 0.0 110.046 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.51 -48.83 79.52 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -68.34 -44.0 76.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.848 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.576 ' CE1' ' SD ' ' A' ' 38' ' ' MET . 3.9 m-85 -61.73 -46.63 88.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.328 -0.857 . . . . 0.0 110.201 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 72.2 mt -63.1 -40.97 99.2 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.324 -0.86 . . . . 0.0 109.687 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.66 -38.77 96.74 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CZ ' ' O ' ' A' ' 143' ' ' PRO . 16.0 mmm180 -65.77 -41.4 92.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.0 109.8 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.8 tp -65.87 -39.75 90.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 109.943 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.4 m -61.48 -44.54 96.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.245 -0.909 . . . . 0.0 109.871 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.33 -46.76 88.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.68 -43.58 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.187 -0.945 . . . . 0.0 109.437 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.81 -35.46 80.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.442 -0.786 . . . . 0.0 109.322 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.97 1.57 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.68 -109.69 0.42 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -144.07 107.35 4.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -1.1 . . . . 0.0 109.395 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -165.81 68.91 1.2 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.56 -0.713 . . . . 0.0 109.079 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' O ' ' CZ ' ' A' ' 133' ' ' ARG . 31.2 Cg_exo -56.91 -30.28 85.27 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.646 2.23 . . . . 0.0 110.405 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.74 172.04 24.66 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.95 144.88 78.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.892 2.395 . . . . 0.0 112.351 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 4.1 p30 -158.37 54.97 0.79 Allowed Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.508 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 25.3 Cg_endo -61.69 106.57 0.44 Allowed 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.533 2.155 . . . . 0.0 111.409 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.5 ' O ' ' N ' ' A' ' 150' ' ' GLY . 76.0 m-85 -84.0 144.57 29.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.262 -0.899 . . . . 0.0 110.05 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -54.23 88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.822 0.82 . . . . 0.0 109.803 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 148' ' ' PHE . . . -67.6 110.59 3.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.412 HH21 ' CD1' ' A' ' 153' ' ' LEU . 16.7 ptm180 -84.49 132.54 34.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.459 -1.024 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -69.87 -35.32 74.57 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.851 0.834 . . . . 0.0 109.711 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 154' ' ' GLU . 5.8 tp 47.25 -131.08 1.41 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.713 0.768 . . . . 0.0 110.376 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 153' ' ' LEU . 97.5 mt-10 41.5 -168.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.015 0.912 . . . . 0.0 110.877 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.49 151.24 32.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.656 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.6 t60 41.54 47.87 3.36 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.899 0.857 . . . . 0.0 109.758 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.44 -44.1 97.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.54 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 86.2 t60 -164.12 77.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.459 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.45 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 77.9 m80 54.99 84.82 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.889 0.852 . . . . 0.0 110.611 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 158' ' ' HIS . 97.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.883 -1.056 . . . . 0.0 109.036 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 56.62 27.04 11.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.14 131.06 45.29 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.742 0.782 . . . . 0.0 110.213 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.8 109.41 22.17 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.755 0.788 . . . . 0.0 109.82 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.1 tpt -172.1 73.0 0.47 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.12 141.14 96.26 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.761 2.308 . . . . 0.0 112.349 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' CB ' HG21 ' A' ' 10' ' ' VAL . 97.5 mt-10 -88.43 156.21 19.26 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.725 0.774 . . . . 0.0 110.055 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 9' ' ' PHE . 8.5 p -74.26 130.82 40.46 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.387 0.613 . . . . 0.0 110.342 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 5.2 p90 28.55 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.444 0.64 . . . . 0.0 110.723 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 8' ' ' SER . 64.8 t -134.99 136.65 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.46 0.647 . . . . 0.0 109.48 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.54 HG11 ' NH2' ' A' ' 13' ' ' ARG . 53.3 t -112.68 132.86 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.849 0.833 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -121.0 141.07 51.07 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.607 0.717 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' NH2' HG11 ' A' ' 11' ' ' VAL . 77.6 mtt85 -136.61 154.16 50.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.673 0.749 . . . . 0.0 109.345 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 57.2 mp0 -142.13 142.77 32.78 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.727 0.775 . . . . 0.0 109.635 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.86 141.41 25.45 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.793 0.806 . . . . 0.0 110.706 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.685 ' H ' ' CD2' ' A' ' 16' ' ' HIS . 4.6 p80 -100.33 117.68 35.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.524 -0.735 . . . . 0.0 109.653 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.2 mp -106.77 127.87 53.76 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.98 0.895 . . . . 0.0 109.744 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.44 76.31 7.49 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.588 0.709 . . . . 0.0 109.908 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.82 145.18 1.1 Allowed Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -41.41 157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.652 2.235 . . . . 0.0 112.14 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -66.75 -33.3 35.05 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.294 1.996 . . . . 0.0 111.587 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.19 -37.21 75.07 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.612 0.72 . . . . 0.0 109.189 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.91 75.85 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.47 0.652 . . . . 0.0 109.287 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.17 -44.66 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.75 . . . . 0.0 109.33 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.87 -45.17 95.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.448 -0.783 . . . . 0.0 109.681 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.28 -44.51 84.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.655 -0.653 . . . . 0.0 109.418 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.9 mt -65.09 -41.29 95.11 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.595 0.712 . . . . 0.0 109.452 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.4 mmm -72.29 -8.59 55.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.763 -0.586 . . . . 0.0 109.579 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -117.99 4.16 12.11 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -115.78 93.71 38.46 Favored Pre-proline 0 N--CA 1.503 2.203 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HB2' HG11 ' A' ' 44' ' ' VAL . 76.7 Cg_exo -51.41 -38.63 63.69 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.745 2.296 . . . . 0.0 112.563 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -64.11 -45.55 88.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 110.777 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -67.9 -34.84 77.42 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.863 . . . . 0.0 109.76 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -63.11 -42.96 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.683 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.4 mt -63.28 -10.18 14.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.605 -0.684 . . . . 0.0 110.023 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.0 -43.58 71.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.419 -0.801 . . . . 0.0 109.499 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 52.5 p-90 -109.84 -18.41 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.8 ttp -129.24 74.76 1.6 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.66 68.4 0.41 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 p -92.57 -88.43 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.487 -1.007 . . . . 0.0 109.716 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -169.73 138.62 1.87 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.762 0.791 . . . . 0.0 110.633 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -173.06 153.79 2.62 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.486 0.66 . . . . 0.0 109.849 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 44' ' ' VAL . 46.4 tp10 -92.57 98.83 11.69 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.543 0.687 . . . . 0.0 110.075 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 43' ' ' GLU . 2.3 m -161.87 24.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.722 -0.611 . . . . 0.0 109.695 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -142.35 69.9 21.83 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.188 -0.945 . . . . 0.0 109.664 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 -37.35 79.42 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.701 2.267 . . . . 0.0 111.441 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -46.27 150.39 1.13 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.91 -0.493 . . . . 0.0 109.841 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.4 -18.27 38.77 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.858 2.372 . . . . 0.0 111.893 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.82 95.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 52' ' ' TYR . . . -97.69 -101.17 2.11 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 52' ' ' TYR . 5.5 tp 51.44 7.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.899 -0.765 . . . . 0.0 109.748 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 6.3 p90 -59.7 -144.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.738 0.78 . . . . 0.0 109.968 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 52' ' ' TYR . 3.6 mm? -68.77 136.64 53.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.393 -0.817 . . . . 0.0 109.784 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.19 163.04 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 121.764 0.792 . . . . 0.0 109.716 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -69.6 78.93 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.781 0.8 . . . . 0.0 110.192 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 57' ' ' THR . 13.4 p -65.13 -32.02 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.658 -0.651 . . . . 0.0 109.397 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER 74.45 69.1 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.858 0.837 . . . . 0.0 109.717 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.48 158.44 19.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 44.8 -158.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.85 0.833 . . . . 0.0 110.858 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' C ' ' N ' ' A' ' 62' ' ' ALA . 85.5 mtp180 -72.8 -167.98 0.42 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.56 0.695 . . . . 0.0 109.901 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 49.75 16.87 0.23 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 60' ' ' ARG . . . -102.71 95.68 6.36 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.53 -0.731 . . . . 0.0 109.284 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -110.01 -29.56 8.18 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.18 147.01 42.04 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.6 t -157.61 176.12 13.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.655 -0.909 . . . . 0.0 109.839 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -151.06 59.36 0.91 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.01 -46.17 88.88 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.786 -1.196 . . . . 0.0 109.434 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -164.98 140.7 5.49 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.788 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.52 129.85 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.489 0.661 . . . . 0.0 109.244 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' H ' ' A' ' 74' ' ' ARG . 3.3 t -130.07 123.36 20.76 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 72' ' ' VAL . 73.9 Cg_exo -47.47 136.91 20.05 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.436 2.091 . . . . 0.0 112.289 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 71' ' ' PRO . 27.7 m 13.4 62.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-O 122.035 0.922 . . . . 0.0 111.064 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' PRO . 1.7 t60 -155.35 -79.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.961 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 89.4 mtm180 -131.77 150.86 52.02 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.186 0.993 . . . . 0.0 110.962 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 77' ' ' TYR . 55.3 tp -140.73 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.55 140.03 25.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 109.674 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 75' ' ' LEU . 44.8 m-85 -122.37 153.82 38.5 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.776 0.798 . . . . 0.0 110.143 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.3 p -93.08 6.47 47.85 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' CG ' ' N ' ' A' ' 80' ' ' GLY . 62.0 t80 56.74 -105.61 0.28 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.596 0.712 . . . . 0.0 110.262 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.533 ' N ' ' CG ' ' A' ' 79' ' ' PHE . . . -88.53 -74.98 1.29 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 74.1 t90 60.52 0.82 0.35 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.979 -0.718 . . . . 0.0 109.777 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 83' ' ' GLY . 47.9 p-10 -66.88 -33.99 76.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.476 -0.765 . . . . 0.0 109.771 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 82' ' ' ASP . . . 80.06 21.05 66.22 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -59.32 -80.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.241 -1.152 . . . . 0.0 109.928 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -79.08 -81.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -140.66 76.2 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.332 -0.855 . . . . 0.0 109.155 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 5.4 t -144.4 54.95 2.98 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.495 -0.753 . . . . 0.0 109.471 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 87' ' ' VAL . 18.8 Cg_endo -58.19 166.01 6.36 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.724 2.282 . . . . 0.0 111.646 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.35 131.24 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.212 1.941 . . . . 0.0 112.66 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.94 -24.86 26.57 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 t -74.55 151.85 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.46 -1.024 . . . . 0.0 110.493 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 113' ' ' GLY . 22.2 p 46.65 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.739 0.781 . . . . 0.0 110.674 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.1 tp -123.4 128.91 50.53 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.639 0.733 . . . . 0.0 109.623 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.6 131.19 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.732 0.777 . . . . 0.0 109.691 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -126.28 127.4 45.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.89 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 109.53 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 65.9 t0 -129.47 135.25 48.41 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.856 0.836 . . . . 0.0 109.791 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 52.2 mt -100.98 128.11 47.17 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.47 0.652 . . . . 0.0 109.312 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.3 mt -127.82 129.4 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.762 0.792 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.84 146.49 49.64 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.75 0.786 . . . . 0.0 109.954 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -147.24 -15.14 0.4 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' A' ' 104' ' ' GLY . . . 98.81 158.74 29.54 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 44.71 15.08 0.05 OUTLIER Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 102' ' ' GLY . . . 160.52 -178.7 36.43 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.4 m -128.43 129.73 46.58 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.968 0.889 . . . . 0.0 109.487 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 60.7 tp -83.84 130.01 34.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.777 0.799 . . . . 0.0 109.915 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 tt -111.17 125.84 54.22 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.84 0.829 . . . . 0.0 109.975 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -109.2 132.97 53.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 109' ' ' LEU . 7.3 tt -128.84 123.59 33.14 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.734 0.778 . . . . 0.0 109.851 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 109' ' ' LEU . 99.9 m -124.02 127.58 48.1 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -124.2 121.8 36.06 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.677 0.751 . . . . 0.0 109.422 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.426 ' CB ' HG22 ' A' ' 10' ' ' VAL . 48.4 t -141.43 146.78 36.97 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.74 0.781 . . . . 0.0 109.55 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 92' ' ' SER . . . 98.56 47.8 1.91 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 34.7 mt -83.05 146.79 52.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.995 . . . . 0.0 109.618 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' CG ' ' OE1' ' A' ' 119' ' ' GLN . 39.5 Cg_endo -67.18 -29.27 39.59 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.651 2.234 . . . . 0.0 111.123 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 t -161.66 161.23 29.46 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.646 0.736 . . . . 0.0 109.643 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.28 78.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.501 0.667 . . . . 0.0 109.508 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.06 -45.09 67.95 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.39 0.614 . . . . 0.0 109.852 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.677 HE21 ' CE1' ' A' ' 123' ' ' HIS . 54.1 tt0 -65.61 -30.85 71.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.496 -0.752 . . . . 0.0 109.412 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.421 ' SG ' ' CD1' ' A' ' 114' ' ' LEU . 1.1 t -59.61 -45.3 92.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.449 -0.782 . . . . 0.0 109.624 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 -45.36 84.23 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.491 0.662 . . . . 0.0 109.872 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.53 -37.91 92.97 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.677 ' CE1' HE21 ' A' ' 119' ' ' GLN . 3.3 m80 -66.67 -41.03 88.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.448 -1.031 . . . . 0.0 109.273 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -58.75 -47.13 85.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.679 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.34 -37.63 74.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.544 -0.722 . . . . 0.0 109.552 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.48 -51.01 45.69 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.83 -37.42 87.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -1.004 . . . . 0.0 109.999 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.72 -49.07 78.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.463 -0.773 . . . . 0.0 109.642 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -67.5 -45.65 75.18 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.615 0.721 . . . . 0.0 109.883 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -61.21 -46.72 89.28 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.633 -0.667 . . . . 0.0 109.915 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.94 -41.16 97.7 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.425 0.631 . . . . 0.0 109.769 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.5 -43.66 99.02 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.467 ' NH1' ' O ' ' A' ' 37' ' ' TRP . 76.5 ttt180 -66.13 -42.14 89.54 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.666 -0.902 . . . . 0.0 109.769 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.77 -40.06 96.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.422 -0.799 . . . . 0.0 109.487 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 69.2 m -61.06 -43.13 99.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.666 -0.646 . . . . 0.0 109.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' GLY . 96.9 mt-10 -61.08 -40.41 93.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.882 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.9 -45.47 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.372 -0.83 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.48 89.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 110.004 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -90.71 -3.56 57.38 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -146.02 -150.56 5.23 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 142' ' ' ASP . 59.2 ttt85 -173.08 154.99 2.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.828 . . . . 0.0 109.852 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 141' ' ' ARG . 3.9 t70 77.59 58.82 0.21 Allowed Pre-proline 0 N--CA 1.494 1.77 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.231 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 144' ' ' GLY . 43.8 Cg_endo -68.69 152.91 74.14 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.141 1.894 . . . . 0.0 112.351 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 143' ' ' PRO . . . -46.86 176.82 0.01 OUTLIER Glycine 0 N--CA 1.486 1.97 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.22 141.6 76.35 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.295 1.997 . . . . 0.0 112.246 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.721 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 23.1 t70 -129.22 23.72 0.11 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.747 . . . . 0.0 110.997 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.721 ' CD ' ' N ' ' A' ' 146' ' ' ASP . 51.9 Cg_exo -47.65 77.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 111.971 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 149' ' ' TYR . 86.6 t80 48.98 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.971 0.891 . . . . 0.0 111.001 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 47.1 m-85 -64.94 -73.4 0.12 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.518 -0.739 . . . . 0.0 110.016 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 151' ' ' ARG . . . 163.33 164.8 19.25 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 150' ' ' GLY . 6.6 ptp85 31.16 60.29 0.25 Allowed 'General case' 0 N--CA 1.504 2.226 0 CA-C-O 121.543 0.687 . . . . 0.0 110.228 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -70.37 131.47 44.15 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 59.1 tp -132.04 125.64 31.94 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.546 0.689 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -133.35 153.47 51.55 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.778 0.799 . . . . 0.0 110.052 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -69.38 -165.05 0.07 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.604 0.716 . . . . 0.0 110.185 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 158' ' ' HIS . 14.6 p80 -157.53 -169.19 2.8 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.88 0.847 . . . . 0.0 110.183 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 79.8 t60 58.52 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.319 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 156' ' ' HIS . 46.3 p-80 -91.99 127.08 37.32 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.02 0.914 . . . . 0.0 110.214 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.0 m-70 47.93 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.893 0.854 . . . . 0.0 110.496 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 76.1 m80 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.822 -179.503 . . . . . . . . 0 0 . 1 stop_ save_